0001437749-15-019529.txt : 20151104 0001437749-15-019529.hdr.sgml : 20151104 20151104074403 ACCESSION NUMBER: 0001437749-15-019529 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151104 DATE AS OF CHANGE: 20151104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TORVEC INC CENTRAL INDEX KEY: 0001063197 STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLE PARTS & ACCESSORIES [3714] IRS NUMBER: 161509512 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-24455 FILM NUMBER: 151195541 BUSINESS ADDRESS: STREET 1: 1999 MT. READ BLVD. STREET 2: BUILDING #3 CITY: ROCHESTER STATE: NY ZIP: 14615 BUSINESS PHONE: 585-254-1100 MAIL ADDRESS: STREET 1: 1999 MT. READ BLVD. STREET 2: BUILDING #3 CITY: ROCHESTER STATE: NY ZIP: 14615 10-Q 1 tovc20150930_10q.htm FORM 10-Q tovc20150930_10q.htm

 

           UNITED STATES SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549

FORM 10-Q

(Mark One)

 

Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended SEPTEMBER 30, 2015

OR

 

 

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from                      to                     

Commission File No. 000-24455

 

TORVEC, INC.

(Exact name of registrant as specified in its charter)

 

New York
(State or other jurisdiction of incorporation or organization)

 

16-1509512
(I.R.S. Employer Identification No.)

 

1999 Mt. Read Blvd. Building 3, Rochester, New York 14615
(Address of principal executive offices and Zip Code)

 

(585) 254-1100
(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ☐ 

 

Accelerated filer ☐ 

 

Non-accelerated filer ☐

 

Smaller reporting company ☑

 

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

Class

 

Number of Shares Outstanding at November 3, 2015

Common Stock, $0.01 par value

 

45,754,041

 

  

 
 

 

 

TORVEC, INC.

(dba CurAegis Technologies, Inc.)

INDEX

  

 

  

Page

PART I – FINANCIAL INFORMATION

 

 

 

Item 1.

Financial Statements

  

  

  

  

 

Condensed Consolidated Balance Sheets as of September 30, 2015 (unaudited) and December 31, 2014

1

  

  

  

 

Condensed Consolidated Statements of Operations – Three and Nine Month Periods Ended September 30, 2015 and 2014 (unaudited)

2

  

  

  

 

Condensed Consolidated Statements of Cash Flows –Nine Month Periods Ended September 30, 2015 and  2014 (unaudited)

3

  

  

  

 

Notes to Condensed Consolidated Financial Statements

4

  

  

  

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

  

  

  

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

22

  

  

  

Item 4.

Controls and Procedures

22

  

  

  

PART II – OTHER INFORMATION

  

  

  

Item 1.

Legal Proceedings

23

  

  

 

Item 1A.

Risk Factors

23

  

  

  

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

23

  

  

  

Item 3.

Defaults Upon Senior Securities

23

  

  

  

Item 4.

Mine Safety Disclosures

23

  

  

  

Item 5.

Other Information

23

  

  

  

Item 6.

Exhibits

24

  

  

  

SIGNATURE PAGE

26

  

  

  

EXHIBITS

 

  

  

  

 

Exhibit 31.1

  

 

Exhibit 31.2

  

 

Exhibit 32

  

 

 

 

 
 i

 

  

PART I — FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

   

TORVEC, INC.

(dba CurAegis Technologies, Inc.)

Condensed

Consolidated Balance Sheets

 

   

September 30, 2015

(unaudited)

   

December 31,

2014

 
                 

ASSETS

               

Current Assets:

               

Cash and cash equivalents

  $ 1,946,000     $ 3,724,000  

Prepaid expenses and other current assets

    40,000       15,000  
                 

Total current assets

    1,986,000       3,739,000  
                 

Net property and equipment

    458,000       271,000  
                 

Total Assets

  $ 2,444,000     $ 4,010,000  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current Liabilities:

               

Notes payable, current portion

  $ 2,000     $ 6,000  

Accounts payable

    126,000       67,000  

Accrued liabilities

    56,000       41,000  

Total current liabilities

    184,000       114,000  

Notes payable, net of current portion

    7,000       -  

Total Liabilities

    191,000       114,000  
                 

Commitments and other matters (Note H)

               
                 

Stockholders' Equity:

               
Preferred stock, $.01 par value, 100,000,000 shares authorized                

Series C: 16,250,000 Series C voting, convertible, no dividend, shares issued and outstanding at September 30, 2015 and December 31, 2014: 16,250,000, respectively

    162,000       162,000  

Series C-2: 25,000,000 Series C-2 voting, convertible, no dividend, shares issued and outstanding at September 30, 2015 and December 31, 2014: 25,000,000, respectively

    250,000       250,000  

Class A: 3,300,000 Class A non-voting, convertible, cumulative dividend $.40 per share per annum, shares issued and outstanding at September 30, 2015 and December 31, 2014: 565,721 and 587,101, respectively

    6,000       6,000  

Class B: 300,000 Class B non-voting, convertible, cumulative dividend $.50 per share per annum, shares issued and outstanding at September 30, 2015 and December 31, 2014: 67,500, respectively

    1,000       1,000  

Common stock: $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at September 30, 2015 and December 31, 2014: 45,754,041 and 45,716,298, respectively

    457,000       457,000  

Additional paid-in capital

    71,907,000       71,559,000  

Accumulated Deficit

    (70,530,000

)

    (68,539,000

)

                 

Total Stockholders' Equity

    2,253,000       3,896,000  
                 

Total Liabilities and Stockholders' Equity

  $ 2,444,000     $ 4,010,000  

  

See notes to condensed consolidated financial statements. 

 

 
1

 

 

TORVEC, INC.

 (dba CurAegis Technologies, Inc.)

Condensed Consolidated Statements of Operations

(Unaudited)

 

   

Three Months

Ended September 30,

2015

   

Three Months

Ended September 30,

2014

   

Nine Months

Ended September 30,

2015

   

Nine Months

Ended September 30,

2014

 
                                 

Revenue

  $ -     $ -     $ -     $ 50,000  

Cost of Goods Sold

    -       -       -       92,000  
                                 

Gross Margin

    -       -       -       (42,000

)

                                 

Costs and expenses:

                               

Research and development:

                               

R&D costs, excluding stock-based compensation

    369,000       262,000       953,000       922,000  

Stock-based compensation related to options and warrants

    2,000       5,000       7,000       (27,000

)

Total research and development

    371,000       267,000       960,000       895,000  

General and administrative:

                               

G&A costs, excluding stock-based compensation

    283,000       269,000       721,000       876,000  

Stock-based compensation related to options and warrants

    249,000       85,000       342,000       160,000  

Total general and administrative

    532,000       354,000       1,063,000       1,036,000  
                                 

Total costs and expenses

    903,000       621,000       2,023,000       1,931,000  
                                 

Loss from operations

    (903,000

)

    (621,000

)

    (2,023,000

)

    (1,973,000

)

                                 

Other income

    3,000       7,000       31,000       27,000  
                                 

Loss before income tax benefits

    (900,000

)

    (614,000

)

    (1,992,000

)

    (1,946,000

)

                                 

Income tax benefits

    -       -       -       -  
                                 

Net Loss

    (900,000

)

    (614,000

)

    (1,992,000

)

    (1,946,000

)

                                 

Preferred stock beneficial conversion feature

    -       -       -       4,250,000  

Preferred stock dividends

    64,000       66,000       192,000       198,000  
                                 

Net Loss attributable to common stockholders

  $ (964,000

)

  $ (680,000

)

  $ (2,184,000

)

  $ (6,394,000

)

                                 

Net Loss per common share attributable to stockholders

                               

Basic and Diluted

  $ (0.02

)

  $ (0.01

)

  $ (0.05

)

  $ (0.14

)

                                 

Weighted average number of shares of common stock:

                               

Basic and Diluted

    45,754,000       45,716,000       45,754,000       45,716,000  

   

See notes to condensed consolidated financial statements.

  

 

 
2

 

 

TORVEC, INC.

(dba CurAegis Technologies, Inc.)

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   

Nine Months Ended

September 30, 2015

   

Nine Months Ended

September 30, 2014

 
                 

Cash flows from operating activities:

               

Net loss

  $ (1,992,000

)

  $ (1,946,000

)

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    85,000       125,000  

Gain on disposition of fixed assets, net

    (19,000

)

    (12,000

)

Recovery of bad debt

    (20,000

)

    -  

Stock-based compensation related to stock options and warrants

    348,000       133,000  

Changes in:

               

Accounts receivable

    20,000       (20,000

)

Prepaid expenses and other current assets

    (25,000

)

    (26,000

)

Deferred revenue

    -       (20,000

)

Accrued payroll taxes

    -       (5,000

)

Accounts payable and other accrued expenses

    75,000       19,000  
                 

Net cash used in operating activities

    (1,528,000

)

    (1,752,000

)

                 

Cash flows from investing activities:

               

Purchase of property and equipment

    (308,000

)

    (43,000

)

Proceeds from sale of fixed assets

    62,000       70,000  
                 

Net cash (used in) provided by investing activities

    (246,000

)

    27,000  
                 

Cash flows from financing activities:

               

Net proceeds from sales of preferred stock

    -       4,954,000  

Repayments of notes payable

    (4,000

)

    (46,000

)

                 

Net cash (used in) provided by financing activities

    (4,000

)

    4,908,000  
                 

Net (decrease) increase in cash and cash equivalents

    (1,778,000

)

    3,183,000  
                 

Cash and cash equivalents at beginning of period

    3,724,000       1,072,000  
                 

Cash and cash equivalents at end of period

  $ 1,946,000     $ 4,255,000  
                 

Supplemental Disclosures:

               

Interest paid

    -     $ 1,000  

Acquisition of equipment through capital lease

  $ 9,000       -  

Conversion of preferred shares to common

  $ 86,000       -  

Conversion of preferred dividends to common

  $ 65,000       -  

  

See notes to condensed consolidated financial statements.  

 

 
3

 

 

TORVEC, INC.

(dba CurAegis Technologies, Inc.)

  

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE A — THE COMPANY AND BASIS OF PRESENTATION

 

Management announced a name change for the Company during the third quarter of 2015. The company will establish its business around two divisions. The CURA division will oversee the Fatigue Management Consulting business, and the Aegis division that will oversee the Power and Hydraulic business. The new name of the company will be CurAegis Technologies, Inc. This will be used as a DBA until the next shareholders meeting when we will officially change the name.

  

The interim information contained herein with respect to the three and nine month periods ended September 30, 2015 and 2014 have not been audited but has been prepared in conformity with generally accepted accounting principles for interim financial information and instructions for Form 10-Q. Accordingly, the condensed consolidated financial statements do not include all information and footnotes required by generally accepted accounting principles for financial statements. Included are ordinary adjustments which, in the opinion of management, are necessary for a fair presentation of the financial information for the three and nine month periods ended September 30, 2015 and 2014. The results are not necessarily indicative of results to be expected for the entire year.

 

The Company was incorporated as a New York business corporation on September 25, 1996. The Company develops and markets advanced technologies in the areas of power, safety and wellness.  Currently, the Company is focusing its commercialization strategies on the following technologies: (i) the CURA system which encompasses a wearable device, the MyCadian™ Watch which measures degradation of alertness and sleep attributes and the Z Coach education and training tool (ii) the Hydraulic Pump. The MyCadian™ Watch consists of hardware and software that measures multiple metrics in order to establish that a person's ability to perform a task or job appears to be degrading. The Hydraulic Pump is an innovative hydraulic design, whose goal is to deliver better efficiencies in a package that is smaller and lighter than existing technologies.  The Company has not yet had any significant revenue-producing operations.

  

As used in this quarterly report, unless otherwise indicated, the terms “we”, “our”, “us”, “the Company” and “CurAegis” refer to Torvec, Inc.

  

NOTE B — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Consolidation: The financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (56% owned at September 30, 2015 and December 31, 2014). As of September 30, 2015, each of the subsidiaries is non-operational. We are intending to let Ice Surface Development, Inc. dissolve by proclamation. All material intercompany transactions and account balances have been eliminated in consolidation.

 

Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates are used in valuing the useful lives of any intangible assets and the future realizable value of such assets. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates.

 

Reclassifications: Certain reclassifications have been made to prior year balances to conform to the current year’s presentation.

 

Cash and Cash Equivalents: Cash and cash equivalents may include time deposits, certificates of deposit, and highly liquid debt instruments with original maturities of six months or less. We maintain cash and cash equivalents at financial institutions which periodically may exceed federally insured amounts.

 

 

 
4

 

 

Property and Equipment: Property and equipment are stated at cost. Estimated useful lives are as follows:

 

Office Equipment and Software (years)

  

3 – 7

Leasehold Improvements

  

Lesser of useful life or lease term

Shop Equipment (years)

  

3 – 7

Transportation Equipment (years)

  

5

  

Depreciation and amortization are computed using the straight-line method. Betterments, renewals and repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and amortization expense for the three month periods ended September 30, 2015 and 2014 amounted to $27,000 and $39,000, respectively.   Depreciation and amortization expense for the nine month periods ended September 30, 2015 and 2014 amounted to $85,000 and $125,000, respectively.      

 

Whenever events or circumstances indicate, our long-lived assets, including any intangible assets with finite useful lives, are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may be indicated. The carrying amount is then compared to the estimated discounted cash flows, and if there is an excess, such amount is recorded as impairment. During the three and nine month periods ended September 30, 2015 and 2014, we did not record any impairment charges.

 

Fair Value of Financial Instruments: As defined by U.S. GAAP, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. All assets and liabilities are required to be measured and reported on a fair value basis. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

 

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

 

The FASB’s (Financial Accounting Standards Board) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at September 30, 2015 and December 31, 2014. The carrying amount of cash, prepaids and other current assets, accounts payable and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.

 

Revenue Recognition: Our terms provide that customers are obligated to pay for products sold to them within a specified number of days from the date that title to the products is transferred to the customers. Our standard terms are typically net 30 days. We recognize revenue when transfer of title occurs, risk of ownership passes to a customer at the time of shipment or delivery depending on the terms of the agreement with a particular customer and collection is reasonably assured. The sale price of our products is substantially fixed and determinable at the date of the sale based upon purchase orders generated by a customer and accepted by us.

 

We occasionally enter into prototype development contracts with customers. In such cases, revenue is recognized using either (a) the proportional effort method based on the relationship of costs incurred to date to the total estimated cost to complete a contract, or (b) where appropriate, the milestone method, if milestones are clearly identifiable and substantive.

 

Business Segments: During the third quarter of 2015, the company announced the monitoring of its business operations will focus on two divisions in future periods. The CURA division will oversee the Fatigue Management Consulting business and the Aegis division will oversee the Power and Hydraulic business. No revenue has been recognized by either business segment during the nine months ended September 30, 2015.

 

 

 
5

 

 

The CURA division incurred $201,000 and $446,000 in expenses in the three and nine month periods ended September 30, 2015. The CURA division incurred $17,000 and $19,000 in expenses in the three and nine month periods ended September 30, 2014.

  

The Aegis division incurred $170,000 and $514,000 in expenses in the three and nine months periods ended September 30, 2015, respectively. The Aegis division incurred $251,000 and $876,000 in expenses in the three and nine months periods ended September 30, 2014, respectively.

 

Corporate general and administrative expenses will not be allocated to the business segments. Corporate general and administrative expenses were $532,000 and $1,063,000 in the three and nine months periods ended September 30, 2015, respectively. Corporate general and administrative expenses were $354,000 and $1,036,000 in the three and nine months periods ended September 30, 2014, respectively.

 

Assets attributed to the CURA division at September 30, 2015 were $300,000. Assets attributed to the Aegis division at September 30 2015 were $144,000. Assets considered as corporate assets as of September 30, 2015 were $2,000,000.

  

Research and Development and Patents: Research and development costs and patent expenses are charged to operations as incurred. Research and development includes personnel-related costs, materials and supplies, depreciation, consulting services, and amortization of acquired technology. Depreciation expense that was charged to research and development for the three month periods ended September 30, 2015 and 2014 was $21,000 in each period. Depreciation expense that was charged to research and development for the nine month periods ended September 30, 2015 and 2014 was $59,000 and $69,000, respectively.

 

Patent costs for the three month periods ended September 30, 2015 and 2014 amounted to $22,000 and $44,000, respectively, and are included in general and administrative expenses. Patent costs for the nine month periods ended September 30, 2015 and 2014 amounted to $69,000 and $90,000, in each of the respective periods, and are included in general and administrative expenses.

 

Stock-based Compensation: FASB Accounting Standards Codification (“ASC”) 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. Under the modified prospective method that we adopted, awards that were granted, modified, or settled on or after January 1, 2006 are measured and accounted for in accordance with ASC 718-10. Unvested equity-classified awards that were granted prior to January 1, 2006 will continue to be accounted for in accordance with ASC 718-10, except that the grant date fair value of all awards are recognized in the results of operations over the remaining vesting periods. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with ASC 718-10.   

  

No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets. We elected to adopt the alternative method of calculating the historical pool of windfall tax benefits as permitted by FASB ASC 718-10-65 (previously known as: FASB Staff Position (FSP No. SFAS 123(R)-c, “Transition Election Related to Accounting for the Tax Effects of Share-Based Payment Awards.”). This is a simplified method to determine the pool of windfall tax benefits that is used in determining the tax effects of stock compensation in the results of operations and cash flow reporting for awards that were outstanding as of the adoption of FASB ASC 718-10.

 

FASB ASC 505-50, “Equity-Based Payments to Non-Employees,” requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as compensation expense generally over the service period of the consulting arrangement or until performance conditions are expected to be met. Using a Black-Scholes valuation model, we periodically reassess the fair value of non-employee options until service conditions are met, which generally aligns with the vesting period of the options, and we adjust the expense recognized in the consolidated financial statements accordingly.

 

FASB ASC 718-20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award.  Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.

 

 

 
6

 

 

Income Taxes: We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of September 30, 2015, there was no accrued interest or penalties related to uncertain tax positions. The tax years 2011 through 2014 remain open to examination by the federal and state tax jurisdictions to which we are subject.  

 

Loss per Common Share: FASB’s ASC 260-10 (previously known as FASB Statement 128, “Earnings Per Share”) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At September 30, 2015 and 2014, we excluded 54,172,069 and 53,514,325 potential common shares, respectively, relating to convertible preferred stock, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. We have excluded 625,000 warrants from the diluted net loss per common share calculation at September 30, 2015 and 2014 as the conditions for their vesting are not time-based.

  

Recent Accounting pronouncements: ASU 2015-05 Intangibles – Goodwill and Other-Internal-Use Software (subtopic 350-40) Customer’s Accounting for Fees Paid in a Cloud Computing Agreement. The Financial Accounting Standards Board (“FASB”) added guidance to Subtopic 350-40 to help entities evaluate the accounting for fees paid in a cloud computing arrangement. The amendments provide a basis for evaluating whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a license to internal-use software, then the software license should be accounted for in accordance with Subtopic 350-40. If a cloud computing arrangement does not include a software license, then the arrangement should be accounted for as a service contract. This Update will be effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. This guidance will not have an immediate effect on the Company operations but will be considered as our product development and offering expands in future years.

 

In June 2015 the FASB issued ASU 2015-14 Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date. The standard is now effective for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect recognized at the date of adoption (which includes additional footnote disclosures). In May 2014, the FASB issued ASU 2014-09,”Revenue from Contracts with Customers”, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. We are currently evaluating the impact of the adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard. 

 

NOTE C – PROPERTY AND EQUIPMENT

 

At September 30, 2015 and December 31, 2014, property and equipment consist of the following:

 

   

September 30,

2015

   

December 31,

2014

 

Office equipment and software

  $ 518,000     $ 218,000  

Shop equipment

    226,000       213,000  

Leasehold improvements

    253,000       253,000  

Transportation equipment

    17,000       90,000  

Construction in progress

    -       6,000  
      1,014,000       780,000  

Less accumulated depreciation

    556,000       509,000  

Net property and equipment

  $ 458,000     $ 271,000  

 

The Company has invested $308,000 in property and equipment during the nine months ended September 30, 2015. During the three month period ended September 30, 2015, the Company acquired the Z-Coach fatigue management software tool. This educational software will be enhanced and expanded to target an array of industry applications and become a key component of the CURA system product offerings.

 

 

 
7

 

 

NOTE D— RELATED PARTY TRANSACTIONS

 

We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership in which one of our directors is associated. 

 

In October 2014, we extended this lease for a three-year renewal term through May 31, 2018. In June 2015 the rental rate increased to $6,256 per month ($75,070 per annum) for the remainder of the lease term. In addition, we are required to pay a proportionate share of the yearly real estate taxes and yearly common area costs. The lease agreement has a three-year renewal option that includes a 10% rate increase at the renewal period. (See Note H)

 

During 2010 we executed an agreement with a director to provide consulting services at a rate of $200 per hour. Pursuant to the agreement, we also agreed to pay the consultant an incentive fee equal to $10,000 or proportionate part thereof for each $1,000,000 of revenue or proportionate part thereof actually received by us for a period of five years, provided the definitive agreement with the third party results from the material efforts of the consultant. During the three and nine month periods ended September 30, 2015 and 2014, we recorded no expense for services rendered in relation to this agreement.

  

The Company has a consulting agreement that extends to December 31, 2015 with SCIRE Corporation, of which one of our directors is president, to provide us with expertise and advice on hydraulic pump technology and related markets. The agreement provides for guaranteed minimum month fees, based on 8 hours of consulting, plus travel costs. During the three month periods ended September 30, 2015 and 2014, we recorded an expense of approximately $5,000 and $7,000, respectively, for consulting services and travel costs related to this agreement. During the nine month periods ended September 30, 2015 and 2014, we recorded an expense of approximately $14,000 and $22,000, respectively, for consulting services and travel costs related to this agreement.

 

Effective April 13, 2015, we entered into a consulting agreement with ProNexus LLC, of which one of our directors, Thomas Bonadio, through his affiliation with The Bonadio Group, is a minority investor. ProNexus LLC was engaged to provide outsourced finance and accounting services. During the nine months ended September 30, 2015, we recorded approximately $60,000 in connection with this service agreement. This service agreement was completed in August 2015.

 

During the nine months ended September 30, 2014, we sold a limited number of Iso-Torque differentials into the aftermarket to Model C-5 Corvette enthusiasts. A majority of these sales, amounting to approximately $9,000, were made to one of our board members at a discount to stated list price.

   

NOTE E — ACCRUED LIABILITIES

 

At September 30, 2015 and December 31, 2014, accrued liabilities consist of the following:

 

   

September 30,

   

December 31,

 
   

2015

   

2014

 

Accrued compensation

  $ 40,000     $ 29,000  

Accrued benefits and other

    13,000       2,000  

Accrued legal

    3,000       10,000  
    $ 56,000     $ 41,000  

   

 

 
8

 

 

NOTE F — NOTES PAYABLE

 

As of September 30, 2015 and December 31, 2014, notes payable consists of the following:

 

   

September 30,

   

December 31,

 
   

2015

   

2014

 

Copy machine

  $ 9,000     $ 2,000  

Automobile

    -       4,000  
    $ 9,000     $ 6,000  

 

In the nine months ended September 30, 2015, a capital lease for a copy machine was fully paid and we entered into a new capital lease agreement for a copy machine with a term of 5 years. The capitalized value of the lease was approximately $9,000, with a monthly payment of approximately $170 and an implicit interest rate of approximately 4.8%. At September 30, 2015, the outstanding balance on this note was approximately $9,000, of which $7,000 was classified as a non-current liability.

 

In 2012, we purchased an automobile for $16,600, a vehicle that we had previously been leasing. We financed this purchase with a 36 month promissory note. The interest rate on the note was approximately 10% and the payments were approximately $540 per month. At December 31, 2014, the outstanding balance on this note was approximately $4,000 which was classified as a current liability. During the second quarter of 2015 this note was fully paid. 

    

NOTE G — STOCKHOLDERS’ EQUITY

 

Common Stock

We have 400 million common shares authorized with a par value of $0.01 per share. During the nine months ended September 30, 2015 we issued 21,380 common shares upon the election of a Class A preferred shareholder conversion and 16,363 common shares issued in satisfaction of Class A preferred dividend distribution.

 

Preferred Stock

Our certificate of incorporation permits the Company to issue up to 100,000,000 shares of $0.01 par value preferred stock. Under the amendment, the board of directors has the authority to allocate these shares into as many separate classes of preferred as it deems appropriate and with respect to each class, designate the number of preferred shares issuable and the relative rights, preferences, seniority with respect to other classes and to our common stock and any limitations and/or restrictions that may be applicable without obtaining shareholder approval.

 

Class A Non-voting Cumulative Convertible Preferred Stock  

 

At September 30, 2015, there were 565,721 outstanding shares of Class A Preferred stock, of which 8,709 shares resulted from the settlement of dividends due to conversion, and those shares no longer accrue dividends. Dividends payable upon the conversion of the remaining 557,012 outstanding shares of Class A Preferred stock amounted to approximately $2,351,000 at September 30, 2015, of which $167,000 was accumulated during nine month period ended September 30, 2015. During the nine month period ended September 30, 2015, holders of Class A preferred shares converted 21,380 shares into common stock and the Company settled $65,000 Class A Preferred dividends with the issuance of 16,363 shares of common stock.

 

No Class A Preferred shares were sold or converted during the nine month period ended September 30, 2014 and no Class A Preferred dividends were settled during the nine months ended September 30, 2014. Accrued dividends payable upon the conversion of the Class A Preferred stock amounted to approximately $2,249,000 at December 31, 2014. The Company accumulated $173,000, during the nine month period ended September 30, 2014.

  

The Company has authorized the issuance of up to 3,300,000 Class A Non-Voting Cumulative Convertible Preferred Shares. Each Class A Preferred Share is convertible after a one year holding period, at the holder’s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of our common stock as a dividend or distribution and in the case of the subdivision or combination of our common stock. The Class A Preferred has no voting rights except with respect to matters directly impacting the rights and privileges accorded to such Class.

 

The holders of the Class A Preferred are entitled to receive cumulative preferential dividends in the amount of $0.40 per share of Class A Preferred for each annual dividend period. Dividends payable on the Class A Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class A Preferred at a rate of one share of Class A Preferred for each $4.00 of dividends. If dividends are paid in shares of Class A Preferred, such dividends are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one-to-one basis. Holders of Class A Preferred are permitted to request that dividends payable in Class A Preferred be immediately converted into shares of our common stock. At times, our board may elect to settle dividends through the issuance of common stock in lieu of cash. Accumulated and unpaid dividends on the Class A Preferred will not bear interest. Class A Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity.

 

 
9

 

 

The Company may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class A Preferred at the redemption price of $4.00 per Class A Preferred plus all unpaid accumulated dividends payable with respect to each Class A Preferred Share.

 

In the event of the liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred, Class A Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred shareholders’ liquidation preference was approximately $2,351,000 and $2,249,000 at September 30, 2015 and December 31, 2014, respectively. In the event of liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class A Preferred are payable in Class A Preferred shares at a rate of 1 share of Class A Preferred for each $4.00 of dividends.

 

Class B Preferred Stock

 

No Class B Preferred shares were sold during the nine month period ended September 30, 2015 and no Class B Preferred shares were issued to Class B Preferred shareholders as a dividend during the nine month period ended September 30, 2015. Depending upon our cash position, from time to time we may request that a converting preferred shareholder entitled to receive dividends in cash consent to receive shares of restricted common stock in lieu thereof.   

  

At September 30, 2015, there were 67,500 outstanding shares of Class B Preferred stock. At September 30, 2015, dividends payable upon the conversion of these outstanding shares of Class B Preferred amounted to approximately $344,000, of which $25,000 was accumulated during the nine month period ended September 30, 2015. At December 31, 2014, accrued dividends payable on the Class B Preferred shares was approximately $319,000.

 

Subject to the dividend rights and privileges of our Class A Preferred, the holders of the Class B Preferred are entitled to receive cumulative preferential dividends in the amount of $0.50 per share of Class B Preferred for each annual dividend period. Dividends payable on the Class B Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class B Preferred at a rate of one share of Class B Preferred for each $5.00 of dividends. If dividends are paid in shares of Class B Preferred, such dividends are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one-to-one basis. Holders of Class B Preferred are permitted to request that dividends payable in Class B Preferred be immediately converted into shares of our common stock. At times, our board may elect to settle dividends through the issuance of common stock in lieu of cash. Accumulated and unpaid dividends on the Class B Preferred will not bear interest. Class B Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity.

 

The Company may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class B Preferred at the redemption price of $5.00 per Class B Preferred plus all unpaid accumulated dividends payable with respect to each Class B Preferred Share.

 

In the event of the liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred and Class A Preferred shareholders, the Class B Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred shareholders’ liquidation preference was $344,000 and $319,000 at September 30, 2015 and December 31, 2014, respectively. In the event of a liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class B Preferred are payable in Class B Preferred shares at a rate of 1 share of Class B Preferred for each $5.00 of dividends.

 

Series C Preferred Stock

 

The Company has authorized and issued 16,250,000 shares of Series C Voting Convertible Preferred Stock. No Series C Preferred stock was converted during the nine month period ended September 30, 2015 or during the year ended December 31, 2014. The value of the Series C Preferred shareholders’ liquidation preference was $6,500,000 at September 30, 2015 and at December 31, 2014.

 

 

 
10

 

 

Each Series C Preferred Share is convertible after a one year holding period, at the holder’s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of our common stock as a dividend or distribution and in the case of the subdivision or combination of our common stock. The Series C Preferred shares have no right to receive dividends and no redemption right. The Series C Preferred shares vote with the common stock on an as-converted basis.

 

The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 that is senior to our common stock, and the Company’s Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, weather voluntary or involuntary or upon a deemed liquidation of the Company.

 

Series C-2 Preferred Stock

 

In March 2014, the board of directors authorized and the Class A Preferred, the Class B Preferred and the Series C Preferred shareholders approved, a series of preferred stock, designated as Series C-2 Voting Convertible Preferred Stock. On March 28, 2014, we sold and issued a total of 25,000,000 shares of Series C-2 Voting Convertible Preferred Stock in a private placement transaction, generating gross proceeds of $5,000,000. Direct expenses of approximately $46,000 pertaining to the transaction, consisting of primarily external legal costs, were incurred, resulting in net proceeds of approximately $4,954,000.

 

As of September 30, 2015, Series C-2 Preferred shareholders have not converted any shares of Series C-2 Preferred into common stock. At September 30, 2015, there were 25,000,000 shares of Preferred C-2 stock outstanding. The value of the Series C-2 Preferred shareholders’ liquidation preference was $5,000,000 at September 30, 2015 and at December 31, 2014.

 

Each Series C-2 Preferred Share is convertible, at the holder’s election, into one share of our common stock, par value $0.01 per share. The conversion rate is subject to adjustment in the event of the issuance of common stock as a dividend or distribution, and the subdivision or combination of the outstanding common stock or a reorganization, recapitalization, reclassification, consolidation or merger of the Company.  

  

The Series C-2 Preferred Shares have a liquidation preference at their stated value per share of $0.20 that ranks pari passu to our existing Series C Voting Convertible Preferred Shares and is senior to our common stock, and our Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or upon a deemed liquidation of the Company. A deemed liquidation includes, unless decided by the holders of at least two-thirds of the Series C-2 Preferred Shares, any consolidation, merger, or reorganization of the Company in which the shareholders of the Company own less than fifty percent of the voting power of the resultant entity, or an acquisition to which the Company is a party in which at least fifty percent of the Company’s voting power is transferred, or the sale, lease, exclusive license or transfer of all or substantially all of the assets or intellectual property of the Company other than to a wholly owned subsidiary.

 

The Series C-2 Preferred Shares are not entitled to receive preferred dividends and have no redemption right, but are entitled to participate, on an as converted basis; with holders of outstanding shares of common stock in dividends and distributions on liquidation after all preferred shares have received payment in full of any preferred dividends or liquidation preferences. The Series C-2 Preferred Shares vote with the common stock on an as-converted basis. We may not, without approval of the holders of at least two-thirds of the Series C-2 Preferred Shares, (i) create any class or series of stock that is pari passu or senior to the Series C-2 Preferred Shares; (ii) create any class or series of stock that would share in the liquidation preference of the Series C-2 Preferred Shares or that is entitled to dividends payable other than in common stock or Series C-2 Preferred Shares of its own series, (iii) acquire any equity security or pay any dividend, except dividends on a class or series of stock that is junior to the Series C Preferred Shares, payable in such junior stock, (iv) reissue any Series C-2 Preferred Shares, (v) declare or pay any dividend that would impair the payment of the liquidation preference of the Series C-2 Preferred Shares, (vi) authorize or issue any additional Preferred Shares, (vii) change the Certificate of Incorporation to adversely affect the rights of the holders of the Series C-2 Preferred Shares, or (viii) authorize, commit to or consummate any liquidation, dissolution or winding up in which the liquidation preference of the Series C-2 Preferred Shares would not be paid in full.

 

 

 
11

 

 

In conjunction with the issuance of the 25,000,000 shares of Series C-2 Preferred stock, we computed the value of the non-cash beneficial conversion feature associated with the right to convert the shares into common stock on a one-for-one basis. We compared the fair value of our common stock on the date of issuance with the effective conversion price, and determined that the value of the non-cash beneficial conversion feature is approximately $4,250,000, which is reflected in our condensed consolidated statements of operations for the nine month period ended September 30, 2014 as an adjustment to arrive at the net loss attributable to common stockholders.

 

The Series C-2 Preferred Shares will not be and have not been registered under the Securities Act of 1933, as amended, or the Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

    

Stock Options

 

1998 Stock Option Plan

 

In December 1997, our board approved a Stock Option Plan (the “1998 Plan”) which provided for the granting of up to 2,000,000 shares of common stock, pursuant to which officers, directors, key employees and key consultants/advisors are eligible to receive incentive, nonqualified or reload stock options which plan was ratified by the shareholders on May 28, 1998. Options granted under the 1998 Plan are exercisable for a period of up to 10 years from date of grant at an exercise price which is not less than the fair value on date of grant, except that the exercise period of options granted to a stockholder owning more than 10% of the outstanding capital stock may not exceed five years and their exercise price may not be less than 110% of the fair value of the common stock at date of grant.

 

By its terms, our 1998 Plan terminated as to the grant of future options on May 27, 2008. Consequently, no additional stock options will be granted under the 1998 Plan, and no outstanding options remain available for exercise in accordance with their terms. There were no options exercised under the 1998 Plan during each of the nine month periods ended September 30, 2015 and 2014.

 

Through September 30, 2015, a total of 1,823,895 stock options had been granted under the 1998 Plan, no stock options had been exercised, and 1,823,895 stock options have expired. During the three months ended September 30, 2015, 100,000 options expired. As of September 30, 2015, there were no outstanding stock options under the 1998 Plan.

  

2011 Stock Option Plan

 

In 2011, shareholders approved the 2011 Stock Option Plan (the “2011 Plan”) which provides for the grant of up to 3,000,000 common stock options to provide equity incentives to directors, officers, employees and consultants. Two types of options may be granted under the 2011 Plan: non-qualified stock options and incentive stock options.

 

Non-qualified stock options may be granted to our officers, directors, employees and outside consultants. Incentive stock options may be granted only to our employees, including officers and directors who are also employees. In the case of non-qualified stock options, the exercise price may be less than the fair market value of our stock on the date of grant. In the case of incentive stock options, the exercise price may not be less than such fair market value and in the case of an employee who owns more than 10% of our common stock; the exercise price may not be less than 110% of such market price. Options generally are exercisable for ten years from the date of grant, except that the exercise period for an incentive stock option granted to an employee who owns more than 10% of our stock may not be greater than five years.

 

During the three month period ended September 30, 2015, we granted 675,000 stock options under the 2011 Plan, 406,375 options became vested, and no options expired or were exercised. During the three month period ended September 30, 2014, we granted 500 stock options under the 2011 Plan, 6,250 options became vested, and 125,000 options expired unexercised and no options exercised.

 

During the nine month period ended September 30, 2015, we granted 695,000 stock options under the 2011 Plan, 472,000 options became vested, and no options expired or were exercised. As of September 30, 2015, there were 1,973,000 stock options outstanding under the 2011 Plan, 1,247,000 of which were vested. At September 30, 2015, there were 1,277,000 options remaining available for future grant under the 2011 Plan. During the nine month period ended September 30, 2014, we granted 11,000 stock options under the 2011 Plan, 131,750 options became vested, and 250,000 options expired unexercised or were forfeited and no options exercised.

 

 

 
12

 

 

During the nine months ended September 30, 2015 we modified 50,000 options previously granted to the Company’s former CFO. On February 5, 2015, in consideration for the former CFO’s willingness to assist in the transition to a new accounting team, the Company has agreed to modify the option agreement so that the unvested portion remains intact for the full term of the original stock option agreement. We used the Black-Scholes option-pricing model to value the cost of this modification which was an immaterial amount for the nine months ended September 30, 2015. These options vest upon the first day the closing trading price of the common stock of the Company shall be $10.00 or greater. Since they are now held by a non-employee we will revalue the fair value of these options on a quarterly basis through the vesting period.

  

Non-Plan Options

 

As of September 30, 2015, there were a total of 6,965,000 non-plan options outstanding, of which 4,815,000 were fully vested. During the nine month period ended September 30, 2015, we granted no non-plan stock options, 337,500 options became vested, and no options were exercised or cancelled.     During the nine month period ended September 30, 2014, we granted no non-plan stock options, 337,500 options became vested, and no options were exercised or cancelled.     

 

Option Summary

 

For the nine month periods ended September 30, 2015 and 2014, compensation cost related to all stock options amounted to $349,000 and $133,000, respectively. For the three month periods ending September 30, 2015 and 2014, compensation cost related to all stock options amounted to $252,000 and $90,000, respectively. As of September 30, 2015, there was approximately $199,000 of total unrecognized compensation costs related to outstanding stock options, which are expected to be recognized over a weighted average 1.5 years.

 

During the nine month period ended September 30, 2015 and 2014, we granted 695,000 stock options with a weighted average grant-date fair value of $0.53 and 11,000 stock options with weighted average grant-date fair value of $0.36, respectively. The total grant date fair value of all stock options vested during the nine month periods ended September 30, 2015 and 2014 was approximately $861,000 and $690,000, respectively.

 

The fair value of options granted during the nine month periods ended September 30, 2015 was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 

   

2015

   

2014

 

Expected term in years

  5.0 - 6.5       6.3      

Expected forfeiture rate

    0.0%         0.0%  

Risk free rate

  1.5 - 2.0%       2.1%  

Volatility

   130 - 135%       135%  

Dividend yield

    0.0%         0.0%  

  

The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected term was generally determined using the simplified method as we do not believe we have sufficient historical stock option exercise experience on which to base the expected term. 

  

The following summarizes the activity of all of our outstanding stock options for the nine month period ended September 30, 2015:

 

           

Weighted

Average

Exercise

   

Weighted

Average

Remaining

Contractual

Term

   

Aggregate

Intrinsic

 
   

Shares

   

Price

   

(in years)

   

Value

 

Outstanding at January 1, 2015

    8,343,000     $ 0.63       6.0       -  

Granted

    695,000       0.53                  

Exercised

    -       -                  

Canceled or expired

    100,000       5.00                  
                                 

Outstanding at September 30, 2015

    8,938,000     $ 0.57       5.7     $ 265,000  
                                 

Exercisable at September 30, 2015

    6,062,000     $ 0.66       5.5     $ 121,000  

 

As of September 30, 2015, the exercise prices of all outstanding stock options, as well as all vested stock options, ranged from $0.20 per share to $5.00 per share.    

 

 
13

 

 

Warrants

 

The following summarizes the activity of our outstanding warrants for the nine month period ended September 30, 2015:

 

           

Weighted

Average

Exercise

     

Weighted

Average

Remaining

Contractual

Term

     

Aggregate

Intrinsic

 
   

Shares

   

Price

     

(in years)

     

Value

 

Outstanding at January 1, 2015

    3,356,750     $ 1.99   (A)     5.6       $ 77,000  
                                     

Granted

    -       -                      

Exercised

    -       -                      

Canceled or expired

    37,500       0.01                      
                                     

Outstanding at September 30, 2015

    3,319,250     $ 2.04   (A)     5.0  

(B)

  $ 9,300  
                                     

Exercisable at September 30, 2015

    2,694,250     $ 2.99         5.0  

(C)

  $ 9,300  

  

 

(A)

The weighted average exercise price for warrants outstanding as of January 1, 2015 and September 30, 2015 excludes 1,750,000 warrants with no determined exercise price.

 

 

 

 

(B)

The weighted average remaining contractual term for warrants outstanding as of September 30, 2015 excludes 743,500 warrants with no expiration date.

 

 

 

 

(C)

The weighted average remaining contractual term for warrants exercisable as of September 30, 2015 excludes 118,500 warrants with no expiration date.

   

NOTE H — COMMITMENTS AND OTHER MATTERS

 

Leases

 

We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership in which one of our directors is associated. (See Note D).  In October 2014, we extended the lease for a three-year renewal term through May 31, 2018. The current rental rate is $6,256 per month ($75,070 per annum) for the remainder of the lease term. In addition, we are required to pay a proportionate share of the yearly real estate taxes and yearly common area costs.  

  

Rent expense for the nine month periods ended September 30, 2015 and 2014 was approximately $53,000 and $51,000, respectively. Including consideration for the renewal options, rent payments required under the lease for the twelve month periods ending December 31, 2015 through 2019 will amount to approximately $72,000, $75,000, $75,000, and $31,000, respectively.

 

Employment Agreements

 

In the third quarter of 2015, the Company hired a Vice President of business development for the CURA division. The hiring agreement includes a severance agreement including six months salary if a termination by the Company is initiated other than for cause or executive good reason. Such severance will be based on the salary at the time of the action in return for a general release of the Company and its officers, directors and agents satisfactory to the Company.

 

 
14

 

 

In 2010, we appointed a new chief executive officer and executed a five year employment agreement pursuant to which we will pay base compensation of $50,000 per annum, which compensation increases to $200,000 per annum on the first day of the calendar year immediately following the calendar year in which we have adjusted EBITDA of at least $300,000 (earnings before interest, taxes, depreciation and amortization, but excluding all non-cash expenses associated with stock options). In September 2014, the CEO agreed to temporarily reduce his base compensation to $25,000 per annum. Under the agreement, the executive is entitled to a performance bonus based upon financial targets established each year in good faith by the Governance and Compensation Committee and the achievement of individual management objectives established annually by such committee. The executive is entitled to participate in all employee benefit plans as are provided from time to time for senior executives. If we terminate the executive, remove him as CEO, or a change in control of the Company occurs, the executive is entitled to six years’ severance pay, consisting of base pay and any incentive compensation.

 

Consulting Agreements

 

The Company established the CURA Advisory Board during the third quarter of 2015 to assist in the design, development and commercialization of the CURA fatigue management products. This group consists of some of the most respected consultants, researchers and clinicians in the fatigue management industry. Each CURA member will interact in an advisory capacity with management to critique and assess the effectiveness of CURA products prior to product introduction in order to maximize the effectiveness and user experience. The CURA advisors will each received an annual stipend of $5,000, will be paid $4,000 per year for attendance at four meetings and receive a grant of 50,000 common stock options, vesting over four years at an exercise price equal to the market price on the date of issuance.

 

Effective as of January 1, 2013, we entered into a consulting agreement with SCIRE Corporation, of which one of our directors is president, to provide us with expertise and advice on hydraulic pump technology and related markets. During the nine month periods ended September 30, 2015 and 2014, we recorded expense of approximately $14,000 and $22,000, respectively, for consulting services and travel costs related to this agreement. In November 2014, we extended this consulting agreement through December 31, 2015, providing for a guaranteed minimum of $1,200 per month, based on 8 hours of consulting, plus travel costs. Additional hours above this minimum incurred in 2015 will be billed at a rate of $150 per hour.

 

In 2010, we engaged the services of a consulting firm to provide expertise with business development initiatives, strategic planning and general funding opportunities. In 2011, the agreement was modified to pay the consultant a commission equal to 4% of the value received by us from third parties introduced to us by or through the auspices of the consultant through January 1, 2017. Cumulatively, through September 30, 2015, we have recorded approximately $3,000 of expense for services rendered in relation to this agreement.

 

Prototype Development Agreements

 

In January 2013, we entered into a development agreement with Chinese automotive manufacturer, BAIC Motor Co., Ltd. (“BAIC”). During the second quarter of 2014, we recorded approximately $39,000 in revenue associated with this agreement, along with related expenses of approximately $50,000. In December 2014, we recorded an uncollectible reserve against the outstanding receivable balance of approximately $20,000 due to the delinquency in receiving payment from this customer. During the second quarter of 2015, the Company recovered the full amount of this previously reserved receivable. This recovery was recorded in general and administrative expense on the Statement of Operations. 

 

 

 
15

 

     

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overall Business Strategy 

 

Management announced a name change for the Company during the third quarter of 2015. The company will establish its business around two divisions. The CURA division will oversee the Fatigue Management Consulting business, and the Aegis division that will oversee the Power and Hydraulic business. The new name of the company will be CurAegis Technologies, Inc. This will be used as a DBA until the next shareholders meeting when we will officially change the name.

 

The interim information contained herein with respect to the three and nine month periods ended September 30, 2015 and 2014 have not been audited but has been prepared in conformity with generally accepted accounting principles for interim financial information and instructions for Form 10-Q. Accordingly, the condensed consolidated financial statements do not include all information and footnotes required by generally accepted accounting principles for financial statements. Included are ordinary adjustments which, in the opinion of management, are necessary for a fair presentation of the financial information for the three and nine month periods ended September 30, 2015 and 2014. The results are not necessarily indicative of results to be expected for the entire year.

 

The Company was incorporated as a New York business corporation on September 25, 1996. The Company develops and markets advanced technologies in the areas of power, safety and wellness.  Currently, the Company is focusing its commercialization strategies on the following technologies: (i) the CURA system which encompasses a wearable device, the MyCadian™ Watch which measures degradation of alertness and sleep attributes and the Z Coach education and training tool (ii) the Hydraulic Pump. The MyCadian™ Watch consists of hardware and software that measures multiple metrics in order to establish that a person's ability to perform a task or job appears to be degrading. The Hydraulic Pump is an innovative hydraulic design, whose goal is to deliver better efficiencies in a package that is smaller and lighter than existing technologies.  The Company has not yet had any significant revenue-producing operations.

 

As used in this quarterly report, unless otherwise indicated, the terms “we”, “our”, “us”, “the Company” and CurAegis” refer to Torvec, Inc. 

 

Current Status of Business Plan and Ongoing Projects

 

CURA Division: CURA System and MyCadian Watch™

 

The Company’s CURA division is developing a proprietary technology and suite of products designed to measure, in quantifiable terms, the decrease in a person’s alertness, thus enabling that person, their employers, and others to take measures to avert undesired or disastrous situations. The MyCadian Watch™ is a wearable device consisting of the latest physiological monitoring hardware and proprietary CURA™ (Circadian User Risk Assessment) software intended to detect a degradation of alertness in a user and also reveals sleep and fatigue problems. The CURA™ software will include:

 

 

1.

unique metrics that will assess an individual’s alertness degradation in task, job performance and sleep,

 

2.

an assessment of an organization’s employee population’s sleep and fatigue problems and

 

3.

the remediation tools directed to an employee while maintaining complete personal confidentiality for the employee.

 

CurAegis Technologies is presently engaged in clinical testing with a number of sleep study experts and neurologists to assist with the analysis and validation of this new technology. The Company believes a solutions approach can be created to indicate a “degradation of alertness” and thus give immediate and important information to the user and other parties. These degradations can be caused by drowsiness, alcohol or other drugs, sickness, psychological problems and thought distractions. Action taken upon a warning of a change in alertness will lead to a better and safer environment.

 

The MyCadian Watch™ can alert the user and third parties to let them know their alertness is degrading. This is especially important when an individual’s alertness is essential in properly performing tasks, fulfilling responsibilities and averting disasters. With the information provided from the CURA software analytics, employees can work with Z-Coach, our proprietary sleep training and education solution, to correct sleep issues and improve overall wellness. The MyCadian Watch™ will contain an emergency notification function through the use of a panic button or in sensing a lack of motion, will generate a third party panic notification.

 

 

 
16

 

 

The Company believes that based upon preliminary estimates, the total market for its invention is approximately 700 million users worldwide. We anticipate the production of alpha prototypes in the fourth quarter of 2015 and customer shipments in the second quarter of 2016. The Company has filed for patent protection for its invention.

 

Aegis Division: Hydraulic Pump

 

The development of our the Hydraulic Pump has taken on added significance in light of recent U.S. government emissions regulations for off road diesel engines that will take effect in the near future. These regulations will require diesel engines to pollute less. To help achieve these new standards, companies are attempting to run the diesel engines, and thus their hydraulic pumps, at lower rotational speeds. This requires larger displacement hydraulic pumps to be installed to compensate for the decrease in rotational speed. Among other advantages, the unique technology of our hydraulic pump allows a larger displacement pump to fit into the same or smaller footprint than that of existing pumps. This enables manufacturers to keep the current equipment layout without the need for expensive modifications to accommodate larger hydraulic pumps.

 

Our goal with the hydraulic pump technology is to give the marketplace a revolutionary new concept in hydraulic pumps and motors that:

 

 

Is smaller and lighter than conventional pumps and motors,

 

Is more efficient,

 

Is as reliable,

 

Is price competitive,

 

Has the unique ability to scale much larger allowing more powerful pumps and motors.

 

Since 2012, we have invested in software, test equipment and personnel to enhance our development efforts and began a drastic redesign of the Hydraulic Pump to improve the overall performance while maintaining the significant the advantages we have in size and weight. We have built our own testing facility for initial testing, which would have otherwise taken place at a third party testing facility. Our engineer and design team has progressively made adjustments to the valve sealing design and each change has shown an improvement in the measured efficiency of the pump. We have recently achieved our pressure goal of 5000 psi. This is a significant accomplishment and major milestone in our development. .

  

We will continue to design modifications to enhance the overall pump technology. We have filed for patent protection for our novel non-rotating group pump concept, and we are also working on additional patents as a result of engineering breakthroughs in our design process. Although there is still much to be done, we continue to be extremely encouraged by our testing.

  

IsoTorque® Differential

 

Until recently, the Company’s focus has included the development of its IsoTorque® differential technology, which is designed to provide for improved traction, handling, performance and safety of a vehicle without the need for complex electronics and clutches that wear out.  At this time development efforts for this technology have been temporarily suspended in order to focus resources on the other technologies highlighted above.

  

In addition to the activities to be undertaken by us to implement our plan of operation detailed above, we may expand and/or refocus our marketing activities depending upon future circumstances and developments. Information regarding the Company and all of our inventions, including regular updates on technological and business developments, can be found on our website, www.torvec.com. The website and its contents are not incorporated by reference into this report.

 

Company Revenue and Expenses

 

Three Month Periods Ended September 30, 2015 and 2014

 

There was no revenue reported for the three month periods ended September 30, 2015 and September 30, 2014.

 

 

 
17

 

 

Research and development expenses for the three months ended September 30, 2015 amounted to $371,000 as compared to $267,000 for the comparable period in 2014. Non-cash stock-based compensation expense for the three month periods ended September 30, 2015 and 2014 was $2,000 and $5,000, respectively. Excluding the non-cash stock-based compensation, research and development expenses for the three month period ended September 30, 2015 amounted to $369,000, an increase of $107,000, or 41%, from $262,000 recorded in the comparable period in 2014. The increase in spending during 2015 is attributed to incremental spending for engineering headcount and consulting provided in the development of the MyCadian Watch™ Wearable Device.

 

General and administrative expense for the three months ended September 30, 2015 amounted to $532,000 compared to $354,000 for 2014. Non-cash stock-based compensation expense for the three months ended September 30, 2015 was $249,000, compared to $85,000 for the three months ended September 30, 2014. Excluding the non-cash stock-based compensation, general and administrative expense for the third quarter of 2015 amounted to $283,000 compared to $269,000 in 2014.The increase in stock based compensation expense reflects the grant of options to a senior level new hire and 4 CURA Advisory Board members during the third quarter of 2015.

 

The loss from operations for the three month period ended September 30, 2015 was $903,000, compared with a loss from operations of $621,000 in 2014. Other income decreased to $3,000 in 2015 from $7,000 in 2014, primarily due to gains recognized on the disposition of fixed assets no longer utilized in the product development process. Preferred stock dividends amounted to $64,000 and $66,000 in each of the three month periods ended September 30, 2015 and 2014, respectively.

 

The net loss attributable to common stockholders for the three month period ended September 30, 2015 was $964,000 as compared to a net loss of $680,000 for the comparable period in 2014. The weighted average number of common shares outstanding was 45,754,000 and 45,716,000, respectively for the three month periods ended September 30, 2015 and 2014. Net loss per share attributed to common shareholders for the three month periods ended September 30, 2015 and 2014 was $0.02 and $0.01 respectively.

 

Nine Month Periods Ended September 30, 2015 and 2014

 

There was no revenue reported for the nine month periods ended September 30, 2015 compared to $50,000 for the nine months ended September 30, 2014. Revenue for the nine months ended September 30, 2014 reflects the completion of our development agreement with BAIC, as well as from the sale of limited quantities of IsoTorque® differentials into the aftermarket specific model C-5 Corvette platform. Cost of goods sold for the nine months ended September 30, 2014 was $92,000 resulting in a negative gross margin in the amount of $42,000. This loss in margin reflects high material cost for the differentials due to low production quantities and due to development costs for the BAIC project that were not fully offset by proceeds from the development agreement. 

 

Research and development expenses for the nine months ended September 30, 2015 amounted to $960,000 as compared to $895,000 during the comparable period in 2014. Non-cash stock-based compensation for the nine months ended September 30, 2015 was $7,000, compared to a net credit of $27,000 for the nine months ended September 30, 2014. Excluding the non-cash stock-based compensation, research and development expenses for the nine month period ended September 30, 2015 amounted to $953,000, an increase of $31,000, or 3%, from $922,000 recorded in the comparable period in 2014. The increase in 2015 is attributable to the re-direction of engineering efforts from the IsoTorque® differential technology to the Hydraulic Pump and MyCadian Watch™ design and development. This transition in effort has resulted in lower costs for material and product components and depreciation expense offset by contract and consulting costs for the MyCadian Watch™. The $27,000 credit for stock compensation expense in 2014 was due primarily to a reversal of expense associated with the forfeiture of unvested options resulting from the departure of the chief technology officer. 

 

General and administrative expense for the nine months ended September 30, 2015 amounted to $1,063,000 compared to $1,036,000 for 2014. Non-cash stock-based compensation for the nine months ended September 30, 2015 was $342,000, an increase of $182,000 from $160,000 for the nine months ended September 30, 2014. Excluding the non-cash stock-based compensation, general and administrative expense for the nine month ended September 30, 2015 was $721,000 compared to $876,000 in comparable period in 2014. The decrease of $155,000, or 18%, is attributed to: the recovery of a previously reserved customer receivable of $20,000, reductions in salary expenses primarily attributed to the departure of the Company’s CFO in the first quarter of 2015, and a decrease in depreciation expense, offset by an increase in outside consultants. The increase in stock based compensation expense reflects the grant of options to a senior level new hire and 4 CURA Advisory Board members during the third quarter of 2015.

 

 

 
18

 

 

Net loss for the nine month period ended September 30, 2015 was $1,992,000 compared to a net loss of $1,946,000 in the comparable period of 2014. Other income increased to $31,000 in 2015 compared to $27,000 in 2014, primarily due to gains recognized on the disposition of fixed assets no longer utilized in the product development process.

 

The net loss attributable to common stockholders for the nine month period ended September 30, 2015 was $2,184,000 compared to a net loss for the comparable period in 2014 of $6,394,000. In March 2014, in connection with the issuance of the 25,000,000 shares of Series C-2 Preferred stock the Company recorded a non-cash beneficial conversion feature of $4,250,000. Preferred stock dividends of $192,000 and $198,000 were recorded in during the nine month periods ended September 30, 2015 and 2014, respectively.

 

The weighted average number of common shares outstanding was 45,754,000 and 45,716,000 respectively for each of the nine month periods ended September 30, 2015 and 2014. Net loss per share attributed to common shareholders for the nine month periods ended September 30, 2015 and 2014 was $0.05 and $0.14, respectively. 

  

Liquidity and Capital Resources 

 

As of September 30, 2015, cash and cash equivalents totaled $1,946,000, reflecting a decrease of $1,778,000 from the beginning of the year. During the nine months ended September 30, 2015, we used $1,528,000 of cash in operating activities, down from the $1,752,000 spent during the comparable period in 2014.

 

A net loss for the nine months ended September 30, 2015 of $1,992,000 was offset by non-cash charges for depreciation of $85,000, gains on dispositions of fixed assets, a recovery of a bad debt previously written off and stock-based compensation of $348,000. The net change of working capital items provided $70,000 in operating cash in the nine months ended September 30, 2015. In 2014, we reported net loss of $1,946,000, which was offset by non-cash charges for depreciation of $125,000 and stock-based compensation of $133,000. Other adjustments to reconcile the net loss to the net cash used in operating activities in the nine months ended September 30, 2014 included a gain on the disposition of fixed assets of $12,000 and a net change of $52,000 from working capital items.

 

The Company had a cash usage from operations of approximately $170,000 per month for the nine month period ended September 30, 2015 compared to approximately $195,000 per month in the comparable period in 2014. The Company anticipates spending between $200,000 and $250,000 per month during the period from the fourth quarter of 2015 through June of 2016. This increase in spending will be directly associated with product development, design, testing and related sales and marketing efforts to bring the CurAegis technologies products to market. The fourth quarter of 2015 product development costs will include clinical trials for the MyCadian Watch™ and advanced instrument and design testing for the hydraulic pump.

  

Investing activities used $246,000 in the nine month period ended September 30, 2015 which included approximately $62,000 in proceeds from the sales of fixed assets. During the third quarter of 2015, the Company purchased the Z-Coach fatigue management tool. Z-Coach is a robust fatigue management training program that will be enhanced and expanded to target an array of industry applications and become a key component to our CURA system product offering. The Company will continue to invest in software development and product expansion as complementary fatigue management products and tools are identified. During the nine month period ended September 30, 2014, $27,000 in net cash was generated from investing activities; reflecting $70,000 in proceeds from the sale of fixed assets offset by $43,000 for the purchase of fixed assets.

 

During the nine month period ended September 30, 2015, we used $4,000 in cash in the repayment on outstanding notes payable. During the nine month period ended September 30, 2014, we generated $4,908,000 from financing activities, resulting from $4,954,000 in net proceeds raised from the March 2014 issuance of the Series C-2 preferred stock, offset by repayments on outstanding notes payable.

  

Current Cash Outlook

 

The Company believes that operating cash requirements for the full year of 2015 will be approximately $2,500,000. Management believes based upon our current cash position and our outlook for our business operations, our current cash position will fund our operational objectives through June 2016. The Company plans to initiate a $2.5 million private placement of common stock (as described further below) to fund research and development of our CURA and AEGIS products and provide working capital for sales and marketing of the Company’s products. Management anticipates the proceeds from this private placement, in addition to sales projected from product introductions, will provide the business with the cash needed for the future. The Company will consider future private placements if business investments and opportunities necessitate.

 

 

 
19

 

 

Pursuant to the Series C-2 Preferred stock transaction on March 2014, we were required to use commercially reasonable efforts to raise $1,000,000, in a separate private placement or private placements, through the offer and sale of an additional Series C-3 Voting Convertible Preferred Stock, par value of $0.01 per share. This effort was originally planned to take place within 180 days of the March 2014 transaction; however, the Company postponed this additional equity raise in order to ensure that we would not jeopardize our ability to utilize certain of our net operating carryforwards in relation to the Internal Revenue Code Section 382. The pricing of the Series C-3 Preferred Shares will be determined by the Board of Directors prior to the initial closing of the sale of those shares; however, pursuant to the terms of the Series C-2 Preferred stock transaction, the price of the Series C-3 Preferred Shares cannot be less than $0.25 per share.

 

The Company plans to initiate a $2.5 million private placement of common stock in lieu of the Series C3 Preferred stock described above. The private placement will be offered first to our existing shareholders and then to other accredited investors. The Company anticipates this private placement will be completed by the first quarter of 2016. All terms and conditions for this private placement of common stock will be determined by the Board of Directors prior to the initial closing. Prior to closing, the Company will obtain all required approvals from Series C and Series C-2 preferred shareholders. There can be no assurance, however, that the Company will be successful in raising this additional capital on the terms that are favorable to the Company.

 

As of September 30, 2015, we have accumulated a deficit of $70,530,000 and total stockholders’ equity of $2,253,000. On September 30, 2015 we had current liabilities of $184,000 and net working capital of $1,802,000. Historically we have been dependent upon equity financing and advances from stockholders to meet our obligations and sustain operations. In March 2014 we raised $5,000,000 in gross proceeds through a private placement of the Series C-2 preferred stock. The proceeds from this transaction are being used to support the ongoing development and marketing of our core technologies and product initiatives.

 

Critical Accounting Policies 

 

Revenue Recognition

 

Our terms provide that customers are obligated to pay for products sold to them within a specified number of days from the date that title to the products is transferred to the customers. Our standard terms are typically net 30 days. We recognize revenue when transfer of title occurs, risk of ownership passes to a customer at the time of shipment or delivery depending on the terms of the agreement with a particular customer and collection is reasonably assured. The sale price of our products is substantially fixed and determinable at the date of the sale based upon purchase orders generated by a customer and accepted by us.

 

We occasionally enter into prototype development contracts with customers. In such cases, revenue is recognized using either (a) the proportional effort method based on the relationship of costs incurred to date to the total estimated cost to complete a contract, or (b) where appropriate, the milestone method, if milestones are clearly identifiable and substantive.

   

Income Taxes

 

We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized.

 

We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of September 30, 2015, there were no accrued interest or penalties related to uncertain tax positions.

 

 

 
20

 

 

Stock-Based Compensation

 

FASB ASC 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with FASB ASC 718-10.

 

No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets. We elected to adopt the alternative method of calculating the historical pool of windfall tax benefits as permitted by FASB ASC 718-10-65 (previously known as FASB Staff Position (FSP) No. SFAS 123(R)-c, “Transition Election Related to Accounting for the Tax Effects of Share-Based Payment Awards”). This is a simplified method to determine the pool of windfall tax benefits that is used in determining the tax effects of stock compensation in the results of operations and cash flow reporting for awards that were outstanding as of the adoption of FASB ASC 718-10.

 

FASB ASC 505-50, “Equity-Based Payments to Non-Employees,” requires all share-based payments to non-employees, including grants of stock options, to be recognized in the condensed consolidated financial statements as compensation expense generally over the service period of the consulting arrangement or until performance conditions are expected to be met. Using a Black-Scholes valuation model, we periodically reassess the fair value of non-employee options until service conditions are met, which generally aligns with the vesting period of the options, and we adjust the expense recognized in the consolidated financial statements accordingly.

 

FASB ASC 718-20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award.  Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified. 

 

 
21

 

  

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not Applicable.

  

Item 4. CONTROLS AND PROCEDURES

 

Disclosure controls and procedures 

 

Evaluation of Disclosure Controls and Procedures 

 

Our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Form 10-Q. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded, as of September 30, 2015, that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)), as of the end of such period, are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

 

Changes in Internal Control Over Financial Reporting 

 

There have been no significant changes in our internal control over financial reporting during the quarter ended September 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

 

 
22

 

   

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

  

Item 1A. Risk Factors

 

There have been no significant changes to the risk factors facing the Company as disclosed in our Form 10-K for the year ended December 31, 2014.

  

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

  

Item 3. Defaults Upon Senior Securities

 

None.

  

Item 4. Mine Safety Disclosures

 

Not Applicable.

  

Item 5. Other Information

 

None.

 

 

 
23

 

   

Item 6. Exhibits

 

The following Exhibits, as applicable, are included in this Quarterly Report (Form 10-Q). The Exhibit Index is found on the page immediately succeeding the signature page and the Exhibits follow on the pages immediately succeeding the Exhibit Index.

 

(2)

Plan of acquisition, reorganization, arrangement, liquidation, or succession

  

 

None

  

 

 

 

  

(3) 

Articles of Incorporation, By-laws  

*

 

 

 

  

 

3.1

Certificate of Incorporation, incorporated by reference to Form 10-SB/A , Registration Statement, registering Company’s $0.01 par value common stock under section 12(g) of the Securities Exchange Act of 1934;

*

 

 

 

  

 

3.2

Certificate of Amendment to the Certificate of Incorporation dated August 30, 2000, incorporated by reference to Form SB-2 filed October 19, 2000;

*

 

 

 

  

 

3.3

Certificate of Correction dated March 22, 2002, incorporated by reference to Form 10-KSB filed for fiscal year ended December 31, 2002;

*

 

 

 

  

 

3.4

By-laws, as amended by shareholders on January 24, 2002, incorporated by reference to Form 10-KSB filed for fiscal year ended December 31, 2002;

*

 

 

 

  

 

3.5

Certificate of Amendment to the Certificate of Incorporation dated October 21, 2004 setting forth terms and conditions of Class B Preferred, incorporated by reference to Form 10-QSB filed for fiscal quarter ended September 30, 2004;

*

 

 

 

  

 

3.6

Certificate of Amendment to the Certificate of Incorporation dated January 26, 2007 increasing authorized common shares from 40,000,000 to 400,000,000, incorporated by reference to Form 10-K filed for fiscal year ended December 31, 2006;

*

  

  

  

  

 

3.7

Certificate of Amendment to the Certificate of Incorporation dated September 21, 2011 setting forth terms and conditions of Class C Preferred, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011.

*

  

  

  

  

 

3.8

Certificate of Amendment to the Certificate of Incorporation dated March 28, 2014 setting forth terms and conditions of Series C-2 Preferred, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on March 28, 2014.

*

 

 

 

  

(4)

Instruments defining the rights of holders including indentures

  

 

None.  

  

 

 

 

  

(10)

Material Contracts

  

 

 

 

  

 

10.1 

2011 Stock Option Plan and template agreements to be used to grant options thereunder, incorporated by reference to annual report (Form 10-K) filed March 29, 2011;

*

 

 

 

  

 

10.2

Stock Option Agreement dated September 30, 2010 between the company and Richard A. Kaplan, incorporated by reference to current report (Form 8-K) filed October 6, 2010;

*

 

 

 

  

 

10.3

Employment Agreement dated October 4, 2010 between the Company and Richard A. Kaplan, incorporated by reference to current report (Form 8-K) filed October 6, 2010

*

  

 

10.4

Agreement dated December 13, 2010 between Heinrocket Inc. as Consultant and Torvec, Inc., incorporated by reference to annual report (Form 10-K) filed March 29, 2011.

*

 

 

 

  

 

10.5

Securities Purchase Agreement by and among Torvec, Inc., a New York corporation, B. Thomas Golisano, and each purchaser listed on the Schedule of Purchasers attached thereto, dated September 23, 2011, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011.

*

        

  

10.6

Form of Warrant to Purchase Common Stock of Torvec, Inc., incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011.

*

  

  

 

  

  

10.7

Form of Directors Subscription Agreement, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011.

*

  

  

 

  

 

 

 
 24

 

 

  

10.8

Investors’ Rights Agreement by and between Torvec, Inc., a New York corporation, B. Thomas Golisano, Charles T. Graham, and David Still, dated September 23, 2011, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011.

*

  

  

  

  

  

10.9

Letter Agreement between Torvec, Inc. and SCIRE Corporation, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on December 27, 2012

*

  

  

  

  

  

10.10

 Letter Agreement between Torvec, Inc. and SCIRE Corporation, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on December 5, 2013.

*

  

  

  

  

  

10.11

 Amended and Restated Investors’ Rights Agreement by and between Torvec, Inc., a New York corporation, B. Thomas Golisano, Charles T. Graham, and David Still, dated March 28, 2014, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on March 28, 2014.

*

  

  

  

  

  

10.12

 Securities Purchase Agreement by and among Torvec, Inc., B. Thomas Golisano, and each purchaser listed on the Schedule of Purchasers attached thereto, dated September 23, 2011, incorporated by reference to From 8-K filed with the Securities and Exchange Commission on September 26, 2011.

*

       

  

10.13

  Employment Agreement effective September 1, 2015 between the Company and Kathleen A. Browne, incorporated by reference to current report (Form 8-K) filed September 17, 2015

*

       

(11)

Statement re computation of per share earnings (loss)  

  

 

Not applicable.  

  

 

 

 

  

(15)

Letter re: unaudited interim financial information  

  

 

None.  

  

 

 

 

  

(18)

Letter re change in accounting principles  

  

 

None.  

  

 

 

 

  

(19)

Report furnished to security holders

  

 

None.

  

  

  

  

  

(22)

Published report regarding matters submitted to vote of security holders  

  

 

None.  

  

 

 

 

  

(23)

Consents of experts and counsel  

  

 

None.  

  

  

  

  

  

(23.1)

Registered independent accounting firm consent  

  

 

None.  

  

  

  

  

  

(24)

Power of attorney  

  

 

None.  

  

 

 

 

  

(31.1)

Rule 13(a)-14(a)/15(d)-14(a) Certifications – CEO  

**

 

 

 

  

(31.2)

Rule 13(a)-14(d)/15(d)-14(d) Certifications – CFO  

**

 

 

 

  

(32)

Section 1350 Certifications  

**

 

 

 

  

(99)

Additional exhibits  

  

 

None.

  

 

 

 

  

(100)

XBRL-related documents  

  

 

None.

  

 

 

 

  

(101)

The following materials from Torvec, Inc.’s Quarterly Report on Form 10-Q for the period ended September 30, 2015, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three and nine month periods ended September 30, 2015 and 2014 (ii) Condensed Consolidated Balance Sheets as of September 30, 2015 and December 31, 2014, (iii) Condensed Consolidated Statements of Cash Flows for the nine month periods ended September 30, 2015 and 2014, and (iv) Notes to Condensed Consolidated Financial Statements***  

  

 

 

  

 

*previously filed

** attached herein

*** Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

  

 

 

 
25

 

 

SIGNATURES 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

TORVEC, INC.

 

 

 

 

 

 

 

 

 

Date: November 4, 2015

By:

/s/ Richard A. Kaplan

 

 

 

Richard A. Kaplan

 

 

 

Chief Executive Officer

 

 

 

Date: November 4, 2015

By:

/s/ Kathleen A. Browne

 

 

 

Kathleen A. Browne

 

 

 

Chief Financial Officer and Principal Accounting Officer  

 

26 

EX-31.1 2 ex31-1.htm EXHIBIT 31.1 ex31-1.htm

EXHIBIT 31.1

 

CERTIFICATION

 

I, Richard A. Kaplan, Chief Executive Officer of Torvec, Inc., hereby certify that:

 

 

1.

I have reviewed this annual report on Form 10-Q of Torvec, Inc.

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

Date: November 4, 2015

 

/s/ Richard A. Kaplan

 

 

 

Richard A. Kaplan 

 

 

 

Chief Executive Officer

 

 

EX-31.2 3 ex31-2.htm EXHIBIT 31.2 ex31-2.htm

EXHIBIT 31.2

 

CERTIFICATION

 

I, Kathleen A. Browne, Principal Accounting Officer of Torvec, Inc., hereby certifies that:

 

 

1.

I have reviewed this quarterly report on Form 10-Q of Torvec, Inc.

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

Date: November 4, 2015

 

/s/ Kathleen A. Browne

 

 

 

Kathleen A. Browne 

 

 

 

Principal Accounting Officer

 

                     

 

 

 

EX-32 4 ex32.htm EXHIBIT 32 ex32.htm

 EXHIBIT 32 

 

 

Certificate pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of Torvec, Inc. (“Torvec”) on Form 10-Q for period ending September 30, 2105 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Richard A. Kaplan, chief executive officer and Kathleen A. Browne, principal accounting officer, of Torvec, Inc. certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Torvec, Inc.

 

 

 

 

 

 

 

 

 

November 4, 2015  

 

/s/ Richard A. Kaplan

 

 

 

Richard A. Kaplan 

 

 

 

Chief Executive Officer  

 

 

 

 

 

 

November 4, 2015  

 

/s/ Kathleen A. Browne

 

 

 

Kathleen A. Browne 

 

 

 

Principal Accounting Officer

 

                     

 

 

 

Issuer Statement

A signed original of this written statement required by Section 906 has been provided to Torvec,
Inc. and will be retained by Torvec, Inc. and furnished to the Securities and Exchange Commission
or its staff upon request.

 

 

 

 

 

 

EX-101.INS 5 tovc-20150930.xml EXHIBIT 101.INS false --12-31 Q3 2015 2015-09-30 10-Q 0001063197 45754041 Yes Smaller Reporting Company TORVEC INC No No 75070 75070 5000 P5Y 170 P1Y P1Y 1000000 P5Y 283000 269000 721000 876000 6256 6256 518000 218000 50000 200000 25000 P3Y 0.1 4000 P6Y -4250000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Office Equipment and Software (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3 &#x2013; 7</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Leasehold Improvements </div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Lesser of useful life or lease term</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shop Equipment (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3&nbsp;&#x2013; 7</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transportation Equipment (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">5</div></div></td> </tr> </table></div> 200 1200 150 369000 262000 953000 922000 0.04 2694250 50000 2.99 P5Y 0 0 249000 85000 342000 160000 348000 133000 2000 5000 7000 -27000 16363 10 17000 90000 118500 743500 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">NOTE E &#x2014; ACCRUED LIABILITIES</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At September 30, 2015 and December&nbsp;31, 2014, accrued liabilities consist of the following: </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">September</div><div style="display: inline; font-weight: bold;"> 30,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">December 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2015</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2014</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued compensation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">40,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">29,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued benefits and other</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">13,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">2,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued legal</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">10,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">56,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">41,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 126000 67000 56000 41000 3000 10000 40000 29000 556000 509000 71907000 71559000 349000 133000 252000 90000 625000 54172069 53514325 625000 0 0 0 0 300000 144000 2444000 4010000 1986000 3739000 9000 9000 7000 9000 3724000 1072000 1946000 4255000 -1778000 3183000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Cash and Cash Equivalents</div></div>: Cash and cash equivalents may include time deposits, certificates of deposit, and highly liquid debt instruments with original maturities of six months or less. We maintain cash and cash equivalents at financial institutions which periodically may exceed federally insured amounts. </div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">NOTE H &#x2014; COMMITMENTS AND OTHER MATTERS</div></div><div style="display: inline; text-decoration: underline;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Leases</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership in which one of our directors is associated. (See Note D).&nbsp;&nbsp;In October 2014, we extended the lease for a three-year renewal term through May 31, 2018. The current rental rate is $6,256 per month ($75,070 per annum) for the remainder of the lease term. In addition, we are required to pay a proportionate share of the yearly real estate taxes and yearly common area costs. &nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Rent expense for the nine month periods ended September 30, 2015 and 2014 was approximately $53,000 and $51,000, respectively. Including consideration for the renewal options, rent payments required under the lease for the twelve month periods ending December 31, 2015 through 2019 will amount to approximately $72,000, $75,000, $75,000, and $31,000, respectively.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Employment Agreements</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In the third quarter of 2015, the Company hired a Vice President of business development for the CURA division. The hiring agreement includes a severance agreement including six months salary if a termination by the Company is initiated other than for cause or executive good reason. Such severance will be based on the salary at the time of the action in return for a general release of the Company and its officers, directors and agents satisfactory to the Company.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In 2010, we appointed a new chief executive officer and executed a five year employment agreement pursuant to which we will pay base compensation of $50,000 per annum, which compensation increases to $200,000 per annum on the first day of the calendar year immediately following the calendar year in which we have adjusted EBITDA of at least $300,000 (earnings before interest, taxes, depreciation and amortization, but excluding all non-cash expenses associated with stock options). In September 2014, the CEO agreed to temporarily reduce his base compensation to $25,000 per annum. Under the agreement, the executive is entitled to a performance bonus based upon financial targets established each year in good faith by the Governance and Compensation Committee and the achievement of individual management objectives established annually by such committee. The executive is entitled to participate in all employee benefit plans as are provided from time to time for senior executives. If we terminate the executive, remove him as CEO, or a change in control of the Company occurs, the executive is entitled to six years&#x2019; severance pay, consisting of base pay and any incentive compensation. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Consulting Agreements</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company established the CURA Advisory Board during the third quarter of 2015 to assist in the design, development and commercialization of the CURA fatigue management products. This group consists of some of the most respected consultants, researchers and clinicians in the fatigue management industry. Each CURA member will interact in an advisory capacity with management to critique and assess the effectiveness of CURA products prior to product introduction in order to maximize the effectiveness and user experience. The CURA advisors will each received an annual stipend of $5,000, will be paid $4,000 per year for attendance at four meetings and receive a grant of 50,000 common stock options, vesting over four years at an exercise price equal to the market price on the date of issuance. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective as of January 1, 2013, we entered into a consulting agreement with SCIRE Corporation, of which one of our directors is president, to provide us with expertise and advice on hydraulic pump technology and related markets. During the nine month periods ended September 30, 2015 and 2014, we recorded expense of approximately $14,000 and $22,000, respectively, for consulting services and travel costs related to this agreement. In November 2014, we extended this consulting agreement through December 31, 2015, providing for a guaranteed minimum of $1,200 per month, based on 8 hours of consulting, plus travel costs. Additional hours above this minimum incurred in 2015 will be billed at a rate of $150 per hour.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In 2010, we engaged the services of a consulting firm to provide expertise with business development initiatives, strategic planning and general funding opportunities. In 2011, the agreement was modified to pay the consultant a commission equal to 4% of the value received by us from third parties introduced to us by or through the auspices of the consultant through January 1, 2017. Cumulatively, through September 30, 2015, we have recorded approximately $3,000 of expense for services rendered in relation to this agreement. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Prototype Development Agreements</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In January 2013, we entered into a development agreement with Chinese automotive manufacturer, BAIC Motor Co., Ltd. (&#x201c;BAIC&#x201d;). During the second quarter of 2014, we recorded approximately $39,000 in revenue associated with this agreement, along with related expenses of approximately $50,000. In December 2014, we recorded an uncollectible reserve against the outstanding receivable balance of approximately $20,000 due to the delinquency in receiving payment from this customer. During the second quarter of 2015, the Company recovered the full amount of this previously reserved receivable. This recovery was recorded in general and administrative expense on the Statement of Operations.</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></div> 0.01 0.01 400000000 400000000 45754041 45754041 45716298 45716298 457000 457000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Consolidation</div></div>: The financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (56% owned at September 30, 2015 and December 31, 2014). As of September 30, 2015, each of the subsidiaries is non-operational. We are intending to let Ice Surface Development, Inc. dissolve by proclamation. All material intercompany transactions and account balances have been eliminated in consolidation. </div></div></div></div></div></div></div></div></div></div> 6000 86000 0 65000 1 1 1 1 1 50000 92000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">NOTE F &#x2014; NOTES PAYABLE</div></div><div style="display: inline; text-decoration: underline;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2015 and December 31, 2014, notes payable consists of the following:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">September</div><div style="display: inline; font-weight: bold;"> 30,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">December 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2015</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 17.65pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 17.65pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2014</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Copy machine </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">9,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #cceeff">2,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Automobile </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #ffffff">4,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">9,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #cceeff">6,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In the nine months ended September 30, 2015, a capital lease for a copy machine was fully paid and we entered into a new capital lease agreement for a copy machine with a term of 5 years. The capitalized value of the lease was approximately $9,000, with a monthly payment of approximately $170 and an implicit interest rate of approximately 4.8%. At September 30, 2015, the outstanding balance on this note was approximately $9,000, of which $7,000 was classified as a non-current liability.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In 2012, we purchased an automobile for $16,600, a vehicle that we had previously been leasing. We financed this purchase with a 36 month promissory note. The interest rate on the note was approximately 10% and the payments were approximately $540 per month. At December 31, 2014, the outstanding balance on this note was approximately $4,000 which was classified as a current liability. During the second quarter of 2015 this note was fully paid.&nbsp;</div></div></div> 4250000 16600 0.048 0.1 540 P3Y 10000 21000 21000 59000 69000 27000 39000 85000 125000 0 0 0 0 0.40 0.40 0.50 0.50 167000 173000 25000 2351000 2249000 344000 319000 64000 66000 192000 198000 65000 3000 -0.02 -0.01 -0.05 -0.14 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Loss per Common Share: </div></div>FASB&#x2019;s ASC 260-10 (previously known as FASB Statement 128, &#x201c;Earnings Per Share&#x201d;) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At September 30, 2015 and 2014, we excluded 54,172,069 and 53,514,325 potential common shares, respectively, relating to convertible preferred stock, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. We have excluded 625,000 warrants from the diluted net loss per common share calculation at September 30, 2015 and 2014 as the conditions for their vesting are not time-based. </div></div></div></div></div></div></div></div></div></div> 199000 P1Y182D 0 0.56 0.56 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Fair Value of Financial Instruments: </div></div>As defined by U.S. GAAP<div style="display: inline; font-style: italic;">, </div>fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. All assets and liabilities are required to be measured and reported on a fair value basis. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in one of the following&nbsp;three categories:</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 1: Quoted market prices in active markets for identical assets or liabilities.</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 3: Unobservable inputs that are not corroborated by market data.</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The FASB&#x2019;s (Financial Accounting Standards Board) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB&#x2019;s guidance for the disclosure about fair value of financial instruments approximated their carrying values at September 30, 2015 and December 31, 2014. The carrying amount of cash, prepaids and other current assets, accounts payable and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.</div></div></div></div></div></div></div></div></div></div> 19000 12000 532000 1063000 354000 1036000 -42000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Research and Development and Patents: </div></div>Research and development costs and patent expenses are charged to operations as incurred. Research and development includes personnel-related costs, materials and supplies, depreciation, consulting services, and amortization of acquired technology. Depreciation expense that was charged to research and development for the three month periods ended September 30, 2015 and 2014 was $21,000 in each period. Depreciation expense that was charged to research and development for the nine month periods ended September 30, 2015 and 2014 was $59,000 and $69,000, respectively.</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Patent costs for the three month periods ended September 30, 2015 and 2014 amounted to $22,000 and $44,000, respectively, and are included in general and administrative expenses. Patent costs for the nine month periods ended September 30, 2015 and 2014 amounted to $69,000 and $90,000, in each of the respective periods, and are included in general and administrative expenses. </div></div></div></div></div></div></div></div></div></div> -900000 -614000 -1992000 -1946000 300000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Income Taxes: </div></div>We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized. </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of September 30, 2015, there was no accrued interest or penalties related to uncertain tax positions. The tax years 2011 through 2014 remain open to examination by the federal and state tax jurisdictions to which we are subject. <div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div></div></div></div></div></div></div></div> 75000 19000 -20000 -20000 20000 -5000 -20000 25000 26000 1000 53000 51000 253000 253000 P3Y 191000 114000 2444000 4010000 184000 114000 7000 226000 213000 -4000 4908000 -246000 27000 -1528000 -1752000 -964000 -680000 -2184000 -6394000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Recent Accounting pronouncements:</div></div><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div>ASU 2015-05 Intangibles &#x2013; Goodwill and Other-Internal-Use Software (subtopic 350-40) Customer&#x2019;s Accounting for Fees Paid in a Cloud Computing Agreement. The Financial Accounting Standards Board (&#x201c;FASB&#x201d;) added guidance to Subtopic 350-40 to help entities evaluate the accounting for fees paid in a cloud computing arrangement. The amendments provide a basis for evaluating whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a license to internal-use software, then the software license should be accounted for in accordance with Subtopic 350-40. If a cloud computing arrangement does not include a software license, then the arrangement should be accounted for as a service contract. This Update will be effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. This guidance will not have an immediate effect on the Company operations but will be considered as our product development and offering expands in future years. </div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In June 2015 the FASB issued ASU 2015-14 Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date. The standard is now effective for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect recognized at the date of adoption (which includes additional footnote disclosures). In May 2014, the FASB issued ASU 2014-09,&#x201d;Revenue from Contracts with Customers&#x201d;, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. We are currently evaluating the impact of the adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard.<div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div></div></div></div></div></div></div></div> 9000 2000 4000 9000 6000 4000 2000 6000 2 201000 446000 17000 19000 170000 514000 251000 876000 903000 621000 2023000 1931000 -903000 -621000 -2023000 -1973000 72000 31000 75000 75000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">NOTE A &#x2014; THE COMPANY AND BASIS OF PRESENTATION</div></div><div style="display: inline; text-decoration: underline;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Management announced a name change for the </div><div style="display: inline; font-weight: bold;">C</div><div style="display: inline; font-weight: bold;">ompany during the third quarter of 2015. The company will establish its business around two divisions. The CURA </div><div style="display: inline; font-weight: bold;">d</div><div style="display: inline; font-weight: bold;">ivision will oversee the Fatigue Management Consulting business, and the Aegis </div><div style="display: inline; font-weight: bold;">d</div><div style="display: inline; font-weight: bold;">ivision that will oversee the Power and Hydraulic business. The new name of the company will be </div><div style="display: inline; font-weight: bold;">CurAegis Technologies, Inc.</div><div style="display: inline; font-weight: bold;"> This will be used as a DBA until the next shareholders meeting when we will officially change the name.</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The interim information contained herein with respect to the three and nine month periods ended September 30, 2015 and 2014 have not been audited but has been prepared in conformity with generally accepted accounting principles for interim financial information and instructions for Form 10-Q. Accordingly, the condensed consolidated financial statements do not include all information and footnotes required by generally accepted accounting principles for financial statements. Included are ordinary adjustments which, in the opinion of management, are necessary for a fair presentation of the financial information for the three and nine month periods ended September 30, 2015 and 2014. The results are not necessarily indicative of results to be expected for the entire year. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company was incorporated as a New York business corporation on September&nbsp;25, 1996. The Company develops and markets advanced technologies in the areas of power, safety and wellness.&nbsp; Currently, the Company is focusing its commercialization strategies on the following technologies: (i) the CURA system which encompasses a wearable device, the MyCadian&#x2122; Watch which measures degradation of alertness and sleep attributes and the Z Coach education and training tool (ii) the Hydraulic Pump.&nbsp;The MyCadian&#x2122; Watch consists of hardware and software that measures multiple metrics in order to establish that a person's ability to perform a task or job appears to be degrading. The Hydraulic Pump is an innovative hydraulic design, whose goal is to deliver better efficiencies in a package that is smaller and lighter than existing technologies.&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> The Company has not yet had any significant revenue-producing operations.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As used in this quarterly report, unless otherwise indicated, the terms &#x201c;we&#x201d;, &#x201c;our&#x201d;, &#x201c;us&#x201d;, &#x201c;the Company&#x201d; and &#x201c;CurAegis&#x201d; refer to Torvec, Inc.</div></div></div> 13000 2000 3000 7000 31000 27000 46000 308000 43000 0 0 8709 4 4 5 0.40 0.20 6500000 5000000 2351000 2249000 344000 319000 6500000 5000000 0.01 0.01 0.01 0.40 0.50 4 5 16250000 100000000 3300000 100000000 16250000 16250000 25000000 25000000 3300000 3300000 300000 300000 16250000 25000000 16250000 16250000 25000000 25000000 565721 587101 67500 67500 565721 67500 25000000 16250000 16250000 25000000 25000000 587101 67500 162000 162000 250000 250000 6000 6000 1000 1000 557012 40000 15000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div>: Certain reclassifications have been made to prior year balances to conform to the current year&#x2019;s presentation.</div></div></div></div></div></div></div></div></div></div> 4954000 4954000 62000 70000 0 0 0 0 -1992000 -1946000 -900000 -614000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">NOTE C &#x2013; PROPERTY AND EQUIPMENT</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At September 30, 2015 and December&nbsp;31, 2014, property and equipment consist of the following:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Office equipment and software</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">518,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">218,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shop equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">226,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">213,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Leasehold improvements</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">253,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">253,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transportation equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">17,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">90,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Construction in progress</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,014,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">780,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Less accumulated depreciation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">556,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">509,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net property and equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">458,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">271,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has invested $308,000 in property and equipment during the nine months ended September 30, 2015. During the three month period ended September 30, 2015, the Company acquired the Z-Coach fatigue management software tool. This educational software will be enhanced and expanded to target an array of industry applications and become a key component of the CURA system product offerings.</div></div></div> 1014000 780000 458000 271000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Property and Equipment:</div></div> Property and equipment are stated at cost. Estimated useful lives are as follows:</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Office Equipment and Software (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3 &#x2013; 7</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Leasehold Improvements </div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Lesser of useful life or lease term</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shop Equipment (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3&nbsp;&#x2013; 7</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transportation Equipment (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">5</div></div></td> </tr> </table> </div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Depreciation and amortization are computed using the straight-line method. Betterments, renewals and repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and amortization expense for the three month periods ended September 30, 2015 and 2014 amounted to $27,000 and $39,000, respectively. &nbsp;&nbsp;Depreciation and amortization expense for the nine month periods ended September 30, 2015 and 2014 amounted to $85,000 and $125,000, respectively.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Whenever events or circumstances indicate, our long-lived assets, including any intangible assets with finite useful lives, are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may be indicated. The carrying amount is then compared to the estimated discounted cash flows, and if there is an excess, such amount is recorded as impairment. During the three and nine month periods ended September 30, 2015 and 2014, we did not record any impairment charges.</div></div></div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">September 30, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">December 31, </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Office equipment and software</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">518,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">218,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shop equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">226,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">213,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Leasehold improvements</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">253,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">253,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transportation equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">17,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">90,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Construction in progress</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1,014,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">780,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Less accumulated depreciation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">556,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">509,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net property and equipment</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">458,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">271,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> P3Y P7Y P3Y P7Y P5Y -20000 5000 7000 14000 22000 60000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">NOTE D&#x2014; RELATED PARTY TRANSACTIONS</div></div><div style="display: inline; text-decoration: underline;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership in which one of our directors is associated.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In October 2014, we extended this lease for a three-year renewal term through May 31, 2018. In June 2015 the rental rate increased to $6,256 per month ($75,070 per annum) for the remainder of the lease term. In addition, we are required to pay a proportionate share of the yearly real estate taxes and yearly common area costs. The lease agreement has a three-year renewal option that includes a 10% rate increase at the renewal period. (See Note H) </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During 2010 we executed an agreement with a director to provide consulting services at a rate of $200 per hour. Pursuant to the agreement, we also agreed to pay the consultant an incentive fee equal to $10,000 or proportionate part thereof for each $1,000,000 of revenue or proportionate part thereof actually received by us for a period of five years, provided the definitive agreement with the third party results from the material efforts of the consultant. During the three and nine month periods ended September 30, 2015 and 2014, we recorded no expense for services rendered in relation to this agreement.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has a consulting agreement that extends to December 31, 2015 with SCIRE Corporation, of which one of our directors is president, to provide us with expertise and advice on hydraulic pump technology and related markets. The agreement provides for guaranteed minimum month fees, based on 8 hours of consulting, plus travel costs. During the three month periods ended September 30, 2015 and 2014, we recorded an expense of approximately $5,000 and $7,000, respectively, for consulting services and travel costs related to this agreement. During the nine month periods ended September 30, 2015 and 2014, we recorded an expense of approximately $14,000 and $22,000, respectively, for consulting services and travel costs related to this agreement. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Effective April 13, 2015, we entered into a consulting agreement with ProNexus LLC, of which one of our directors, Thomas Bonadio, through his affiliation with The Bonadio Group, is a minority investor. ProNexus LLC was engaged to provide outsourced finance and accounting services. During the nine months ended September 30, 2015, we recorded approximately $60,000 in connection with this service agreement. This service agreement was completed in August 2015.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the nine months ended September 30, 2014, we sold a limited number of Iso-Torque differentials into the aftermarket to Model C-5 Corvette enthusiasts. A majority of these sales, amounting to approximately $9,000, were made to one of our board members at a discount to stated list price.</div></div></div> 4000 46000 22000 44000 69000 90000 371000 267000 960000 895000 -70530000 -68539000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Revenue Recognition: </div></div>Our terms provide that customers are obligated to pay for products sold to them within a specified number of days from the date that title to the products is transferred to the customers. Our standard terms are typically net 30&nbsp;days. We recognize revenue when transfer of title occurs, risk of ownership passes to a customer at the time of shipment or delivery depending on the terms of the agreement with a particular customer and collection is reasonably assured. The sale price of our products is substantially fixed and determinable at the date of the sale based upon purchase orders generated by a customer and accepted by us. </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We occasionally enter into prototype development contracts with customers. In such cases, revenue is recognized using either (a)&nbsp;the proportional effort method based on the relationship of costs incurred to date to the total estimated cost to complete a contract, or (b) where appropriate, the milestone method, if milestones are clearly identifiable and substantive. </div></div></div></div></div></div></div></div></div></div> 0 0 9000 39000 50000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">September</div><div style="display: inline; font-weight: bold;"> 30,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">December 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2015</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2014</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued compensation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">40,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">29,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued benefits and other</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">13,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">2,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accrued legal</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">10,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">56,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">41,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">September</div><div style="display: inline; font-weight: bold;"> 30,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">December 31,</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2015</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 17.65pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 0pt 0pt 17.65pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2014</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Copy machine </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">9,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #cceeff">2,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Automobile </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #ffffff">4,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 18pt; BACKGROUND-COLOR: #cceeff">9,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 4.45pt; BACKGROUND-COLOR: #cceeff">6,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Term</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Price </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at January 1, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3,356,750</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.99</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">(A)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5.6</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">77,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 48%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Canceled or expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">37,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.01</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 48%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at September 30, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3,319,250</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.04</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">(A)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(B)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">9,300</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 48%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at September 30, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,694,250</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.99</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(C)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">9,300</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Term</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Price</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at January 1, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,343,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.63</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">695,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.53</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Canceled or expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at September 30, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">8,938,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.57</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.7</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">265,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at September 30, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">6,062,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.66</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">121,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 8%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="3"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected term in years</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6.5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6.3&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected forfeiture rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk free rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">1.5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.1%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;130</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">135%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">135%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Business Segments:</div></div> During the third quarter of 2015, the company announced the monitoring of its business operations will focus on two divisions in future periods. The CURA division will oversee the Fatigue Management Consulting business and the Aegis division will oversee the Power and Hydraulic business. No revenue has been recognized by either business segment during the nine months ended September 30, 2015. </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The CURA division incurred $201,000 and $446,000 in expenses in the three and nine month periods ended September 30, 2015. The CURA division incurred $17,000 and $19,000 in expenses in the three and nine month periods ended September 30, 2014. </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Aegis division incurred $170,000 and $514,000 in expenses in the three and nine months periods ended September 30, 2015, respectively. The Aegis division incurred $251,000 and $876,000 in expenses in the three and nine months periods ended September 30, 2014, respectively. </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Corporate general and administrative expenses will not be allocated to the business segments. Corporate general and administrative expenses were $532,000 and $1,063,000 in the three and nine months periods ended September 30, 2015, respectively. Corporate general and administrative expenses were $354,000 and $1,036,000 in the three and nine months periods ended September 30, 2014, respectively. </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Assets attributed to the CURA division at September 30, 2015 were $300,000. Assets attributed to the Aegis division at September 30 2015 were $144,000. Assets considered as corporate assets as of September 30, 2015 were $2,000,000.</div></div></div></div></div></div></div></div></div></div> P5Y P5Y P4Y 1.1 1.1 0 37500 0.01 0 0 3356750 3319250 1.99 2.04 P5Y219D P5Y 337500 0 0 1.3 1.35 1.35 0.015 0.02 0.021 6965000 2000000 3000000 0 1277000 0 6062000 0.66 1823895 100000 100000 5 0 0 125000 250000 1823895 675000 500 695000 11000 695000 11000 50000 0.53 0.36 265000 0 1973000 8343000 8938000 0.63 0.57 1247000 4815000 0.1 0.1 0.53 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Stock-based Compensation: </div></div>FASB Accounting Standards Codification (&#x201c;ASC&#x201d;) 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. Under the modified prospective method that we adopted, awards that were granted, modified, or settled on or after January&nbsp;1, 2006 are measured and accounted for in accordance with ASC 718-10. Unvested equity-classified awards that were granted prior to January&nbsp;1, 2006 will continue to be accounted for in accordance with ASC 718-10, except that the grant date fair value of all awards are recognized in the results of operations over the remaining vesting periods. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with ASC 718-10.&nbsp;&nbsp;&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets. We elected to adopt the alternative method of calculating the historical pool of windfall tax benefits as permitted by FASB ASC 718-10-65 (previously known as: FASB Staff Position (FSP&nbsp;No.&nbsp;SFAS 123(R)-c, &#x201c;Transition Election Related to Accounting for the Tax Effects of Share-Based Payment Awards.&#x201d;). This is a simplified method to determine the pool of windfall tax benefits that is used in determining the tax effects of stock compensation in the results of operations and cash flow reporting for awards that were outstanding as of the adoption of FASB ASC 718-10. </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">FASB ASC 505-50, &#x201c;Equity-Based Payments to Non-Employees,&#x201d; requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as compensation expense generally over the service period of the consulting arrangement or until performance conditions are expected to be met. Using a Black-Scholes valuation model, we periodically reassess the fair value of non-employee options until service conditions are met, which generally aligns with the vesting period of the options, and we adjust the expense recognized in the consolidated financial statements accordingly.</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">FASB ASC 718-20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award.&nbsp; Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.</div></div></div></div></div></div></div></div></div></div> 0.20 5 9300 77000 9300 P10Y P10Y P5Y P6Y182D P6Y109D 121000 P5Y182D P6Y P5Y255D 861000 690000 406375 6250 472000 131750 337500 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">NOTE B &#x2014; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div></div><div style="display: inline; text-decoration: underline;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Consolidation</div></div>: The financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (56% owned at September 30, 2015 and December 31, 2014). As of September 30, 2015, each of the subsidiaries is non-operational. We are intending to let Ice Surface Development, Inc. dissolve by proclamation. All material intercompany transactions and account balances have been eliminated in consolidation. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates: </div></div>The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates are used in valuing the useful lives of any intangible assets and the future realizable value of such assets. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div>: Certain reclassifications have been made to prior year balances to conform to the current year&#x2019;s presentation.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Cash and Cash Equivalents</div></div>: Cash and cash equivalents may include time deposits, certificates of deposit, and highly liquid debt instruments with original maturities of six months or less. We maintain cash and cash equivalents at financial institutions which periodically may exceed federally insured amounts. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Property and Equipment:</div></div> Property and equipment are stated at cost. Estimated useful lives are as follows:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Office Equipment and Software (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3 &#x2013; 7</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Leasehold Improvements </div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Lesser of useful life or lease term</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shop Equipment (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">3&nbsp;&#x2013; 7</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 44.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Transportation Equipment (years)</div></div></td> <td style="WIDTH: 1.1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 53.9%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">5</div></div></td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Depreciation and amortization are computed using the straight-line method. Betterments, renewals and repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and amortization expense for the three month periods ended September 30, 2015 and 2014 amounted to $27,000 and $39,000, respectively. &nbsp;&nbsp;Depreciation and amortization expense for the nine month periods ended September 30, 2015 and 2014 amounted to $85,000 and $125,000, respectively.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Whenever events or circumstances indicate, our long-lived assets, including any intangible assets with finite useful lives, are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may be indicated. The carrying amount is then compared to the estimated discounted cash flows, and if there is an excess, such amount is recorded as impairment. During the three and nine month periods ended September 30, 2015 and 2014, we did not record any impairment charges.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Fair Value of Financial Instruments: </div></div>As defined by U.S. GAAP<div style="display: inline; font-style: italic;">, </div>fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. All assets and liabilities are required to be measured and reported on a fair value basis. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in one of the following&nbsp;three categories:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 1: Quoted market prices in active markets for identical assets or liabilities.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level 3: Unobservable inputs that are not corroborated by market data.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The FASB&#x2019;s (Financial Accounting Standards Board) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB&#x2019;s guidance for the disclosure about fair value of financial instruments approximated their carrying values at September 30, 2015 and December 31, 2014. The carrying amount of cash, prepaids and other current assets, accounts payable and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Revenue Recognition: </div></div>Our terms provide that customers are obligated to pay for products sold to them within a specified number of days from the date that title to the products is transferred to the customers. Our standard terms are typically net 30&nbsp;days. We recognize revenue when transfer of title occurs, risk of ownership passes to a customer at the time of shipment or delivery depending on the terms of the agreement with a particular customer and collection is reasonably assured. The sale price of our products is substantially fixed and determinable at the date of the sale based upon purchase orders generated by a customer and accepted by us. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We occasionally enter into prototype development contracts with customers. In such cases, revenue is recognized using either (a)&nbsp;the proportional effort method based on the relationship of costs incurred to date to the total estimated cost to complete a contract, or (b) where appropriate, the milestone method, if milestones are clearly identifiable and substantive. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Business Segments:</div></div> During the third quarter of 2015, the company announced the monitoring of its business operations will focus on two divisions in future periods. The CURA division will oversee the Fatigue Management Consulting business and the Aegis division will oversee the Power and Hydraulic business. No revenue has been recognized by either business segment during the nine months ended September 30, 2015. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The CURA division incurred $201,000 and $446,000 in expenses in the three and nine month periods ended September 30, 2015. The CURA division incurred $17,000 and $19,000 in expenses in the three and nine month periods ended September 30, 2014. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Aegis division incurred $170,000 and $514,000 in expenses in the three and nine months periods ended September 30, 2015, respectively. The Aegis division incurred $251,000 and $876,000 in expenses in the three and nine months periods ended September 30, 2014, respectively. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Corporate general and administrative expenses will not be allocated to the business segments. Corporate general and administrative expenses were $532,000 and $1,063,000 in the three and nine months periods ended September 30, 2015, respectively. Corporate general and administrative expenses were $354,000 and $1,036,000 in the three and nine months periods ended September 30, 2014, respectively. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Assets attributed to the CURA division at September 30, 2015 were $300,000. Assets attributed to the Aegis division at September 30 2015 were $144,000. Assets considered as corporate assets as of September 30, 2015 were $2,000,000.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Research and Development and Patents: </div></div>Research and development costs and patent expenses are charged to operations as incurred. Research and development includes personnel-related costs, materials and supplies, depreciation, consulting services, and amortization of acquired technology. Depreciation expense that was charged to research and development for the three month periods ended September 30, 2015 and 2014 was $21,000 in each period. Depreciation expense that was charged to research and development for the nine month periods ended September 30, 2015 and 2014 was $59,000 and $69,000, respectively.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Patent costs for the three month periods ended September 30, 2015 and 2014 amounted to $22,000 and $44,000, respectively, and are included in general and administrative expenses. Patent costs for the nine month periods ended September 30, 2015 and 2014 amounted to $69,000 and $90,000, in each of the respective periods, and are included in general and administrative expenses. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Stock-based Compensation: </div></div>FASB Accounting Standards Codification (&#x201c;ASC&#x201d;) 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. Under the modified prospective method that we adopted, awards that were granted, modified, or settled on or after January&nbsp;1, 2006 are measured and accounted for in accordance with ASC 718-10. Unvested equity-classified awards that were granted prior to January&nbsp;1, 2006 will continue to be accounted for in accordance with ASC 718-10, except that the grant date fair value of all awards are recognized in the results of operations over the remaining vesting periods. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with ASC 718-10.&nbsp;&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets. We elected to adopt the alternative method of calculating the historical pool of windfall tax benefits as permitted by FASB ASC 718-10-65 (previously known as: FASB Staff Position (FSP&nbsp;No.&nbsp;SFAS 123(R)-c, &#x201c;Transition Election Related to Accounting for the Tax Effects of Share-Based Payment Awards.&#x201d;). This is a simplified method to determine the pool of windfall tax benefits that is used in determining the tax effects of stock compensation in the results of operations and cash flow reporting for awards that were outstanding as of the adoption of FASB ASC 718-10. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">FASB ASC 505-50, &#x201c;Equity-Based Payments to Non-Employees,&#x201d; requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as compensation expense generally over the service period of the consulting arrangement or until performance conditions are expected to be met. Using a Black-Scholes valuation model, we periodically reassess the fair value of non-employee options until service conditions are met, which generally aligns with the vesting period of the options, and we adjust the expense recognized in the consolidated financial statements accordingly.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">FASB ASC 718-20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award.&nbsp; Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Income Taxes: </div></div>We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of September 30, 2015, there was no accrued interest or penalties related to uncertain tax positions. The tax years 2011 through 2014 remain open to examination by the federal and state tax jurisdictions to which we are subject. <div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Loss per Common Share: </div></div>FASB&#x2019;s ASC 260-10 (previously known as FASB Statement 128, &#x201c;Earnings Per Share&#x201d;) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At September 30, 2015 and 2014, we excluded 54,172,069 and 53,514,325 potential common shares, respectively, relating to convertible preferred stock, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. We have excluded 625,000 warrants from the diluted net loss per common share calculation at September 30, 2015 and 2014 as the conditions for their vesting are not time-based. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Recent Accounting pronouncements:</div></div><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> </div></div>ASU 2015-05 Intangibles &#x2013; Goodwill and Other-Internal-Use Software (subtopic 350-40) Customer&#x2019;s Accounting for Fees Paid in a Cloud Computing Agreement. The Financial Accounting Standards Board (&#x201c;FASB&#x201d;) added guidance to Subtopic 350-40 to help entities evaluate the accounting for fees paid in a cloud computing arrangement. The amendments provide a basis for evaluating whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a license to internal-use software, then the software license should be accounted for in accordance with Subtopic 350-40. If a cloud computing arrangement does not include a software license, then the arrangement should be accounted for as a service contract. This Update will be effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. This guidance will not have an immediate effect on the Company operations but will be considered as our product development and offering expands in future years. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In June 2015 the FASB issued ASU 2015-14 Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date. The standard is now effective for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect recognized at the date of adoption (which includes additional footnote disclosures). In May 2014, the FASB issued ASU 2014-09,&#x201d;Revenue from Contracts with Customers&#x201d;, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. We are currently evaluating the impact of the adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard.<div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> 0 0 0 21380 0 0 0 0 0 0 0 0 0 0 5000000 2253000 3896000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">NOTE G &#x2014; STOCKHOLDERS&#x2019; EQUITY</div></div><div style="display: inline; text-decoration: underline;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Common Stock</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We have 400 million common shares authorized with a par value of $0.01 per share. During the nine months ended September 30, 2015 we issued 21,380 common shares upon the election of a Class A preferred shareholder conversion and 16,363 common shares issued in satisfaction of Class A preferred dividend distribution.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Preferred Stock </div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our certificate of incorporation permits the Company to issue up to 100,000,000 shares of $0.01 par value preferred stock. Under the amendment, the board of directors has the authority to allocate these shares into as many separate classes of preferred as it deems appropriate and with respect to each class, designate the number of preferred shares issuable and the relative rights, preferences, seniority with respect to other classes and to our common stock and any limitations and/or restrictions that may be applicable without obtaining shareholder approval.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 9pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Class A Non-voting Cumulative Convertible Preferred Stock</div></div><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;"> &nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At September 30, 2015, there were&nbsp;565,721 outstanding shares of Class A Preferred stock, of which 8,709 shares resulted from the settlement of dividends due to conversion, and those shares no longer accrue dividends. Dividends payable upon the conversion of the remaining 557,012 outstanding shares of Class A Preferred stock amounted to approximately $2,351,000 at September 30, 2015, of which $167,000 was accumulated during nine month period ended September 30, 2015. During the nine month period ended September 30, 2015, holders of Class A preferred shares converted 21,380 shares into common stock and the Company settled $65,000 Class A Preferred dividends with the issuance of 16,363 shares of common stock. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">No Class A Preferred shares were sold or converted during the nine month period ended September 30, 2014 and no Class&nbsp;A Preferred dividends were settled during the nine months ended September 30, 2014. Accrued dividends payable upon the conversion of the Class A Preferred stock amounted to approximately $2,249,000 at December 31, 2014. The Company accumulated $173,000, during the nine month period ended September 30, 2014. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has authorized the issuance of up to 3,300,000 Class A Non-Voting Cumulative Convertible Preferred Shares. Each Class A Preferred Share is convertible after a one year holding period, at the holder&#x2019;s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of our common stock as a dividend or distribution and in the case of the subdivision or combination of our common stock. The Class A Preferred has no voting rights except with respect to matters directly impacting the rights and privileges accorded to such Class.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The holders of the Class A Preferred are entitled to receive cumulative preferential dividends in the amount of $0.40 per share of Class A Preferred for each annual dividend period. Dividends payable on the Class A Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class A Preferred at a rate of one share of Class A Preferred for each $4.00 of dividends. If dividends are paid in shares of Class A Preferred, such dividends are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one-to-one basis. Holders of Class A Preferred are permitted to request that dividends payable in Class A Preferred be immediately converted into shares of our common stock. At times, our board may elect to settle dividends through the issuance of common stock in lieu of cash. Accumulated and unpaid dividends on the Class A Preferred will not bear interest. Class A Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class A Preferred at the redemption price of $4.00 per Class A Preferred plus all unpaid accumulated dividends payable with respect to each Class A Preferred Share.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In the event of the liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred, Class A Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred shareholders&#x2019; liquidation preference was approximately $2,351,000 and $2,249,000 at September 30, 2015 and December 31, 2014, respectively. In the event of liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class A Preferred are payable in Class A Preferred shares at a rate of 1 share of Class A Preferred for each $4.00 of dividends.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 9pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Class B Preferred Stock</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">No Class B Preferred shares were sold during the nine month period ended September 30, 2015 and no Class&nbsp;B Preferred shares were issued to Class&nbsp;B Preferred shareholders as a dividend during the nine month period ended September 30, 2015. Depending upon our cash position, from time to time we may request that a converting preferred shareholder entitled to receive dividends in cash consent to receive shares of restricted common stock in lieu thereof.&nbsp;&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At September 30, 2015, there were 67,500 outstanding shares of Class B Preferred stock. At September 30, 2015, dividends payable upon the conversion of these outstanding shares of Class&nbsp;B Preferred amounted to approximately $344,000, of which $25,000 was accumulated during the nine month period ended September 30, 2015. At December 31, 2014, accrued dividends payable on the Class B Preferred shares was approximately $319,000.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Subject to the dividend rights and privileges of our Class A Preferred, the holders of the Class B Preferred are entitled to receive cumulative preferential dividends in the amount of $0.50 per share of Class B Preferred for each annual dividend period. Dividends payable on the Class B Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class B Preferred at a rate of one share of Class B Preferred for each $5.00 of dividends. If dividends are paid in shares of Class B Preferred, such dividends are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one-to-one basis. Holders of Class B Preferred are permitted to request that dividends payable in Class B Preferred be immediately converted into shares of our common stock. At times, our board may elect to settle dividends through the issuance of common stock in lieu of cash. Accumulated and unpaid dividends on the Class B Preferred will not bear interest. Class B Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class B Preferred at the redemption price of $5.00 per Class B Preferred plus all unpaid accumulated dividends payable with respect to each Class B Preferred Share.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In the event of the liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred and Class A Preferred shareholders, the Class B Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred shareholders&#x2019; liquidation preference was $344,000 and $319,000 at September 30, 2015 and December 31, 2014, respectively. In the event of a liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class B Preferred are payable in Class B Preferred shares at a rate of 1 share of Class B Preferred for each $5.00 of dividends.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 9pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Series C Preferred Stock</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has authorized and issued 16,250,000 shares of Series C Voting Convertible Preferred Stock. No Series C Preferred stock was converted during the nine month period ended September 30, 2015 or during the year ended December 31, 2014.&nbsp;The value of the Series C Preferred shareholders&#x2019; liquidation preference was $6,500,000 at September 30, 2015 and at December 31, 2014.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Each Series C Preferred Share is convertible after a one year holding period, at the holder&#x2019;s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of our common stock as a dividend or distribution and in the case of the subdivision or combination of our common stock. The Series C Preferred shares have no right to receive dividends and no redemption right. The Series C Preferred shares vote with the common stock on an as-converted basis.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 that is senior to our common stock, and the Company&#x2019;s Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, weather voluntary or involuntary or upon a deemed liquidation of the Company.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 9pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Series C-2 Preferred Stock</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In March 2014, the board of directors authorized and the Class A Preferred, the Class B Preferred and the Series C Preferred shareholders approved, a series of preferred stock, designated as Series C-2 Voting Convertible Preferred Stock. On March 28, 2014, we sold and issued a total of 25,000,000 shares of Series C-2 Voting Convertible Preferred Stock in a private placement transaction, generating gross proceeds of $5,000,000. Direct expenses of approximately $46,000 pertaining to the transaction, consisting of primarily external legal costs, were incurred, resulting in net proceeds of approximately $4,954,000. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2015, Series&nbsp;C-2 Preferred shareholders have not converted any shares of Series C-2 Preferred into common stock. At September 30, 2015, there were 25,000,000 shares of Preferred C-2 stock outstanding. The value of the Series C-2 Preferred shareholders&#x2019; liquidation preference was $5,000,000 at September 30, 2015 and at December 31, 2014.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Each Series C-2 Preferred Share is convertible, at the holder&#x2019;s election, into one share of our common stock, par value $0.01 per share. The conversion rate is subject to adjustment in the event of the issuance of common stock as a dividend or distribution, and the subdivision or combination of the outstanding common stock or a reorganization, recapitalization, reclassification, consolidation or merger of the Company.&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Series C-2 Preferred Shares have a liquidation preference at their stated value per share of $0.20 that ranks pari passu to our existing Series C Voting Convertible Preferred Shares and is senior to our common stock, and our Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or upon a deemed liquidation of the Company. A deemed liquidation includes, unless decided by the holders of at least two-thirds of the Series C-2 Preferred Shares, any consolidation, merger, or reorganization of the Company in which the shareholders of the Company own less than fifty percent of the voting power of the resultant entity, or an acquisition to which the Company is a party in which at least fifty percent of the Company&#x2019;s voting power is transferred, or the sale, lease, exclusive license or transfer of all or substantially all of the assets or intellectual property of the Company other than to a wholly owned subsidiary.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Series C-2 Preferred Shares are not entitled to receive preferred dividends and have no redemption right, but are entitled to participate, on an as converted basis; with holders of outstanding shares of common stock in dividends and distributions on liquidation after all preferred shares have received payment in full of any preferred dividends or liquidation preferences. The Series C-2 Preferred Shares vote with the common stock on an as-converted basis. We may not, without approval of the holders of at least two-thirds of the Series C-2 Preferred Shares, (i) create any class or series of stock that is pari passu or senior to the Series C-2 Preferred Shares; (ii) create any class or series of stock that would share in the liquidation preference of the Series C-2 Preferred Shares or that is entitled to dividends payable other than in common stock or Series C-2 Preferred Shares of its own series, (iii) acquire any equity security or pay any dividend, except dividends on a class or series of stock that is junior to the Series C Preferred Shares, payable in such junior stock, (iv) reissue any Series C-2 Preferred Shares, (v) declare or pay any dividend that would impair the payment of the liquidation preference of the Series C-2 Preferred Shares, (vi) authorize or issue any additional Preferred Shares, (vii) change the Certificate of Incorporation to adversely affect the rights of the holders of the Series C-2 Preferred Shares, or (viii) authorize, commit to or consummate any liquidation, dissolution or winding up in which the liquidation preference of the Series C-2 Preferred Shares would not be paid in full.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In conjunction with the issuance of the 25,000,000 shares of Series C-2 Preferred stock, we computed the value of the non-cash beneficial conversion feature associated with the right to convert the shares into common stock on a one-for-one basis. We compared the fair value of our common stock on the date of issuance with the effective conversion price, and determined that the value of the non-cash beneficial conversion feature is approximately $4,250,000, which is reflected in our condensed consolidated statements of operations for the nine month period ended September 30, 2014 as an adjustment to arrive at the net loss attributable to common stockholders. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Series C-2 Preferred Shares will not be and have not been registered under the Securities Act of 1933, as amended, or the Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Stock Options</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 9pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">1998 Stock Option Plan</div></div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In December&nbsp;1997, our board approved a Stock Option Plan (the &#x201c;1998 Plan&#x201d;) which provided for the granting of up to 2,000,000 shares of common stock, pursuant to which officers, directors, key employees and key consultants/advisors are eligible to receive incentive, nonqualified or reload stock options which plan was ratified by the shareholders on May&nbsp;28, 1998. Options granted under the 1998 Plan are exercisable for a period of up to 10&nbsp;years from date of grant at an exercise price which is not less than the fair value on date of grant, except that the exercise period of options granted to a stockholder owning more than 10% of the outstanding capital stock may not exceed five years and their exercise price may not be less than 110% of the fair value of the common stock at date of grant. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">By its terms, our 1998 Plan terminated as to the grant of future options on May 27, 2008. Consequently, no additional stock options will be granted under the 1998 Plan, and no outstanding options remain available for exercise in accordance with their terms. There were no options exercised under the 1998 Plan during each of the nine month periods ended September 30, 2015 and 2014. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Through September 30, 2015, a total of 1,823,895 stock options had been granted under the 1998 Plan, no stock options had been exercised, and 1,823,895 stock options have expired. During the three months ended September 30, 2015, 100,000 options expired. As of September 30, 2015, there were no outstanding stock options under the 1998 Plan. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 9pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">2011 Stock Option Plan</div></div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In 2011, shareholders approved the 2011 Stock Option Plan (the &#x201c;2011 Plan&#x201d;) which provides for the grant of up to 3,000,000 common stock options to provide equity incentives to directors, officers, employees and consultants. Two types of options may be granted under the 2011 Plan: non-qualified stock options and incentive stock options.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Non-qualified stock options may be granted to our officers, directors, employees and outside consultants. Incentive stock options may be granted only to our employees, including officers and directors who are also employees. In the case of non-qualified stock options, the exercise price may be less than the fair market value of our stock on the date of grant. In the case of incentive stock options, the exercise price may not be less than such fair market value and in the case of an employee who owns more than 10% of our common stock; the exercise price may not be less than 110% of such market price. Options generally are exercisable for ten years from the date of grant, except that the exercise period for an incentive stock option granted to an employee who owns more than 10% of our stock may not be greater than five years.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the three month period ended September 30, 2015, we granted 675,000 stock options under the 2011 Plan, 406,375 options became vested, and no options expired or were exercised. During the three month period ended September 30, 2014, we granted 500 stock options under the 2011 Plan, 6,250 options became vested, and 125,000 options expired unexercised and no options exercised. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the nine month period ended September 30, 2015, we granted 695,000 stock options under the 2011 Plan, 472,000 options became vested, and no options expired or were exercised. As of September 30, 2015, there were 1,973,000 stock options outstanding under the 2011 Plan, 1,247,000 of which were vested. At September 30, 2015, there were 1,277,000 options remaining available for future grant under the 2011 Plan. During the nine month period ended September 30, 2014, we granted 11,000 stock options under the 2011 Plan, 131,750 options became vested, and 250,000 options expired unexercised or were forfeited and no options exercised. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the nine months ended September 30, 2015 we modified 50,000 options previously granted to the Company&#x2019;s&nbsp;former CFO. On February 5, 2015, in consideration for the former CFO&#x2019;s willingness to assist in the transition to a new accounting team, the Company has agreed to modify the option agreement so that the unvested portion remains intact for the full term of the original stock option agreement. We used the Black-Scholes option-pricing model to value the cost of this modification which was an immaterial amount for the nine months ended September 30, 2015. These options vest upon the first day the closing trading price of the common stock of the Company shall be $10.00 or greater. Since they are now held by a non-employee we will revalue the fair value of these options on a quarterly basis through the vesting period. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 9pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Non-Plan Options</div></div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2015, there were a total of 6,965,000 non-plan options outstanding, of which 4,815,000 were fully vested. During the nine month period ended September 30, 2015, we granted no non-plan stock options, 337,500 options became vested, and no options were exercised or cancelled.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During the nine month period ended September 30, 2014, we granted no non-plan stock options, 337,500 options became vested, and no options were exercised or cancelled.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 9pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Option Summary</div></div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For the nine month periods ended September 30, 2015 and 2014, compensation cost related to all stock options amounted to $349,000 and $133,000, respectively. For the three month periods ending September 30, 2015 and 2014, compensation cost related to all stock options amounted to $252,000 and $90,000, respectively. As of September 30, 2015, there was approximately $199,000 of total unrecognized compensation costs related to outstanding stock options, which are expected to be recognized over a weighted average 1.5 years. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the nine month period ended September 30, 2015 and 2014, we granted 695,000 stock options with a weighted average grant-date fair value of $0.53 and 11,000 stock options with weighted average grant-date fair value of $0.36, respectively. The total grant date fair value of all stock options vested during the nine month periods ended September 30, 2015 and 2014 was approximately $861,000 and $690,000, respectively. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value of options granted during the nine month periods ended September 30, 2015 was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions: </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 8%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="3"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">2014</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: top; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected term in years</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6.5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6.3&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected forfeiture rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk free rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">1.5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.1%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;130</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">135%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">135%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: top; TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 7.5pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 4%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.0%</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected term was generally determined using the simplified method as we do not believe we have sufficient historical stock option exercise experience on which to base the expected term.&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following summarizes the activity of all of our outstanding stock options for the nine month period ended September 30, 2015: </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Term</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Price</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at January 1, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">8,343,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.63</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">6.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">695,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.53</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Canceled or expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">100,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.00</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at September 30, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">8,938,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.57</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.7</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">265,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at September 30, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">6,062,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.66</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">5.5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">121,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of September 30, 2015, the exercise prices of all outstanding stock options, as well as all vested stock options, ranged from $0.20 per share to $5.00 per share. </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;<div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;">Warrants</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following summarizes the activity of our outstanding warrants for the nine month period ended September 30, 2015: </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 18pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Term</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Price </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at January 1, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3,356,750</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">1.99</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">(A)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5.6</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">77,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 48%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">-</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Canceled or expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">37,500</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.01</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 48%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at September 30, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">3,319,250</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.04</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">(A)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(B)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">9,300</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="WIDTH: 48%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 2%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 9%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="WIDTH: 1%; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at September 30, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2,694,250</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">2.99</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5.0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(C)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">9,300</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95.1%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 3.1%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 3.7%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(A)</div></div></td> <td style="WIDTH: 93.2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The weighted average exercise price for warrants outstanding as of January 1, 2015 and September 30, 2015 excludes 1,750,000 warrants with no determined exercise price.</div></div></td> </tr> <tr> <td style="WIDTH: 3.1%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 3.7%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 93.2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95.1%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 3.1%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 3.7%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(B)</div></div></td> <td style="WIDTH: 93.2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The weighted average remaining contractual term for warrants outstanding as of September 30, 2015 excludes 743,500 warrants with no expiration date.</div></div></td> </tr> <tr> <td style="WIDTH: 3.1%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 3.7%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 93.2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> </table> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95.1%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 3.1%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 3.7%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(C)</div></div></td> <td style="WIDTH: 93.2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The weighted average remaining contractual term for warrants exercisable as of September 30, 2015 excludes 118,500 warrants with no expiration date.</div></div></td> </tr> </table></div> 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates: </div></div>The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates are used in valuing the useful lives of any intangible assets and the future realizable value of such assets. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates. </div></div></div></div></div></div></div></div></div></div> 1750000 1750000 45754000 45716000 45754000 45716000 The weighted average exercise price for warrants outstanding as of January 1, 2015 and September 30, 2015 excludes 1,750,000 warrants with no determined exercise price. The weighted average remaining contractual term for warrants outstanding as of September 30, 2015 excludes 743,500 warrants with no expiration date. The weighted average remaining contractual term for warrants exercisable as of September 30, 2015 excludes 118,500 warrants with no expiration date. iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares 0001063197 tovc:StockOptionPlan1998Member 1997-12-01 1997-12-31 0001063197 tovc:StockOptionPlan1998Member 1997-12-01 2015-09-30 0001063197 tovc:EbitdaBenchmarkMember us-gaap:ChiefExecutiveOfficerMember 2010-01-01 2010-12-31 0001063197 us-gaap:ChiefExecutiveOfficerMember 2010-01-01 2010-12-31 0001063197 tovc:BusinessPlanConsultantMember 2011-01-01 2011-12-31 0001063197 us-gaap:VehiclesMember 2012-08-01 2012-08-31 0001063197 2014-01-01 2014-09-30 0001063197 us-gaap:WarrantMember 2014-01-01 2014-09-30 0001063197 tovc:NonPlanOptionsMember 2014-01-01 2014-09-30 0001063197 us-gaap:PatentsMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-09-30 0001063197 us-gaap:ResearchAndDevelopmentExpenseMember 2014-01-01 2014-09-30 0001063197 tovc:StockOptionPlan1998Member 2014-01-01 2014-09-30 0001063197 tovc:StockOptionPlan2011Member 2014-01-01 2014-09-30 0001063197 tovc:IsoTorqueDifferentialMember tovc:BoardMemberMember 2014-01-01 2014-09-30 0001063197 us-gaap:DirectorMember 2014-01-01 2014-09-30 0001063197 tovc:SCIRECorporationMember 2014-01-01 2014-09-30 0001063197 tovc:AegisDivisionMember 2014-01-01 2014-09-30 0001063197 tovc:CURADivisionMember 2014-01-01 2014-09-30 0001063197 us-gaap:PreferredClassAMember 2014-01-01 2014-09-30 0001063197 tovc:SeriesC2PreferredStockMember 2014-01-01 2014-09-30 0001063197 2014-01-01 2014-12-31 0001063197 us-gaap:SeriesCPreferredStockMember 2014-01-01 2014-12-31 0001063197 us-gaap:WarrantMember 2014-01-01 2014-12-31 0001063197 tovc:SeriesC2PreferredStockMember 2014-03-28 2014-03-28 0001063197 tovc:BAICMember 2014-04-01 2014-06-30 0001063197 2014-07-01 2014-09-30 0001063197 us-gaap:PatentsMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-07-01 2014-09-30 0001063197 us-gaap:ResearchAndDevelopmentExpenseMember 2014-07-01 2014-09-30 0001063197 tovc:StockOptionPlan2011Member 2014-07-01 2014-09-30 0001063197 us-gaap:DirectorMember 2014-07-01 2014-09-30 0001063197 tovc:SCIRECorporationMember 2014-07-01 2014-09-30 0001063197 tovc:AegisDivisionMember 2014-07-01 2014-09-30 0001063197 tovc:CURADivisionMember 2014-07-01 2014-09-30 0001063197 2014-07-10 2014-09-30 0001063197 us-gaap:ChiefExecutiveOfficerMember 2014-09-01 2014-09-30 0001063197 us-gaap:DirectorMember 2014-10-01 2014-10-31 0001063197 tovc:BAICMember 2014-12-01 2014-12-31 0001063197 us-gaap:DirectorMember 2015-01-01 2015-06-30 0001063197 2015-01-01 2015-09-30 0001063197 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001063197 us-gaap:EmployeeStockOptionMember tovc:CURAAdvisoryBoardMember 2015-01-01 2015-09-30 0001063197 tovc:NonPlanOptionsMember 2015-01-01 2015-09-30 0001063197 us-gaap:PatentsMember us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-09-30 0001063197 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-01 2015-09-30 0001063197 us-gaap:CapitalLeaseObligationsMember us-gaap:OfficeEquipmentMember 2015-01-01 2015-09-30 0001063197 tovc:StockOptionPlan1998Member 2015-01-01 2015-09-30 0001063197 tovc:StockOptionPlan2011Member 2015-01-01 2015-09-30 0001063197 tovc:StockOptionPlan2011Member us-gaap:ChiefFinancialOfficerMember 2015-01-01 2015-09-30 0001063197 us-gaap:LeaseholdImprovementsMember 2015-01-01 2015-09-30 0001063197 us-gaap:MachineryAndEquipmentMember us-gaap:MaximumMember 2015-01-01 2015-09-30 0001063197 us-gaap:MachineryAndEquipmentMember us-gaap:MinimumMember 2015-01-01 2015-09-30 0001063197 us-gaap:OfficeEquipmentMember 2015-01-01 2015-09-30 0001063197 us-gaap:OfficeEquipmentMember us-gaap:MaximumMember 2015-01-01 2015-09-30 0001063197 us-gaap:OfficeEquipmentMember us-gaap:MinimumMember 2015-01-01 2015-09-30 0001063197 us-gaap:TransportationEquipmentMember 2015-01-01 2015-09-30 0001063197 us-gaap:MaximumMember 2015-01-01 2015-09-30 0001063197 us-gaap:MinimumMember 2015-01-01 2015-09-30 0001063197 us-gaap:DirectorMember 2015-01-01 2015-09-30 0001063197 tovc:ProNexusLLCMember 2015-01-01 2015-09-30 0001063197 tovc:SCIRECorporationMember 2015-01-01 2015-09-30 0001063197 tovc:AegisDivisionMember 2015-01-01 2015-09-30 0001063197 tovc:CURADivisionMember 2015-01-01 2015-09-30 0001063197 tovc:ClassANonvotingCumulativeConvertiblePreferredSharesMember 2015-01-01 2015-09-30 0001063197 us-gaap:PreferredClassAMember 2015-01-01 2015-09-30 0001063197 us-gaap:PreferredClassAMember us-gaap:ConvertiblePreferredStockMember 2015-01-01 2015-09-30 0001063197 us-gaap:PreferredClassBMember 2015-01-01 2015-09-30 0001063197 tovc:SeriesC2PreferredStockMember 2015-01-01 2015-09-30 0001063197 us-gaap:SeriesCPreferredStockMember 2015-01-01 2015-09-30 0001063197 us-gaap:CommonStockMember 2015-01-01 2015-09-30 0001063197 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001063197 tovc:CURAAdvisoryBoardMember 2015-01-01 2015-09-30 0001063197 us-gaap:DirectorMember 2015-06-01 2015-06-30 0001063197 2015-07-01 2015-09-30 0001063197 us-gaap:PatentsMember us-gaap:GeneralAndAdministrativeExpenseMember 2015-07-01 2015-09-30 0001063197 us-gaap:ResearchAndDevelopmentExpenseMember 2015-07-01 2015-09-30 0001063197 tovc:StockOptionPlan1998Member 2015-07-01 2015-09-30 0001063197 tovc:StockOptionPlan2011Member 2015-07-01 2015-09-30 0001063197 us-gaap:DirectorMember 2015-07-01 2015-09-30 0001063197 tovc:SCIRECorporationMember 2015-07-01 2015-09-30 0001063197 tovc:AegisDivisionMember 2015-07-01 2015-09-30 0001063197 tovc:CURADivisionMember 2015-07-01 2015-09-30 0001063197 tovc:StockOptionPlan1998Member 1997-12-31 0001063197 2008-05-27 0001063197 tovc:StockOptionPlan1998Member 2008-05-27 0001063197 us-gaap:DirectorMember 2010-12-13 0001063197 tovc:EbitdaBenchmarkMember us-gaap:ChiefExecutiveOfficerMember 2010-12-31 0001063197 us-gaap:ChiefExecutiveOfficerMember 2010-12-31 0001063197 tovc:StockOptionPlan2011Member 2011-12-31 0001063197 us-gaap:VehiclesMember 2012-08-31 0001063197 2013-12-31 0001063197 tovc:SeriesC2PreferredStockMember 2014-03-28 0001063197 2014-09-30 0001063197 us-gaap:PreferredClassAMember 2014-09-30 0001063197 us-gaap:ChiefExecutiveOfficerMember 2014-09-30 0001063197 tovc:SCIRECorporationMember 2014-11-18 0001063197 tovc:SCIRECorporationMember tovc:AdditionalHoursMember 2014-11-30 0001063197 2014-12-31 0001063197 us-gaap:SubsidiariesMember 2014-12-31 0001063197 tovc:AutomobileMember 2014-12-31 0001063197 tovc:CopyMachineMember 2014-12-31 0001063197 us-gaap:VehiclesMember 2014-12-31 0001063197 us-gaap:PreferredClassAMember 2014-12-31 0001063197 us-gaap:PreferredClassBMember 2014-12-31 0001063197 tovc:PreferredClassC2Member 2014-12-31 0001063197 tovc:PreferredClassCMember 2014-12-31 0001063197 tovc:SeriesC2PreferredStockMember 2014-12-31 0001063197 us-gaap:WarrantMember 2014-12-31 0001063197 tovc:WarrantsNotDeterminedExercisePriceMember 2015-01-02 0001063197 tovc:StockOptionPlan2011Member us-gaap:MinimumMember 2015-02-05 0001063197 2015-09-30 0001063197 tovc:NonPlanOptionsMember 2015-09-30 0001063197 tovc:WarrantsNotDeterminedExercisePriceMember 2015-09-30 0001063197 us-gaap:SubsidiariesMember 2015-09-30 0001063197 tovc:AutomobileMember 2015-09-30 0001063197 tovc:CopyMachineMember 2015-09-30 0001063197 tovc:StockOptionPlan1998Member 2015-09-30 0001063197 tovc:StockOptionPlan2011Member 2015-09-30 0001063197 us-gaap:OfficeEquipmentMember 2015-09-30 0001063197 tovc:AegisDivisionMember 2015-09-30 0001063197 tovc:CURADivisionMember 2015-09-30 0001063197 tovc:ClassANonvotingCumulativeConvertiblePreferredSharesMember 2015-09-30 0001063197 us-gaap:PreferredClassAMember 2015-09-30 0001063197 us-gaap:PreferredClassAMember us-gaap:ConvertiblePreferredStockMember 2015-09-30 0001063197 us-gaap:PreferredClassBMember 2015-09-30 0001063197 tovc:PreferredClassC2Member 2015-09-30 0001063197 tovc:PreferredClassCMember 2015-09-30 0001063197 tovc:SeriesC2PreferredStockMember 2015-09-30 0001063197 us-gaap:SeriesCPreferredStockMember 2015-09-30 0001063197 us-gaap:WarrantMember 2015-09-30 0001063197 2015-11-03 EX-101.SCH 6 tovc-20150930.xsd EXHIBIT 101.SCH 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheet (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheet (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Disclosure - Note A - The Company and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note B - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note C - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note D - Related Party Transactions link:calculationLink link:definitionLink link:presentationLink 009 - Document - Note E - Accrued Liabilities link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note F - Notes Payable link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note G - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note H - Commitments and Other Matters link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note B - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note C - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note E - Accrued Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note F - Notes Payable (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note G - Stockholders' Equity (Tables) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note A - The Company and Basis of Presentation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note B - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 021 - Statement - Note B - Property and Equipment, Estimated Useful Lives (Details) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note C - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 023 - Statement - Note C - Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note D - Related Party Transactions (Details Textual) link:calculationLink link:definitionLink link:presentationLink 025 - Statement - Note E - Accrued Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note F - Notes Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Statement - Note F - Notes Payable (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note G - Stockholders' Equity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Statement - Note G - Share-based Payment Award, Stock Options, Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Statement - Note G - Share-based Compensation, Stock Options, Activity (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Statement - Note G - Outstanding Warrants Activities (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note H - Commitments and Other Matters (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 tovc-20150930_cal.xml EXHIBIT 101.CAL EX-101.DEF 8 tovc-20150930_def.xml EXHIBIT 101.DEF EX-101.LAB 9 tovc-20150930_lab.xml EXHIBIT 101.LAB Employee Stock Option [Member] Document And Entity Information us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Note To Financial Statement Details Textual us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized statementsignificantaccountingpoliciespolicies statementnotebsummaryofsignificantaccountingpoliciestables Warrant [Member] statementnotecpropertyandequipmenttables Antidilutive Securities [Axis] statementnoteeaccruedliabilitiestables statementnotefnotespayabletables tovc_TradingPriceOfCommonStockUponVesting Trading Price of Common Stock upon Vesting Represents the closing trading price of options upon vesting. statementnotegstockholdersequitytables Antidilutive Securities, Name [Domain] tovc_SharebasedCompensationArrangementByShareasedPaymentAwardOptionsModifiedInPeriod Share-based Compensation Arrangement by Share-ased Payment Award, Options Modified in Period Number of share options (or share units) modified during the period. statementnotebpropertyandequipmentestimatedusefullivesdetails Amendment Flag statementnotecpropertyandequipmentdetails statementnoteeaccruedliabilitiesdetails Conversion of preferred shares to common us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable Accrued payroll taxes Research and Development Expense [Member] statementnotefnotespayabledetails Income Statement Location [Domain] us-gaap_ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted statementnotegsharebasedpaymentawardstockoptionsvaluationassumptionsdetails Income Statement Location [Axis] Plan Name [Domain] us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense statementnotegsharebasedcompensationstockoptionsactivitydetails us-gaap_IncreaseDecreaseInDeferredRevenue Deferred revenue Plan Name [Axis] statementnotegoutstandingwarrantsactivitiesdetails Minimum [Member] Notes To Financial Statements Maximum [Member] Warrants Not Determined, Exercise Price [Member] Range [Axis] Notes To Financial Statements [Abstract] Net proceeds from sales of preferred stock Expected forfeiture rate Range [Domain] Customer [Axis] Document Fiscal Year Focus us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Customer [Domain] Document Fiscal Period Focus Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Accounts payable and other accrued expenses Document Period End Date Subsidiaries [Member] us-gaap_ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement tovc_WarrantsWithoutExpirationDateOutstanding Warrants without Expiration Date, Outstanding Warrants Without Expiration Date Outstanding us-gaap_ProfessionalFees Professional Fees tovc_WarrantsWithoutExpirationDateExercisable Warrants without Expiration Date, Exercisable Warrants Without Expiration Date Exercisable Current Fiscal Year End Date Class A Non-voting Cumulative Convertible Preferred Shares [Member] Type of stock. Products and Services [Domain] Series C2 Preferred Stock [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Stock Option Plan 1998 [Member] Stock Option Plan 2011 [Member] Information pertaining to the 2011 Stock Option Plan. Products and Services [Axis] Non Plan Options [Member] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Conversion of preferred dividends to common Transportation Equipment [Member] Award Type [Axis] Net Loss attributable to common stockholders Office Equipment [Member] Entity Current Reporting Status Entity Voluntary Filers us-gaap_CapitalLeaseObligations Capital Lease Obligations Entity Filer Category Machinery and Equipment [Member] Document Type Equity Award [Domain] General and Administrative Expense [Member] Cost of Goods Sold Cost of Goods Sold us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Cash flows from investing activities: Entity Well-known Seasoned Issuer us-gaap_NotesPayable Notes payable us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities Weighted average number of shares of common stock: Prepaid expenses and other current assets us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Options granted - weighted average exercise price (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Canceled or expired (in dollars per share) Segments [Domain] Segments [Axis] Statement [Table] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Outstanding - weighted average exercise price (in dollars per share) Outstanding - weighted average exercise price (in dollars per share) Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Outstanding - aggregate intrinsic value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value tovc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageRemainingContractualTerms Exercisable - weighted average remaining contractual term Weighted average remaining contractual term for non-vested equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. us-gaap_ResearchAndDevelopmentExpense Total research and development Research and Development Expense Current Assets: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 Outstanding - weighted average remaining contractual term tovc_EmploymentAgreementTerm Employment Agreement, Term The term of employment specified in an employment agreement. Research and development: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Exercisable shares (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net (decrease) increase in cash and cash equivalents us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Exercisable at September 30, 2015 tovc_ConvertiblePreferredStockHoldingPeriodRequiredForConversion Convertible Preferred Stock, Holding Period Required for Conversion The holding period required for convertible preferred stock to be eligible for conversion. us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Exerciable - weighted average exercise price (in dollars per share) Income Statement [Abstract] tovc_OperatingLeaseRateIncreaseAtRenewalPeriod Operating Lease, Rate Increase at Renewal Period The amount of rate increase to an operating lease once the lease has been renewed. us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 Exercisable- weighted average remaining contractual term tovc_OperatingLeaseLengthOfRenewalOption Operating Lease, Length of Renewal Option The length in which the reporting entity can renew a current operating lease. us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net cash (used in) provided by investing activities us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash (used in) provided by financing activities us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum us-gaap_PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Canceled or expired (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Outstanding shares (in shares) Outstanding shares (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number us-gaap_StockholdersEquity Total Stockholders' Equity Recovery of bad debt us-gaap_EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage Fair Value Measurement, Policy [Policy Text Block] Segment Reporting, Policy [Policy Text Block] us-gaap_TableTextBlock Notes Tables Risk free rate us-gaap_PreferredStockSharesIssued Preferred Stock, Shares Issued Earnings Per Share, Policy [Policy Text Block] us-gaap_PreferredStockSharesAuthorized Preferred Stock, Shares Authorized Volatility Iso Torque Differential [Member] A specific product sold by the reporting entity. us-gaap_PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share us-gaap_DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion Expected term in years us-gaap_DividendsPreferredStockStock Dividends, Preferred Stock, Stock Stock-based compensation related to stock options and warrants Stock based compensation related to stock options and warrants. Chief Executive Officer [Member] Chief Financial Officer [Member] us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit G&A costs, excluding stock-based compensation General and administrative costs excluding stock based compensation expense. Revenue Revenues us-gaap_PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Stock-based compensation related to options and warrants Stock based compensation, research and development. us-gaap_CommonStockSharesOutstanding Common stock, shares outstanding (in shares) tovc_PreferredStockBeneficialConversionFeature Preferred stock beneficial conversion feature Preferred stock beneficial conversion feature. In Process Research and Development, Policy [Policy Text Block] us-gaap_PreferredStockRedemptionPricePerShare Preferred Stock, Redemption Price Per Share tovc_StockBasedCompensationGeneralAndAdministrative Stock-based compensation related to options and warrants Stock based compensation general and administrative. Director [Member] us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears Stockholders' Equity Note Disclosure [Text Block] Relationship to Entity [Domain] Dividend yield Income Tax, Policy [Policy Text Block] Title of Individual [Axis] Proceeds from sale of fixed assets us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Outstanding (in shares) Outstanding (in shares) us-gaap_AccruedProfessionalFeesCurrent Accrued legal Accrued benefits and other tovc_PeriodOfSeverancePay Period of Severance Pay The duration of severance pay if an employee gets terminated. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number us-gaap_WarrantsAndRightsOutstanding Warrants and Rights Outstanding us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested Exercisable - aggregate intrinsic value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms Outstanding - weighted average remaining contractual term Additional paid-in capital us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Outstanding - aggregate intrinsic value Outstanding - aggregate intrinsic value us-gaap_Assets Total Assets Assets Stockholders' Equity: Class of Warrant or Right [Domain] Class of Warrant or Right [Axis] Current Liabilities: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Outstanding - weighted average exercise price (in dollars per share) Outstanding - weighted average exercise price (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Canceled or expired - weighted average exercise price (in dollars per share) Legal Entity [Axis] Net property and equipment Net property and equipment Entity Registrant Name Entity Central Index Key us-gaap_LesseeLeasingArrangementsOperatingLeasesRenewalTerm Lessee Leasing Arrangements, Operating Leases, Renewal Term Entity [Domain] us-gaap_NumberOfOperatingSegments Number of Operating Segments Commitments and Contingencies Disclosure [Text Block] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less accumulated depreciation Construction in progress Leasehold improvements us-gaap_CapitalLeasedAssetsGross Capital Leased Assets, Gross Entity Common Stock, Shares Outstanding (in shares) Commitments and other matters (Note H) us-gaap_Liabilities Total Liabilities Shop equipment tovc_SalesCommissionRate Sales Commission Rate Sales Commission Rate tovc_OfficersCompensationAgreementRate Officers Compensation Agreement Rate Agreed minimum expenditures for salaries of officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold. Net Loss per common share attributable to stockholders Aegis Division [Member] Information pertaining to the Aegis Division. Long-term Debt, Type [Domain] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] CURA Division [Member] Information pertaining to the CURA Division. Long-term Debt, Type [Axis] Business Plan Consultant [Member] EBITDA Benchmark [Member] EBITDA when it serves as a benchmark in accordance with employment agreement. BAIC [Member] Additional Hours [Member] Any hours above the minimum of 16. us-gaap_DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties Scenario [Axis] Scenario, Unspecified [Domain] us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued us-gaap_AssetsCurrent Total current assets Property, Plant and Equipment Estimated Useful Life [Table Text Block] Tabular disclosure of the estimated useful life of property, plant and equipment in the normal conduct of business. CURA Advisory Board [Member] Information pertaining to the CURA Advisory Board. tovc_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice Exercisable - weighted average exercise price (in dollars per share) The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on equity instruments other than options outstanding and currently exercisable under the stock option plan. tovc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsExercisableNumber Exercisable (in shares) The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are exercisable as of the balance sheet date. us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements tovc_AnnualStipend Annual Stipend Represents the amount of stipend for each year. tovc_PaymentForAttendingMeetings Payment for Attending Meetings The cash outflow to consultants for their attendance of meetings. us-gaap_LiabilitiesCurrent Total current liabilities us-gaap_StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues us-gaap_StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues us-gaap_DebtInstrumentTerm Debt Instrument, Term Property, Plant and Equipment [Table Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Adjustments to reconcile net loss to net cash used in operating activities: Changes in: Notes payable, net of current portion Supplemental Disclosures: us-gaap_DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders' Equity Schedule of Accrued Liabilities [Table Text Block] us-gaap_Depreciation Depreciation Property, Plant and Equipment, Policy [Policy Text Block] Accumulated Deficit Property, Plant and Equipment, Type [Axis] us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years Property, Plant and Equipment, Type [Domain] Leasehold Improvements [Member] us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years Statement of Financial Position [Abstract] us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Extraordinary Items, Noncontrolling Interests, Net us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period us-gaap_PropertyPlantAndEquipmentUsefulLife Property and equipment, estimated useful lives Net loss Net Loss Statement of Cash Flows [Abstract] Capital Lease Obligations [Member] Cash flows from operating activities: us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage Notes payable, current portion Notes Payable, Current us-gaap_PreferredStockDividendsShares Preferred Stock Dividends, Shares Basic and Diluted (in shares) us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount Acquisition of equipment through capital lease us-gaap_AccruedSalariesCurrent Accrued compensation Interest paid Preferred stock dividends us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature Accrued liabilities Basic and Diluted (in dollars per share) us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Loss before income tax benefits us-gaap_DividendsPayableCurrent Dividends Payable, Current Accounts payable us-gaap_IncomeTaxExpenseBenefit Income tax benefits Cash flows from financing activities: us-gaap_DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period Transportation equipment Transportation equipment gross. Office equipment and software Office equipment and software, gross. R&D costs, excluding stock-based compensation Research and development costs (excluding stock based compensation expense). Preferred Class C [Member] Preferred class c member. us-gaap_DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment Revenue Recognition, Policy [Policy Text Block] us-gaap_CommonStockValue Common stock: $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at September 30, 2015 and December 31, 2014: 45,754,041 and 45,716,298, respectively Class of Stock [Axis] Class of Stock [Domain] us-gaap_CommonStockSharesIssued Common stock, shares issued (in shares) Significant Accounting Policies [Text Block] Accounting Policies [Abstract] us-gaap_CommonStockSharesAuthorized Common Stock, Shares Authorized Cash and Cash Equivalents, Policy [Policy Text Block] Preferred Class C-2 [Member] Outstanding nonredeemable preferred class C-2 stock or outstanding convertible preferred class C-2 stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer. us-gaap_IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable Accounts receivable us-gaap_CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share us-gaap_RepaymentsOfNotesPayable Repayments of notes payable us-gaap_PreferredStockLiquidationPreference Preferred Stock, Liquidation Preference Per Share us-gaap_PreferredStockValue Preferred stock us-gaap_PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value Schedule of Debt [Table Text Block] Use of Estimates, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Share-based Compensation, Activity [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other current assets Related Party Transactions Disclosure [Text Block] us-gaap_OperatingExpenses Total costs and expenses Operating Expenses us-gaap_GeneralAndAdministrativeExpense Total general and administrative General and Administrative Expense Statement [Line Items] Related Party [Axis] Related Party [Domain] General and administrative: Vehicles [Member] us-gaap_LeaseAndRentalExpense Operating Leases, Rent Expense us-gaap_GrossProfit Gross Margin Consolidation, Policy [Policy Text Block] Debt Disclosure [Text Block] tovc_StockIssuedDuringPeriodDividendDistribution Stock Issued During Period, Dividend Distribution Number of shares issued during the period in satisfaction of preferred dividend distribution. Reclassification, Policy [Policy Text Block] us-gaap_DividendsPayableAmountPerShare Preferred stock, cumulative dividend per share (in dollars per share) us-gaap_DividendsPayableCurrentAndNoncurrent Dividends Payable Equity Component [Domain] Other income us-gaap_GainLossOnSaleOfPropertyPlantEquipment Gain on disposition of fixed assets, net Equity Components [Axis] Automobile [Member] us-gaap_CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent Copy Machine [Member] tovc_CapitalLeaseMonthlyPayment Capital Lease, Monthly Payment Capital Lease Monthly Payment Patents [Member] tovc_CapitaLeaseTerm Capita Lease, Term Board Member [Member] Member of the entity's board of directors. Common Stock [Member] us-gaap_PreferredUnitsOutstanding Preferred Units, Outstanding Pro Nexus LLC [Member] Series C Preferred Stock [Member] SCIRE Corporation [Member] tovc_RelatedParyTransactionExpensesFromTransactionsWithRelatedPartyRate Related Pary Transaction, Expenses from Transactions with Related Party, Rate Rate for expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. Preferred Class A [Member] tovc_DeferredCompensationArrangementWithIndividualRevenueBenchmark Deferred Compensation Arrangement with Individual Revenue, Benchmark The minimum benchmark of revenue necessary for the deferred compensation arrangement. us-gaap_PolicyTextBlockAbstract Accounting Policies Preferred Class B [Member] tovc_MonthlyRentPaymentUnderOperatingLease Monthly Rent Payment under Operating Lease Monthly Rent Payment Under Operating Lease us-gaap_OperatingIncomeLoss Loss from operations tovc_AnnualRentPaymentUnderOperatingLease Annual Rent Payment under Operating Lease Annual Rent Payment Under Operating Lease Convertible Preferred Stock [Member] us-gaap_AssetImpairmentCharges Asset Impairment Charges Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Property, Plant and Equipment Disclosure [Text Block] Line of Credit Facility, Lender [Domain] Lender Name [Axis] EX-101.PRE 10 tovc-20150930_pre.xml EXHIBIT 101.PRE EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`*`]9$>.CI^1L0$```(6```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RV[",!!%?P5E6Q%CIZ4/`9O2;8O4_H";3(A%'%NV"?#WM0-4;916 MT!)I-GEPQW-O,LY9,'G;:;"#K2PK.XT*Y_0#(38M0'(;*PV55W)E)'?^UBR) MYNF*+X&PT6A,4E4YJ-S0A1[1;/)2@S$B@\'C7@B]IQ'7NA0I=T)5I*ZR5M>A MRG.10J;2M?1+8N>MXM2[%````*P(```L```!?.0Q(OW[CMB`PD.MQ-*O>X^NO`ZIK`XTHO8<4M?'5$Q^ M#*G*_=ITJK$"2+8CCVG!D4*>-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7.U49V M[M,41Y26M#;3"&>6X9MY6&3I//B)]!=C;IK>TI;MR5/0!_ZS#0//>997'L=V M+YRO+0O]C^AY%.!)T:'B1?4C9@,2[2F]@OIZ`(4QOCLEFI2"(S>C@KN_V/P" M4$L#!!0````(`*`]9$>NKFRH?P$``/`4```:````>&PO7W)E;',O=V]R:V)O M;VLN>&UL+G)E;'/%V$MJPS`0QO&K!!^@\HSR)LFJFVS;7D`X$]LD?B"IM+E] M72^*^]#01>#;V-B&T7]A?@CMVI!OG^3J8MVUH:K[,'MOKFW8#N_W615COS4F M%)4T+CQTO;3#UW/G&Q>'1U^:WA475XKA/%\:/YV3'78_9\^.IWWFCR?*9B_. MEQ+WV5OG+Z$2B<&,-WH8%A@^WWKYS_+=^5P7\M@5KXVT\8\*\[5`9M)!G`YB M2)!-!UE(T#P=-(<$+=)!"TC0,AVTA`2MTD$K2-`Z';2&!&W201M($.6*C#DF M2<,:HS4I7!/&:U+`)HS8I)!-&+-)09LP:I/"-F'<)@5NPLA-"MV$L9L4O`FC M-RMZ,T9O5O1FT%Y;VVQC]&9%;\;HS8K>C-&;%;T9HSC-&;U;T9HS>K.C- M&+U9T9LQ>EM%;XO1VRIZ6XS>5M';@LY*M,,2C-YVHG>HG)?3<_1U6X9[UWP; MKA9-\`[Q=I7[IXQ3U8:)UG%820YB;27F4;>,J;J*F+G@"L:4*UIRY:",^N,L8L8FS;C.@W)U(_6C M^YXMS(0C5%&'+\K=$VXAIJ0'N^^=1::] M\*Q+O[T$.W^Y-_!8ZM6,2^NBX08'&Q!H[+9,&WQME6(C?-'=W8*^SW78`W?@ MS=3O%Q%D M'48&>V;15K8#WMZSD*C`W2YGW.)_DJ+@M!.BW^]4V.^V8",=LZE&:D?V69>I MJ'A52?;6V-!<:`;=4$N9'\02KIC[!ZP$<">,-1 MBIP_**@/_>1YHQ&/B5$Q3?F;@@3F]8AK0I"RJ43/U!7$;S$!>US=BI*>A%E3 M8^H5FU$]12.)NHKT&BI?5Y'>16MUV\V8 MMIUJS:!M,>'[]GT0?O@+QM_PI_XF M\#KDY4G_\]\QOH?H.*6[H!ESNT:'5!L_I??W*;/[L[@ M\#]?]!M02P,$%`````@`H#UD1QL[;VX_`0``:0,``!$```!D;V-0 MS"LM`RZ[<:MKOX]?QTDA'9?6PZ.W#CQJ"%>'NC*!2[=(MHB.,Q;D%FH11K'" MQ.3:^EI@#/V&.2%W8@-LG&77K`842J!@1V#J>F)2%DIRZ4&@]1U>R1[O]KXB MF)(,*JC!8&#Y*&=)^6QVQC:F8(.^+*+C2@1<6J77&M1-.Y3]3L7."+X.)SFH MOCW]_=,#95C251Z"[JN:IADU$ZJ+`^?L=?GP1&>3:A-0&`E1%33'UL$B^>K\ M,KF]6]TGY3C+9VF>I]ETED M4;1<^B20@B"]=JBMN0A'F&]B@H7]^P=(O!S4">FR[:!MK%>AI/LU1,>7$U>V ML;X]I7Y$9Z^J_`102P,$%`````@`H#UD1YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/`0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW`A(5M>5`TR`` M6'!VULS2`Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D`4.`#?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5`9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E`L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+` M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O&`RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M#`DL6XA9$N)-7>W5YYNTB42%(JP#`4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH`1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW>`,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_`5!+`P04```` M"`"@/61'<$FNPSD"``#G"```#0```'AL+W-T>6QEAJ&T8A,-C*H/FP;T6V94>@%T\^9TY__?3BV'$@I$WWEB\Z/;I[ M[KFS=X2S3#,+ED0POO7PW`*NO;V?8%)IE]MG M.,PS"\=,NLH2'/:_YZ?+1G:WV/(8Y]/R#)#&-0&@6B[-!O7V:EN;XJ22U(MT M?B>\*TVVT?QZ+\`M)F^F=$'UD#G".RB-.2W!!&A6K>T*JK;2%8`2QB@8J90D MW%+N(GK#T.:4\P=[F;^7$^ZN1-['/N,0(ZMB9YI&].9X#5Q3@WTVS[U'>W,6 M+>K*@=]$D[KFVT^<55)0K]5#2]7O3M%'1^C3F.Q8T5II]F3\[3W(#4`U1ANJ M@>7[R$]-ZA7MH+_`05<>4WANR?^[IC&_N7,O2>Z@^U9D5"_=,'JYI/N[>Z^63"C1/4MC;NCT%%D8"R#8D- M1*OMV4U<##: M5="X[)'FWD)SC96B=)64OE8=K!:@L^,C-UF!DC^E=0AFHFE^B%I.LWN5,26< M/R_!RW*:#;%KUG)KP+;-:0LJ=$;]4=8+L*>E7EM6F%)VL$4%[M?CC8R5!88")PL,?N1#+:=;/F&B]^0+*2SL37GZU MIFU`WR(K8RNPSL_#6&-4O&M<".^A%]P M_T9PCAZ*K0>]6-Z$G9AFXSX"_X"#)2CPFVD6VTJ&E?1>+"6&_[G%=`S.TQ:S M$UVR<^V1PBYTMWD8FC`'?/BBC!^V$\"&O2CS+E04=&9T*;63)<.6,PI*C$K) M3H42NI",@#@!\7U!`P(:$-#@S:"YQPLNF8"&!#3<%S0BH!$!C?X'_3!>LA/V MD:%]R*H;H3=,Z+`X!X[&:$Q`XP3H%$'SMJZ%W3"S8G.XU8"G5FA/0)\)Z'," M=(:@:XOGUOIN.N>_6VB"%01T0$`'"=`,03IWF2*LY3BJ=VD.<415WG M*==/WY('^%;Z3MF>DH'3_,VI[7R'[:^CAA1%;>:_LRI[8.4[2]1X0#AKQEK%8JBM@]>R^Q7K7<>G0HY])>P*`-FYA.* MHK8/]LWM@ZUJ9:M<&3R6:,]5&1:FH&49:E87/X-%7Q$*6;QTOYGA*&27T/^. MQ>TT"Q4H%INM4F?7"AKD9!#=HUXSS`Z:U-+(AC' M>=2BI@NK4L^]LJJD-T&:#K^R@-_:%K$_>TSHL`U!^)AX:ZZU4!-154:3[]RT MN.,-[0*&+]MP!S8'D"F)5OQL\,"M^T`E?Z3T70V^G[=AK'+`!)^$"H'DY8X/ MF!`529)_CT$_FD?$<<'2GXU9U'+;.,P..,+NA'Q1H=O>%R# MSO!$"=>_P>G&!6T?EC!HT8>Y-IV^#N9)!D>;WP!'`YP,,/^G(1D-R60`J5ZI MR4ROZPL2J"H9'0+>(_5O@XV4,Q5$1@ZXCL;,ZY(KXW+V7L5E=%=A1@74BKVM M`),BDK&]`!C.[="R0Q_@8"N294#R`)CA+K'LZ1Q@%'M;D2T#4@>06O9\#D@- MP"@Z\XKB/`'K8AF3.9C,PA3>==B*U3(@=P"Y95][`;8"Q,N$PB$4MA]X$3,) M7$:L',3*]B=>Q$R2+B/6#F)M^S,O8OV?"!`[#'7`?$;P[JK#J#';*LV*+(W3 M)PH0`),TU[EHBZ[1O,;OJ+LB#$[UUPASV MT^S4:7>Z'T6?\JKLT17_0.S:=#PX4B%[CFX0%TH%EDG$+S*)6GX+3`."+T+= M%NI=F.YH!H+VCV8_?7%4?P%02P,$%`````@`H#UD1WV_[E*0`P``6A$``!@` M``!X;"]W;W)K&SGL`*D MA:IJ+RJM>M%>9\%`M$E,D^RR??LZ)SHV-H3>D`/_C#]//+\)\Y.L7NN#$(WW M4>1EO9@=FN;XZ/OUYB"*M'Z01U&J;W:R*M)&759[OSY6(MUV047N0Q"$?I%F MY6PY[^X]5\NY?&ORK!3/E5>_%45:_5F)7)X6,S(;;_S(]H>FO>$OY_XY;IL5 MHJPS67J5V"UF3^1Q33M)I_B9B5.-SKT6_D7*U_;BVW8Q"UH&D8M-TZ9(U>%= MK$6>MYG4R+^'I/_&;`/Q^9C]2S==A?^2UF(M\U_9MCDHVF#F;<4N?D'_TQ*[OCJ?\F#H8P>P`,`7`.(.QJ`!T" MJ!'@]V3=O#ZG3;J<5_+DU<>T?=KD4Z^+R&<^^]M MGD$"G62E26R*M::(SA)?C6^%@!&BOWP"'!_?CJ=C?-C'4QR?W(YGQO@,Q=-` MGV+4%Z&7E)V$A*H7K++U%9F3AALT'-.0V_&A48WPSFI$QOC1E6JPOAH1FB;P MX*(:O6Q]1>:DB0V:&-/`[?C$J$9R9S5(8`"T7G"K'H.FGVGH*H=;Y:8A)@WN M-4HG9`"C(`3NK0@U&>B$BE#<"T.3!GD!#.T^HU2AVURC4:D23:4RFS1#-9R([ M$W80QF,GDN8TT<259%H-T;PFMA/%>"3&F!,IUAXOF>9^)#&9L'_1Q,Z48"8G M4'*W^X#IA8"]D-D['[#+$7`N(TT71M.`3#L$;(>,V($(&HB[>;",35M"76,5:'_4]U3*,&;-0LM,U[I6N8O38.C9O$M&C0+-KZ!%::QD7B MT+A)3&,&;,PLLC\EW9@OU\SXE*[HW$2F,0,V9F8W9L!^&Y$DN&0:&UU7ET:QGSBQDI-DZ;8I+G=I"DV7X`.RTJE"6F< M3-LXJ.G3%/LT)]8U1;$!6[?685%I0OO6ZJ.WX&.Z%]_3:I^5M?/8AT>[[(Q:YI3R-U7O6O_OU%(X_C/QGGOU.6?P%02P,$%``` M``@`H#UD1\".G[(K`P``7Q```!@```!X;"]W;W)KZ`7THIOCK1K M,!>GW2EBEX[@0U_4U!&,XRQJ<-6&VW5_[;G;KNF5UU5+GKN`79L&=W]VI*:W M30C"Z<)+=3IS>2':KJ-[W:%J2,LJV@8=.6[")_!8PEQ&^L3/BMR8RQ98?+R3DM2U["1&_CTV_3>F+%2/I^Y?^^D*_%?,2$GK M7]6!GP5M'`8'1N^ M*>*QS%P`QP)X+P"ILR`9"Q*M(!K(^GE]P1QOUQV]!>R"Y=T&CR+>R2:B<\#Z M;MVP7&)F3%Q]WR*XCMYEGS$"^\A.C1@3Y2R1WR.1&-\(`2>(X?0)JO7%>9$U8&$&L0TI]+>V_,>"R,.VFG`CH56-Y_8\:' MRIFT4^GR`ZK]$NC10=[!&"JM(3N+ M+D+@84*@&@YE*(?`O#RS7)&#V,,:0! M+@2JXUR;T)&S$^DJ!"X73GMPIKH'9-Z#MI#]"4LM/H1H4>1H6S)\4X=ORI M6(C:N72KPIE5"_,JI5ZK9$W9:72OPIE75^954GV9NE?)';5SZ7:%JETSXV`[ MJ%HS13E*X]3L5W?23J4;%JJ&S8QC[<;,?2SQ8+LJS%3.Y$`5*:^"%WPB/W!W MJEH6O%(NWBK[5\`CI9R(?D)J87`6;_OWDYHIM?Y^_\4 MMG\!4$L#!!0````(`*`]9$=;K$IW;`0``+,6```8````>&PO=V]R:W-H965T M&ULG9A-![Z?#L1L&_/7*O]OM3A6OVY.HO8;OWQ;O M:)EC,B`C\<^)7UOPW1N"_Q#BY_#PU^YM$0PQ\))ON\%%T7]\\I27Y>"IG_E? MZ?1KSL$0?K]Y_V.4VX?_4;0\%>6/TZX[]M$&"V_']\6E[+Z+ZY]<:H@'AUM1 MMN-O;WMI.U'=3!9>5?R:/D_U^'F=_D(#:68VP-(`WPWN\Y@-0FD0?AE$LP:1 M-(A<9XBE0:S-X$_:QY7+BJY8KQIQ]=IS,>PGM.SQ9G#2>_;:T5LS):1?N[8? M_5P3O/(_!S\2P2.R49#0A&0007?"[^ES))M#Z*1E0NH1B8/^Y[F<2),303G$*"=Z M+N%-HGIDVTH2#,D"0P3("E$,,$6[`,8DDL'4256BJ4J@*F14E<",4633E2@9LP6=02PA M@4T;Q%@2.VE#@;:=AZ+]I0X[>$#:\B!896AH7!_)2.7,M@E3E3-L?;E""D>Q M;<%SA6.4N*T1UA7BY_M:,C+RR!9YJG#,NKD5+(QL)R57.$3<*@[2*RB"E8T: MWYT;I)2VT'IV%2Z,(ZM"R*&`6%],&A@Z)E$OJPB6.QJ;-2KU+K!O4\@1Z_;+ M%`X'V*X1@B@)D9M&O=8B6`,I,6M4BN"<2`6<4ZF`LS(5$B4T=--)=)VP"%-J MUDG@/K2*A)3UA:SZLK]M(.98;)#>'R#8(%"F3B0;!$35'#Z6"-DBJ"!!CZ=1 M-@DJB)+$UD[D.ADYGD>]5T!*LZ`U0K(Q5!A+9^C`9`Y,;F/LBO0^`<%&@1E7 M;X,2U\PEKIE+G#.7_%;F<*#IQ+!E8,B8.86Q9,Z!R689>>PD,^F*L.._75CO M8S#L8Q@VI@_#?H+8S,B.%L-FACD<9*RW"ABV"DQK%9A<*5BQ7X+7 M`)NP]`%#)BQ[P(R3YCJ&7-3%^OK`)H$1!P]Z^<6P_#)S^<6P%D8QM3:"J4ZB MQ_,BR["SSWS>YZ34!S=R%6\.XUUHZVW%I>ZF2Z;[Z/V^]1T/-WK:^`8M4V08 MS]`RGVY3O]RO5^?BP/\NFL.I;KT/T76B&B_]]D)TO`\]>.T7_!2$O8#``"0$@`` M&````'AL+W=O-2RF"@7&^37W:\;]:.MS4UVW_NS M$"KXV=1M_QR>E;H\15&_/XNF[#_)BVB'7XZR:THUW':GJ+]THCQ,1DT=01RG M45-6;;C=3&M?N^U&7E5=M>)K%_37IBF[_W:BEK?GD(3+PK?J=%;C0K3=1'>[ M0]6(MJ]D&W3B^!R^D*>"P@B9$/]4XM8;U\%(_E7*[^/-E\-S&(\<1"WV:G11 M#E]OHA!U/7H:(O^8G;[''`W-Z\7[7U.Z`_W7LA>%K/^M#NH\L(W#X"".Y;56 MW^3MLYAS2$:'>UGWTV>PO_9*-HM)E3_U=M=/W3?_"T]G,;0"S`=P-[G'< M!G0VH.\&;,I4,YOR^K-4Y7;3R5O07\KQ:9.G`=Z-3@;/03]YZW2YALSZ8?5M MFV6;Z&WT,T-@@NQ,"+DCHL&Y,P*$V!P,TM&HPD012+R2X189;I*A3C(<5VVMN!@&7FPRBTUFLF%.-ID9 M9HQBL=&>"M,3\]BVN<4D-YDD3B:YP82R;*TN)HQ0ZE47$EM[;M2\=SZIAP=B M)41,I3PP!F:?\V&I(QA$Y`Z$G#O)XY>#Q]TK0ED MD/B]VB"S^Q;I+:$>+FQY!"2/A+G[-O^@;^=9$="PZ)4/M:61(FDD;FFDIN(] MCO3S$(U<^4S1U)XZ*1)%DCJW(37GR>SQ>2]LR.^RL?65(GTEW%T:4SO3QREF M8;,BPYI-9/S1;T1WF@Y`^F`OKZW2_\+OJ_=#EI?IC,5:WY&G0A^5O+O9;B[E M2?Q==J>J[8-7J91LIC.#HY1*#.3B3X.(G$5YN-_4XJC&2SY<=_K`1-\H>5G. M?^Z'4-O_`5!+`P04````"`"@/61'MY4K1*$!``"Q`P``&````'AL+W=O&T]X@`^"-@-*N8>.]GQ%>? M/%5'FG@+(*&T7H&[Y0(/(*475%KG$DIN?^[-*#@VLOXI2)"6HZ3N^,&E>]%&EZE[.+%YHPD7+: M8!8$<^I?MLCHEIZMZ-GW]-U,OXD.=QN'/[X7V,\"NRBP7PMDR7;$B#EM,9^' M9*L]5:";<'4,*7'H;-S2I;K:7%?U!+`P04````"`"@/61'02@_)]&&\F<3TU+;&^`U9$D!:%9=DLD MXPJ71:P]F;+0@Q-<([GPC-O.Q<*I"S(PJNY!&6Y5LA` M<\+W^?&\#X@(^,-AM*L8!>\7K5]"\KL^X2Q8``&5"PK,+U=X`"&"D&_\;]+\ M:!F(ZWA6_QFG]>XOS,*#%G]Y[3IO-L.HAH8-PCWK\1=,(QR"8*6%C5]4#=9I M.5,PDNPUK5S%=4Q_#G2B?4Z@$X$NA&]9-)X:19L_F&-E8?2(;,_"V>5'#S=! MQ"LC&]5,FMX;M;YZ+7-*"W(-0A,F4F6FYLNBBG3_9>`R-U@Z\B>SF@%'GW\^2"&A<".]\;-*52HG3 M_?Q`EE=:O@-02P,$%`````@`H#UD1VT1ZE6E`0``L0,``!@```!X;"]W;W)K MTF[8I&RJ:KVH5*4A_;9 M"P-8L1EJFR7]^_H"!*)(><$SPSEGSOB2CZA?3`M@R:N2G3G3UMK^Q)@I6U#< MW&$/G?M3HU;!5(2K(L28Y,<='1(@^U)UWD.%@I.GC2Q`Q*N(YG]>]A6N?^R@T\HOPC*MLZ MLPDE%=1\D/89QQ\PC7#P@B5*$[ZD'(Q%-5,H4?PUKJ(+ZQC_'/83[6-"-A&R MA?`E"<9CHV#S&[>\R#6.Q/3.JMR+-#CF[>:$) M$RF7#69!,*?^88N,;NG9BIY]3M_-]&-TN%MW3[]^+K"?!7918+\9\;@=,6(N M6\S]NR9LM:<*=!.NCB$E#IV-6[I4E]OYD(4S>8,7><\;^,5U(SI#KFC=R89C MJ!$M.!/)W8&2UKV?)9%06Q_>NUC'*Q43B_W\0)976OP'4$L#!!0````(`*`] M9$>/.+AHI@$``+$#```8````>&PO=V]R:W-H965T&ULA5/; M;IPP$/T5RQ\0`[N;)BL6*9LJ:A\J17EHG[TP@!6;(;99TK^O+T"@BI07/#.< M<^:,+_F(^M6T`):\*]F9$VVM[8^,F;(%Q]1P3`;P&C6<7$>[\@OOKD9W6BB;<`$DKK%;A;KO`(4GHA MU_AMTOQHZ8GK>%9_"M,Z]Q=NX!'E'U'9UIE-**F@YH.T+SC^@&F$@Q5@+*J90HGB[W$575C'^.>03K3/"=E$R!;"71*,QT;!YG=N>9%K'(GIN3^[ M].C@VHLX96*"FH[3.Z/&5:]%FMWE[.J%)DRDG#>8!<&<^JS]+(J&V/OSF M8AVO5$PL]O,#65YI\0]02P,$%`````@`H#UD1S2/JF>B`0``L0,``!D```!X M;"]W;W)K&ULA5/;;IPP$/T5RQ\0<]FD[8I%RB:J MVH=*41[:9R\,8,5FJ&V6]._K"Q"((N4%SPSGG#GC2S&A?C$=@"6O2O;F1#MK MAR-CINI`<7.#`_3N3X-:<>M2W3(S:.!U("G)LB2Y8XJ+GI9%J#WILL#12M'# MDR9F5(KK?V>0.)UH2I?"LV@[ZPNL+-C*JX6"W@CLB8;F1._3X_G@$0'P6\!D M-C'QWB^(+S[Y69]HXBV`A,IZ!>Z6*SR`E%[(-?X[:[ZU],1MO*A_#],Z]Q=N MX`'E'U';SIE-**FAX:.TSSC]@'F$6R]8H33A2ZK16%0+A1+%7^,J^K!.\<_7 M9*9]3,AF0O:.P&*C8/.16UX6&B=B!N[/+CTZN/8B3IF8H*;C],ZH<=5KF>9I MP:Y>:,9$RGF'61',J7_8(J-[>K:A9Y_3\X5^%QWFV^[IM\\%#HM`'@4.NQ&S M_8@1<]YC\G=-V&9/%>@V7!U#*AQ[&[=TK:ZW\SX+9_(&+XN!M_"+ZU;TAES0 MNI,-Q]`@6G`FDIM;2CKW?M9$0F-]^,7%.EZIF%@ROM+R/U!+`P04```` M"`"@/61')J-U5J4!``"Q`P``&0```'AL+W=O'5Q[$:>,3%#3<7IGU+CJM4SS74&N7FC"1,IY@UD0Q*E_V2+#6WJV MHF??T_.9?H@.\W7W]-?W`KM9((\"N\V(^^V($7/>8@[_-2&K/16@VW!U#*K4 M(&WMK"'ZI;)@VZ*.M.-AQ#HY0%9R*YV6/4N?>S)!P: MZ\,?+M;Q2L7$JGY^(,LK+3\`4$L#!!0````(`*`]9$>.XJ:=I`$``+$#```9 M````>&PO=V]R:W-H965TV/C)FR!<7-#?;0N3\U:L6M2W7#3*^!5X&D),N2Y)8I+CI:Y*'VK(L< M!RM%!\^:F$$IKO^>0>)XHBF="R^B::TOL")G"Z\2"CHCL",:ZA-]2(_GO4<$ MP&\!HUG%Q'N_(+[ZY&=UHHFW`!)*ZQ6X6Z[P"%)Z(=?X;=+\:.F)ZWA6?PK3 M.O<7;N`1Y1]1V=:932BIH.:#M"\X_H!IA(,7+%&:\"7E8"RJF4*)XN]Q%5U8 MQ_CGD$RTSPG91,@6PGT@L-@HV/S.+2]RC2,Q/?=GEQX=7'L1ITQ,4--Q>F?4 MN.JU2'=W.;MZH0D3*><-9D$PI_YIBXQNZ=F*GGU-W\WTV^APM^Z>?OM:8#\+ M[*+`?C/B_7;$B#EO,?\W8:L]5:";<'4,*7'H;-S2I;KRO-+B'U!+ M`P04````"`"@/61'UPO?R*0!``"Q`P``&0```'AL+W=O<.>-+,:%^,1V`):]*]N9,.VN'$V.FZD!QED6H/>FRP-%*T<.3)F94BNN_%Y`XG6E*E\*S M:#OK"ZPLV,JKA8+>".R)AN9,']+3)?>(`/@E8#*;F'CO5\07G_RHSS3Q%D!" M9;T"=\L-'D%*+^0:_YDUWUIZXC9>U+^%:9W[*S?PB/*WJ&WGS":4U-#P4=IG MG+[#/,+1"U8H3?B2:C06U4*A1/'7N(H^K%/\<\QGVON$;"9D*^%S$HS'1L'F M5VYY66B:$9$RF7'69%,*?^ M;HN,[NG9AIY]3#\L]/OH\+#MGG[Y6"!?!`Y1(-^-F.Y'C)C+'O._2[;94P6Z M#5?'D`K'WL8M7:OK[7S(PIF\P3N2$GG MWL^:2&BL#S^Y6,&ULC5;-CILP$'X5Q`.L M,03R(X*TV:IJ#Y56>VC/3N($M#:FMA.V;U\;!S9C>14NP7:^G[%FAJ'LA7Q7 M-:4Z^N"L5=NXUKK;(*0.->5$/8F.MN:?DY"<:+.59Z0Z2&EGB_'M6_#]^)HB^"_6F.NC;1)G%TI"=R8?I-]#_H[0ZY%3P( MIH;?Z'!16O"1$D>7ACX-**&.5(#6K2W=X$JLSIM<*+K$17*W3#.,H.8"8$,NI!BS2&]/2.GCZF M9R.]>R1H(A!,/,3,2CQ// MQ;;^G40X]1YH1NXQ]GU`&^;A[$-0,2/]./5]4B`1+@`/-*,"<.;[@,8NPC7@ M@684`?;;'X/>+L)EX('FU('_!L"@O8LOZ@""YM2!_Q+`H,.++^H`@)9^':"[ M(<&I/`^S4$4'<6FUFQ'3Z31OG]-AR'S"J[(C9_J+R'/3JF@OM!E5PUPY":&I MB2)Y,K>MS1?!M&'TI.UR:=;2S4BWT:(;1_[TW5']!U!+`P04````"`"@/61' MU*+GX:0!``"Q`P``&0```'AL+W=O6B?O3"`%=M#;;.D?U]?@"Q5I/8%SPSG MG#GC2SFA>;4]@"-O2FI[HKUSPY$Q6_>@N+W#`;3_TZ)1W/G4=,P.!G@324JR M(LL>F.)"TZJ,M6=3E3@Z*30\&V)'I;CY?0:)TXGF="F\B*YWH<"JDJV\1BC0 M5J`F!MH3?X#X(U2AN_ MI!ZM0[50*%'\+:U"QW5*?P[Y3/N84,R$8B5\RJ+QU"C:_,P=KTJ#$[$##V>7 M'SW8-9$=T)9TIZ_W[61$+K0GCPL4E7 M*B4.A^6!K*^T^@-02P,$%`````@`H#UD1[?46V"D`0``L0,``!D```!X;"]W M;W)K&ULC5/+;J0P$/P5RQ\0,\QK=\0@91)%V<-* M40Z[9P\T8,6FB6V&[-^O'T"&*%)RP=U-576U']F`^L4T`):\*=F:(VVL[0Z, MF:(!Q8:]E:*%)TU, MKQ37_TX@<3C2%9T*SZ)NK"^P/&,SKQ0*6B.P)1JJ([U='4X;CPB`/P(&QY/Z0YC6N3]S`W^E?<;A$<81MEZP0&G"EQ2]L:@F"B6*O\55M&$=XI_-SY'V M.2$=">E,^)$$X[%1L'G/+<\SC0,Q'?=GMSHXN/8B3IF8H*;C],ZH<=5+OMIO M,W;Q0B,F4DX+S(Q@3OW3%BE=TM,K>OHU?3W1=]'A>N'P&P*;26`=!38+@=UR MQ(@Y+3'[#TW8U9XJT'6X.H84V+9QVOX3?7M6@-.:-U M)QN.H4*TX$PD-UM*&O=^YD1"97VX=[&.5RHF%KOI@&PO=V]R:W-H965T<.>-+/J)^,RV`)>]*=N9(6VO[`V.F;$%QLBQ\%*T<&S)F90BNL_)Y`X'FE*Y\*+:%KK"ZS( MV<*KA(+.".R(AOI([]/#:>L1`?`J8#17,?'>SXAO/GFJCC3Q%D!":;T"=\L% M'D!*+^0:_YXT/UMZXG4\J_\(TSKW9V[@`>4O4=G6F4THJ:#F@[0O.#["-,+. M"Y8H3?B2$;")D"V&?!..Q4;#YG5M>Y!I' M8GKNSRX].+CV(DZ9F*"FX_3.J''52Y'>[7-V\4(3)E).*\R"8$[]RQ897=.S M*WKV;_IFIM]&AYN5P_\0V,X"FRBP70E\6X\8,:<59I_\U81=[:D"W82K8TB) M0V?CEB[5Y7;>9^%,/N%%WO,&?G+=B,Z0,UIWLN$8:D0+SD1RLZ.D=>]G2234 MUH=W+M;Q2L7$8C\_D.65%A]02P,$%`````@`H#UD1V#0"[^D`0``L0,``!D` M``!X;"]W;W)K&ULC5/)3N0P$/T5RQ^`LS0-:J4C MT:#1<$!"'.#L3BJ)A9=@.QWF[\=+$A*$-'.)JRKOO7KEI1B5?C<=@$6?@DMS MQ)VU_8$04W4@J+E2/4CWIU%:4.M2W1+3:Z!U(`E.LB39$T&9Q&41:L^Z+-1@ M.9/PK)$9A*#ZSPFX&H\XQ7/AA;6=]052%F3AU4R`-$Q)I*$YXKOT<-IY1`"\ M,AC-*D;>^UFI=Y\\UD><>`O`H;)>@;KE`O?`N1=RC3\FS:^6GKB.9_5?85KG M_DP-W"O^QFK;.;,)1C4T=.#V18V_81KAV@M6BIOP1=5@K!(S!2-!/^/*9%C' M^"??3[2?"=E$R!;";1*,QT;!Y@.UM"RT&I'IJ3^[].#@VHLX962"FH[3.Z/& M52]E>IL6Y.*%)DRDG#:8!4&<^H\M,KRE9RMZ]F]Z/M/WT6&^[G[S'P*[62"/ M`KO-B-EVQ(@Y;3'YMR9DM:<"=!NNCD&5&J2-6[I4E]MYEX4S^8*714];>**Z M9=*@L[+N9,,Q-$I9<":2JVN,.O=^EH1#8WUXXV(=KU1,K.KG![*\TO(O4$L# M!!0````(`*`]9$=ZY$U!OP$``'L$```9````>&PO=V]R:W-H965T@.(J4OF#/^%QFQ-CI(.2'J@$T^N2L54=<:]T="%%Y#9RJ!]%!:TY*(3G5 M)I0549T$6C@29R2.HH1PVK0X2UWN36:IZ#5K6GB32/6<4_GO!$P,1[S"4^*] MJ6IM$R1+RV]K,0'S;X61QQ9$L` M!KFV"M0L%W@&QJR0,?X[:GY96N)R/ZF_N&Y-]6>JX%FP/TVA:U-LA%$!)>V9 M?A?#*XPM;*U@+IAR7Y3W2@L^43#B]-.O3>O6P9_LHY%VFQ"/A/B*0+R1*_,' MU31+I1B0ZJC]=ZN#@4LK8I21,HIP,P(8M1O M6L0XI,<+>GR?OI[HB:]PO73??4-@,PFLO<`F:'$;MN@QIQ"3W#?97IEL`X'= M39,0L[]ODER9)('`XTV3`/,879F0Q71PD)6[!`KEHF^U'XXY.]^SI]A-UQ<\ M2SM:P2\JJZ95Z"RTF5$W4*40&DP1T8-IM38OP1PP*+7=[LQ>^LOA`RVZZ:K/ M[TWV'U!+`P04````"`"@/61'3GNQ4Y@!``!O`P``&0```'AL+W=OQ]FKJ"B@C_G^6`9$!/P6,-M-3(+W$^)[2)[; M`\V"!9#0N*#`_7*&)Y`R"/G&?R^:7RT#<1LOZC_C:;W[$[?PA/*/:-W@S6:4 MM-#Q2;HWG'_!Y0CW0;!!:>.7-)-UJ!8*)8I_I%7HN,YI9[?0;A.*"Z%8":D/ M2XVBS1_<\;HR.!,[\G!W^=[#31#QRL1&-9-.[XU:7SW7^4->L7,0NF`2Y;C% M[,H5PKS\S1X%O>87&W[Q?WJYT,MDL;RR6%Q;_)9:)(R^V8)M)J+`]/'B+6EP MTBX-9*VN;^NQB!/]@M?5R'MXX:87VI(3.G\O<8@=H@-O(;N[IV3PKW]-)'0N MA-]];-*#2(G#<7G>ZS]6?P)02P,$%`````@`H#UD1WJ@(>PQ!```PQ0``!D` M``!X;"]W;W)K&ULE5C;DMHX$/T5%Q\0N]MWBJ$J M8*9V'U*5RL/NLP<$N&);K&V&[-]'OC%JC03*"[;%Z=;IEG1:TNK&FY_MF;'. M^565=?NR.'?=9>FZ[?[,JKS]PB^L%O\<>5/EG?AL3FY[:5A^&(RJTD7/B]PJ M+^K%>C6T?6_6*W[MRJ)FWQNGO595WOR_826_O2Q@,3?\*$[GKF]PUROW;G%UW-@)=MWO8M< M/-[9EI5E[TGT_-_D]*//WE!^G[V_#N$*^F]YR[:\_+]PS\MV^'7VU[;CU6RR<*K\U_@LZN%Y&_])O,E,;X"3`=X-$!X: M^).!;VL03`;!AT'\T""<#$);@V@RB!1*[IBL(=59WN7K5<-O3GO)^PD(2P%O M>B?"L],.WIIQ!$6R6]'ZOH;47[GOO:,)@P-F(V,B+20C;NX(5Q#0LL`%[0$) MBT#7Q99B0BT-BHETF!W%Q#K,*\4DSP/RYX#\,:T^<9`^=Q`H#@+)@1`#RG+$ M;"@&=)C,`O-JPAC)A@K9D#C`YPXBQ4%$'"A3+!@C&3'U.`LQ]-2DC+#=`YB1 M3JS0B0F=X+F#1'&0$`?*7(W'>!*)J`7'5.DB)5U$NBXVJ=2%&-A/*1MA6QD& ML2&QF8P*@LC@;$>TJJE`1!4LJ@RHJ@I$5@'U&9)U%=&8H83(F3%#B3%T6?0(++64 M&%71@4@ZZ*L@I'^F#ZAJ*Q)MA4";1/2TOE$+#M)=MWX+B1%1-M^DITCWW<:20W#B MK&!RN"-`<3(%NU2J90=IV=%OAR;0K!W&HD%P?FBL&@0'7F0.D@)]NPT1JH41 MZ7E#OR%"4A@#<\U[#HRG4S*IH0UCW#:I;KGA\;SS($AY%IV6<$ MET:?=\"S`,NX)-4L:%>Z<*E8GHFZ=-]YUO!KN=(Z<=TP0][X(>3BS_'#_*-FQ MZU]C\=Z,=VSC1\I2YD(`@``_`8` M`!D```!X;"]W;W)K&ULE57);J,P&'X5BP>HL4/( M(H+4=%1U#B-5/$HJM2M`+7O@V@_[?12_DNZHHU>"# MLT;MDDKK=@NA.E:4$_4@6MJ8-VJ>:T4;5H@*3G7?*( MMGN468A#_*YIKT9S8,,?A'BWBY^G79+:#)31H[82Q`Q7^D09LTK&^>]-]-/3 M$L?SN_JS.ZZ)?R"*/@GVIS[IRJ1-$W"B9](Q_2;Z%WH[P](*'@53[@F.G=*" MWRD)X.3#CW7CQMZ_R?,;[6L"OA'P0/`^T!NYF#^()F4A10]42^S/0UL#EU;$ M*`/EU*0_O0FJS.ZUQ&A5P*L5NF$\93_&H`$!C?J7%C@)Z7AL,4U?W.D+GW`1 M)%Q/"V210!8(;,(C>LP^P.!TVF09F2P#@1E?*8\$\ADI`PR>\2U7D2E;A0X"&UZI&MH9R$T-2G2!U..E;F*A@6C9VVG*S.7OCG[ MA1;M_:X9+KSR/U!+`P04````"`"@/61'W`_8/[T!```%!```&0```'AL+W=O MN-Q?U5]"MZ[Z,S-0*/ZG MJVSKBJ4855"S@=LW-?Z`J85'+U@J;L(7E8.Q2EPI&`GV&==.AG6,?W9THJT3 MDHF0S(399YV03H3T1MB&3F-EH:_OS+(\TVI$IF?^LC=[!]=>Q"DC$]1T/"[7 MF7'92YXDSQFY>*$)DP3,:8G9S`CBU% M-?'MWN,I5A$Q,F!2^DPI78,52]@V7:)B-61QO`)T$\;.H%(-TL;6Y^P\V]:R!7TPWG33HK*R[_'!3M5(67'GTX1&CUKW).>!06[]] M__/P?4$L#!!0````(`*`]9$?N$F=-+`(``#,'```9```` M>&PO=V]R:W-H965TN[?G. MKX48M@#P8TTZS)_H0'IYYT19AX6W\YV!; M9HK0P*^&C-P:>\K]0.F;FORH=CY4"J0E1Z$R8'FYDI*TK4HD"_^9%+*U[I^)U,+2"5\$A;KG^]XX4+VMU" M?*_#[^;:]/HZFCLHG,*6`\(I(+P'!/&G`=$4$,T"@#'3?7W%`A M=K"5.%-)9&:/ZVS,_%VR,RY7KT48P1Q<5:*)"36S=Y@EHG2(](X`*;!H$=XL MS/0Y="P"MT9J+`S3:P8%&PCA$E;:6.ABJSK13"=R=&8MQT8GLNN$R0<=@Y4. M%D0/Z<0SG=C1B19U8KL.BM9T/L%6==!,!SDZ\>+#0E:=(%VSL:D,/B23S&02 M1P:Y90RSMYDX7C1)+)/D(9'4=SM.[8YA$*_U;'/IYK&F-[.F-T[3R>*&V%AU MOB"TND%=#F8/"64SHNX= MJ)!'I3[73I0*(I/!)[G!:OD%NT]:ZF0@ZW#Y1]^]D\0]02P,$ M%`````@`H#UD1Z!H\GE'`P``P`X``!D```!X;"]W;W)K&ULE5?17?*NF7IB3J]Y?LCUV[HORW@I$% MK7Z56WX0U8(PV))=<:KX*SVOB>H!RX0;6K'N-]B<&*?UA1(&=?'97\NFNY[[ M?[)\GSE@4:)^RKL%LRQX,9NT]!RP8R%?(SB6^%;F$LRC MBE:@7DKL!)/;D_`$ M==^`GK-@>P"V>T16BF0,@+?I6/;$C1]*??)8=L)-/P$8/?HZE8Q\JL6V4Z! MP'=*L=J[Z*`D<6$>/#"K;S'J.XJ`M4SMMB)M/UJ3=M\=@%BPH:>&]QN$(3H< MLNZ1W,]:\3D<+Z`COH3C!U=\!WF;AO^P-6_\#I\7)>'`ZML[]02P,$%`````@` MH#UD1T1DD_[2`0``\P0``!D```!X;"]W;W)K&UL MC93=;ILP&(9O!7$!-1A(E(@@M4S5=C"IZL%V[(2/@&IC:CNAN_OY!YA)R50. MXA_>]_T>8\?YP,6;;`!4\,%H)P]AHU2_1TB>&F!$/O`>.OVFYH(1I8?BC&0O M@%36Q"C"4;1!C+1=6.1V[D44.;\HVG;P(@)Y88R(/T]`^7`(XW":>&W/C3(3 MJ,C1[*M:!IUL>1<(J`_A8[PO,Z.P@E\M#-+K!X;]R/F;&?RH#F%D$(#"29D$ MHILKE$"I"=*%W\?,?R6-T>]/Z<]VM9K^2"24G/YN*]5HV"@,*JC)A:I7/GR' M<0F6\,2IM+_!Z2(59Y,E#!CY<&W;V79P;]+=:%LWX-&`9T.<_M>0C(;DQH`< MF5W7-Z)(D0L^!+(G9K/CO98+$Z*3`VG3A/M<>F52SUX+G.UR=#5!HP9;S=-" MLZ8H%XKM+$$:8)4"3Q1N^(A]_R9:UM@Z"J?IK":-]+.F*GT5WOFJNS#)#4RR M@(F795('DWAEXN03C%.5O@I_B26]84D7+'B5)?6JW$7Q17'T)98L7&Y`YD5D MFWL;X*O2^',AY)W/GISA)Q'GMI/!D2M]U.VYK#E7H+.B!QW6Z!MH'E"HE>EN M=5^X/Z4;*-Y/5\Q\SQ5_`5!+`P04````"`"@/61'BJZULH@"``"<"0``&0`` M`'AL+W=ONJ5)+RO(@BL3O1EH@7=J:=>G)@O"52#?DQ$F=.R=Z0VB9*XKB(6E)W856:N3=> ME>PBF[JC;SP0E[8E_.^*-NRV#%%XGWBOCR>I)Z*JC`;>OFYI)VK6!9P>EN$K M6FP0UA"#^%73FQC=!SK\EK$//?BQ7X:QSD`;NI-:@JC+E:YITV@EY?RG%WUX M:N+X_J[^S2Q7Q=\20=>L^5WOY4FEC<-@3P_DTLAW=OM.^S7D6G#'&F%^@]U% M2-;>*6'0DD][K3MSO=DG1=K3_(2D)R0#8?#Q$]*>D$XE9#TA>Q`R4QJ[%%.( M#9&D*CF[!>),].>!%@K.M8A2#H11X[:^JA1"S5ZKI$C+Z*J%>DQB,"N`26<^ MS'J,00,B4@F\,9(06B0@1N:U`!@?8@,0^'F*])XBM<5(08K\N4#F"&1`H(`A M+68-,1-2YHY)#@1FSP4*1Z```G-O2H"94DOLF&#P+F)H@JV)Q70&,X_C^+G+ MS'&9`1<$72QE/1NY(#S!9.Z8S(%)XC69__=24.S8Z'^ID4_J]>E!U@A/,T*N M$6AHG$V02%P)V&JY[_6N>E!?^:*8%-;M202:$GM[:@5!R10?MW41Z$N,_3X` ME$UH"^1V+P+MBV?^RN6CRN79E/6X38Y`!^.YSV?3@ZQ/-NUK=&:S1N M]61L!.*,4<77.-%H;VLI/YI#@@AV[-))N[4-L\-!Y#4Q>^,#7I5GJ>V\.#'4AVOI^%A@-9]0]0 M2P,$%`````@`H#UD1W`':MO*`0``!@4``!D```!X;"]W;W)K&ULC53;CILP%/P5BP]8TP5J<&.%$/HH/6O*F% MY$2;4IZQZB20RI$XPW$89I@3V@9%[GI/LLC%13/:PI-$ZL(YD7\.P$2_#Z)@ M;#S3[8/0 M6@`&)VT5B!FN4`)C5L@L_'O0_+>D)<[GH_I7E]:X/Q(%I6"_:*4;8S8,4`4U MN3#]+/IO,$386,&38,H]T>FBM.`C)4"J0Z8C]VM#-P:46,,E).3?KM,LF4Z5Z+^%.8XZL5 M&C"QPQP6F%N(&ULG9S;4'L(@3`:1L M5ZVC6")FDIJ:B]UK):9CUTB65U+BV;=?'4@/NMEHMG,S23P?@`8!_G\#!'SU MNMG^M7MLV_WD[_7J>7=]\;C?OWR83G??'MOUY>6F?#__G8;-=+_>'?VZ_ M3W+FZO2S/[8W5YL?^]73<_O'=K+[L5XOM_^[ M;5>;U^L+=='_X,^G[X_[XP^F-U?3MW+W3^OV>?>T>9YLVX?KBW^I#U^4"D?F MA/S[J7W=97^?'*/_NMG\=?Q'%VW7 M"7>L\-MFM3O]=_+MQVZ_6?=%+B;KY=_G/Y^>3W^^GO]/J+IB=`'=%=!O!91E M"YBN@)$6L%T!*RW@N@).6J#N"M32`KXKX/\I4+,%0E<@2%N(78$H+7`<\_/( M5>(B;X.MQ$7ZX5;B\5;]@"OQB*M^R!4>\^EY^IXF_VRY7]Y<;3>OD]W+\J@) MZL.1WQ[K.50^V9TJW)Y?JL/\WQU^^O-&!WLU_7FLJ6/TB;F%C*.8CY"I*68& M&(KXE!,U&"!C4H00T&U6!`#>B9G(O,S\SSB0F^BH)F+&K&@F8,UGXR*^LPU5H4:.II*UXJEAG770N1EZ MY,>19AQ)!83IC\+]R87$T2]7QYQ;,::J\HF:OUY2L)&"B069;F*Q4U#M`CUL M.FM,&Z<&4?6#)P0;"&H;"V!B:V3ZB259Y9KLR/=LIG)-=K7S6M&C*>,:R`6O M*I)+7'U,%[$=*.@'D1Y**QNA3Q`LC]"=%)Q+FUY(:TQLCN@KBWZ91I%4@%A M@L5.KCP(%EE@Z"(!7GXI<@ULYRJ`A@P]DW)#+[C@*)(*"!,LS@M4GA@X,K^9 MJ2C41!G70([11*8^)I7'68G.LQ)C)%7@1$##%07YF.8ZMV/1HF.PZH!&3*?I M6K^W&>R#&JY-Z#1-`T,B)^@XD@H($RQV-)T[6B$'T[D',"F8D&N$7.(XIHO8 M>C1<#='YE\XEVUA;L@HAUT!.%?V5JX_I([8*G5M%(??2N<;7WI5&480U,BPQ M&-,];"X:KA/IO$M[X1#*N`9RS!`R]3%]Q+ZFH:_1&9+.'4F[8A=%6&(P)G#L M<3J"P.DT1>=F0_O;.)(*"+-MA-W*`+,Z,44@B2+J1KK7ET)9*.N1F5C'$D%A`D6:UP--$Y)5OPUEIY:@SIH MLZ_I+QP9LB@@3"18EVJ@2XKTG'EMQB.A$282+%HU%"U/-V/?VPP6K!H*5J"; M`;O]1KB?50^.74&]BO2\!GH5U'`7N!\%(9A8D`D?*V`-%%"3CB/=`O3ZS'NM1< M"B8I^#L+,OW$`NJ!@&J)@'HLH%X+9,N/"^@XD@H($RS66`\T5B.U-UTSX&NT MEOBHQQ+J@81J\JE\]+F$:G&2Z;&0>B"D^$"TZ1J#D&0Q[[&*>GAZ-=(-@16_ M%3V^P2%7H'>FHAN"D"2%\%B9/%`F0QYP^.+?>];58U'R0)0,F7XF#_9H@S8A M2CY-!:Q>`1XOL:19!"`AY0P6<.8!DEA.PQ@2@,99>N@7Z M2'V&W`%$$4.#L^E M8&)!)GPL@1%*(+U'%,$E(%]Z.^X`5SKY`2N+IY`FNH^@-J^+XY-S MRAQ79)(>8JN(P"H*FQ01G$$X2$)Q@(1@8D$F_,&-+FA`DFW:PU1&E1Q_DN]` MTAMR/=4YBS)!=%V@&MRGJH"06S)7GO=4_T75U+*^#:XU5>`[1^'Z5I6O6F(W\$V[V#3&,MU>G#'J0)G`^A)W4/]>\MW6LPV[V#3&,MU>G#KJ&LUW M("A->%0UN$M4P7V7PFVB*E^FA'@PD^*C%9(-(@]N6!X$KD[N;O#`.L%M9V/) MH\\SI>`1@^'LZ.]:`C`6M[#:L7P%5`@F M%N0Z,$@$P`5G8^E%)J8DJTPUO&,,+AD?AH?68'#=M[K$R4GHAQ!BHJTQ-;P4 M#&X%&YQ]OXU+;E6A+E_-!6`=I;8]O'(+[]RZ@E\IZ#"23TQJ>%45WE5UY!&* MN0+73"4[KVIXSQ1>-"W^VH#<#+PUI46K%$PLR'5@X"[P`JNC=[25@J81RAV0 M@8D%SQV89K_2YV7YO?V\W'Y_>MY-OF[V^\WZ^OB;?!XVFWU[J.[P4EU,'MOE M_=L_5NW#_OC7XZ>9[?F779W_L=^\7'>_O.OM-XC=_!]02P,$%`````@`H#UD M1USR>>!+`@``K0@``!D```!X;"]W;W)K&ULC5;= MCJ,@%'X5XP.,@E7;QIJT;C:[%YM,YF+WFK:TF@%Q@=;9MU]`ZPBQHS<*^/T< M#L(A:QE_%R7&TON@I!8[OY2RV0:!.)68(O'"&ERK+Q?&*9*JRZ^!:#A&9T.B M)(!AF`045;6?9V;LE><9NTE2U?B5>^)&*>+_#IBP=N<#_S'P5EU+J0>"/`L& MWKFBN!85JSV.+SM_#[8%B#7$('Y7N!6CMJ>#/S+VKCL_SSL_U#%@@D]22R#U MNN,"$Z*5E//?7O334Q/'[8?Z=S-=%?X1"5PP\J&5_0C<@WUO[` M_1Q,A"=&A'EZIYN0C#XHOD?11_>N:O-NNR_KL*=-$V!/@`,!I%\2HIX0.82@ MB\S,ZQN2*,\X:SW1(+W:8*O@7(LH94\8-=ZE2\U,J-%['L5Q%MRU4(^!!G,8 M8\"`")3ZI`7T;3H&403%&)*MYA^CAT'7WD36)9%Y@Y0BL+('4#K+#',88 M"--YD]@QB2V3]:2)C=G,FR2.23(62,))$QNS8$53QR2U!."\P-H16"_(MX5) MHGF3C6.R69!O"[/DUP.AXZ*/BMF,.Z!X@0]P?1H<*O(>ZBCCC!UV9377YE,FS!EWQ+\2O M52V\(Y.J1IF"@0?)&ZF:HV[ZIIUY&L>5P.AAM*_A]0 M2P,$%`````@`H#UD1QLZ4=>Y`@``0@H``!D```!X;"]W;W)K&ULC5;;CML@$/T5RQ]0&_`%1XZE3:*J?:BTVH?VF4U(8JUM4B"; M[=\7C.,%A#9^L0&?F3,SF,/4-\;?Q)E2&7WTW2#6\5G*RRI)Q/Y,>R*^L0L= MU)DL]4+2U,EL=VA[.HB6#1&GQW7\!%8[4&C(B/C=TINPQI$. M_I6Q-SWY>5C'J8Z!=G0OM0NB7N]T2[M.>U+,?R>GGYS:T![?O7\?TU7AOQ)! MMZS[TQ[D646;QM&!'LFUDR_L]H-..>3:X9YU8GQ&^ZN0K+^;Q%%//LR['<;W MS7S!Z606-H"3`9P-4/FE`9H,T&P`OV;()H/LDV$T2$PJ8R%V1)*FYNP6B0O1 MOP=8*3C73I3G2(S>N*FO*H50J^\-*D&=O&M'$P:.F(V-"2)VKA-`T#T09.J!'`>%2V),-@8SC!B,,I2FZ6.BS"/* M'*+2)<*&*+.(TF\%>LR2>RRYPX)=%H/9N)@JA-DY&+P@W<(+I+`=(!2L:V&E M6U2Y758+MK5A`"PJ?NE%4SKI@&#Q2Z?X^8+B8X\%.RPPF#.VDTG31=E4'D_E M\'BU+0U/9?$L.!8@]3BTA#X\&!-H.AF5^E'"6[AS@4N/$`!^4&#!(9I`\T8& M43L/M>2L`>B'XZ@/SH(;,8$,$2SR99G[,@4#MLH2K2`B[C\I4*.%*% MBW"5/:TJ%A#Y8@57XN`(T:X"N^3(S,PH#.)==/VE)_&ED5$ M>W8=I+GAYM6Y+7J"^J;VUC=@M37-S:>;IKZ0$_U%^*D=1/3*I.H#QDO[R)BD M*D#U)\?1635T\Z2C1ZF'I1IST^*8B627>\PS M.K*T+(1_;4\0O M+2T.G5%=10B`+*J+L@E7BV[MJ5TMV%5494.?VH!?Z[IH_ZUIQ6[+$(;WA>?R M=!9J(5HMHL'N4-:TX25K@I8>E^$W.-]!HB`=XG=);]RX#Y3X%\9>U7_W_KT[KI3_4G"Z8=6?\B#.4BT( M@P,]%M=*/+/;#]J?(54.]ZSBW6^POW+!ZKM)&-3%N[Z637>]Z9T<]&9^`]0; MH*D&<6\0#P:#,+]!TALD@T'R*3[M\>F#`'>AU$?O`K6IT/&3HN5]]6,0&+Z$TYZC&HPVQ,#/0A=I87C`9,)!5X9:#0 MID"&`^2EL!!XG"&^,\3ZH+%U4.<8B5:A,8W&Q&F&4S!.E#A$B47D'$9CUC8F MMC&Y%I,88N",D'$EJ:,DM;*2^Y1L3`PRXFI@MI8?DO@P.QN3CHO-'+&9Y2"S M2;`6FQDAP1B`"=G!#@TV:2#VE@$VRT#6P`2:W*')K=-@;X)S@P;,`!QG(0X+ MF5#3Q*II2%`*?+@=^4KM0^`H4IUYM/H=D+_\>Y`6A&8@\:%V%FK:6P*AJQE. M*+T>I(E(#(`/M;-0$RL4(E*'U6%@72,U$SGK&SC?0M\ZFF]]>)E&:9!Y=F0*Y`[V[N1R M)_?N$+G3S='1XQBKQ:4XT5]%>RH;'KPP(2>^;CP[,B:HC`Z8R=">Y:@_/%3T M*-0M5C'7PZ]^$.QRG^6'/Q2K_U!+`P04````"`"@/61'_B!.ZN($```\&@`` M&0```'AL+W=O+HS$EWV@P%QNL^9Z>DS(S0[%.7/ M:J-4[?S.LUUU,=G4]7[JNM7+1N5I]:78JUWSS;HH\[1N/I:O;K4O5;KJ@O+, MY9X7N'FZW4WFL^[:]W(^*][J;+M3WTNG>LOSM/RS4%EQN)BPR?'"C^WKIFXO MN/.9>XI;;7.UJ[;%SBG5^F+RE4V?9`?I$/]NU:$RWCNM^.>B^-E^2%87$Z_5 MH#+U4K",7'%V+#DCUYP=B\YPU=U^Q7?] MGVJ>MB[!IBR_;/$URI^H2EGT?-BU3-5??Y](+9NY[FTEC>(=9 MF!@N(AMF:6("88,D)H39$/E2L_&<@DPH0UR!=-8 MQ5Z;F$!:)P6DL2%NSB>YY:!"5KW)6:*[\T3W($D4VS`/4(QU*3Q"C#7/-SC! M5LE/$",(JT$<5X/H%[DQ^QZG5[[1R#R$9$/B+B5 MR#>(!)4H0$0!(*+,:H@RA"`#6DL]YL'$<*/)AEDBQ!*=G_GKR)QYWYP/`W5# M0MV14`\FRB=6($8CB\'(?-O\79L8$5%8F(=HVOW1X`DH.1C.`1R96[4F`"09 MI=B,8R)@&BRBY,#=SF"[Q[8")AKT44$*$W8%!FR!6Y=*PDQ?D$0F;`O,]`4A MT,8J-9/_B57)L#&P`/BMI.3`UL!`W\O8MEZN((B3Q&)W8*8]-.UJJ\""F=T: M<#^PH:Z&42-Z<$^S&.BQVM5"@WJFT/="J^RK$=C(00BW/_>`(NN.\J1!I[V+ M0H0]@H/VYXR2`[<_Y^?%/FI0+Y;Y)+'8([@`1#XE!^Y^+D$.ZZI:);4/@]A>P_:U4EQK44_W#J5S8)@0X)>![-[T;"M,F?#%TWH,P1E3TUQT& M.'/PR*9H*QMAI5H* MGZ9H&#:B"#N/`,XCF%U18#8B&S+G$=B((NQCPK2HH7.>!NF32CPT27<`QZB2 ML.,)X'C"NA$LA7EX&NJU9!@UH@>[IQAU3Z'U@)LKZ[WI#0&3C&*.#A)_PC\E M=FHYYM1Z5``S,"H")AG%Z,4CS5TA)KJ0Q+N").P*B1S9%VZPF;WMFNW[/I M0_]8XT/.?+9/7]5C6KYN=Y7S7-1UD7<_PZZ+HE;-.+TOS61N5+HZ?&UL[7W9;N-8EN!SSU<0A:AI!T`KM5A> MHJH+D+=(5\?BLAP9R$G,`RU1%C,I4DE2=KC1#_DP?]#STD#WRWQ:?LF<[6[D MI20O45LW"I4A2^1=SCWW[,OOR[(*5EGR\RH^R5=9]4^_V1L,?A-\6:19^4^_ MF5?5\LTWWY23>;R(RDZ^C#/X9987BZB"/XO;;\IE$4?3_SK)J7\,XTGM9_'3EO=/8$M%E,)6IO&7X)_CA_IS)ZNB MP&V?)^4$GOL^C@K<2G`:58W9=G=[_=U!KV6J\R2-B^`$WKO-B\8\XT64XN]7 M\3(OJB2[#4[RQ3+*&@^JA&[/`4\B0I96>.Q#WG+ MBY_C--W]*Q=/@HBQ7<=&VUGRQ`!095_GDIS`8$YX$'U=56479 M%)>^DV2"/J_K0VB\NWY8-@#>Z^[^J?6%R[A(\FGK82G4^Q__\`\^_-+#V`=_ M#E\VX%1_4N;U/ONG0?V;$;PZY=?3Z+;^ZRQ*R\;*3W)`UJP$J,.G,D^3*6QO M&AQ':91-8H`OW.%@1R&(+.=3%JVF"3SW&J[JI_%IL/.J">MX`B#IT87;J_]X M6<2S&(:$6=.H+(.3X(?W\>(F+OYW`[)XSO,\G0)2_6-P]O,*<.!-^W`E/KYQ MMMU^ZWSU9T=;/WG<^N1)5,X#P,Y@@A]BV,-=E`(X&R<*0RZC9!K$7Y9X)B6] ME%=SN,H3.0&8*6Z^>)U7@"SKG_D`![DL@%H7<(MP8%S($K'%/]K(/TI>P;J6 MT4-TD\:AGI+H1IXU$'(R0?ZA7_#\7JP`@FD2W21I4B5-`N-N;E,MH$O_3;X!GE7%Q%__F#X%_#>_:YT:BE%0(2_O,@)M5@+;!#BXM M^+9Q1824$_45PG2 MRBE/:A'!J`)RNJP('S5/I*?@7LJWO0$_MG;#_M'AV$` M4RSC2978RF0`,`I@`:Q-I=H+N3:)D`J#S'O%JL4J(LI_$LF20M..>[ M[1L/@Q:]S9O/I74[EQ'^,H^K!&ASB<3O5?!-BZQBR(/+JD;Z##=0,;Q^`D`*\H(D"/CR M.T1FA"4/U7(%GO_J1NC:ERVLW9XU(H/WM7P[<:,%WVA[3"N`0'V$LR.I%^C$ M-GQUL+4,W."Z5_%=G*T\@"R)5+[-\VD9C.$.U9]X6^3`X-Y'Q6W2(/%70#6C M8L(,;@HSI#DQE0:3OOJ?T6+YN]-@`M.5(?"X2;HB"!)L=V\B!-0$Y%0`6>1C M)N.6YX!(,6FI\B!?,BAQ,?=1@;)\"T3Z8.M&.8[*9,+\.$E7 ME="@S>3\6C6!//0@SFOZX*D7R`I@7,:#)!%10DO_P!?P6/Y/L MO<*MP':WFO(T!I$04`^O2PARRS*-B=P@[$8+E"?_Q7N+WT8X`YQF4B[SDD0D M!-,L^8+G1E(UB:=-2CK)X50?\.&;"(G23>.9;6@@(_\VE/!D'F6WR`:SQN:U MY`X@B$%?\0COI^JV%7Z^HH1[$,D+0&RD!TW25-<0+/$YDO?;J-J';4YU$_(E M0%3*39APN0)&`3#'D]E.A;HL\DD<3V62$M2].@JT[F9'MO,:IT("-@UN'KSK MW+2W69*!8+O%Q5HV5EOR5M>JU5>@K#YH*I#9ZM.XR$!EA),FE:IY66!*0U$T]@75O,A7MW.E?P4I@L9#S!4#=0^7&8=F M?]N^I]EK^ZND^(Z`%5S/8V6#)``B%R*TN40Y#*#B(Z2LTR*F=3+!#]?QERHX3@'Q&P:=#Q^OSV!;O_[R?X/K M;\^"DX_O+T@A%GK1\BN4J)$:H*0`(S/C]"";@U8S>%B-$:]S.^1O,,[ MWSY,BVB5@D"BQN)U9?$]`P?V6M5W>1.CP9JGNHXG\RQ/\UN@&&$`@B>^#]^K M!XG<1`""X/1X%`"C25(:,,/#)<07`2U8@/*/F[J?QP"(6%8]8^$S?5#'1"_# MRGB="=[6!+F(<5Z``%*!!`#S`A.+$X1J-5>&%,1F/M$B9EX'%"<.%JC2">DH MD9*@D.6WWZ!B%\Q!_$.*"UN$U8K(!3"LX)>2OURB+;%@Q@A+PO6A^9P6(QH& M[`IX+$XSQ0_(AQ$"2\"[2;)$)H!(J?8XTQ?&WBTN*!*FW//\KQBUE,@.2R8 MH3QJ@[ZI.XA+."F\",2`MH#>C<@2-^_GR60>(GQQ7_D2%#4F+0M]6T)Z.P,1 MJBSQ=9PN"F914@3+&CW",?P@5I3A>3C#"`N3PN4M>5D`6K6T)$418YI,V-P$ MZU%/`L+"/4(9;$+G)(N!I0.P@P?0H3L.=;^/2M(1BV5>T,G2[?L`%_K[O/C) M$"7U!&T_LU;>'X9![^AHWQU6-'269Q=1\5.,NYC>141**XL,J`.)4#X@CH7D M)@2Q9A:+V'8?IRD3&S'V*>14LR6(&1-\]A(:\N'$K;)J`,P)+I6DJ4?%A45)`'#5I-)S`MZ_W`2 M39,H^_7__+_@9QO%2ZZ5B*<5A M_Q?L-,(53%<3I[!N6;@ATI>KQ9*/I;DNO,U)R;(@T-7I/:G$ MN(A\5M$?Q`STPA?(1.`.PC>PO`D=&UPS0`#`.,/(Z*4(T;S,LW^$'9#5]P$? M@N_PDL"O553^A(;#'_.;(%HN8]2A&6\9/+`G7K:[%3SF*(.)L_R.\7ZN?Y_& M97(+@L3]/`]X@V#>^$O"$KV-+R[6(S7':_H0(V5',_]#@.M*8%)T4XOFM0O"-)PD MR:[:P`.TM]2J485,400(N.H%.7I#8(@IX@KI6_<)2=-$`^(IHQ\\O2A!SOF/ M^_C77_XSQ$_YJE`?5Z7Z9-T=^(JV"M\J+HU?D=2(\+O.B[MXPKS:*RX>@[@X M7BT6$6O"8VN[(T/#+X%S3#QJPH;'UXEU?F<0R7K').N-/[U_/[KZ'J6[\<7; M#Q?G%R>C#]?!Z.3DXZ MH4J`PDYPL4#=2UCL.SA_EBD!568K4!V2&?([5B$(`8+Q/%]:T]1'OBZBK$1\ MXLTV'QP&MBF%[9J6_828$5)"LD8QT46$0A*+]V4W)7875_-\V@F.Z=[1XM$] M!9)BE#)A(^'#*L1`[WA%S6-:]>4;6E=!7T`G8^JE&8!Z#@D]&GB&Q ML!:QLD5,64P$/H?\`][_C'^RP4?='7R)]VIYOZ8.($`GA/,7P$%-62VGY2MKB2+DMV1K*MC25;,Y)62\R>$^_(O81RP3;[`C6WG=V7`Z M\EQ-#'FLQ`I#PL+90/6J?T!>3?SQU>"(O)R.I_&Q2WJ2#.VLZ'!H5M3K#WU+ MPB..D?(CS44^5P23I("C15?0A*@_T\XP`!H))Y+=[B*K,#8_EF/)S($R!@A_ MV6U"-B\^>I+-008$8=[UB M@=@L"EM4%`^T4X(R^D+(P.2N$K124+CE&,Q:0WN#B^@!&;EF3*+VUL9/:.B, M%<6"E^_.U3(3Z2^T9O1MD#R`:T6EMERA=TB/CW>IF+)`:]8'J&KKZ<^1T$-4 M.Z?)E#@^S\:(8H`!2FAQBT+".:H0["!U;!D7I(H1=7P3A$#=`7>#WIO@3ZL< M=\Z",RI`$Q%7"+VU0$W(-479'H./!"V1O!AO>T<&[0,#ND$>2?1+!F;#=)(! M*:?W5EENGI&O-:K!!HO\1K0$P&,9`WAFI"89O`D^K1L"(;5V&,25>0(B43&9 M@UJ(MXE.:@Z,A:QL<#:%R).KC+6[&$TM!*[GP"G8$>`KD9<.Y;6FW(!^S04T MMRJC#-Q1>&/GH_'QK[_\.SQD$,"2><;HH@9)O`R.<_CG=7"[`H$$^9FBFU-C M[HIN\E7%FNF=0BM;'=5HI?3LTGX;-8],7S:MSCJC34"&06[E'94WM,WTRU51 MKE"Z0[N@`L#+[`SX<9%_$7H!H\`;FL[0J^5CXFK\A`H!`>0G9/M,,FV/\0H- MM[=](W6OB+WJ4E9M;7:ZBH46)NA3!":*84DK1+G6!3JF?'=\:^2;>!(A`R@Y M6H/94IK0_1<;=D'O6`/H+=8>T15B]_;- MW#53#X''/V+N!?^-2]FK+^5$&0#7A+.8J/;HT?$BO!H.^A86A-W]@8+`RQW`4]8U&.XYZQKL/WM= MC=,8B=JK+($:MNZ-\7,W62:'HJX9JX9YM<'LL7I[>\Y89#NX6ZON[L_#'9`>KQ+\E4)2^;DF0CPFAX$ MJ7\V"RZ5$6CG?'P)P`70PZ]!KS_8N7J].R&C+=GM^*DSW!9^N#)A1)8FH1#N M&I9Y-IO%$S;S4\SM[C$=QB6'@@2C>]0X.K_^\I^OQ16+2C7*;R`;SE`Z%`B1 M*1W%.41BDIS6`D59TY5!6[VK56]X.#9+XQ@H!T,2)7BQ7PL>,K9R$]2!9@$Q MCZN=1[0E\64C6CJ!]J6V@$PYY(H4X.^P2_#E(W84?N1@^Y-GN M&<`K?XA!^F3KN>A<"!=R6\L=6%JO9?!:K%^SK$VW%/QEP"*A8:'X2%PCH?AH M-WAFB4Q[KI]QO*+#GZ\L:+1HIV;J83SZ.HR`@M,DNH!L!NBD%^>.F%\SSC0H M&R:J&[IQG>`3R>)1<)Q&0!_&DWF.WEU#`A;Y-$[)P,++P&M(?A#ROI4>==6& MI@ZFX[6I'=76!0L)Q3UG^9_3Y#83!0,G45%<+C3TB;!W4MS,;,$2R#[IE(SS MO>/B9+]K<(K]<@`3XXR09;'[!PV=9J<2=X3N"+X7<`05P%&Y>LE^QK$2:G-% M,D('G36,C*M'LWIUQC<2#JH:.VT3PST M8:L'TB=EF2]%=8Q@&+C):?(3S+.+/L%=9?H3I9:DDI*\-H[V2!Y#8B6@KR:5 M.3!K%OCCISCK$-%VR2B&N@A\MIX>_KO"5<2-TTC))%E9]@.;<(>&RM/J(SNK M!533&^70O<&(,'5_\-`1Z+PV=I?BVA3!8K=-L%K"B$A%R+8`3+KB&#MU0UHB M.PBIT$:_1*_@@XH;IMME+!,19=L`3I`USXJOM2+@5887@&(K^6?4(LF&8H"^ M)W^OMO'HM0`J>9?2@E^L">)7Y('#*7HZ1I"D0+AP$4?,9N1O_Q+!BOG6W3PP M[.*IW@]!C\;[<54D)5!/1F-XD\_KGL(M4);Z$4ASQP3(JR0=9%GD]8Q=ORQ@ M`(?#B0'A(@O^N`*!@&362FR<*DUG-/Y$/^S"!I0%B%QC)ZXAYT09INBPLR>`!84HOPZP4FREB",A5(E+@,T2VLFP5I5K8-A&C MT0Q-3=H$B`<*"ST0]X($4*G7*HX+"UT#DB)B)HK$B&1KG"P)08%Y*QR0P%-!W8H>R& M-DG5INI5AL$NGSKC3O!V-+I4X9Q%;.+3<.?6"B4"Q=`J&;]D;S3`=Y$@D[BE M1"[4;5A0899%^*2TFMQ8.\F]D2GR30Q"D*C48@8JYY'"`MXZ,GK.R&=Y3$>* MX9>ICA3CZ)G:>CK.KD#72LCR"/3Z#O$S7G)$.B=O`,XDL$\.8:G!!S"9%-9I M3FE6>Y*/3QVR=X6BNBAIT&DG/%(QS$NRVQ)]X,A[HJ3"X3",!O0D%>4Q@]0G%E5Q>?;P\N[KF MJ.JS/WVZN'Q_AL$VVSM@PI9<#16JUB"Y;WQ#-X95<3>Q$W>CH]Q>!(5E5 M7@5]^40!-.;Y?I]-?/T>FR!-:$YBA^;TA_RS^K<69V/&$_,V&W`H]$B%XP9$ MIO/;`O%X-^!I>V%7#-$'AUU90%FVAZD,A_S>L,O6HO9"`K#EO:'>_`';F^OQ M;)S)@A;I0?=0F3I;QK-BX&WS9[L7H.&,M\UC:\RX=O!G-)%K3I&2NQPI.9-( M>!/;:P4VYGDJQ@X=4(GW5/VN@M'C;,[AJI*K&=%RT+*%(G1%5!@$%`I[2[(I M$&B,.#8G6#"Q%B<>:LE M`(!#T8`"1A-6%9"S,'U4AN)Y'$TENA'S'I(4E=XP4(X$0+"K?((.?PP$5K'( MBHG;D:LW.6!+_"6>K"0.>L;\DP+"LA4LH6(,HSA!Y;66=:%6<9^QT0[C0#$2 MMR`''V8!T%SH=T/+$ZR>0VKR@BUD.BB'!):/\`/%0JNP$`YG(YR$ISDVCQ5I M0O-=E/-5-!P'[2EQ'V4?(5V'G:9\7;#>35!4.55B&P[[PWT2XOD.[;PZ&(;= M@RY]A9+PXK4V#+(Z,35BK(D>I#F5E!8J34&S4G3.1@0NXSA%78XR:F6P!Q:M M4.VCR=>18Y$?)><6@;[:2\]GP.B(@@'QGYQ3-Y(&9$G+)S*B%RZ#7_:T+ M&R68JO>8LG2"G3$0&ZGSH:@0`+G+AX?X1/?>6@H)E9%&@X#=U)A291O'C`B' M8="%B,.O^ET^!]#*BTYP:<5$D%RA)F%XIV7.7VEP6Q8XYM6XOSAC12@0AP M*(6E@E*$X55",=9*#X\^X3)X"\\M0W9^ M`79RC!^+OCE2;&L19/6+LUN0*Z?V34(W$RQGHI4_'0"FK&=&G_8>];JX!>=H MWC9:'6+;HV&J+[%DAD;2U22 M0"!,%I3P:(I?7)3Y[G5>_(P1;PF*NS%Y=$M&!^*):**3V%#XZCTZA(*3W2$2 MO3O,*4`,FJ_*)")2,`(2]".?&O,$C'3#Q/A0+"6<)U6'G02SDYMP$4TI@,O" MK!L,Q`2M')E]A$ MR>D/=DTM(\N'NCSDTW)GSBAW9G1RPX'RTGOE_XZ"J<8$+F=FK7F1,[I1/#C&%2O[T?'[\Y:/1-MQ^'&B-HJ MU%-.XB1?8N#V9(Z$X%5PI`Z`X;JJ\D5^@T5==H,]^4D]PF"]R!Y!^B*W3((( MFA-["4BYT,K^0&48E%>VQF+0A>F.9$B?;TR6]TDY`S`-69950;@Z%\GU2_*X MN)P60L.#TIYIM1R%X>'0!\R>4=3'4(Q)4@O";;ZSUSG\;<=_2=E@8L=!W$@1 MO5QR#2%O>Z1A.G,_%"5\I,1![SL%S M!A;O+K'B4J,X16U&ESBQ*.OF=8[7Z,\>DMIW->?SSYYV\_OCL] MNQK_^LN_DY'Y^GNGP#`B`]G7]P!"BR1-.2S!%/VR:W(J_-`U/$E3[U)93U70 MZ]&2&J*K^*KZO7!PV*U-3RYP"HI0(5QXCW7QVEJ5%X:<74H-T0\NRF!_4!M8 M)L7:8,`8RUFD1V^.K:M33M'IC1%[\"@*N4YIR.`CVNQ0*:1`DYC-G'8=``Y[ M*QUK+#K<<2FP4_S<:U9%-5#6@*]5+NH$G\@X17*@JI',%X8E,AC"J+9S"6R0 MD^7<'!65K$1!`1)Q`O0L86(V%MR@)(>4<_J=:CEH^4;_3+PH[:!\YBVU"B%D M2Z%10DE$EYDMB;=1OP>AI`/U38H!(&^!6;1D-8E),IZ@V%?&F60>U6>79!39 M!(V6B[W5U)439O+`LK@Q3W]#KF3$`A4C0!$G['FS$EYQ4LS+R6\J*3I@(R@! M"(ZRHY$-8^+N-_AOO#\*#?)1"+]4M21)R3&74*5@Y@:QLIP22'45-/,Z4!`] MDA*_-!&8.*6:C&46=S8<`JOM]1^W6R=O+9-T M88E!SQ0)]M=P[&!TM.>`^&%"95*,\\+:@M=UM@%.>VS;]$UFK9_FDPT_SD&W MU]%*TO0Q2/PDY.SO'2GD;,G-,PX_@Y$@*`]81'T2`#UV62,?U`^=.=H@E-0* MA]9]MRVM(R3H!&?(,IIPHI^#1.,VIYM3M%)$A@ER@N#E,)$_H?)Q\)VA!$LE M781\&?!-[:*ILP85R:)/D1THI0H/X^!Y54=)Q>I15KTZDB9FB#`M861IC)4Z.V&6,I@Q$6H/D,1L2YK\4%!RMPF\X4`@=*F[$ M9:R-8]8=5"63=`@G"%2BG6)-3R15OCJ5\Y*1OJYJ. M)"!0D"]H$#@,F58PRLI)$[74)Y?3YH4NSX5FMB*VX^!(\@L;$WO`:GO>',Q? M`Y)7>QUV@EF,^\)>&PZAYES#AJ4,@?L>1OO8!VT(F!T/9[W#[&I1QNF=B8,R MO$(;29U[IO!,B!D%[\+V=ZM\%Z%``;N=X-LF8W4QTN2R$$K^O(I+<4LU>8`7 M_EC]P8K'KBW;P*YYB4$$K)(%2KN6\14VSW&,^#*Q,;N2I=CWZT3(`0RL,DWB MEI71R5J(N!;M.?$Q*K3MH-/.[2E)&AVZ]OFC=S.9)$ORK18Y M(FM$87%&YL1Z0P4O[YL:R2S94EVG7QC):&DR"$%;=.0D`)??`6SUA8MN0"99 M5?6;IP\"'42H#='U0CTO6;#JPO(S_H5(B?_2-R1FD3N$G,$MY$#5%XU2'>9K M+]I[N5E,GL:+I83])3P'7V&*8FZ\1LY#G$2.VA%J&VCMU>]:F'5'&3,=AI@F M/Z^DFE2($"78*G:'&5.XN]6R=F=#E;2MV&YMJ!8F),>D6O-8M*@%+15G(E-) MY,Q@=$XO@D6-FZ,E2T,W$<4N7I<60]]*6&[ M^40\1Y2CB=$E$[-;43UD6*6RT+#SJ\G9)#9GG?5?&5%`LQ\B4JRQ*AS7%;?6 M<1^C%9;QUI.NT1,'*E';&"NX_%>;K>*QB.&WU4>M:K!SKWVXW21A`ZYIT0G& M+J77.+T%F7=$SJI-VSC^:MK&T*MM'+^@MG'\UZMM'#]"V_""Y-7P&=K&\=^R MME''R"=I&\=_Q]I&`^U;M0T/L?EO;>/YVL;QEMK&T-4VCK^&MG'\-Z1MT'/K M)?UP':O\RR@E;-P81(':Q MA[60-=9X,A2SCH#=+H=UG[(>4YGBVWV-Y*#QK($).(=!/L@9K[*.!OP$>_DX6<$KZS^6^OQ-.]$FVG6:I,4*:S?NU0-&>+ M`='#FT:^HT`>G;CMR&V18.]N&S'_4NSUL1*4;=A))O4Z,A1MZHI4>-:DTE0!Y MB>3M-)I(8H_)O`RE^$C%Q9ZH]H;JZ$:2I2F0=\IUO'4)PF:@J!3F7'*1!XER M1_@[$TK`K^J65L#KU$,&,XV*C`)B;U5K4@F'5Y4H0PF5H=XJ&55;LU?;"$X\ M&NIB@?X0Y="/GTTAD*M%*RI%(K[O3,P0C<"/;0QBWB.WFL7##$(YC:JPAFFW M[FD3VS;+>!;;=N^\AW$_ES&'5MQ>(UKR17GV]OS:\(SU'+JN\;F;R648>/X]0CWT,JGUGW^YG&$]5ZLV;J MA9/&0/@*FP7N4NILN98@,:A"(J8.VH:"M+1^]Q+437TZ.9[NFTVUZS;!>PS3 M5Q599LFL>D!\G5C772)SJ.67"8%4>9,=Y'->:%*@[-X"SVE6,.&B7['Y<:VGNF>ZA@RBQ.!H87& M;]XD7V->OHVN'J^>N6M)UA`3UDXQH]*32/MX/PA9*K#&96IHRU*1LXPG*TY9 M+;BJ!C9.E+6$*D[1L=Y%F\_EQY7O)#P';MG[R(LD+PH_WTGN7L/]X%P.7-AZ MY(&'Q8O@VXQ]E-P>I^Z6>]:YXOP(8:6U$DG5"[><7MX7$1M-L]@3-^'EPDEX M(?F5.N,B)>)4)#FU>QHT+Q_)[=XP?:O4AX5O"N1V2A;]8J-NRI=SB,.FG M7Q@^,JGTKQR22"')8@U+`Z1Q$LY="1[_WJ12-_(U[JWN6%[-#_'5M.J>;TV;ORE2LM+9!7B:6J9T*<:*Y/04BB2>/4(SH5A57J208<_\YKFGG:_]K MU;3+G<+?#6JY=9N9L-.\ MPB[(1WFE!79%X+SAE4Y"&S.AQB%'7`ZP=S08A+3T!6U,BXCNHZ&4HGI0$U)M MKY@46#)#"4O[E%&!!&IMCDU3*12(EU)HM3)R6A#&7Y0@1AY0YV$IUR0%="6; M3VIB]XZ.#IVOJ``@7F=3#_7HZ,#VBBM3'=R(YHL[N/Y??_D/&A>_P5KR@E&Z M[H]""RIM+E8H3J?H>ZA#S=Q@54N2VA]4Y@O]B5;I#RROILNI$]BYX)JJ#%1^ M@T5M2C)OHKB:)MS,SQ)^=5$ES)?/L*82I]622I3FD?(0J?+BLDF$`IIP$/CT MO.AIKFXD94T/J5OR84>?!X'$P38-22F?CIV,2QW/8M=84CF64C>8$$&1&AJ7 M_>=JC%CE>@^7M?&;(KCRYCJ=3\.BQ_4[E'R MU'[H''WCKQ&A3?B]\+`_"`^/AC7(81$!HO!K09?E;:_I73)\VZ?A"N)8+:^M M0M6Z:A<]58]-`U>&VEB+7)V*K40[2_-LN,.UQKWL`'\)_3X;%NS\;RI^0#_[ M^4'I\@-#R0::&;A"U%+7+U?%ED2#TA2;>WT;;F!8A,L3+'X`&'4/]_1A*4$M M2Q7N]."_8'I#;TCF,NS!722[CE5U/N>W#IDUVUZL32Q65B^O<_>$)VZ5(>2] M7?B74)\ES](';1OV-2-1\XNQ17D([^>Y%6VF7M1Q+,IIO@9088V%:*+M$&Q- MJ*44E"-I>T5L(=:UA;2<2.LB&IR#5.3F2CR!`LAO52,2!!-PO++)[^J:PN^V M7HGB8;0BNT.L)5.8?B8>":(":F8)#`W@;6;T7%R_!:@.[]\:%BZ?)PQ%"U&A MC,>*X3^]9O"]P?K]`XX9;Z./^JJ'P5YW/QP<#/5#V+!JP7UA%"MP6"%1:U+& M8P/Z=E:P23MRECW<;LD4';5NP=(QN['J5698>6-COHT\)J/?!O_1]N`_Z#M+ M?3+XMV*?O?"(T\EK2[-YJG>9O;"_=Z#JJ*K:[85:YS9N:!CAX,#9JBD%X4IK M(DPRZ_2LYFDGY&):K[?M`?4&O?!@/;JI6+UUZ*9.##8XBY/J\0BXOB2/[BQ4 M6XI55WQ0K=/T-U3ER[46K[8*2;\R;-!!*[[#T M3+5***DI\ M4FXYS4MIZ\)1C2KPN^FY<=UT(#"SBO:JU^UP*69A99U@C!P3GWX0)]Q],(]3 M*4#N=#!3G1^*V,"HH;"6CDH9J:)>J71G"NQ\!;>1&4NB)*\KF6$K`FGI6?OA MD51/P863$<1#+JU$K;WPL">I6G33J<:8(I#/9RI9;A92D_$&`TEZVXJ)N)R# M3/"H#J?I4]>Y]Q=8IVAD8_0<`*4Z?T8+TM#3YI;V M!H-FL>&.7EU+$6<.5_E*Z^L/K2ZPJJ=JO1OOAIO13/$#!5M)`WQA5IG5+*FQ M7J>,C#D<-_*8M_W(]YUT[]4,Z\^<6%4P5IWI_+_6X`1?<[`_.02(,H[E(H(3#4W_)_KI+R)U!?8_D! MD7LWZ.,O_4[OM\%W.4:,49>/W@"'[@V&O^7_J+33X"%!UFN&1&@KU"I@^%T: MWJT/"DS5:>Q(K:2PG6:Y*BQ_OK2@4'W23--9@WHD+EG./7VA[\S2S1E8S8B5 M8,*(*HK_]=PF"0C:^\@V`U@3F4&;37XCY"K!-!<=/*5&7O=24[-L*EKB/>!RGL+=%3]71# M]](^V@IYID6!7?C?"#0SWY\`#>.\`JSR+VG5EF M)?\`^V%WOV]6OP\##.%CK\^D;RU?K9G"2GWZ[=R1L!?S`3GY4FAW[2'J72QY MI!PO:T)H41[0:9T2T?R9VAT#A]X:1^O(>:]&^#O"RT$X&.Z3W@_'V3DZ"G9& MK^%T]^%/L6(H%$5T=DY'J%-']/9N\&.\>OJ=;X8"OT M[(?[1WMZ&-@$#7%BAL!A\=@;DD?-3(L'JT^YV6V\#CQD^9[E4#PI.D?(H"(U M+6108K!9[C(,>PT=VKMWL<:.-+'P@IC$AH6O6^0!T*6A;XETI"S:,I]#B#YK M8;;]>O/">KW#[1;F+6S]+2(HA5^9CHW<;>$]UP>LOU5_&.\>;`E8G]N6X8FU M_[^ETMCZ^NQJS/T(R__*+=A,-Z_3UQL; MLL7/Z,>&BU?UU9U6;.7?00.V*]R5W>3J)?4=:8I)Z@X7\&JFP"N?H]^6ZK9^ M0U9.+:94'?Y:MU?WG,FZ<(\%3OSFA6:?"ZO]]I$T85VHOB^UK1U(!Z57[%6R M/DAU`-]NS\C21];9D3*AELIKR4W0:C7Z:\9?VFL4?(<,Z%*U]J(+B1(^IXW` M5/E2-[B@U['?I,J0DCJE2>&V7;+ZZ94QTNK,:1-D?,-E\D697,LH11:7S*1E M1JT[N96B0;W?6.^L=)`UM9N*5IQ#88@)=B)&-"YQK6/T=YH%J4@81Q^398BI MF^J#J&0+W6"UB($@97+]51OX(F9DJ1ESR;U+=*[AA>>$O%LZ-EUR'WM+N`X$ MU0"CRU=YN5V]B:-FN-"#EE/D9204J7 M8W*B)-.NRAMEVF1(N_6@ZJ)8LJFL6WLG:%C.E7T\2F-L4\QKMNOS6/W2F\]E M9O6<"TJ!K0,&A$E*K\V[K\<2.4L$LQ]!#DUI]C4>."8AXD:7MD]6K9O%S["R#9L]:[\*](!Y+\!8`)3GF!4P`V<"Z;RC=@MV%5 MY&F=[J`@5Y0;CA?)+REMF%IL".,2ZRRY"=^$8IR4P8G4)G+#1CP.1)1<;XLK M75LKLT]&,Y011]8^!,<4+SRU0QT\G*SI^^0L_]!A61RN!;2C0!RM)R/BM)XF MS])#N90F=[?8UL\15\O<\(0%NPI*L459\5/$K6,L':!"GR8I,"Y82*;KX7EF M5UV@57UW7"1WCV-R3*0)G:P)9WLIL$TBD(UU;P]K0(QQQVCRGR74B`INLU)7/8 MG2Y]&O_@<0TO_VI[N[YH?]*_='-2X-@?`!T6;5HB%TWP->AEO:"A,:@NQ_BX MR);-AK=X"7JAZ@9-`'Q2Y]N1B0_G5Z(;9#0>-FE<[!(S`GZB&L= MJGM#NT.U+;/J5J! M)7/8$QRGDL^QI!_'L:/2N\HHPZ9CPI0=L8CT3QWR4_E[:+,845*2E+[R>SH[ M@%UN]1[7'"^I.E0GG#E&9)4G0@'K@5.!3.@%Z#5+!;3:*M1C+L$XZ%A%#Q#A MJS6A[TI8;FL/.U".Z&>UK[XL\BK'6&E`?'."KN:J-M%&\ASF[M*\$VRY6,;2 M$Y`HJ3$>H07J>'1Q$KS/L?'Z2=X)@W<5FGU^_>4_\`>,,-_(+D&IB/5 M15>U06_F$-H@`>4>.SZI@H1,9];4Z1E*11\[S\K;M7F537*J!4#926(-A'DQ M1HO56MM0RPA*IE'=/[`Q=Y]YHS2R8GD+Q!E,.)D\\)9Q%`H/DI1E`!4&B M`9FIV**+H&NAP$W=Q3I/:/.EFQV=MP#$(H19XA;IO0N\L<&W#"L>ZH3Z]; MFOT0G1?K/WYB=GHFCOWR$0/[+=#U M`=\T`';5*(:S_5[J[S9-ZZB"DW*)'[!YY!W:"ZK';*Q]D/J#EU)V(Z3`5E8_ M\/$EW_;M9U0#N2.\"3Z2;<=\PWZ@?%;=H^ZY(^ZW0?#K+_\6'+!1'_-N@HL% M)=TPF7T'3)0O',CE<*>"-)F1T&0(@HZP3'VZBX6L2A59,)50CP6`I".@RQYL=66 M=N242*$93<_=CKADU`CL:T#EB@T2+/RI,"G*7KZ?QYF6B#K!9_QSF@`82E7) MCN+&:*]VZ50'$";YEA78F$3,*E$55%G=MUH*1JJEM[*#(!6GT\)LYEPM@8-^ MA=9)&!<^1YO$EIN@LN[(5EYW-IQ.W8#?$E2WP8+OQL@=6+5NCWS6[,,-A&N+T8E,R9)`4>+O'-"DMN4RCQP*BGX.0XLTHIY+6Y6F8B@_Q, M`B^3DM5W.,U22N&;\8U,55KK\^3A4%CM4_79:<+E,7@V1A0#C,D<#:MEP]5\ MCD%]'&CQGF+'XL3@B5C@'`3J4D&;X)/ZX;@$I%KAF$'%TA\Q63^$-QRIBA] M=XO.;3:32<_@5:8=#C\SN)X#IV!'@`^L4!\Q<%?%"@"?FPMH;E5&&;BC\,;. M1^-CRBO9,0A@":)C5!(BK/]$9MG7P2U6@_T9]A,N4>H?U1?LZI_>=G9I`+S,SBRU2145T(2+7BT?4^+= M3_ER;@M!W9W1_BDIO,3J562!8D!:?%"EFD0\H58TQC=E5EW*JJW-&J4/2T?. M@2MCITL*4VU=(/:!MR:UQ[=&QNP$Y"A2CY+Y7)JPOF]B9IT%ZBW6'M$7VDUU MF\8W8B`HDP5\KPH1-%4)5MFO6'YZI";B5WX\8[Z1&)NH)-,;UL_%;;!]8ZDM M)+:=0T4VB;2@E&DV7;$W"_VKH;8ZN%(@RPIQ0NBQ$[TFW+8B/U(TV-.9<@"O MXPQ7]AR*IR&;(HK%VBR("?/DLY)ZP10;;Q@PR<-<8V>9QEA]2F^&RU;=8%8_ M)069]N@L9\!1P3BYU@)"9-GZ2Q'G4XY#82HZ2S1^ZW*)=[%'08]O":Q7,4$` MK:/;\\QC982448!#:E^&+AJKP?,*[K`1,O>DSG*2F8NG\O:>(D5TUD[=LP3N MWM%+3BQ4:835@OPS=^TXG;W'S%UNW+4OP:%U*7V[S]_AP:/@OW$IC08<)SHR M;K-=J59#*E5!5^,T1J+W2[TO`UOWQOBYL2Q3U5!O':N&>;7![+%Z>WO.6"I`C;4+$U2I MS!5M0:H\FBYYU>!CP!,NL;8ZX,Z5^)]%MM`?QRBT+4V]<,>\2WZ^J6'?RE]4:5I(A:QZ1F8#:I)G;*/! M\C"R^14T1<5*2.WOWF+2FL` M)XI)67V4G!B1W"@F(HP"BU3M>[+=1135/O,63,8"@%-5Q@\7IMF56US#D(!TMHSG!*9^M1:36J`Q43]8Y@ M-#X)#GJ'N[WN[OXPV+&<&3]E6/XU@FM$#X(>-IO!D8B=;^=\?`G`[01C^#7H M]0<[5Z]W)R'63+HV)0#.I"0_$`+MP[9T.X7?U[!,CCY@FD/(SORHKOX`%S;5`405G5ZSRZW>U=04>CLW2."2C%EZHKL\J M;522I*`;9?E!4R\+?.Q;IRWQ"@@MF[D+A`53R4M#$XE[9!WSQ;`[W!UV"?YG M5%7*A1_%/F*V_)DNCP2@-%HP)8U:=W1IO6:G]#L&Q5M)N9@URA'5TWE5<2&[ M^J;17JTZG,2(/-?/)`%2](OEQ;?*]EEN:0)A06E2[#)#*TZ5I$XL(7K_$CFG M9C8RX%,G^$2J2U1+'S4D@#)'R8;&R\!KR$'K)L;)5=J=`@FF*`FN3>VHMBY8 MB(IKM4HBI*P7LJ#7I!P%:HW M@G]3*#Y;FJB6;#VY'F-,V!C%Q0X))&R#3:AN>MA>8E%'9?#,&B6;3];6:`<1 MJT!?58R1SUI&]@A5Y$`!2OELV$C*GNU MFR8_P0YV,>A]5]F-Q;I`XE5)+C]'C:>P+&)2"\!04V;:G@7^^"G&>/X&@<:X M.8'\UM/#?['L,]UD]YQ3LF=7MB/?FC&T\].X6KG=7#B_8>.HE">QR@Y313!> M6T#Y`+@V10K9Y\^5[:ZQ0>,D! MRT%L2&(G;$R\;[C+!2>`!2:Q>KT@MTW9B"S7]CR]%JR?[EM*"WY)98-(8H&Y M-I.5O;*G:GX";Z70GOA+5$_/F,53O1^=+Q3\N"J2$NBR+KZHH_/QODE/GZ;` M>J;B\2]ATR20//O>O:,>65A(B<,[:=1F-`*FJ=F!&$6>Y0BUQ2.#!MH4)VH= M8DVP="9X0S%0JRQ6"41LH%==QD;C3_3#+IR(LBV2H_C$-1&>*!-AL'.=+Y-) ML-_=?_T&-#44?TW'!Q-R>DI9EM]-=H>19%FZ!/!@AXF(`X&*N"IR MK321`9'#AZG\N)(@Q>%NQWV;+8H*QG'.1CP4+JZYNTB`B/?4UUG=H26"G*@J MWMAIPBB"=DTJQM^V0M.\PU`VJ?)@B0.2?Z0"A;4W M/!>26$*E@G5*B0>E]G:[1RB3;H55\)PBO.5JB:T,<"$9&V,I14)UB%(6:9M' M:#\+)]E1^8NWH]&EZOQ%212PO629TLZM%9+/UR:^,G[)L1D`WP6EB&.JB6IP M(6&]16QWXR&CM+XD$DDON7G4^HJ1J-02F4DEU#0,92)J+B2B:RG<1J=7L'Z5 MEW%S/1UG5Z"6)F33YB2MLHJ7W!]/2KQQXHN$TKGPB;#+!RI..44QYR'SP1]7 MTUMMD%'V>%VX5:%GINSBHT'WAHCKAUHQ1UXE)O49M1\10V:3(B2@8^#75T! M"UGQINB^:W1"-&/[/I`[C']\5-28CIR;@C9$\2'O,+;I!QKJT?SG;RB`S'L: M)W`:_MBX5LBOA^Y3X>@Q_36M.!JPD=?1>VVE4[9;BHQXQM4+OOY:#[SG/<6)5_ MZ:FQ!-8P^AKHG0/TF/1U:`+JAB-SO_/]ZK`DF7W,H6KE'][2$0L>YOZ]]*(;O6.4=P$M,DY4H#5A>S MLR_BP!:S`N9]:).,S]8W8EW\7P,_D"B"XU0%7;2M1FP9C;<-UIV)H;6Q#W(- M-[ZE6(\MIFT)CI#96E^T$R#JO[VUK,4CUUI<'Q:@)B$83UYB`Y>4QVPL/K)V MTH_>@V,IC*%/6\O"+>-_LBL;6R.`U&#<)8`?RJ+-X0IBZQ8IV7N&J+>J0/H3 M#J1_/&1;:9)?$PU]*ON=19<:][FAE%M'^5XRL=N.\M*K7X5VQH655E)_>\#L M[U$+PE(/:Q9TX!^RQ930-LI[U@V*NI;_",AL,\2&O;1:*=I>&/HWO]%V4>=8 M\&@+[;PYH/,,@LOJO^VM__>,J,Q)'XU30 MDZ9$A^8F[CI![]#_(PD=F'"/!1L:/TJ1D'4D:!:7',\>G,?K&.X[;GM_Q3(Y M%P9#,?5*ZO)=DN>E`;&N3QAIC/HNSFXK"JA3P['NZ3M\X&7X%A4I,H$J91C4 M1H5OU&"H4C1H#)Y5^L!E#Y79@(WCM8&:HA)YTA[_HH6$#@Z&6IIAONN@)_EO M'/3E0V@B@OA''*YM08A'NM"UMT+.B29+B5)^E/CV[,&5CS-$>6`RQ\2I!G&I M%[I9(_.T7-Y'`LZ#_<&'^,NJ#-Z].VF=G8M:\8\V![HH\^`Z+[`VTVE"?7TI M9K%UG/4VTA;'NF:9YL>Y(,E-L:(+>GE*/5K29H_ZM2VO&9Q`5RKHF$^(N/L9BKQ MXR'`#.4BR:XE"CK7 MKGF)M#5]+5%IMYYO?V'?1T6'VE.W"AEXF[$U>/W'\_BF$W2'?L'FC]B0KMOW M_V@;3'K-!3UT=(_D)N76#`F+B`0CAX3DV1U6G\)SLMJ_DTF[71!RGU/V=+@E M8Z\=P[R`S=M1^C!&P*88I@>KS2.6]@9KI#5<<)B'0\#4.IP*8IGC86]B[Y>2659F35U,]#6WJ>.``[89JW5X%(W;"-#[3>V#7' MK\$@H*6@0@.NC5O2FQ=*IRRH\I198T+"D4^?;(QY%4_CA310)LMV*X3',5D- M3[9&ZFW0R$46&W;&"/@H"'^;4RUYF0BV)W$G,ZK=U0;J'FG?;3ONO\B6"?'6 M71RMH*MK0\]1P-,)IA5YY$>NDT'"IWZ6<"*Y0^$#E'H.#]S(K2R8AF)#HX`9 MZWS.8\S<;J"%HH"8I'"7D_9ARL>U$4.^!NU<1;IYJ^Z`K>!N,28ZJL'-PSH7 MK;`JJW*%E/>AT"7M@GS+*1-PL?R2W`NL1,^EO#]?=[HM-WZN6Z+^6?;^G70; M-)X>/_][^3G9EF6EDGQ'5;P_VMTD>55?82UX>22AKGDN?ZY%;(D1`JY6=-`] MBT`X#$YU4)W!:V$T;9=:OX\').U_M M3M2O`$:WS'/L^O15R('I3]-F2O-;J%]@;J-5D6O7(<;@Q<3`3SWFKI[?LO@5V``+FU_MTK=RN!8SPJ_2U=F!M7/TFW]>U=)R^5!VG5=(+ MC4P:BU"^1\[]-<_U7(>T?5U$:I)DIV`07:&FMF+![REZ@XZM.T7_,J:_^RRO MN@Q(ZS:?[Z'_D*ON[9S5'=8;;Y05,7V,IK_2;OD_^X3*]D9G8A50\BM]0>^P MC]UCOBJE:Q+71C0:/4*\)C#E]?X,8J^UIL?/&S9E$_%%-:A!V1``KW#%8?`N MOX?GZ8_@7;)(&C?H:T[^:;E[[!NT- MAKZO]5B87^49JRV0NOZ<=R/]3J_YI1L]O14>;!.*KX!N) MJ=LB4'&+",5-X]EJ`#]!0;?\L1E78CV]N[%EZ@[EO:4I'K/NMOL:I".SJ$=. MT-Y-M#[04&5*#X=>]-IO":RJ]5[_*IOT11JO`7K;X\\";:1#KQ,=>LVE&6", MYETT,_"OBLU;P(BK11L\V1VAY0:3)B@ULS*"$9]5B`>MCNFL`N M:]2O?$_K8_[0:_"#'_IM`79!O^US^ M8>`1*^RQMX8TYA#\+?3"WFK=?^&VV"^ZQK^J#MF/"3JP8R+;@PY\D8T4$]GV M)AN(SG3CQ+J!"*BSM!35P6FM@JV\6]:T/=V_R!>*)X'O.UBWY+6IQY!D*SQ+ MTX%&53+2H2YB(;""7W@H.Y8^)E4*L($*2>%ENH"CEF@>;B>9XC1J"`H5:!I% M-H#(;S-@S7V1;-T?# M?L-!G6-N5]CB&:9K-Z+NA`CB]]*4L"&)MT8VPLZLWFW?4N^VUKA#54>63'DG MIFM8JPTK2BG"0_?.\7_A\]%!5+ M?:'!SK&BAG>L4Z[O;H>Y.@$;WY1E]8?_#U!+`0(4`Q0````(`*`]9$>.CI^1 ML0$```(6```3``````````````"``0````!;0V]N=&5N=%]4>7!E&UL M4$L!`A0#%`````@`H#UD1TAU!>[%````*P(```L``````````````(`!X@$` M`%]R96QS+RYR96QS4$L!`A0#%`````@`H#UD1ZZN;*A_`0``\!0``!H````` M`````````(`!T`(``'AL+U]R96QS+W=O^R`@``!`H``!```````````````(`!AP0``&1O8U!R M;W!S+V%P<"YX;6Q02P$"%`,4````"`"@/61'&SMO;C\!``!I`P``$0`````` M````````@`%G!P``9&]C4')O<',O8V]R92YX;6Q02P$"%`,4````"`"@/61' MF5R<(Q`&``"<)P``$P``````````````@`'5"```>&PO=&AE;64O=&AE;64Q M+GAM;%!+`0(4`Q0````(`*`]9$=P2:[#.0(``.<(```-``````````````"` M`18/``!X;"]S='EL97,N>&UL4$L!`A0#%`````@`H#UD1ZCRX5V+`P```PP` M``\``````````````(`!>A$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0# M%`````@`H#UD1\".G[(K`P``7Q```!@``````````````(`!DAL``'AL+W=O M``!X;"]W;W)K!2$O8#``"0$@``&```````````````@`&5(P`` M>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`H#UD1[>5*T2A M`0``L0,``!@``````````````(`!P2<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`H#UD1X\XN&BF`0``L0,``!@````````` M`````(`!3BT``'AL+W=O&UL4$L!`A0#%`````@`H#UD1R:C=5:E`0``L0,``!D` M`````````````(`!`S$``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`H#UD1SXJ),)'`@``@P@``!D``````````````(`! ME38``'AL+W=O&PO=V]R:W-H965TWU%M@I`$``+$#```9```````` M``````"``>XZ``!X;"]W;W)K&UL4$L!`A0#%``` M``@`H#UD1V';S#:E`0``L0,``!D``````````````(`!R3P``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`H#UD1TY[L5.8 M`0``;P,``!D``````````````(`!=D(``'AL+W=OJ`A[#$$``##%```&0`````````````` M@`%%1```>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`H#UD1]P/V#^]`0``!00``!D````` M`````````(`![$H``'AL+W=O&PO=V]R M:W-H965T@:/)Y1P,``,`. M```9``````````````"``4-/``!X;"]W;W)K&UL M4$L!`A0#%`````@`H#UD1T1DD_[2`0``\P0``!D``````````````(`!P5(` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@` MH#UD1\-<"@V1"@``34P``!D``````````````(`!BED``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`H#UD1TZ$_"84`P`` M7`P``!D``````````````(`!Q&D``'AL+W=O&PO=V]R:W-H965T v3.3.0.814
Note H - Commitments and Other Matters (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2015
Dec. 31, 2014
Oct. 31, 2014
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Jun. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2011
Dec. 31, 2010
Nov. 30, 2014
Nov. 18, 2014
Dec. 13, 2010
Chief Executive Officer [Member] | EBITDA Benchmark [Member]                            
Officers Compensation Agreement Rate                     $ 200,000      
Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Extraordinary Items, Noncontrolling Interests, Net                     $ 300,000      
Chief Executive Officer [Member]                            
Employment Agreement, Term                     5 years      
Officers Compensation Agreement Rate       $ 25,000   $ 25,000     $ 25,000   $ 50,000      
Period of Severance Pay       6 years                    
CURA Advisory Board [Member] | Employee Stock Option [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period               4 years            
CURA Advisory Board [Member]                            
Annual Stipend               $ 5,000            
Payment for Attending Meetings               $ 4,000            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               50,000            
Director [Member]                            
Lessee Leasing Arrangements, Operating Leases, Renewal Term     3 years                      
Monthly Rent Payment under Operating Lease $ 6,256   $ 6,256                      
Annual Rent Payment under Operating Lease $ 75,070   $ 75,070                      
Related Pary Transaction, Expenses from Transactions with Related Party, Rate                           $ 200
SCIRE Corporation [Member] | Additional Hours [Member]                            
Related Pary Transaction, Expenses from Transactions with Related Party, Rate                       $ 150    
SCIRE Corporation [Member]                            
Related Party Transaction, Expenses from Transactions with Related Party         $ 5,000 $ 7,000   $ 14,000 22,000          
Related Pary Transaction, Expenses from Transactions with Related Party, Rate                         $ 1,200  
Business Plan Consultant [Member]                            
Sales Commission Rate                   4.00%        
BAIC [Member]                            
Revenues             $ 39,000              
Cost of Goods Sold             $ 50,000              
Increase (Decrease) in Accounts Receivable   $ (20,000)                        
Operating Leases, Rent Expense               53,000 $ 51,000          
Operating Leases, Future Minimum Payments Due, Next Twelve Months         72,000     72,000            
Operating Leases, Future Minimum Payments, Due in Two Years         75,000     75,000            
Operating Leases, Future Minimum Payments, Due in Three Years         75,000     75,000            
Operating Leases, Future Minimum Payments, Due in Four Years         31,000     $ 31,000            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               695,000 11,000          
Due to Related Parties         $ 3,000     $ 3,000            
Revenues           $ 50,000          
Cost of Goods Sold           92,000          
Increase (Decrease) in Accounts Receivable               $ (20,000) $ 20,000          
XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note D - Related Party Transactions (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Jun. 30, 2015
Oct. 31, 2014
Sep. 30, 2015
Sep. 30, 2014
Jun. 30, 2015
Sep. 30, 2015
Sep. 30, 2014
Nov. 18, 2014
Dec. 13, 2010
Director [Member]                  
Professional Fees     $ 0 $ 0   $ 0 $ 0    
Operating Lease, Rate Increase at Renewal Period         10.00%        
Operating Lease, Length of Renewal Option 3 years                
Lessee Leasing Arrangements, Operating Leases, Renewal Term   3 years              
Monthly Rent Payment under Operating Lease $ 6,256 $ 6,256              
Annual Rent Payment under Operating Lease $ 75,070 $ 75,070              
Related Pary Transaction, Expenses from Transactions with Related Party, Rate                 $ 200
Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount                 10,000
Deferred Compensation Arrangement with Individual Revenue, Benchmark                 $ 1,000,000
SCIRE Corporation [Member]                  
Related Pary Transaction, Expenses from Transactions with Related Party, Rate               $ 1,200  
Related Party Transaction, Expenses from Transactions with Related Party     $ 5,000 $ 7,000   14,000 22,000    
Pro Nexus LLC [Member]                  
Related Party Transaction, Expenses from Transactions with Related Party           $ 60,000      
Board Member [Member] | Iso Torque Differential [Member]                  
Revenues             9,000    
Revenues       $ 50,000    
XML 15 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note D - Related Party Transactions
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
NOTE D— RELATED PARTY TRANSACTIONS
 
We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership in which one of our directors is associated. 
 
In October 2014, we extended this lease for a three-year renewal term through May 31, 2018. In June 2015 the rental rate increased to $6,256 per month ($75,070 per annum) for the remainder of the lease term. In addition, we are required to pay a proportionate share of the yearly real estate taxes and yearly common area costs. The lease agreement has a three-year renewal option that includes a 10% rate increase at the renewal period. (See Note H)
 
During 2010 we executed an agreement with a director to provide consulting services at a rate of $200 per hour. Pursuant to the agreement, we also agreed to pay the consultant an incentive fee equal to $10,000 or proportionate part thereof for each $1,000,000 of revenue or proportionate part thereof actually received by us for a period of five years, provided the definitive agreement with the third party results from the material efforts of the consultant. During the three and nine month periods ended September 30, 2015 and 2014, we recorded no expense for services rendered in relation to this agreement.
  
The Company has a consulting agreement that extends to December 31, 2015 with SCIRE Corporation, of which one of our directors is president, to provide us with expertise and advice on hydraulic pump technology and related markets. The agreement provides for guaranteed minimum month fees, based on 8 hours of consulting, plus travel costs. During the three month periods ended September 30, 2015 and 2014, we recorded an expense of approximately $5,000 and $7,000, respectively, for consulting services and travel costs related to this agreement. During the nine month periods ended September 30, 2015 and 2014, we recorded an expense of approximately $14,000 and $22,000, respectively, for consulting services and travel costs related to this agreement.
 
Effective April 13, 2015, we entered into a consulting agreement with ProNexus LLC, of which one of our directors, Thomas Bonadio, through his affiliation with The Bonadio Group, is a minority investor. ProNexus LLC was engaged to provide outsourced finance and accounting services. During the nine months ended September 30, 2015, we recorded approximately $60,000 in connection with this service agreement. This service agreement was completed in August 2015.
 
During the nine months ended September 30, 2014, we sold a limited number of Iso-Torque differentials into the aftermarket to Model C-5 Corvette enthusiasts. A majority of these sales, amounting to approximately $9,000, were made to one of our board members at a discount to stated list price.
XML 16 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note G - Stockholders' Equity (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 214 Months Ended
Mar. 28, 2014
Dec. 31, 1997
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Sep. 30, 2015
Feb. 05, 2015
Jan. 02, 2015
Dec. 31, 2011
May. 27, 2008
Preferred Class A [Member] | Convertible Preferred Stock [Member]                          
Preferred Stock Dividends, Shares           8,709              
Preferred Units, Outstanding     557,012     557,012     557,012        
Dividends, Preferred Stock, Stock           $ 65,000              
Preferred Class A [Member]                          
Stock Issued During Period, Shares, New Issues             0            
Conversion of Stock, Shares Converted             0            
Preferred Stock Dividends, Shares             0            
Preferred Stock, Liquidation Preference Per Share     $ 4     $ 4   $ 4 $ 4        
Preferred Stock, Shares Authorized     3,300,000     3,300,000   3,300,000 3,300,000        
Preferred Stock, Liquidation Preference, Value     $ 2,351,000     $ 2,351,000   $ 2,249,000 $ 2,351,000        
Preferred Stock, Shares Outstanding     565,721     565,721   587,101 565,721        
Dividends Payable     $ 2,351,000 $ 2,249,000 $ 2,249,000 $ 2,351,000 $ 2,249,000   $ 2,351,000        
Dividends Payable, Current     $ 167,000 173,000 $ 173,000 $ 167,000 173,000   $ 167,000        
Convertible Preferred Stock, Shares Issued upon Conversion     1     1     1        
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears           $ 0.40              
Preferred Stock, Redemption Price Per Share     $ 4     $ 4     $ 4        
Preferred Stock, Shares Issued     565,721     565,721   587,101 565,721        
Preferred Class B [Member]                          
Stock Issued During Period, Shares, New Issues           0              
Preferred Stock Dividends, Shares           0              
Preferred Stock, Liquidation Preference Per Share     $ 5     $ 5     $ 5        
Preferred Stock, Shares Authorized     300,000     300,000   300,000 300,000        
Preferred Stock, Liquidation Preference, Value     $ 344,000     $ 344,000   $ 319,000 $ 344,000        
Preferred Stock, Shares Outstanding     67,500     67,500   67,500 67,500        
Dividends Payable     $ 344,000     $ 344,000   $ 319,000 $ 344,000        
Dividends Payable, Current     $ 25,000     $ 25,000     $ 25,000        
Convertible Preferred Stock, Shares Issued upon Conversion     1     1     1        
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears           $ 0.50              
Preferred Stock, Redemption Price Per Share     $ 5     $ 5     $ 5        
Preferred Stock, Shares Issued     67,500     67,500   67,500 67,500        
Series C Preferred Stock [Member]                          
Preferred Stock, Liquidation Preference Per Share     $ 0.40     $ 0.40     $ 0.40        
Preferred Stock, Shares Authorized     16,250,000     16,250,000     16,250,000        
Stock Issued During Period, Shares, Conversion of Convertible Securities           0   0          
Convertible Preferred Stock, Holding Period Required for Conversion           1 year              
Convertible Preferred Stock, Shares Issued upon Conversion     1     1     1        
Preferred Stock, Shares Issued     16,250,000     16,250,000     16,250,000        
Preferred Class C [Member]                          
Preferred Stock, Shares Authorized     16,250,000     16,250,000   16,250,000 16,250,000        
Preferred Stock, Liquidation Preference, Value     $ 6,500,000     $ 6,500,000   $ 6,500,000 $ 6,500,000        
Preferred Stock, Shares Outstanding     16,250,000     16,250,000   16,250,000 16,250,000        
Preferred Stock, Shares Issued     16,250,000     16,250,000   16,250,000 16,250,000        
Series C2 Preferred Stock [Member]                          
Preferred Stock, Liquidation Preference Per Share     $ 0.20     $ 0.20     $ 0.20        
Stock Issued During Period, Shares, Conversion of Convertible Securities           0              
Preferred Stock, Liquidation Preference, Value     $ 5,000,000     $ 5,000,000   $ 5,000,000 $ 5,000,000        
Preferred Stock, Par or Stated Value Per Share     $ 0.01     $ 0.01     $ 0.01        
Preferred Stock, Shares Outstanding     25,000,000     25,000,000     25,000,000        
Convertible Preferred Stock, Shares Issued upon Conversion     1     1     1        
Preferred Stock, Shares Issued 25,000,000                        
Stock Issued During Period, Value, New Issues $ 5,000,000                        
Payments of Stock Issuance Costs 46,000                        
Proceeds from Issuance of Private Placement $ 4,954,000                        
Debt Instrument, Convertible, Beneficial Conversion Feature             $ 4,250,000            
Class A Non-voting Cumulative Convertible Preferred Shares [Member]                          
Preferred Stock, Shares Authorized     3,300,000     3,300,000     3,300,000        
Convertible Preferred Stock, Holding Period Required for Conversion           1 year              
Convertible Preferred Stock, Shares Issued upon Conversion     1     1     1        
Non Plan Options [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period           0 0            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period           0 0            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period             0            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares             337,500            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number     4,815,000     4,815,000     4,815,000        
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number     6,965,000     6,965,000     6,965,000        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period           337,500              
Warrants Not Determined, Exercise Price [Member]                          
Warrants and Rights Outstanding     $ 1,750,000     $ 1,750,000     $ 1,750,000   $ 1,750,000    
Stock Option Plan 1998 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period           0 0   0        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period                 5 years        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   2,000,000                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period   10 years                      
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum   10.00%                      
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date   110.00%                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number                         0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                 1,823,895        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period     100,000           1,823,895        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number     0     0     0        
Stock Option Plan 2011 [Member] | Chief Financial Officer [Member]                          
Share-based Compensation Arrangement by Share-ased Payment Award, Options Modified in Period           50,000              
Stock Option Plan 2011 [Member] | Minimum [Member]                          
Trading Price of Common Stock upon Vesting                   $ 10      
Stock Option Plan 2011 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period     0     0 0            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period           5 years              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period     0   125,000 0 250,000            
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                       3,000,000  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period           10 years              
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum           10.00%              
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date           110.00%              
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant     1,277,000     1,277,000     1,277,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     675,000   500 695,000 11,000            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number     1,973,000     1,973,000     1,973,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares     406,375   6,250 472,000 131,750            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number     1,247,000     1,247,000     1,247,000        
Common Stock [Member]                          
Stock Issued During Period, Shares, Conversion of Convertible Securities           21,380              
Stock Issued During Period, Dividend Distribution           16,363              
Preferred Stock, Shares Authorized     100,000,000     100,000,000   100,000,000 100,000,000        
Common Stock, Shares Authorized     400,000,000     400,000,000   400,000,000 400,000,000        
Common Stock, Par or Stated Value Per Share     $ 0.01     $ 0.01   $ 0.01 $ 0.01        
Preferred Stock, Par or Stated Value Per Share     $ 0.01     $ 0.01   $ 0.01 $ 0.01        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                         0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number     6,062,000     6,062,000     6,062,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           695,000 11,000            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number     8,938,000     8,938,000   8,343,000 8,938,000        
Allocated Share-based Compensation Expense     $ 252,000 $ 90,000   $ 349,000 $ 133,000            
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized     $ 199,000     $ 199,000     $ 199,000        
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition           1 year 182 days              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value           $ 0.53 $ 0.36            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value           $ 861,000 $ 690,000            
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit           $ 0.20              
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit           $ 5              
Warrants without Expiration Date, Outstanding     743,500     743,500     743,500        
Warrants without Expiration Date, Exercisable     118,500     118,500     118,500        
XML 17 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note F - Notes Payable (Details) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Copy Machine [Member]    
Notes payable $ 9,000 $ 2,000
Automobile [Member]    
Notes payable 4,000
Notes payable $ 9,000 $ 6,000
XML 18 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note G - Share-based Payment Award, Stock Options, Valuation Assumptions (Details)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Minimum [Member]    
Expected term in years 5 years  
Risk free rate 1.50%  
Volatility 130.00%  
Maximum [Member]    
Expected term in years 6 years 182 days  
Risk free rate 2.00%  
Volatility 135.00%  
Expected term in years   6 years 109 days
Expected forfeiture rate 0.00% 0.00%
Risk free rate   2.10%
Volatility   135.00%
Dividend yield 0.00% 0.00%
XML 19 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note G - Share-based Compensation, Stock Options, Activity (Details)
9 Months Ended 12 Months Ended
Sep. 30, 2015
USD ($)
$ / shares
shares
Sep. 30, 2014
shares
Dec. 31, 2014
$ / shares
shares
Outstanding shares (in shares) 8,343,000    
Outstanding - weighted average exercise price (in dollars per share) | $ / shares $ 0.63    
Outstanding - weighted average remaining contractual term 5 years 255 days   6 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 695,000 11,000  
Options granted - weighted average exercise price (in dollars per share) | $ / shares $ 0.53    
Canceled or expired (in shares) 100,000    
Canceled or expired (in dollars per share) | $ / shares $ 5    
Outstanding shares (in shares) 8,938,000   8,343,000
Outstanding - weighted average exercise price (in dollars per share) | $ / shares $ 0.57   $ 0.63
Outstanding - aggregate intrinsic value | $ $ 265,000    
Exercisable shares (in shares) 6,062,000    
Exerciable - weighted average exercise price (in dollars per share) | $ / shares $ 0.66    
Exercisable- weighted average remaining contractual term 5 years 182 days    
Exercisable at September 30, 2015 | $ $ 121,000    
ZIP 20 0001437749-15-019529-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-15-019529-xbrl.zip M4$L#!!0````(`(8]9$?GCV%KF+D``$@9"0`1`!P`=&]V8RTR,#$U,#DS,"YX M;6Q55`D``YO].5:;_3E6=7@+``$$)0X```0Y`0``[%WK<^+&EO^^5?L_])+9 M5%)E;#UX&#OC6]C&,U1LXXN92;)?4D)JH&^$Q%5+MKE__9[3+4!@-4@\QC!Q MJI)@M=3].Z?/JU^G?_G'R]`E3S3@S/<^%O1CK4"H9_L.\_H?"U\>B_7'JV:S M\(^+7_ZG6/Q$/1I8(75(=TPZ@\AS:'#M#RGY_;)]2XI$U\[TRL,=^=*Y(H:F MEXNZ5C2U8O'BEY=NX+(S_"^!]CS^L3`(P]'9RZ(\3/]$EJ50P[A?,O3J,K;)-R8?N,S[ M:\G;6-RU^)3)GL5LGHY)%"$D?1Z2YWM>-$QOPPF#DW`\HB?P4A'>H@&S)]]Q M9JAY*4#T(IEP[(Y1RX]O6G&P9T]_FQ[0^G;_M/,SBA'SQ! MY5",]9:UFJE-WHMXL6]9H^FK/8MW!:EQ@?A@'D@4!LH>J)U`Z>1%+'`6A"Y^ MKW(B"Y.OLAS*\_)*#IY-\;9>J]5.1.GT59[V'M2JG_Q^=_MH#^C0*KZJG[,\ M7UW\]W\1\@NV>L9%49OVB$!Q-@AH[V,!NZ,XX?WQ"W<*<3%*T\<"9\.12PLG MLAY0R+/ZD'H._!O>N%:?V+X7TI>PC54Y?TZZ1-/CG[4B=BAS/A;LHFX6+GJ6 MR^DO)Z_JF55_)>Q$>,.X;;E_4"MH>,XU6,`\+4%#Q:)N@&3(IE1USEJ]]NUH M.'WE`;3'=V[@&<]%H%&X^*5O42],\ M;4!_::`W6L74:U794FJ=KYKTAT/?>PQ]^Z_'@150WHI"U#=TX7/M,]DH&DRS M0!QJLR$HP,="\_YF@N&T0"*/R=>%K2ER467AHE2NEDM:29\#MJ3E5RBEU+?I MR`]"*'\,K3"?>)4+%W]0/M=^:IV++8/5I\$5B$'?#W)U2*EP\0@<@J_)M`D" M-(\L;YR$,=?`8NMMVF<3+2W4M=C4;]1U?_7\9^^16MSWJ-/D/`)NY6BRNMBDHD[9 M-+J'LSK$'9;;1B6WQJB'7]#?MT88FD(/W<)WZ7RNS"!4`,*?;>IB,/M@!>&X M`^SDEAU"%,POQ\F2^@OCQ6L64!O"@SLZ[-(@77D,PS`UU*RI!L4Q63$"/W91 M+6M5,%*92=B8XA*&WY)B\=/4=T&Q4:GNC.+'D(W`+6>1IS\[+'1IJP=&DCTQ M!SX65%Q]:=?KSA/`"L:7OA4X*\FIE53DE,$ZSU$3PTO`OK)&++0$,1T:##,! M?PA\X$(X?G!!H>N>T_AWQ$;(HJO-1F*^B M803:Q)YH*B3A*5]UH5D!__^@3[MP?6+V@B6/4#/E5_.M+A!=T?1J>?M$7\=? MHJ>F8.+0PM4#L'9]`?4W%@YF5J)-GZ@7T4OJV8.A%?SU.F#2,';7S=UXBYI2 M]C7Q3\R8C4A*L*8!PR=?Z$V]'U#Q;;J=TF9]K&S!/ACE0H'O+&B^U&CHCW0#8NP2;,,:;Q@C_3 M0X#J8A2BZ!JC8BC]@'%JSGIF"T!W379I1G9I-=EE)=F5VD&1G19SJLFN*(,8 M0S\HLDLSLC/TMC)V.ZU6=D5V[,#W-8`W5"P!W:C$#,E$PN8D?ZL(7BG\&Y"\ M$`:"[#SZO?`98I]/@<]YVL3$"FFMEC1E:*Z?SJ1U114*2-E;9&L)6"W0]@T['RTJ6=!3"@(:W19Z%C3 ML$>2M%TF*,VEH7T[+I26CWC7HJRF5"VCO"9AR]#G:RJ_F;$=1 M0`L7VK&>2O`2$A)DQT8>!EGU,*1B2O>.4JPDTY3B]N9CE`%I:2:82\`F21(T MPB@5!D@!KD?!9ZD!5&T^@-IHZ&/4=)"]RD3VTC`D(\&64:B56>YLH'M# MK1"Z-]OH9A;I550*3E[XFMW,@.:(4,SD-7@(<,`0?>&T%[FWK$<[5M>E'2#DTH7Z M@-X>'8I?`%XR/7&I\1YKG,H^>D!]45>]:0N?`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`N8Z"Z5'7:QQQ4O@(;2'K M1LI=\_EB\D3>CI6+$&7UM(%>,2MFDNYL!"3([@26.->+(Z!6+P'K"\#]"E&[ M(H6)9A2UQN#-_'.'3B5831U;"?CW-.8%=+9D98;_*W1-G-CNKVR++'H?Q#M($ M?P:@Y;?,ZN+L+*/H\,6@._$(]-UV?0YCGCA'SQK;Q_FIH9O576T@W_M%]$QD M/XLY#=QJX3KGF3Y#WA=!DN(5PS,BLN6),O']?:O3((W$/MG2.:E?7;6_-*Z! M$?7+YFVSTVP\+EWA3_E-#F/GPNK-'0="2#TDCW04"D]'3.U(Y.,4>^NOJ2V> MSD@U=5%<.B*6U&WBSC09]96#]\8]EZ#D(':NZS^#D3A3;NH]$!;EZ&OY!]G) MP1-=2SUYLN'!D\D_E?%C1Q_QM.GV^9:/`-1U988OC=V M:Y]@[L)<)8C1S4,Q5S'H0_/+[_+]IO)M?-?BO5>#YO>![\/P=_UZ<_TJZ>_Z MMRZ8:\F&]YF^OA6GF2KZR^ M[+E270?6`N_7YUA5>9'+1?D5P]);71OMXZ^5?"LHOQ7M M&3I1:4+*VJM>W`7MT^RQ#Q9SFEY\)?LZSNU4F;VGJM>T!3^2WNR:V%8[./5% MB%6]7*ZM@,M>Z%:U+6,O:!,G5/3-J?`"YG#7'%=XB.UHT`$.#*U+'4P M6316$PPHP/1]_H(%H!(Q6E"V-RY\;MG0Y3J\@1R)*TYR[4GP^*4,E MOE1UJXSY)KS.D_FG5M64'"B7]*JA56J'R(,\:8-J575JCK)9UDNF43Y$'J2D M''I[G0-N&V^JNVTDM)^^O3"[#"K9BTKC'@H)VZS;'5=UA=N M8(GH*D?1E^/.>"33S\DD\=.2E:GW2DH1GJ=#`38314W/1OHS)@9;3:4C]6)Y*L*=$&R5`[^JH5X+`">U&]@RYRK81W$S MR#65_]_0M!M*BU/4J]73#)2DP]HF07F&Y%5UA&;JI^9NZ?%=9H_7R(4)R$LE MLW;Z#;)AOM?X7N.6LSSS+A4;">!(,Z^'LA0R!M`&7 MMZMS?DQ^HP2OS`GA7XDQ%:P5DM[D6BS1'`LC.7AZ'C![0$;">@)B%Z`A9?3% MIA#-]ZB#MS^X2"INM7&()>;8H.',V46V_'NE(Y@WYPL>`*^4"^7T!7P)O`17 M3H$M=-F\0FSLS8IZU7[Y<"5/J]-0-]&J:H)GW59G>Z?63`%=*K^G@'Z#%-"? MYU-`7[7N[IJ=N\9]YY'4[Z])J_.YT08>=3J-]M)DT)L`R:3XWU^VX3TGY&V$ M4@SVE=[ST'FZH7#L4Z`%48)OV]%H3"Q@,,[0D%Y\D2O(1D#\"*\ZE5=64S*@ MEO/OR`I"&G#2C9B+":V/2+RY`$!!._8`[^\+CD2S?_C!7T=Q*!&G)A' M8(:^4%NLZ,$3G'J2J2(`9]3#"_[P7A*"2;3I,>E@+O,)+@95/'N88@)1CP". M!W@&;(0`9%N^AY4*]$Y\@3O'[RS.?=QA19UC\M,CI>3>![*N?SY.].GT5],C M+?@2DY_*A.O/%#"'%$3=$=G5!<,$FRSX.Z"T.*960`(*[@S"*>#"$)_[47]` M[B!VBE.WGTIZ)C.2^!]X6S`8('ZH'!GE"@9>,J0C/WVHEH^TJB8>69X7#7\6 M;2*"0%R+"*HW2?@N(6'+QP3P6_&F)X'="O`#"(@P7`M]X)S@7^#C-1ZX,PH` MB`78265(#41X,&!V"70JEH?62]Q/<:$M[D[!NBWXS44`^-T8SQ2A.'R5;Z/0 MT7@#TD20/*@ZEC<9\G,BY5QQ+P$J!'FV0!1&($`O#,8C%*3A0UD<^Q6O?"B+ M`Q%'(#\<[U8$17?'*)7QY=32(.`P0ER4-!-IJ3V^O)_L2.@'RJHHX]T-0:Z91 M>^@*L&;TL%);_D:\V#"2:@Q'KB]DG]3[X&*&RZ8E#IW%2KG9=<<>MD4'1R\L MWX`%#HGC,_3A:.&.1!'NCK*\,1D(TVF1KWBW]P.8*KSO3=P6TXTW<1`G<0G? MQ*;BKA,(I.1F#AF]0$UH4:V)3$ZFO,`C`#*\M-F#)A:+14@WFZSB>'8!`KH> M!E`0LS!/^@(([)*H(2IB'L0Q(L@4J<2@V)(NP[8B,/[P8Q9-]GW?P:"%(];' M",+!&2!AXKN4B#N!(4P4[<0PK%"R$>?LX@@(XE#$`W%E0"$B]>)@KR_O/H6' MTO?$;T_PHC]@(M`5]\Q#7\V"4"RS^L*5X>9;CJ&N#XV#OTE4:O$)W M)^<-#T1_054U&:2/1C[S0J&E."MF#QCMO1HJ!4*.Y%/Q:@_+Q.B#SAS&3/M& M4<`C2X8U30M\;+=E- M8D0&Q3C2#I@8=3F1C7:6I_2/8'9YGM?'Y,LT))[VO&QE)CX,8^&0A:YLT,+/ M@2=#81R[OA?QV#1&(XS)ITL#(>YD!)N%P\#_;^]-FQM'XQ_Q34M,/HKYU;817!J<1BI3U<=ECH47[S\Q4WK.""(/MU%P)M=G[,H7YZ? M59GH8^S`T(P)N=X6[2P7'P!,]*]40-0MW%YRG\$AP!&I@*ECC_E)@=N&_XLG M@\LL0SZ*P!F^'2"S!H<;BV\'>@MC(!/L\AA?`=Q04^B$T48X!Q6!PO"[8YO) M,P:C-GBRS-U>/&IQ@]PH.GS^23H-0?AK05P&61OM`.0UB@R@&%ATE85+OL8Y M,/N:I_0G5-D0V8]?<@5.[4]B4637CBSUL>UZ0>R%9YLB>^+\7`K)T$!O)NQO#4@) M:A_UNH`YY>UP`L&V.=-3Y0;/.0)RS(]O,IS(B`#CG0X.C+0*LFDJSGWTIMP, MD!8$0FEX9?^WST\]H!KZ6Z3`!P-^KI$'!AC1VP+\X1]XJN!YQ3_!=_-_">>$ MIDGB#\;J#V-L_(>EK(JO!%?)(9/%,9@5Q-7I70)\E^-&)SM81`P>U@D[.F&! M*0TX`71N'O)P5^!0351#5]YU0I.$[`+RECR,F',S`#U*WP$R,H_L,81)O`:] M*JP:PK6%Y2E"RS%+JJ:\BD'C:%WPY>B$P\4!4,;'.>-)C2XN^QO!%K[56'6^ M,T]\(PQ3'<]DM#=??&$V"($E-""#:?R!(?$62)0_Y MC20:A(BSUFBJ.ZIO&AIX7N,)'*;:R+)->S@5+$_U_H(A0;]=1TIVE4`\4<'! MLQI_&(3VT1>*1[";G2@XWVK-AJMK/*(2T0_VX36\F/,<\+A,?LD3HD"BA1=K M`:7)T[D#X1QGW9L9;OH6!:'XF2!]39`=?R[B+\`#H"O0:P*SVABCHPDJJ5EK M">U#!*Q%49XS900[2QP4O1O6-6$C9;Q.E:A-@'A$?4$#G<`.WF4$-0V&Q3O"%J:M.=!IV?@K,IE?*F`^/>G"@ M02*XV'R?WP;$]VYM.&!Q*D4!7_FZY5'R@=;(,QIBC&K<8KT:HSU&W>?;8)CLT MRD_")*?+B]LKY2MPB0-VY6E-^>)A9E$4;M,^X2^BO_5/'V+FG@O,9R6=ZH1! ME]1T-,R):S+P[=";3,2>XUJMIJBF#:^CKP*[+8Q;SUJ)W/NB0R7TQ&3K:#=OI0Q3QRPL[V/1<.`#K2^!F#[07!+#/)'YQ]=XM[?KK/ M`J=-9\`'X#);VI2CC*O@>B(C)#RLP*H$MK/'S%E,X,2M*"+U2AQ!L0`_R@*A MHXQ[`:^&[;L4ER<\=0DA$:`0RTSI7`X)A;%Q<;IS'P&M2#(#D)M"8YV[HV%- M/;[Y?B)R8]P9LW&_TB__6\JZ7RJM?#8EW;:>T--_4)U[A^B@4RE=T,-C^6K$ M=J.;40U7!\K6XQU'&J>-9AR7!?!L`($%Q:OML[-V1O'J5A&@;]T+WQO9CO&? M1.EV7LIG=Q/J-,3_I4*;?/D:4.8@;W6[BX*G:L5JQ:K*=^TJ7UGL ML^S9C[S6)$Q\<0.+W(V*>BE=A7=,3Z1EU.@"X6T$?M&TSHM47/_%-70#'=!; MUZX_VPY>`,8N(6A"*MZ+J7^!.>'-/EE3;L%=>O(=<#QCL8@:IM.#P]GM_21J M8E0OZZ8@&5?O@"=Z00BDQ=OH"E`@%P)"D4"7LI_LP#E13:HU5D5>%3\#P7DS MF;<`:M@WV`]P@EZF&%#53'4L5Y[#KWMOL04TN/;N@I8_<@^- MSHIEPDN\=7$?GDYF>[]$6YCLU\[`!]ZV2PT?Z:3G71[YQ[#IS76[9&5V'CF; M@7@^(&O#O:!55E:'HT7;&P>#&Y/+@1$U`;PR5=<-$,)V4@\.&S"\):-O+A9V MX)UCJL^C=1+J-"0I0!7"U1_K\DEFIZ9>-X5/%@"S$?@7 M\$M6CZ8<_!('9<:;^S:QK6B+!ZINKD3Z>8>XOH5[?XK<7O!V^?BK='"([.9&9OI M)B.7,:"6A#BM`W9XFO0:JS7JS$&FF=;1TDNS;+/U7CHGU(,O7='.6HQI[G9X MO4:FL7'>RK_EU^S%6[O53_N\:O6SAU8_G^.M?O"S)^7AXM\7EU]NYCF@Z[RX M:NU30$2R8C?IP9Z:8MG8=6["1_S%\NCIUCLHN_M8*7K5L=8;ZD=Q)8&I1XN#O%)M1IE,LT.<04^LI&MK%]. M6I$"SQ+=^"IE/%A#);C,H9>Q%NK1W$'=BG^/$(=*!M-V1[8XCE5^^-].[._J MF#Y"'#)GSC_=;^"5L M\R&P\2'@L!%1;/9/>]T-B&-4%<07+)]X=BKQ7,L8"-YU>7'UO[\]WG^[NZY? MW7^Y?P2^U#3&!H.3K5!-1"7Z&)3(8]7*X9SH.`(JSP>[%!&B*WN"LPPTK.V9 M']G<$@L'(:(Y>S&?S@D&W!^8<25YMIA#WNT"X%9.)G=0L%=`@@JPBD3Y!:() M6O#-42>_G/#_+18+E9'3.Z>=[@'P>CXT6@?-[4N?T@/ZO^V5E._LMV_%<" M56R!FF,V2!AW"F`V%$BL"A4-*+DM7A8PTR6M#9*FV_Z+RY60S3NB@T\P-9!_*#NBY6F!=6#MO.)=4K/; MH]:P^:$ZP<+QV*0^30[_8ZLF;/@TY0V,,75VMD$8S>&(K12U"4M;$QMM\8$V MU,V8-R@60__X,M2PAO=>C`WN2YFH=A[T6:9%"6>"=AJTB4HV>>TW1.]^Q1A/ M3$,SO'#@1=B4-/Y,Y_3LIU/E(JURO#;3QRMLWF7QUEB85CP'[K#![KL^M?;" M7VI8TL.[5N)S?)J&F(9H&NH+C7FL6J46"A?>@K1%3>`FOJ.-J+4NM@:/8G8H M"^^:O5J/AN(IKPPVWL1^":K'^W?JNHA8"O.E"T",X>$G`^>U> MT!;9L;&A*?9:1][C>#@VTUO.D#L)!W8>DXO9XZ9EQ.GZ<31IC_SJ5J<=5S)ZM<[==FKY>-:03G M/&QNA;P]P@9QMGR@;N5Y2LC^_&);0SP=<AP^>P>0@=9C2!FLSO!!# MM3/;YBY`M9D'T230\Y#EY#"T!V&@S/`#X']K^S`$8HDE"*NGAI2M.%X^`8*7S@#SA%;\.A6E>J.[IX4QW] M-^JCKV"ZG\C>$TK68GK!PHQJ9W=R:24V\ M-F9)4DGCWG)4'O]Y:VGVF(6GT1><=XY`(+Z/8K@,[+#4XNB&]W6=3P1L'Y?9 M9*;53!`A@GD9;&:+M[>%3:MUWLJ4OG_VEL%&_BWR0@T"V4LG):8KWU`%I1G_4R:M_J94&;!L@GHT_H09$.?2>-V M-HVW"?TRC8S.^EE]@7X]Z^Z+]KD[(YSU,W5/L[4V^$'+I0=>/#8Y+[V-K(9+-#`57HHW, M@>02?=>+N9,+VFHACAGF:VIK]DY!]S('FAEM&_>*YH;;A`&:699K*IK=@NYF M#C0S.D9M%VI>V0T[(=E7:WF0>O&,B;0'+S3-C+[-G;:G7.]X+D%O@SVVGK M=/:TD1O5^XAC9MNX=G-S^QB[BUDO$-#K97?5S=J4V.M7A'$9=[_7RW28>[TM MPKB,4]_K9;O%B8Z!&R=D_JZ&OF&*BV+1J$ M13=;63U%%^O?;`;+.CIG,4[0QF?/MA2TQUO4913OO':DF1>."8,E'PAQN&]4 M!Z>ENH')>:FZAH:14,/T/9:S:VDF`_;SAQ[JC=-&*T)F`5QK(K&4.NIGJ,P, M))J[0F(I?945A,Q`HKO#GE(-#L;0F*]44:=1J\:952M6.@5"YL> MEPOSS8TR^H)#6#`UC0\Z4TC\/V86S7Z^>+J,N@:??W*5BZ M::8Z<6`1YD0M..43)L%X8MI3QIX83;X/;(AX\@Q.5P&4F4Z),NZS[6$N8_0] M]HZ_L[U_,S`=-'MHK3@$MM6>XWO&HPY;`WM'U.'Y8Y]M1WR$O\LY?THB5__D MUX?FOYMGK>L=4"85Y!7(]:S^X!FQWF<07/D;D9FRED/0;K/]F,<<=&9-Y.9Q!`.\+&ZKF#2A`D1OW)`W26SC=HR7' MS>-9F]V>A'I>,#>&79C&NSIVK;/>5K'[K!H.#7[]RE1,7*<<3]*;Z_I(C%@5A5KL10.$C%?_&8&'!*>6*)0*#&>':0Q,9AU->Y>9)A5;N2X8PV"X4K4B M?$'S4,'25]2H4`B=%/@M38XP8R-385GO#0_`>=(?08A:N'H'S$C[/:RD=-K%Q+"-ZAN^*!U^#9P.@T_-E8![,P!C0$4NR2+?DNJ@^#A9VV(SHU.B(BMOY#!T3SPV MM/$XS!RJ4AK9S54_M@PFX7_:O?VA]07SJ)7F1^7_?!O9-)`+%$=R]E7RM,7G MW&?$BQ:0&C44"OA,XJG,NM42$ZCU4;E_@0]?:4J.(!(/T1C6Q.DRG#FS`,SR MG%BE'5^EXK#"8((<-AN@?Q\9K!=\Q#W:14\8K<40CW)IP_]\4(:^H5.YN8AF M!D8*5EBK+[8?LVO`7AF$JQJ1&1Q%ZZ6GL4N$I6!D="R:1I"M$UM-8XZG`G.G MKLH+\_.\'AQ_UP<;%%EXEA*;05&JOM=%V!>-ORE2E1N)1(JH[JF'T'0UT;F_:\#8G+.?GHEX#?4";&@WDHYX=FN;X`!_C\:@8U*Z` M6D)6A_^@#T"?NR.PM$&_>'A5,>NJK:ICT6MQ)G;UXO+>#:X"SJSK4,&6^^;2;@'ONX%$\YO0; M2`+>R]U;3ZK)[@>Q^M^P^'?-](BS[*+9>$0]'S2;P6"IW(BSS)S29FM]#)@% M1[6)Q5PZ.($&R+^*Y^Z\4'3N+*'S1B;HW78"]OEPK`]T;HXYSRHXPC+K7GN' M4"^3RW0^)Y>LV]DMT+E9^[R9>571;+1[:T#M@!@`^P^,=/4Q;SIW5@;AW)G5 MQI77I:LUT1\I[0 M&I);@1&YD>H,>?U4R5R9TGQT1ADYKFU9S*P[/)^;O[2& M?@A0$_0E/>OZ$_0>X'-=JKVOT1!RWR3/UN4W]RY/XU+EO@#HB6K!'0/31I9M MVD-LAR8WUQ"XB3L4[*<6X>=DX1%XE#Q<+]K+B?2NK+:244H1ON5=JTG92^`$ M,U4+GMXD;%&KRV5!ZU(+1OKP74^T8Y2SQZH84&$PX4(N)'8]KN2N/F>N=ZU6 MQ`*=SBP+"&ES6"#2=+((JRTV?#P\!HU/R0EYN.##:X^<$TRKCG35$7=F-L98=EVROKZZX_`8%WF%#HOL,-@?++A3Y\DU_"$/'U)\-T@J MY0FT&#+\`L.Q>!L7TG,PO7`R]; MU3P!$[]V1Q=7\\*T7/2A>*<,=@GX-O"ES]M/4I.Q'5GANPC/P6^.,[ MLTY1=0"WD)4B\E'&C(ET]_ROA_\6J?E1CCM/!C0QG.MZ4IJ-)[VQ%B6EBT1X MS1]3V2I&L!S[)5!$E!0O%4&GBXPM,[[B3V!%C*%3"@Z77!&C3^@7-_`LW%/E MED025T/1SSLZ+`Q/F5/4!.#@O\! M1[4EBIJGG'9,#_$AZM%Z?_F.X>H&;X"/3XH9+HSTJ.O3"7*:'.R3][!;;E#+ M+J.4Z7;WC'7NX`"/:\;_]]82R8MAWTA+O^`[^T4NPU@GCM//ZAM\\FN_F_1< M5X!N.Q@N$UKI-[(32\YWB.$C5211!E\*/CCXHBE7OWY5_[*=*SB9@'$26"BN>9S;MVA?X2X7QSK-G.&P%>N1%*1HD M^'3)2$:_D15\7!1,6!V@Y20XLPEJ/8>.2@=I$2[!W)1']LHL?UF2]LZS(H)+ MDG0A&,L1,CMHOY`_$Y`L`OR!9W$'3XEH%VC0>[141$7AFKHBL_%A:Q%;Y(%N M.Q@NITXRE7EKYDI@`QAR8_$!JV.7U""M+$`7L/N\-R[%V:WLQ.@$H:)7QH&A MV6E`GT=LB6!NI/U&*WND23>>/)SZ\I7@6X)J`%^F8DUT8V MABB3=UC0EF:DYZ50Y@$2'QB1]KY5(`II)(&PTAWP5SYNW)G*LR57/ZVRIS0D M#+7L]ZX.7X[3*C/(TVJV5X+OCGDX+/(!3C1#9_KE])N+7I:HNX4C`>^!-A&? MRAJA@Q4B,>\<;9-7'A"3^RYM,R3=7YGU;[_6F]U6+I9-`6ISR"P7^\BT->K-?K>U M*62B!*^+H&+[V>:-AF6CA5J3KSOE8TYZ<&]&.2X#V(:Q6FXNR)PTW;-&@;!: MKC/_G,A;TIC<^V8MT:L_.VVUUS[?*%IO42L7"YJSLO.`3N];*C7TF,7V0MUW@MN',;H_Y]$WA6JBKW%J>:@VQZ[PKC0AH M?U)^LVV=DK4P?X)B]G6*75NJ60=K1'FR!]X;YDR\=_T7SYZ`*F]W&^`3?5"" M6^/$T(*(7IA9])G!&RGPCOVUE"O3]G4<9! MO!413C50=4QJ"QL2>;;R%(<P$D?.)S4U"@H0>P< M,.HVZB@[!#8%4PDV^6_,=2,.H54MRP?.#,L9.;B(#='3&$=3)X`0E-IENVSFL1A?(J``TY.,REI)D,JJ48XS'3#<1"9(N*;#L4*]6:RJ7B+[X7 M=4J%#X`=14H@)R454IH-`![GNO*#-+)R:[!O$$S3S;EJ>CN1^6] M\0$;)OLFYH5[CAU6/%/#-2R&=MC`Q,^"Q';LL*"%#1.\&(I!'287N_"9*<4FTQC5,W\`2J84+F>X/`S(`P7%=*=Q5:Q8GF MBHBVT[IH,JCJ`HKW(@TV/&5T/K@%H!C8MH=][*1.@.X'.`TLY:LZ%5-V,E@* M_<&:?*CG8B_Y@2`_U_6Q^073R0A6L=$VYJVS'P:?)>.(=>54XE#M^A;HRJBK MN&C6A]F^L$5@I$Q,HH4$LZA"B')TQ?IB#!%0?&Q@3X.24H,N MX:)+MQ:*#>\4+M*6*3%:L%4X+8?4NAKP!4<=^T+2V`=19."*I&3ZT!0')3^A M9N`YC6'%>ZSCD3I`[G`]-D%U\1(/N`):QENDC[`V]090+>I?8A=X^G2 M?_GZ,#QL@NZ5KC(&QGB1>I6'QRA+W:D0!LRZCC4YYUL7;K.TAW_P!!1'X M0;+'J&$YG*":%PAGR.>)?<9/?(O.?IA(E!KY.I MN'U:-/^DGSW?.)[1FWW=F.N:<0.`9M_&;P30N12]\$%1V2^&R9()'0#82IWF MUJ#:+##91,O,Z^MLDFCS(,B,K&^4O^9!D!D%[ZT`P:*<@S]C[4'EJ]_+:;B# MOS-0A>;BV4N-S@K[EYJED`N%Q4D*V=HB6PA7AV=Q&L>"EI='/FN^,@AE_?!.W3+ZZ-5P-' M)2X?4/;B">*S8"Z"B:9P]`W@$DF&W<2U^OK8S)[8[=13+(GUO6U MM*0LB4IF^L59?]/::ZDLBNPYJ^>-]M;991Y@F5JRU]K^R34/L.RJE$9K"R3+ MGX[0SJX".6^O1K,H96'=9G[9&2"9C!:]?`7HEFN.-R>1(XO;UH)N*8[+SJ^M M9[/82MC(Z`)H&,,U0MT?'Z*@S^PA\7EOZ`3:(MC_Z\'X2)#*%M`R9, M<`^R0O:8>]9J@K.__=RQV%VDR09>(2XB5PU^+W@,:5_7L0\2;=M'?G%`W]'S M=_?/-\J%E##3^:0\__-&N;K_^G!Q]V_EXNY:N;QXNGU2[C\K#X\W3S=WSQ?/ MM_=WJZ8&+0(H5R=D)=G6I+A[&H*?>DLQ'Y$B792OR)]?54L5J2RJQ6]`=$55 M+'5,K?^M831/;>D$L]FW76U@#9%AHOM.<&/FC0P'1RFJCL?OS8,4%D;I/OAK MNM**>K-A?Z+/89 MY'3H,T7:R:MH7D*`92WL%D?.;-&PXB,/DJ@]V&^8G`:`_W.J.ZHO)T;Q'<*3 MA7A57)?&]OME,SSK.YQDS\%,"9I0`4;MS&"$55(G*=$J`)>F4U/JV/7EA8(W MDR;OEP]*67%'JL-$WC@U)A,9?%9X9VMC$U\X\Z/(/:;*FP^<[`$@('^:A$#"B_1QFXF@:OD:7$V[#S!$Q?%?@ M*$\+C;#EV5PX/52T>:-\8_@:B%K_OU-*(<:.U4,@Y,C=T.YZ2 M:LZ^.\AP@@:L" M[]0I+XZW=`U^*1*6@AZI`3"8P20R4;,34YIL]7ZI/RA>IA'1FN(#JB@S-C04?5H4)?)'(]; MW]@TTV1LHJB>YQB@Q9D;VJK_#U#&%%&F^UJD]0`W@[)L/=LV>7(I_CBR$1_\ M\40BX_-\2"E[T>6=8<'$TBGKG\`*2@!$*UB!RAA-:TPM'#,`6*.]Q3;&3KS_ M,Y]G+$:?_7^`D^C>"C^"SU#!P;>>ZG['M,>_[!=,B*7H$]Y.'+( M`9B%#Q[;*]=9H_![G;G&T,+T4YY8B?K4Y4V83?BE@VVET4]B9"S")@OV!%!5 M[;LZ%.C",^X8#A%A@)MHV""*F.D8IC7*K'2Z'[LL)I`CU0WS'$JQ]U>8Z."Y<[8*2K@?]%1`&,`YX+7P./ MS$2=1:/:WPR7!58#$VWA:32Y(A>'O;%X4KC\G>T[V5_Z;O9WTED@_X@$5?Y= MX+K&?N1@U0/J@V?;>65:NB<[/W-VTT'H1(B;VO;-=)]=/2VNW\U.7DE<6\;36@_+.MNSX9=Q&!IWWLEO7I9`U$XCU`%[N[CYY`_8/LM!X3VF.L].2FPGNC/E!VESJ"S7ZB9397;:F\$DQA:8`Z8S2W>?,!:[9&K9#.N% M:],W%PL;GL=R?GBR,L6$W9-?94SG0;P6 M]VE$"\VVHG1;VP+OR\,&",OIFD;,?(F3Y@PD8`/4^6+\[0L3CG^!`XBR:R@V MQ])9J6)UD,UZ'-5.%IZIP&\`VQ798,Y&GF6E.P[18/6V$7 M+&D6-#,LXA2<&Z>=3,6V=[27-8?:&7F!J7BWMHSW[ZKI;T![+9Y`DFV=][J) M::AYP=X=LJOM=#M[4C='>8\X;T%A9W>[;2?*$HJWP4LCFUT_UNJ6A?P=S*M?T,^_QS6SIJ:L:0KL`R&A:34PO.ID37((Y52 MW:U3ZI'I;#SA2M'0UM(+2_-,AB9?)D"0`?Y>,,ZQ]_DQS@P2K(`Q#XE=^-[( M=JB]V*XB!.U8!5T`"=F=; MKS;>)5V%K>12PZ[TPL72F!V2;K=WB'V.$S@[0ERXG5K*HF^?G<4F.>Y38#8< M/T+4F@5!;>E=:RW&+9LE6POVWPE*6S`YFMGV^FXX;PNF1C/;72RF-"T^B%O9 M!GVWU^VW,@.$^]FD'`AEF_'=LWXS.^*YGQW*<>YFV^X];&=2K`W*@4^VO;Y! M?.Y]CUIE8UG)#F*%W>QS-H\82=#N&+4<0<%L#9%COW:)V:HW=MD&13ZMOK_= MRV%:K&O:;@ZY+=A-V5*W:^2V84$5AR^W84MEV[Q%QRZ'$9)M*.8Q0O:'VN+C MNYUM7VWN.)B?M!$+MJ\TACW7VY)#W_%M6356Z[]MT]DWK6YVDT)0CG/$:V'. MR8Y2.EO=L\RZGNU@L&DECBADIK;-/Y]VM@DY4,C.N]P*"INVS@&#S&3*7@&V M(`?\F:6=VX!_TRX$P)]9Z3DO;7=7],\!?V9J^:KP?X/5MN*C;J_N*=MM[W;[ MC68KA0Q)+&>(@7-418WIA:7S4FK79=X:]>7=;O:\BAEMM>C]&P!X\5R6;K9T M=-<%V+"=!VK+],@TY!+JO4'-`<+N4=?,U1QC$C8,RS^]O'U>32^O5BSVBH7M M;[+[Z>4Q^7>S&HM\5*[$!%$G^0CO]4W4^?+*5T6ZU^,^NX6."#;@:VI1H"-#/MILYY-UG8LPI\^7`T7L$D>C!5 M/D]R3RTJ,OW`W*2(HY&-^I-JTN^WTJ^BW\STR6=<\MP@;1"7Y?@S[B087UGW$*L,H;FEY.Y6^(&Z\-T-*>[2QN5Y&) M:AS-&+3+XI+2<&,KN&0&)#:(2\K@LZW@DAF:V.R^),>%;0673,]K*5P,;P.C M>[)#/O7F^?F,IA(OS0_,4FV8LN,W`$RR1=$*P"S5)RRKRH\&0LVHO54(D[\% M6#>S6++>:\Z>K=*KY*GN8KW(E=4UL?U(>'N\?;AZ?^7"5F__[ M=OOP]>;N>5D3O_1M0TN&R(67U0#\FFF)=L[M)GW=J8$WR&69?LAD(P][`H>M MR8/FR1]+3J0E=IO_07]YU/A9P+0&")^4/VZOG__Y43GO_A20H_[(28"?$,EN M[ZY!VI!*/SXI;X;NC3XJ8!O#7R>*QDS3G:C8N?>7DP;_>Z+J>O#W"_5AQG\* MZ/G_$0Y.]!']K6\$H=]!4=Q>77P)=MJS)VF$]O3C>/LGY?+^\?KFL7YY__Q\ M__6C\C\\KT)I3GXHU"?V4TPP-(;S%4)>^'+SF7;>@ZVU<:>M7TY:T=BI+/&* MKT(+*/W3+OQW@_]G7^(65TB9(E=*W%"]SCT']\AU8Z8;_EBQ;$3TX>+Z^O;N MM_!+8,5*1"L1%6P<&`<*V@0')Z&=`Y50_K<3^]MS`N@O+Z[^][?'^V]WU_6K M^R_WC\#CFL;88'"R%7R%4=,[^RD#]RQ3,!(FH,]\F)>R+HO!?O?=+N!MSP%89E<'??CE<>@VSVIP M3)6(\J#=WAQU\LL)_]]BL5#%Z87E]-:!<_K2A_>`_F\[A_V$\C M>Q(=U^4YH26R%T9O%0G,;:@K"9E6JU<6=26@+MO!7#'X?AF\V3YH!B^4,UTY MT.%Y_(6I+@W\5HSQQ+%?^?RT\IS+1?0GB@3FMMV(;FG45N4P'R28%8-7?O(! M^LF4O(@#82FEJ/*8#P_,+3L4S7Y9]%;E,!\DF%OF[_/&0?-WY2\7\US&4>2> MXU-5`0YQ!Y]YZ#"W\I@/!LPM.Q3U,JBLRE<^2#"WS-JEN:(Y4$^Y2-9?28S4 M>6`NS&`M$B+S1'NY7-Q5_R'949N69 M5U*U)ZEJG%=25:Z`P'%>G=\Q+Z/E0GFLD!(Y;FW0,KKMOYAL>?;:>R5-#IPV MX,-UND4HMEE&=;:KR,C>-Z@2L/S9\_UF)6#S;)/@$VRRPS^4S[^R-!9:L'Y6 M^ZZ%_8CRTZ)(K9:?1TS!/OBJ-55&J@OKOC(7`R_OV@TZ;T1^0EKO*=UWL#T_ M]IVR`!AE#*0;N0JS='A^ML75J7(=/>"-'":>4";45#CSN1H]$`"I:O!^!WZ( M'_Z_^I6M:B-EH'K&T(?U5$L=\DZV0?T^&+&V>:H\CPR`3/=YPV+5C+Y_,TQ3 M>6'P^A%VD]4YDC_@90@.=FE6G2'#I@"*ZCCJ%%MM&98.>^@`-).)&;:`Q@=? MF&:/F:(JW]E4T8(!`T%[KJMOCQ>*.P4"CY&H``Y^-6!(%C=7C^=8T[_L!NG">0+^;W=7V;*:_X_IPHA>Q"CFS MQS1TS_)!"6]>!\8EF,5P7LUBJ%8L](HE-I;H MRXT,8GB0[8Q0^+-;63ZDVR5XJKL>71^IJ-M<[U2Y`9-K3!_Y+AOXIF(:8.C0 M3\'JX6TSW92=[-Q9TV`U>FUO-KD'>J> M&UC=Q!I8/04&[GL<+>)^R!.W3*5>\W3U>YIRT$^2G'QNWCQR==N'S6SM>`_J M?EY"!9&$I6XX-B'.*]]$[+^<_E8JI\_L^;AY`2X=Q?8IP*4C%N;8,`=#$J$I M-&"*[0"$P'>*QYSQQF7ZZ(]H:ED5'=#5F5QDD2X=L=H):E6'\ZYJZOHZ*D;&Z29=JS!O9^JERR3RTS-`3J"D.L]B;:O(K)YI\[+CPK.HI[(?' M+'XYQLTZ?O&DTB!D_D9U0J&Z_S!8E:8DARO@:F/5L&`)O`JCT!E_B/&YRKKR M-F)8LDQ32^'Y/_!/))L-7_*+.GR(XYJ1QAUOLUA8_!Z M=&7@V&,.OJ;9/OI`JL!MB$-8T63%>R`[`,'@!=6XF&8/+401KR]M0A*`QINY M]P*5#Z?*_-T1OU,&\)KT&\OLJTY:#:]1<$D`G%\DOFM1.PWZ\EV;$B%Q*]T) MTSSCE9G34R5-")8#,[J)717*LVX$9;/530$S553S_JOD(GTXF*#LLE?@!_@O ME"U@(,UP0&9Q)#T.*S8L'>^V64VQ?10U:UC'J+DN1+:&(F7Z&+95\&8>](9J M#0T4:R'3;P9PX<"P#(_%PNXUDG*/)QH@XQIC5$!D1KU,)57(PJC]P/=\4EXN MK(BQ>A!Y'+UH3O%E-HH':B=X84TH"=4+-9AI`DH?*.9J0I8B6&LR@F-UBND&`7%US$V8 M7=^@I2TZ'U1')"+$WI7Q)D3>()@!>0,U)L'JXM;[VDA:'Y6DH]-V2O"E9&G@ MDJNHE9KRQ@!,>-CVQ-LXHT3$T$:87)$O]6$;_\YQ2YVX>\YY8[W*776]V=O6 M/?7>!J-MYO(GQ0W8=*+[G%RX`WUQ-5^I&H$VU]/>.L.M,5NIDLECD,EJYEG) M1'(#%T*;L$ZJ"6<;GG"V^2W:=.WO;B%<:]K3%D#=_4BSXM([?Y%+Q=5'S=4I MX\N*2^_EN'H#][E5)?F^AI7M72TMK&L]2@AW/YVL@-IHZ4+2HV25XD.X^TED MA\+,^W9Q*[=V`W/']B[S!;/\"P+A[N>UUGA-C> MI;XR_?=@^L_.#"N@6JK]C5<>,MGV[F&`\^#7UT$[25S]>K*&HG5 M.\^<@E9OS0P7RP1B'7`[$;B=Q!@LA"]K^-E<"7]D%.5]4('*M$\J92K=\+Z3 M[F?''DL?NW\8WDA^))6F_02/9+S#O9S*WQ"K/%W=/MY&Z9:)V(:)U=$*V=.2>O1$1+T49;)5H_8@P5:)J+8>KX&:OV,_?/?+EZN%!&MG'C.]QLX)YJ9,&\W?\M(]:S7;6VMZ M6?R6YWG03IE%O.`QI'U=QWZK)($?L2TM<^@['FR]?[Y1KJ-!$9U/RN/-EXOG MFVMPC1^?_ZT\/U[WSW-B[^N`T1F.S?YWV69*;VP)W1Y!D+_P11; MT_S)5%'Y0"!=&:B:81J@]+!5,[:"UH1Z9\J(J?K?/N@$YKC*BV^8V,>UIH`6 MH,P`PX+W:"-L].S4Z+7_MIWO->5M9&@C5!.N@1WF[0'&;48*^\$T'WN,XU!D M`UM0\X[TE@\@>+PM,?:.9;QG<@B7`4N\6?"^%X1Z`N"`X^2.C`D"P-]E6]39 M&:'GK9]M`!C;(X?-HT\/:1B=V.\8M2+APB<>!%/-;>!?XF)P;+'-OVTA*.X(?R460^3,*3P#@#(:=*IX MZ@\A+>)+S1Z/^8@)E8]QX"+#X5"'0"/J`SBB9N@I-+,G5(Y";=1YFW=<'S;P MISAM<,*JH!L]QYN#GRKOGQA3[FSXY3\_9'?N++MZW[9Q4&[!%8WD0;8:7&91 MNV._>4OB0)H1H(9*F00`8QXZ19>P.S]I?>:\\@/!@Q\3!X(PO`,'@<1O!'K] M5'GP'==784W1*S]\"1H#A+]) MF9@X(B$NEWC6\%[[``Y*/U/AL'E'EQ_\B0&(QBNS?+;@83S@5)/$6F,T98$F M(0BMQL4*5QL@<#1JJA80BH]$T1E-6L"O$]3EG?P-1ZR:6(>ZE@((B111JR)[SK;H)L#@( M!DJ^I$]\,9$$&0Z$T.4\K.K(<3A$:#35'=4W#4V9^.,)G-;:R+)->S@58Y9X MMNM8=;ZSX#R-L!$OX0([!),8I`95S9A?1P@I`:T"I'HAHP+>>$::B^0M(A'( MM0F@>H[ZRLS@\)X1O[6D3HWF!J'JF0#P/VBL".B?=]+XG_[L\)\:(9BJFG'L MB@1T2+%9L97165^'S,6&5Z%P=%JM;>%3?J%=-1:1;Y)?Z3J;<*A0NG8C31.$]90O7ZX6J"V`802PN,HE&`>Z8=="CX58 M#?QA4XP`HY51^8A?*K_![R8U\F91W=@.^<36*_@&-II%$A#*FXKB-52'P@H2 MJM'V/1?`T=#;-_CP-S'"#6^:9+'(D-ULH4W(:EPZ>]Q*,G#0D64Q+4*0)$R\ M5):TY]3/"2^X\(?`3@3!BE9"D=CQD,R#Y?B'ZWH7F_RIBFF,#=Q? M<+9?N'-]Z]KU9]OYV\=)4R"SZ+\;.!F19).\@`&ZW71H(\=_M750Z%?U+IH4 MKSA4$<5YY+N&2@?M!1SP?W$1XE8PG"JN:M+0LG$@#"CV<486T_S><.K66-5I MLJ$DYB^V"N;WF#`33DPPOPM_24Z\#NBY:$@`9^<:B+4PTI\6G$]&]<$/HM2/ M^P%ZZ^Z#.J5146O=A/>;F3=AR8NP]->O"F3:_72E"ZX)5IHPM+ MOP:/S[0I#4%1:\[7YS;TIC#L"M3&9L]9(9+[N3W'D`9W/$3!;`[L1G'L"9 M:5AGY\E$K"4`]E0P(?4;U0%31%7)UVQ@:(87@]K(1=MN9I[?Z^BH M=8$8YAD%X M>"((:\CD=?T7I!]&7^#!@?&#(O/8'01A,BSRV`5.NKC`]8)5^8V(/P$`)CZ< M_9A90(.@765(MK,79/?$X%8U#>-%XJXT.PQ?&N'.%4TO`R8\C4S%R@7B!PJ9 M\Z`<,(UG@USAE75HWI$)X:C(2\2KDF3>6GQR/:R&[PB$3$RP)\D#UG%1")B! MU^G*>_5#1$FA!H)[]^"26QDS;V3KT5TP`6/`.'HH`Z_1J_"^+0_&J`L*JAU+Y_^8"J`;0*!0]!DN"Q&K^!-TR,UF,T ME,"J*<8@^I"K(LWDJ3UTL0G:D`L4#O(,).^5S1>!;?Y;-B\7F(NIUF6NXIL_ M0_?Z$C>X3&U)DCMSLJV^/%]<&KY>9[U-W6F#(9YG,C1EEM6J'S%M\UQ#_%M6=&CU7'+'Z=H9$:"NDG'/VT_G[01TWV3W0_`JP8H M]2^@IS%+V6#N,VKL59SF>K._+8>9ZM$W6I3?:/PD6@C@V/[EY,&_WN">;'B[Q;7?@X=T#MI0/ ML?V![@X[Z(OX0+^1+.UW8%9G3*,HZR:V5=,O=0<\STWI#^>_O)KGK(KMYC?]RG[ MPBPV,#Q>T6ECAD`ISMJB]<$N!H3;T$;RW+IV";11U=/],"#<,B^W#I65]^W* M5NXK/UA--E3-4IRE!3/Q2S.O:IZ&VLF\JCT?QP6:5E7)3R4_R\M/\R!'R!Z4 M.UX08[3XYO)A#6E:035L>$A3F8:I5@//*EDJLBQUJGEG:>?LHGEG^=/EL]+L MK]F+MT9B_5F56%\E]QT'^%7Z4)587SZN+3GXE=!5B?558OW1@U\E]ZZV=55B M?0&8M^3@;T3VFOW37G<#\A?^1RQ8/GFLDNVK9/M292MWQRE* M0+A@MZUQ17A6[HSD//`?;$9RQ=495.Z<=KKEYNM\&)0A)?"@+O>/)M?>!W3M M%\,LR1%;CCO7^0E-14M97C^A*?-PEE"M%V:7-I3,5"4L5,*S">&98P'(B0KE MR5/8L@CMVT[@22F$CB^VTEBJCSE'0M3\9WI#8A3/B0/ M,L-V;0<]?U;@;'9?5A[@TTAUV"4V<[^2FJIJ0E1V- MFQ_,T0RW>-'?G8ICMLU9$*U0$#`JY50.1`Y$.3VRL6K@J,O2;\B5F"?EJV;I M<7EFSCB)P[93WH[A7=6)6Z2CKB!@'/B)>S$<.@RGBI9=*=Z"?C^DPL6>TO$4_MW[GNNI%N8U M**JG_$NU?-69*LV:LK"LO,H$*S"$>;,35FXYW.[V:OWN0=9)'1NOE&C0SI;9 MNGEZ?EX.6N^3H^=FC^Q"4A8_K_@\4GP(*R[>-Q=7T8IC@'"Y@M>B0%U\NE;2[CB.7%7JJ4QD^F*[2CLQ\1P2N+.%2V>L4J+ M]()%DM;OD)XG^;]?ZY:E8VO^_N@%N$>IY.Y1C@/#P M[E%2A:X88%VF>A/ M\L0F'AN_,$=I-ZH6)1N.U,BCG8J!Q`JAFF7F4^5K=-(\K[7VV>BD0`.J*B%: M?>);L:O,=R--K=-&IS`[=CB"5#5D.6@(M]Z098^'V\'*W;$8Z.\OB]@+MA!R M6S6@B68FM_>9,+#',:Y5P+A4H9\2+59Q14=%(<\.K M@'$5,-YYB*O6.^]4`>-*B*J`\48"QOMLR'VP@E3E]1T#A%7?#(_03_Z::OIVBV MY<$?CVP`*N)/=*_KC2;\O_CG>;W=.%$,_9<3K=YJG/RZ2*D,8+GZ0!T;)GSH MT?Y9L'\.[I_XUC7^P_AVAVJ*2+51KN[^%.[S(]>+^`DQ].W=]&O M>O>B\HECI471]N&`AD;^P?!T9;J295"5!9&+5^:HP^SIS67!(^BJEXG(T4A> M)?5;E_JR"XL0^K*C\1U((D`[VW8GUL( ML5BZ*5'%M$?*M`^.H66>217/5CQ;0)Y];UC*E*F.N^L+SXIQ*\9=AW%_5TW_ M,)5ME;!=G$201(>/?ZF6KSI3I5EE:Y<R*I4L.85Y.SK)L%R'2VV>&<,7)1P3AEG5RT<>'[:M-P=8OU@YY M]N9OCFK-R=\HE$PO65-])!!N0^M(>/3.NR7P;P3`)3I"*V;>`S,W3KM%=VOV MRM%0'2"JP#`.OPV:VZ0-ASH5Y)Y[X7+?ZZRMSJHD5HMS>X M6L*TV6CL]T)B.[.KJQN,2H)V)$'=TTI\BASO/$ZPRA/'SCO8N0BP5F!5/+B+ M"Y;UO52M4*U0K%'"%*GI5B,J%DL_A+9@Y546OEJB>KC5Z MK2IZ54E1%;W:3/2JURO,EE625$&XT^A5]VA<^J-CGBIZ%8#?;#6/-GJU[KS5 MQ;-2%\]>?5"G8]!0%V^JH\OK81]F>LF%Z_IC_MGJS9^U>[NX8A@PY;Z*K>7AP62>FJKO1/N_#?#?Z??85)BA4)H?W9VPB` M`C%O)G$*,A*@,,S;*3WS[KO%S8)S(\Y0?_FN9PRF&VYWDUBU0!QV\V/"-!QM M#`(P5H)!*L7AN8+4H`?S));S#^8#W=UV\^:\T*[:?7K+'47R@K]:>ZK>/D,. MA6^(4AJ)+`&$K:TW@6]+N,S_UP%R_+[OH;=H7N2]DRZ!>3&PG0$S/-]ABC-G MZFVAE,4>@J7SSKSB0[B)JX#&:>.G8F"P8I"W--JVNKTX#`BW8E_L5"+WP\I5 M7*+`AL.CX7Y7!@XKD;E0]GA$<]L>\0''(Y8%M55\G5J%'PX#PFV''UJGS8-D MY2JN4&#SX'?;5#W#-+QI*4R#`OOI2[:":K;+>&DAH5*^2PLY@:S=+;JNK:(* MAP'AMJ,*A\K*552AP&;#M?%JZ,S2E:G!S'+T\BY85*'X$&["IRGG)43!_-\J MRG!$$&X[RE""2XBUHPRKE$BL7M*0*)=@0USGD4ULQS.LX8-M&MJ4__:/9ZHUE11 M+@A?;$^:0QG*5-\,T`5#-AT\MQ7NS%7BW MX=)WAJ4,?,HC@M\;MNZ>*L^P\-6WQXOP5WP!^Y4Y+F/TWL^P\M!GRE?54H<, M$52N8#7?1%T7P:!:',P+-C3<.E-FN$?%= MM]E9AO'`3%!:74GXSOI+"=]"4#I)4,J^JWN2BI)3 M[NV`[SYV8G"U>VO#M1$9//9CJ1+V MW/!?N"X#QT7U/,=X\271C=M@J3WY`BG@?2K^%5"1EI#5IO[NW(%O\MQ;ORQ*028:S4WB$7CJ-:W.V[ MG*;'SNB_?FG_?KS58\VO7G@ZE:=^J87?PPW+H4@,//X8FS MKT3E,"C6ZS5;C9-?'[K_EM#<(,P[HT9J[&\N->!GS00U6NWF>?-PJ4'//4\G MG!PWXXEI3QF3R,+)\>>SX6%0]]9"<==]U:3?HS:YT$'^;6=Z:<-*,\1KG9\! M\3K%)MZUX6JV;WF?'7O\576^,^_!,31`=\`PUG&-JBE3T()_MINY!4UGFC%6 M3?>7DZ;,9[VS$\6W#/Z.'R^.:=0GOL-.?FV>-C=`OQQ8[HV>ZXEJ!CW/#H6> M-W_[AC>]MOL?0W/-(M<1-RF=>NWMW6>)N.U>8X:X+@+OGOS:V`!QET>Y0+1.8>4G#]@!U^/K(U"VAU)6]H3.`D[K6:_[KMZ'5S">D(P3AN;4#P;I=2N=H_>["XE,VOIIVYWO_HI MCF]1J+SI4Z#;.T8J`Y%>P0YE^IU/_JE,9H/3EAN$F]$PS4ZVUH<=`,6_"U(G MD"X,K3>LS6=MQHC6S?/6<=!ZN?-U&RS?S7VH-D_/SW>Z)X4Y4M?9K@U+S7GN M[6J=-CK'N5W2*-\$3(]LK!H6?'X%V^2HFN>KYC-SQNZ"`WP%B9-$K$]1K5;S M_'H7^[$"]J7:F'7]BVAC.AL+-Y9Y4WXGX=V9OP#_/^?@WY5O'4=Z0Z0.%9V4 M9AOTO`J*31YSAN1D`K8EINV?]3-B;9N@6UX,]DZP6?C;B='ATPYY'GQW&;K%$!DZKK0EU/^OR!H.HVR)G&G8%)V8^D9Z]K`F)V3HF M6BXCSLTY--M$&'_'1`-[F%N9LU9HY`4L"K*M9V)G7QGVSGM@8F_"]%D"S4T1 MEA83!6_NA>^-;(>**.)47"M/($[)9B_;66GQ812;H&0&7KLE&][SYR!;>CI` M@FPIEDWHXY64;*^J86+)Y&?;H$UW6 M2#))J+5&]I5!$^R8K7#5EHAX'UB5X=CFC`,AX*KU55E_NWDD61CMFF!I`93D MG<>%ZHU,Y:[;/S3;A@V4CNFHJ<=/V-4W'.T;`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`#:%] MNGBZBO[4/WU0^LVS>K.A..QOWP#EB)V[%=*3`I0)UWXML/09=M[!`,2E*GMN,#PU(MS5`!F:"E@JMPC&SZN>$H M`Q7^ZQ5C;J[XD".CX!*GRC=+%^",B9Q(#,<..G(K8^:-;)RKHGK*&U-4'?!E M>DU1WV@+Q.>.6!._"9:I*;8#*'J>R:&!O]0!3IKYEVKYJC.5QA)C$^-&3X'M M@/>IKD_MC[$;.=]U1!2>!@+@!XX.*#/ES?!&"NRSV%I$A+\3@R<"(,W^,EP*K!KFMLXO%WQVDO[0SR%;*D`!0) M(3&2V'G@6]_D/"B-VPFYR0D:4R0X1\S8,<835?/PX4&43\/!&JM3Q=8TWXGH M$2QAH*BX(!/PYYA8#O=%ZE(M8%/'2!$)Z%/E%NBBZP9"61,`@O;X#Y<%`,-3 M?P`Q+3;`04(TTD&C24(#L9@KDP`)'3&[$S255L!JG-AA6_X9^5.#A^"G*C(T M,,8"/I):N*?]ZT"ZTQ_,(),[.\Y()-ZS'=E=Z=A)5@6?*Q,;-O$G[P9EC[`5\905VG8 MPMCP/#ZGBA^<(6?7>UWE_<1AKX;MNP#R=\M^`QS=C_R'<*P.!LJ#[1K\./W\ M]!!QR9TMR<43_%YIMMKO'S_4M9HBG[O/H-S$`C>(,?[CD9G!B`SI%$<2(G;/ M@,'-8`"_Y:WMZ4PF;T$1/HA"3HA[&CO04:>!;D+UI+B@VDRNZ(/3RH:-\)`6 M%A_Y-9]PI`1A*=_E"BUX-AR4!C]F$8S\W(]QT5P-31I3=4?*`-A)TEU(@IF3 MR8[<5='MGSA%YV8&_IW8UD.>6E,V3,*MZ3:Z]6XC+AN\[#K.VV1OWME6V%_> MKM>#Y!3;K(E,UMVV99=-&IFN6=2LX68L&]ZE1[`&-0U0,)OX:Y&), M6A=^R^T';A$Q$7$4X(.L@]'GTDK*I:F"?G_21K8)U(I4.!BCS*RAY5&N.3,AGK?HY9Z MMB.S'+J@I$J"PP-DP0.&]H3)2Y;T""4KY#+'&`*;"/>"GSL4OJ"_I9,=;';- M(1Y2S;B<:[9+1V3DGKF"2]%H!Z4#5KLUK05OC(M4S+GD,(1:8O:7"6B-\9CI M!F`'0O7"`'9&DT!,2[ M(<2F)L.=G1>=$/.:1F(_YWQ3XAZSFC=*_1I31P9N!>2BDB;>BE$B30M(T_MW M\ZR5[+1^8.1)*W"0R-#F9&C,-)PO,AEFN__$E7ASE>3,9N:1U&RE%'%M!>ZM MT2=G)_E[06[;.^'B`P9"'9I3%K.+UP=YY2 M<%H2,L5;4^ZH&49VL56GT6OWD]&E#2.Y#S)NI1U&=I%?;W;4V0$0<2L=,;)[ M!'7Z*6T[#X",6^F),:>Q`?80.@XRKE$QM"BJSYX,$R(H=L@ M@[G/0(=+DR>8Y#3+W#-@D=8.,N`+FM6V6B+RHL>0]G5@*-L1^^REX9J;C)0\&]%*[^=YQE?Q6FB`"39%'O(^4% MIR:0\!PBGCLGLIW#G`14B_RNWW>4MY%MFM.Z_89ID9@2:>B&ZDR56]>N/]O. MWS[^WID(=N5Y+OC<6/W+=C`=*OED3;G5F/+D.P,5_O>:O3+3GB!0-4Q..%7> M=WL_*?PAU5.>V,0CW:^T&YBPW>S2&ZZ9)CZE-.YFY\.IJ"E,U48! MDZ+B9Z52(J](U\547'S).-1P/&>;'C4-]04GAQEB*:"79MJ8 M_D1IVE03,L0W9SW#WT*E'D%>5&JVGJ5G@N.`*L'"$_R-R`AT%=UW@M1DJ1*" M`AJGH(1`FTDT`&B#O&9,LPH>A,\&O@GPOC*.MX6%$1X8N<:+R624"&X?RT6" M"@[\09BRY>+[@DQW8`"7)=X.*O4OHKBMJ,H(F`O,]*'#Z.&_?'U(FX MHWQZA:>O@7*D:%^85@V<8.(VP`XZR@#L5H#-EM]W$+JNLGI6552/+*CY$FF4 MV9;/%7.PE@.S:^./2(?J6-6IXHL714V9ZD1'+WPL-%A08:+YCH.H\"\T M]0$QT,P3+``"!#40$"X5_'P0WW`+'K4X'-*F`6N!0F8O'BP3)OGP`SU,XP7- M#.<5G8AX7!@_E#&@-J*T9CC+>7U44%S%84P%%H[3Z/C$UQF>ST66Y]['$OP1 M,\Q-Q@QYI@NC`A[BNI\J>AM:S'+2W\J>H"/%A:Z&:_J23;E=]6$:R(?WED0`J8 MU@#AD_+'[?7S/S\JYXV?/G$"W=Y=W]P](TU^?`(UI'NCCTJ_@7^=@$8S37>B M8BWP+R<-_O<$*Y3%WR^V`XH"_RF+#8?8"<"]O+CZW]\>[[_=7=>O[K__)[^@(2-D^;*11\L3W/'A\&$9Q+^`8,`<=AM!\&C#N,0`'4O7?UD2].M!Q_:>1/9&.\^H$ M+X>DEXYB[03)JJ-\-W2G5BUX><"O:O8MZ:6CW]XEO704ZZXJT<$G&#>(@@KE MC941XHN;^CZ8SJ#S^-@P=VCZSDJAN+J"(/HV72J M7#(/S3IT*&J*PRSVIIK\!A)OE`U'W-^R'YAY0>MPFU!T2!(7EOA&=4*Q0>I" M1Q6GX0JX&H6:F24ZS+A>U%S&PGO2MQ'#?DYTG0//_X%_(MEL%UL:\OXKKAWTF.$F$Q,0Z,P%]YZ>#UH$* MD!I>D9%F@YDU(IC.N_*\:_5KC4:#OGS7/L=_XU8&S23-Z:F2)@;+@6D1TZP# MY5DW@K+9ZJ:`N:`)X$HM`LLCU(>$"\HOPV8SF$CA\5XZA@-RB^5&>)-K6#K= MM";.5^6NDY$G3;-3`LPXMG5=1(TCW>Y((:A8Y1"9&-]3*5 MU&'46U.D683-XEP0>Y`,#Q-B7-=&$4$-!2^L"46A>C.ML53'I'7&N>*K>B.9?J.%/"E+?SY#=H;@)*W\),&"%/$:PU&4&\?WMA(7%U MWH,TN;Y!2UMT1JA.U*TQ>E?&FQ!Y@V#&7+R@Z1%U(N+Y*.'ZJ"@=G3M*K%93?@\2 MKSZ'E^%2@XWLW+P+%YN34OM2T#Z4;O?;Q<7#JBC48B^2NGAQF<:D&8V)OI:4 MML4;#C)2K2#F+L-VQQ;70*B505JX_*-?B@E>:IA,QUOVHCF$N>ZQS%A8UGOC MR3K.=U@(U(AG:,9$%1D#U'J,]RPC4>0]KS'I-BMICZPSRBZ,&@U*+:G#)#TT M5>3N92^J:X`FO5!&!G-41QM-2>D#J-\#1?.WKQ(V?)T(.Z&,#F,^<"C^J6(-?1$O`!=V1Y9[844:C,"*M*$V1KJ(-5PP*OU>5]2>WH-^+C MT/""X]ZQ7["\@>M5L0:H&?4P2=;^J'R;1Q"T@G9#E$-2&WL+`E-_\>"\&E** M$N\Y/AR!$64>A*.^%EI*/9_=#&/^`\V<6@%F^ M$ZNTXZM47%8H7)#+L/EM/"WZ?63`IDYWH5'E'Y2A;_!!#4'\1RK#4%]LWTNT MD(WGB`8IJ6'!2+R(`_U&X6NFMZ[51)YXZJK,SJ99%@MJ=&5BCZ'SF"O_<'8'E':033S,!A!.(22^5UY?-=3'O0>1M M\O",:=#)#_8VZAZ'E[!$"X0H)GX2'G[JJVJ8]%K<21%R[F>W$I'!,_XX&O8+2<>Y(6GVV*10+JU(WN-*CPC<\],CPS M$.1H78P4"&=?BOV%D)TJ"+LKS@.IX;_$R!N?43,P?@1^OP@I<`TY6Z9(JW(_R)\``'!\ M:2/,NZ((C"OJ-(5UK\;A#BLW*<9]+#469<'E#V)YU:5J=N`)AB<9GF=8YF9[ M-L@65@&%]>M4YHI=U\0]AR2=MQ:/M<-JC&YLN:#%+R?Y+0H\%$RJO75YDP(_T!QG/#`^V4&(077H[_'0OT1)PHDU3VS((_V9)(Q=;1D.NNMPQO!3 MCW>\X%D,O,V$:EE@.6O<9\#++P.GC>'I-:!!&R_!BZ6)5A1.'MB@#$A"WT#^ MC%?#I>_06>+7F+'Q@U??'B_"7_$%<`:(RWB3D<^P\A"TQ]>HGO\JFA04PA!$ M!R[8T'#G+/>`8R+HU_^EQ-= MKKR/[@JS+PD/0NPW4F%8)(QFV3$\2=[!KD6Y(9U.C_XPK,A?%3.85KHS3I.$ MZ-5-*7>F>;[)%W=6Y<,B)L\E$-DWZY>)Z1-:4V:]1L1[W69G&>9S%[)],@5L M+BBMKB2`9_VE!'`A*)V9;+32[^N>)*/T=`NZDH6C"[GSJN/83\Q/I?N,D.G( MP,"K+9S^;)JV%@1+D!635@)8&$NNCK['NVZ[)1T`M4:O'?#^YD1O%;C:W4X, MKG9O;;@V)(?'?CQ5`K\$!D&^S,QHZ+@]EGY%(B2A0<=DE'LSLU;B6$LL)J_5 M['1B:TDCU6G&:B"G09I21O="L1II#EJODJ0C-_1V?AGA,LP>$+>(4>`0_WY0 MO?E)B;&GXV%'5R2W36@-Z<(00VZ44$M2)\_9CD*"ITKFRJ+?$9U1KFU9S*P[ M8D(YO;06MN-T110/BSF0QG*)1TT>9"SF`HN\Y%CQ`MXQ:T$V(=-&EFW:PVFB M,B.H<.#9DBC^$7Y.%A[K56W@6]ZUFJ%UK88-E#8)VTJE&@1:]SRR.7IIA20' M(*@'I'2XH`NIW60]44N.QLRR@9`X:LA+8DV9K#ELVU,E%>3U:XMZ$N.>-SC$ M@8")V[4(@>`E:Z!1?MXY)#G8\>%+TR3J_*I,GE:0?>#R&>1IZ597=C1_7'D? M)2AIGRZ>KJ(_]4\?:'YY4YI?#AZQ0N,4!"@3/A6!+L_9>&+:4\9BA51#1Q7] M;8.O`7.<>6#S3KTUD7DO!>7)*)8&D@?G4CA(7!S"0J24]U$O8?P6)^U&77(_ M!-YKU"D;JZ_2FO/*]Y"QW"0WN)PD9$1A`8UBCL\[GSAV*.[B;I.?I6#;ZS;> ME->"0>[BLB=\$R]!%)7@"GLFAP1'N`[S3^9=J^:HSC82(\K<:/3X:7:Y< M$/E803&:11\X//&,[G:#T?3-!B(BIC/S4?-UN7`@`UC1)Q5V+A,F"J/PQLD\ ML>N%+0-6C8J\)IY(*HG1/I$BARPI`.45'7*YK%#"U%,8LR8B$S+D)B>8.I;@ M''&;A<5=&F6;`=`#9N!]ER`)5KY15DE$CV`)+%0S75NZFN:)'J'G)V`3N6P1 MT'39CJWJN.G)`:16S(&1Z:D_@)@6&QB\O3:OAB-*B&;2$@F0T!&S2RVD?0?+ MG-VP7"0N?VKP$*;;(4,'E3G9?+2-2MDB^JH'=(3=V7%F(A&?C72XTM&3JIB# M!$N5A%+4=F-9$6<4U0U[O@J.C"I?.@O0P`"HH5_T#+"`S*GA%-D#?&4,=96Z\LZWZ36A[RJR>SV[%P2\+;-=%)FMN&S/+ MMHU,V"PK5W"S%(M2HT%EO'C-,TS\-966\I8G%KX]UG,;H#:H0[@GJ"S&QD9]Y80%!VI5TB,P=>5T6?"H9+3(&W),>4 M&^228QOJ?Y&3[+\NR#E8^$V\N5Q+;C2-,M[RT%QN6\^4]_A.Z\<.;I M(0\?DOK=\)8/37Q*\X+0AD<#DXX`@\>27&P!9[BC-*]@IA-"&(:& M@\=V<"@=GQS$J.U/T#VOYPQ*_/>*@5_7N+E/P/E4994G,?'KP7$WSX=;Q'E3ZPWE^^ M8[C@>XC9?K;8KSUX\N2:O7P+NRM#AA&";DZD!IMLX2P0W5P9"9 MJSP`$/3V^#VPV)0YE&Q48IK"@B40#XIU2'HMU.,<=]2CX#VH0RH.0HQ% MA".*H-5$VRC3Y]HD2D18.Y2F(WSR-PI0"`,*G*]7G#-&\X"8%HP)`VT0 MW+[SLMT1FY)0!R\&[979R2#LR0<>%+]*[W9JS7ZKUNB=TP^Z[1JFN+=;77GB MI$"8QK4G2&7^R#2Z^I#'"=N\\G%^ M.>6.X1K\Q%--XFHW#^@Y<2K\%$XJ:AF=.ZB4?:I"BZW MV`M@&;3)J0MO[J?%0]P)$#M,_6S$JF3&<]=,-#]#3&D0W"6Y[P6=/)QU[8T+#H8I/GXX2-E-"3"HH^#:G'4Q@Z MH1,:G,DP#AN82\*QOA(%VM+%YXOO1:T\8P4#4N>/6"8NM6?"J!>U8?@!"^IR MB3;Y9-7Y>SQ5,+>6\B_?8MQN\T1?-O`%7/3QPR,&3+F@R1`9BE?Q)B#!4>$J M[Y]).?0:O0\?@?71&E;#P.%-*(S7E!Q'_6J"=CX&*HFWA,#&A6NA;/5%(_"$ MO%+\P@#L8\U'DJUM>3,@'EOBT6?WH_+>^(!I3KZ)H6!/RMRCSB"8PPLF/^5A M!+%L/NDA3,.*H1CDU5,>F)1FQ6\KPUM,D8F`L0]<.NPY-T&24V0-HS:ZP2=C M8,,2@\#,@#!<5XIN"1=#708X< MAJK7I^S,L/6UZ""'P3W8(C!4)B;10H)97#S,M),2CBE0?&R@#SVTD?$H;,]+ M07BCJGAWJZCG%F]G+:*4%`<5;!7Z3Z3:U8`O..IX`8DGV%3<*[@B!DD?FN*P MY*?4##RG,:QX(W">T?>*',LFB`NE#&)"E38R`$_L'N(FZ0.\30GMNDV5+W:- M1T?_\O5A>.`$^8UN,`8@;*@='J4L=:="&##(&NO$S;?3,?GB7IJU]__6_ M_TM1_A$^@S&.6Q)KWF'F@?08Q:7<*PJ+8%#B?G`5A4B>HJ`.&FZP\",;`*I_ M;S?^#&-A5YAN?#^@5U[`IM>?=OWH((B[TS53V[O.)8NB_G&BM5JO=[G1.@',,_M(?+XYIU'F$Y^37AD2,M1#;+I$Z M$9$Z]6:KWFYNGDC=LA-I%4YJ+4NE_B%3B:?1H<=A6ZCFB%(\[)V+/(UN.Y,\ MK6;[;!\D`C.8OEHD58L8)F04^N9B(:>TU^>4$/3-H+N4?,31O5PL&,V]H$M? MWO-X^\T/YF@&ST1?C#IE/S]/)XS0O;.M!U.UQ$H+L>VNO[FID&\>\Q0>7P_S ML[)@#AO=3^PY(GJGCCGBTC+X.=Y(S\>^UV^VUC\D=X=]DN/7Q;[7.R\+]BE< MOR;V9V?GI<%^R;UOGI^?+9+[9G]]_5[,O<^'?:L4V`,N?70/-KWWO3UB3X/. MYAMQ[7KK3/[GIJW^9E,6?<.U.ZUFO^Z[^LFOW0;]WT(JQ+%(01Q3VL#DY19X M#$M#VLM,&%O=\W86C/!E>Q;&V`N7!TBXH?,`ZF0!U#X[[ZT)T)WML>LP_AB& M*O+H0@ZC>]9J@LWZ:Z[HRT`=&R9\Z%%@'3/['0RL![>^QG\8C\.GQ>X+6K2Z M8M!IP6-(^[J.*<>B`0$%[.@[7E5Z_WRC_"9=5G<^*4_/]U?_^\_[+]J%_")0,F^[UBA!#O_3/"O?UFZP0?>QLWF0*8AJ:]GH;'DN M$8/TLDZC@?4\_'13_?F*H7`.II/#?K1%:(QRA9'K M8"JGQL!)/GBMS0LQ20=@Z0)OJQ#' M2)6$VB61DRNWY`ESN?@U]0NEG^'4(IJ2;CLN30.@7W+UQ<<.!OU^\1M*GN*: M`$>F4!,+@-1E```-"#/YU"!8-0($^Q+B/2$;N_*$$9XEC-I19!M3!@#>X-,J M6*WB&D,K2&2+IBPEU!?72N'4D6A>"FAH!UG6K8E'J/(-M\420Q63;Q>#W`02 MM)HM[D6E?'`J*P&L30.V+&K)\#,E.:"J"THR@G8X+V&>!`*)+\69=O:+)UKL MR%J8"`1;62G*7%B=%UQIKI`8N]#&$BF>_RK*=)%NC92$?MUUAN]B M1V3EF_P-"\$G_OCMW?7-'7YTMOM]5O-6&5( M=*(%_/W@)*M+@FKHLUJ_<1X\P5OD8+I*4-(A%1_2Z<;-4#<8IAG9N35Q8-C1 ML6;9BFE;0U3$5/@7/0Y&>KA2,%PSM+,EVSELC&QCS!R]LHD4=`1\U^/U/;/4C+8_S`LD<\'B$P.%EQ/MA_RZ M@ZCHEC%(53?EP>7.3A,7OG74ZXHF==J.Q%"I`ZL6<&V'CW,0+XN(EL%6]&+! MA\O-Q^J<8F$(E1?KR^B6E71&JW,>Z(R,8<>!4,F*XEVSW^9-?%>B9#79XNCM M`IFST+^40F-)9-BG8I\?/D.2[/Y#/S.;5_ M"1>4-^N2.R=@GG"8ORN3:]8QQ8SF,.R&,WFER)LH%>`JA6;9BG1]_T4/YG60 MZAR_!.T',E&8I>N(=TL0_@AWNX-NM4DO.^C4P.,..#F44I0#[2(>IIX/#D!F MLB$+NH]QW4:-8PB&#;9F.@A'N6B"+UE_Z0<7M>`+\O=YI0%#X8YU)N&Q&ZI3 MC\[)>*]@'@GK-**@>KIQ346+*A434*E-*"WA\(>9@S@H1YM9*ZA$"\HIJ24G M17:H9YDR\'$98%_>N^]5-4Q:,&C,)-HMQIT4VZD%J&&9B<4E*X,#94[1K#A$L$[YW@P-2Z@\>>P7$#>Z,C(D$ML MI&>XI3]VF?D:%5)$AAUI6VX>R:T:!O'208MK];IGUY$*5+AZJOQSUB>)+WAG`"QT@N]XC!:1YZ51^#"9 MFA(@03.9Y/$0(PQ`:1K,Y^V`W1$9GJ&1A[3V+=I9B1'GLCWO?:4Z85^ MSL#")#@\[(1_H4+"_Z5/*#H!3W-9S#H*^`!J76XW)S-LJF+GT26=C2>B9LS@ M[^#JF_KUS#PV,7W>[E>(>2P6-*/24B]E,FSIXY&F\EE@MRD.A&G\C>6@W&6! M-Q+7!^X!=C-'O@-'+'Z2UL0HL-!-22R58;0+`>*L+G.3><2L M4Z2S)XS57\Z+U:\25.YFA.>S7B1RUKS%#P2G3SR.MA*,-$62!7HXJ*['`$'0 M&;268CF^,?+U8AZG&H8JJ6=76N9>6@`E%BBA%V-M/YX>TH\B1S1(7*'*BA2_ MD:YQ[4$UT&AG=W6EE/J%20!*KU_KXHD_YS+\,GFQE='NLK;4K9G+YKTT72O, MN5!K!^,XH\OVL,=DZEW[LOKC(N6>KA:V(Y[%/&:]I>G"64.UW3RO9F8?K[`^ MQ=VY\,#+X5J#_:[#?F+R66#DC'7[,?@9:V6> M)9(K!I_7'"R_.%9A^`V&X7GWD)A2J>+PY9"#.>FWE!#*@^/-7JW539:6AKL> MY-YFEY:=*G>VDL(EW"=Y4]TU4_*[E,T:/4A9NORWL\GLT?;-G"UI(*YRN/0P MB+G@1$E-M"\_0QW>*%%*%4]3<56N^`9RQ;-$S@W:2'-S-OWN2MST24X7_7C1 MRJ^VQZ0^\+'`$6\][M8CA<2#1< M]^@^Q/8L""^]B1PHR0U3X0SR^``AGDR0X9'E>BF?\(8!0KIZ,54^Z8]/95&% M(*](^] MD&:[\"$F1&1XW#%P:LD//L2-A^KA9R[V[>$)7!8--Z&+`.SUP&>4T<1.&=HD M.+7S;H?#7GYA.23!SQZ\S=D[PC6NV&>#T7@W&9GQ=.^3)BK1$C,-)3(SBZ2, MI51)C-;$-\S,"4X):Z<"M%+P(8*G"CZ4&)=8V"%NPJ0$'C866*A)S>)F^E!N M-.:0/]X0N5GS(PS)6]JX9^_03#C;&:J6\1_A[,"AI4[(YI0^04N!=^(+CR0^ M]$J\=@!F#;?T=UV#/@OX/T@B!!. M:LL91(^"`CGB$7(>WJ&&'L0TX:S00VVIV`/0*>5'P8Q'O)(U<>P>=G3'*X67 M:3*G$7;:9"KFAKW9=6]D.+H[]USGI*J131)3+S6A7`C^N+)*YK2!>N6)Q:07 M9>,GF?SV9BEF.#9P8`R\*?*K)JEET9=C8K]%>HT;TZHETO4X23$VJ@&)Q� M$)@&JD8CQD,/W1=YKF75LX.7,/42-)E(G M4YNEC,=:>-^@).X;/O'["4FDTZL3DLF=<<#BJ9*V%=-OXJK*-&<[[A%"`FL] MS$^FN=A<7)#_TZ@!LI.N^MWXG4P:Y5>YE<'QII@5"SM6"SOG!CUR`X'=@*+& MP<>:PWA;XBG/+17S8T4\B`,:7!E()S[]*CBP%[SH$Y]=G/M-;S01GAL>PMS. M.'D7(\EU*@=?9M?9+$1)\1G6C)$]]Q4#!;M8XXG$\4'*TK1FC0;9$LH\.Q=^ M0$,-Z62'-]-7`2RUH'=4+#-*7;PO?_EI.Y&RX5(N%26QBP>%E?7>>/T`\L'; M;R-@\YD'?BR2F-.0D;<26UT9,U4!:^TKOA\I'$1*Z7P+`9=R[E,?1&Z$C1[R M)MM7\1[EM[$>Y>3]H6N(\3653]3VHH9=L\*X$'"!]*2TYJ,F4ZK"PS?,IX!']9#H(8\DB._7&D!0X4U0.],(N!Y!@4O`XC*`-0]+Y#IJ>M&>10AH"% M>0_BT(L,_;36MV&)R\!VY!J7/SAT5$"!"PQ0OX0@SN1]B`338.Y]2)P0*D:" M3:59$1J4ZLZ=S]B\;Q&36H4BQDPY8B?(00MFW1MN,!>>8K?!A'(=;7\]/JM< MFE".6$_$\'@WK,%:IONK2\9(%.A"Q>0>,XYG]5M[C MX1E%G37.%\0*X8?ZIP_"W,2%*/X?V(Q#!Z/(/%.%]R9OI;@.B-$TAH:P M,8-@I6%AB!W^54.3^V\?A&Y@<-O!8::M!M47-E?8`9)(%TPC0,FAWXO;CO@- M`Z8K32.J8]82TNXT4/^<-C$K**0MAYC/.@[[(*B!V1W2LMF(UL=,>I=;*H%G M0B_@-;_!8DR4W(;>`5I-T!"8>0H`,AOO'<187WX:31%*R"B,4F]+;XH[>3$@5 M>QC(Z%=^2+%PN9Q2J!2=:=$#(A(@[F$'J88BF,D%@DK:R8$.6)7+JM+JH_O: M`!&]PD9??_N@',PIZ@8Y!IA0":*_R!QAK@4U&#)S!\_S(4>)CBR&$+)_;6@O&=$I^+I;+S(;VX@,CW@S'04A`^)`:O*KGW[D\!/S8K?ZKD M>A;\*=S'6GKU`[\;2=WG63^*?K?`CW+C?E1D^+=#)RI^,R&T&690\!6"F^+0 MTW'Y?77H146N5=R7DOPH,#/>P'Z:3D2'E$G056J:;OB$F'VDBXS(K8H#R0MD M!5CQ[X[D!8C@\88[3:='Y)OL2US&J:)!JO6 M1#8BCS;P]XL,GZ`4ZFUD2QW6@@?#QC1!G?8K=WOAC]Z89HZ M9@J[1/!2&[BIT"SVN#PN-PWFWDWJ-ENUOKS MA3_H8$>TP<]FK8O@N&G61D M916U1*0$UAEC0]C/]U3\_YF].#Z6,74#::/,:@N]")&5$WC+T9/Q>AD,U@-6 M%EFE-F84&FY8A$EE,&'-CJI80!T,OOO\`M-CZK@6*VZA7G!@\'%\"'M^#R@L M2OJ.LM]<.[)*?8N+DC*Q'9%*A&J!\A55S8MPP#("#/.'5V..,322%Q#12RB- MT7=%%.+25+7O]2=M9)OHM=-OZVAO\YLWG9D(,_<&^+V7*]*H#5=L)*_M#)0? MS^@S*(_8P7Q$T4Q^-CDPFTGHOL*-KEV0$-&XB8'AN'CAQFFHF;9+9'=4WALL MZ!0\6_@0+SER1RJ_D7G7;%!33BW*GE]D=G/ M^,T.L&Y(HYG;0C=V@Z0JX#,Z\![@1NXXAKU.-LDSJON&ECFT>Q"C?G M#3=CS(8"CRLFFQWN.5P67'(9N-+E7J]VWN-F.&HR2E)),7>E:3N=VEE3S-LA M2\W'T$M@X*[O%("M%P*2"%^UVV*$42XG(&[Y4TD+7H>;)L"9.UTU_-?ZMG1! M$2L_QU='1R&.#G%M]81%8\ZT.CC*ALOGK'J='%D]5#N(_\&-+\+6ZK0B^\T8:>`M/ MW=D9<,WS\R!2Q`]CWW)`NH86]=R;@=>5`<[,2`D*N/A5R(07<,$#+U1T'BQN MOU(G9:X#,,8"?ZM#!KS6%1J_L<^BQ-7L]ZTFCQ M7KH:*#^G'9+4/,\6Y2:2S%=D$^0.#,R,59Y6,'NMK/ANL'".F%I8`CRP3=-^ MHUB_Z_J\C-#]>%QL)<+>^!>O[A4PK0'")^6/V^OG?^*#C9\^<2+=WEW?W#TC M47Y@1QC=&WU4^@W\ZT1!9\J=J+A#OYPT^-\3S.46?[_8#IB^^$\Y1L]!=J*/ MZ&]]D_#WS@#\WV\>GV^O+KX$^^S9DS0:>_HV(6D6!9`,BGQ2+N\?KV\>ZY?W MS\_W7S\J_].@_U.:DQ\*5:]_B@D+)G;S\0;'FR^C;Q@_7+2YKL] M3^3BJW!/LG_:C?S)?N.63\G!Q?7U[]UNX2[`[1\S+F63:."^W MRLW+GWQ_MO=]?UJ_LO]X^P[YK&V&!PLH\CYM,\ MVR+B,>#5^6`O'8DK!,_=A+XT7JT:(J>P8%SX8GN>/5ZT`SO5:)TY8,H[3QUY M%D'>/6T4".0L+;L(BWJ!<)"K/?)CT#OM[IG#EX$8[^L==?++"?_?8ISJ!135 MLH#9VK)\]D[;2]V=':(4+&V8#.C_2F>8R&"7W#`1&9.8$HK#`\ICFDA[4!C3 MI"1@KJSN)&0:IXV?"H2&,`27Q:)<.ED`7C;+I(CT+A*86[%,=B^J^V'O*A92 M%I/CT7"_*P-,PRB7H7$0,9#F3GSO0X^!+`MOJR2:MPIY'"28VPYYM$Z;A\O> M52RC+(;%[S9.03,-;W[V<*%T0M'#`ME&12KDS79IKU@D?/9M7JQXQ2)AT&QW M2Z&1JTC&08*Y[4C&0;-W%,+<=V2C+E-%=:/ZI6^G3Z>*YS#5]1UI1BS_K26F$^)4!-$Y)RK* MHQY"TG3"L/#T-0SH2/50(\/U;,?0<#BAZ-;#2_A$7\_GD5RZBNFV6&X5=?F4 M7A0MZAKCB6B\.F;>R*;Q#6\`E2U:;)H&>Z7^/-1-WO6QTZN!398D<&(=DL(V MH`B+8_#)I>%T4YMH)_J%2K">KLM%1>R_?6""$179T8!;G'WKTDZJ6,=I\''T M8G@]=27.;/^_](C+[B9K^8K6P6D18N*F605`?H-T[T!5`.RH]&U?^O6/H(="IGHM"2(7PAPM.QXW@5VXCW!A065P M[P`7CW['S MZN&R<+K%OM]4WTY:JN_FFC^5(WOA7KJS5SWE7ZKEXPRP)K^%WP=#EBPQKR1@ M-K:;(WM6:W=H',&>25ZER!:7W@CCNP/@]<9IKUTBLE=L?EA@YN7NU=OZ54K\ M`-FF)&!N67?OHN"Y."SVL;79OV%Z]=SF\JM_XV)3RN$]5G??NU9*$C)@U M50;E5#4R.$@PM\S@.`2MXNYUPK$%X)4RPK9&BY^*E!5L%0OFAJU05SS'?JT3 M%%^4R`6I(B-59*0*^ATEF!5K%X"UB\PH981MZ8[E%2DKV"H67`&VZNJC0)[' ME6IIS,1N20YV_#&<,OD@A8P2+TR,+1(B\TRYY5)\5XPT-QN-`ERE+)D]6Y;H M="551RI5W=-*I/9N#)4^1%P?NL M9*&J=GG\ZJ.2K&5Y;^]EF+L1L<9IMU^LS:NDJW#252`PMU+:&8OB[EL<*I8O M`)BE.RTVD6HL-HQ^U=QMVJ9:IEJF6-;IHJ[%2CN)DI1:)!5%7>KXF[[ M#@KT:HU>JP"V8!49*`(_5G&WK<3=>KUB;5XE7863K@*!N?VX6_>X`@]'S$M5 MW"V>CM]J%L#6VG/<+?AD4_/FRS;0N-@.Z@5-:I_U2VMB:KD88TE3U]UPY'76 MK.L:'Z@./X'_Q5^^,A?'DB9^Y*C6$#X=./98>=^H^?_4!ULA#A_2E)Y%<>Z M&C!-M>]M*"2HNH%MFO8;:31_/%8=XS_P$.I`5?.,5\.;HO*S?2>F_-[$'L/3 M#OW8`GB4,3#4"/678>L*`Z[04Q3LQQFM=CQ'HE`@9`91:'2C-AT:=42QV[OK MF[MGH3C?#-T;?53Z#?SK!+P9$T>E:+"+OYPT^-\35=>#OU]L!Z09_RD9,D$P M?9N6W)S!'$4RZ(\;EO.E?.;CIE4Y8#GP"4O!;/#L0ZB'.#_A M7=W\VX["[$V!9I)73%XF)G_`>_!B!FU*P.25?5D)W)("]]ZPE"E3'?=#)725 MT%5"MQ.A^UTU_4R7KUA;LZ:\I;M6JQ<);]GY.IX93HF&5?]2+5]UIDJS;%5S MU?2;C212K#C\IEUK=WNU?G??*=CE&()3+M;9%+T1QET4&VR9U9NGY^ MN3S;+%Y$Z?<7'RHI+!F86Q:^[NF^2SZ/1/8JWJX.P@4H]/L%J+G;GC@N[;$N M:.\B.YT;*B65Z%/T%<]+`&,95BP#'5LE@+':F:+">.@[4T5""QH)_0TK#,LT M1[*(=G"!P-RR^5O-^SX\EBD)F!5G%X>SJQ#+$8*Y7%ERH4`O"84KL3I","NQ M*FZ#Z2UZBC+8I?`4@Z+R$OF*1>Q46"`PMV%12[B4PJ*N>G`>(I@59Q>'LY*5ZJE,9/IBNTH[,?$<,KD-18RFK*P M9*Q`B,S34LO5OJU:F-&O=?>>I+=D*5G);H`JF3HRF6J<-IK%VK`#DZCJ\N<( MP3S0RY]4:2P0[)6L'2&8E:SM_O:UJO\H.HQE6+$,=*RJ#(H*8[4S^X>QBM06 M-%*;Z(13YA'R133.5ALA7T0+>8OCK>,M=9KGM=;>6^IL9\9U44)-QR%89>M. ML!L):YTV.L7:NP,3KJKUSS&!N?76/_L^"0];((_%S']_6=@.Q\61Y:K540R% M\UI[[TD4.]8^5?C[<$-0Y5VQ#'2L@JQ%A;':F?W#6(6_"VH7BZ)6]<5D5?B[ M"G_O/3A7ZYUWJO!W)5A5^'MKX>^]-[(_;.&J4BN/$,PJ"EYJN3P6:__]514% MKZ+@511\R6A%\`EZR?Q#67*4C(6+R!:=*30HU^"C4\>U(B4@3I*:O2X+Q]FF:$E(L( MSR.FO#$\2IBNJ*_,48=,8:(UGC*A`=X#VU'>5`<[J[N*+2?8PI^#Y+1)!;Y, M"3S"HIKIZP!.$T<,XM29:-$WPQN!3E=TYC%G#(CI"1A.<^Y40M57@GV,@KTA M4AR$?"]-B[2KG:2I5)WNA[+;AZL$EL@0.USI3SW='396#0O/;\VV/$?5/%\U M%3QX%YWT\T[U?J>-36IFSW3JEZ1ZAFTINNI5)WDEQ-5)7IWDU4E>*8'-1[D/ M5_K7.LF9G!6T\"1O-L^V>9(G])#\X#]^]MWZ4%4G'Y\\6_L^LDW0`>[-W[[A M3>]LCUT;KF;:KN^P9_;#NS3A-[_^]W\IRC^"Q[Y9#M/LH67\A^G/ZH]+9K&! MX;FWEF:/&7SPP"S5]`SF7ECZ+79%8:YWH6F.#T1%$L*JCVSPRXGQ)Y*DWCBO MMT$7Z4PSQJKI_G)R>_?Y1#'T7TZT5JO5;L/>*[YEB&=!)!WE2?.L"&IR%<[%]M6*U8NX58YKW+Q\X?3`MA/+-A3E]"9]YJFEH MG_(_Q[4Z7HZ9.G\,!!UU="CJ'Y4L38NGPL1A$U6H97AJ8%BJI1EP#H#S!CJ> MH08W+%07<":,09-R??[M].E4&8(RI@P#3X]0C/ MJXGMT$O&^`XZB>#WS../FH;Z8I@&ZD+Z6P_5/?X0]1U`A6_.>H:_!<\F?`#_ MG4H-?"X+'(>],LMG]!LX[YCEPL*Z[R`]HF>(.L`>MGZJ//G:2*8!0.N[L"C0 M_%4U_>!!^&S@FP#O*^-X6U/X"?C70X,?RR%*!+?O(=H.`V;Z#YW;N!:AY>+[ M^,]/%6``ER7>[OHO?Q'%;4551L!<<(`-'48/_^7K0]H\?-$$CE2@*1!'&P$< M[%2YX!8$;+1O>GC$^"9N`^R@HPQ`D`$V6W[?:29G;OO?TOD:.Q;C1^8?PH2! MH_41I_##<>K`>&"/7X55%,$CH`2\J MOI)5-<=FZ#6S;(9FOXL9@A%F\Z!?$T^T#K:*9ZM[O@T\A05\P0W@.Q^!N!\\ MC8#OI8_=KK] M;B>.RTH0;@?+3H1E9S&6Y_.P;/8*BV6:V9N)Y5FCO'O9S+V79\T=[268,=\_ M#FS;L^`H^0)_*#_H(\=&>V?D>9.//__\]O9VBD" M[9S\'%LS`/G"T90PT"2>4QUM`?CB%S\/P.&N!TL%C^,QF0*,_*XQ0B51TTDH>*O`UUF^XZ&GXY-6!NCQLRJ?WLZ^;4L M&2W_^#E&IIRT:^Z>=GN^+UR-3JWBTFE+T=@T.B4^PQ.:?TY&P4>T$P"BCS\MTULVQ0 M/_-?N(@RR3?.+AI\*^&=14YAVA)%]3^;Y^?]>K.%IFWPSW;SSP>0MCMUS,@9 MI;N`>PHIX>?PLS/A?<9ICK$,;YHD`H`#GP\,$"Y7&[%Q7!FX3#L=VJ\_7]W^ M[\FOH,";C5Z[>=X/8(\>3B[K,HJC)&FJ`Q@_)J:A&1Z'4=$-^)T+L/]R$EC< M,G8GOWKVJ_8Q$T<.RK$L/!)]*KPX^$MR0BT&DT$7%(*5BD&CG-L\@L'8C'>)XU9*JQ*G'+S8GBZ>LDL;316G>^<5'\^&Y[)[@>W%FDO.+3IMU2N637X.OYY![]RP>\=0R+-[8 ME@Y,9_&C8=N*<];AG&;$.4W!.>`'`)VN'*8;WF=5P_NS*3'/I>_"5ZZ+1\R5 M;>$M$/@:>+&2%WIN'\E[8I[D\^S2WR#YPSI\)]J%_HG7NV+"8-T62>1>6 MC@DZ$R3`Y?09/&?BI-_9R-!,YI:;=W)@&NFA.,I[X1VQ6GA$W'%7 MECNU)3\H8I@)RR(-OXHQ4AGCLV$9&)Y^99@"*W*B+BC'Z7+Z5?W+=BA7A=CF M0<6L)4'//WD:;>C8?L%+,B`W_?(WGMT&Y_:%/H8WN![&RU_9#<_K*C?'+4&R M2$G%:+=)YW[.-D1OS[4?E82D2L@\/G]D+E,=;839&>R5F3:9J`?!Y;GX*@?^ M%5>E46]=^MIV_ M?79-J>,\R5P8;(_,!'CT!\!D^@P>DZMJ9!]?3N5O>#32!J.:/U9R/DLADN"W M.:3:I'V6G^I!6#1)^XK_4_E_"7:^-ARF>7;)>7D93@J>B6-><=*ZG/1T=?MX M./P^F7+"AX5X;KX9;>C::BZC@ MG!1T*[99@6VNOCU>'`_7S&);,1,\:"MP\"Z=9C.@Y('PC-)-*5` M:QJ^%=*@1(,1&DO1Y)3L+T4GUF2+I;) M(Q')\"?96)='*/?#0;Q]$V98V%9H0!Y$7LE<%$N?&;)5;FG76V?R/RL;H.@V M`&[3DC:`_,BF&:@3&9$]-")YQH/O>O:8.5S'7%[<7I6;3V:1"J+S(6K[8H?. M\B9A;XLF8;+/21E-PGZQK.P$2:L7EM\K1VJS2*;B$5#E:I?W':F4KED:;DRWL(F M^#B3*IN\FL[PO,+01PJ9*Y;.P=)5BZ6*,:KTG2I]IP#I.\67D"I]IWSI.\7G MJB^V-<09,-?LQ0O/Y2MU@G-BOS#59?@DH%4&:C:C.VUS5BY&:3*<:P8)">#S+NJ_AQ,`C^(J^I- MLM0&`C6Q*_)T2E>,G<[8.6P]LGQ&MJG?CB>._;@7W'5RESU M5=5&AL6#FHSOK]\+-U2F_$6ZF!,^) M[?`$L&,\[>=2H.*L5,XZL+.[.BW7Y8)#./.J4V8U+JCJ(PZX/J*@G`0G_!W[ MX;M?OI2\+FOI;A`SF%?,M"XS5?U%BM)?I/AL5?47*6!_D;*S3=5?I&*:>4PS MTZB:UP+6PF&^=,D%NQ`)05K2<'ED?'Q9<4U*W%- M-96D4CN;8*`CX9^BCM$J$0=EF&/CL6T=$N\L,GX2^%9J&HQM"J[]")VJ9HOEBNYH+<\)VVS^6(_KGA*V7QQV?[G6Q;.!$FK M-D_+BW?5YFFS2J?@$E*U>2HX5U4M;O;=XJ;$#%*UN*D8I'*KRN-6 M'0XG56FV!4JS+3A;56FVQ4RS+37;5&FV1\TTQI_@./3%D*?*A]JU#V58L/?P M?+0)(0W$-^MO<*O1.*LWNO56OQ3QW@#Q".QMDJ3B^;WQ_'8WN-E`>6JV*[>N MN&Y=Q`G!;FV/$^!X"PV$)XU9*BS%IPZ]&)ZN7C)+&XU51Z2U',_,U52B"%61 M2II-WK44?^!KDD6W]A[L3];V?LVYZN2^5T!V%LA2:?>:-=;9U5I1^%* M.R0&$)NT+08H3>Y9G"1R_&T;)*D*C(M18+SC7:]L_B+:_-O=>;0XSZI[XI+< M$\?8@K9N>VRQB?2!C$C7A:X;^"/5_*?M.R5W,G;$0IL*I:72?E_\NSVU5D9O MI[-5;X='=[ZPH6K>$'1<;OT7U]`-%:W^^9X_M%\,L><9Z^E18KLX2*![3]E[9DZF8Y'.P^SN#XX%N^Z4>UYT>ZY=6M8@%N%7?(`%7C MI7TT7MK1;O,>/:T_!=\+5.^=1V,X\N2==N]L[YJADPN>K'[S@SF:X;('Q]!* M[KMG8BY$/R_^>V`,L7G;8HQ6O='-F4UW:,.Z-IEEM\Q[BS(D+,YDR`C;8K(R M9K!TMWBC'=0:7KRICAY&SNXXTW'V*WG\+(:9$*XT_/;#ZUO?V.JD+>=)NW7& MJ&XV#W1?JYO-H]O>ZF;S<#:XJFO>7UWSWC>X*A@[A`W.D9O`LZ3#;TJ^Y\ND M**1B?J"<4#5^*D;CIT)M>]6XZ;`WO9IONNAZL_#S30O#.E5"6[7KU7S1+?#, M2C"48KYH0;FX2LL\QEVOTC*/<=./:L^/=,NKM,PC/]ZK.;Q'Q@%58NZ>$W.W MN]O-9KW1+E]J'(&]!DF"3_"_X<__'U!+`P04````"`"&/61'RW1TC"0(``!- M9P``%0`<`'1O=F,M,C`Q-3`Y,S!?8V%L+GAM;%54"0`#F_TY5IO].59U>`L` M`00E#@``!#D!``#M75]SXC80?^],OP/EGA4@Z?6:3'(WA"0WS)!+AB3MO=T( M>PF:VA*59!+ZZ2L92`CXCV2,K4S[$D!>R?O;7:U6Z[5R^N4Y#!HSX((P>M;L M'+2;#:`>\PE]/&L^W*'N7:_?;W[Y?/H+0E^!`L<2_,9HWKB?1-0'?L%":'P_ M'PX:J-%IGW0^W5XW'NY[C<-VYR/JM-%1&Z'/IP&A?YWH/R,LH*%N247\\ZPY MD7)ZTFH]/3T=/(]X<,#X8^NPW3YJK:B;2W)]U9!#D1<>.`>5C&0LN%T$BE MT+_0B@SI)M0Y1$>=@V?A-S___%.CL1`=9P$,8=S0GP_#_LL])>,S\`X\%K:T MP-O'1^V6IFDI?B6$0"6B3`+RT)2S*7`Y1YCZ"/Z.R#2^ZH/$)!`*6'R?"8?Q M65.RF8=6XVE6/A0<3LZG<-84))P&T&RMX?%PX$5!++^!^KTDUYSO#=J"%WB6 MH,QV*=P5.P'SW@A@W<;&6(QBA44"/6(\C;EI02#%JB46%6IWEGK[L&S^T?6\ M*-0HP;^`*0>/Q(#5]P#TER[UNR'CDOP3M]\N8=P&F$IU[7*%9(4@P",(SIK[ M&GXAH$";->-+;>U70*DL?>5,B!389IT<`O,-TC1HTB4+R-HLZG*OP;CRQV=- MY<&?@#Q.E*]$L3]?#(2Y]V9^;3NC)45+1&$8#XJ(FFBK_F/.0DO6V;Z-57%L M))+.JTB5Y22^#-;9;8%I5M^W$GF_76NX@&_Q\*IXB8&-81X M\MRS^/+-5+<)939_8LZ5`6UZRQ)&JMZ%]I1@%2/Z0\^&&0ZTR&^!$^;WJ<=! M0;F`Q6>*2RTR1/5`35Q@"D";KM4#^XH)'2CW=4/OE.1OQF^<7%Y`8]>Y>G"; M]M.G:E5CD;8O/,>C`+0:/(]'X`\('I&`2`)I8J(FF6+:&NMW5 M$6!:[.J"VMO>XV=8J<0&7_8(+L"\@#%P#OX09D`CB;=R`GPKA"PM5"6,UCUX%54J1- MYW&P'J"55X`'XXDIM(/M"1#JUJ,.=I:>)XW+%Z:(!U,6X M)3V)L,-@]8)/B/-,5&P_0BTPQT0.,O-8&P2U,#DC.O-_Q?@%BT9R'`6KV"R= M[=PNU0,9JJ5Z,>]OQM^8S(O8\LAW2KKM+<-4P'^SPH%<@=3:_K*-92.W#^U, MQ7'HO!VD^1U3A$?.(RQC:VTJC5_?IS1,=J>F(OCHO`CLFV* M^9/['K]()M$4_N_NP[=/N)F"/W;6WDM[X&$JBAHC/MM4!2MA[_0>XL%=Y%(P M;?`.K"4KHY=B&47S"._!2`S%8;9%=$G]A1Y]LM(GE7.%&7N22VZBW*4MXYYD MD)LZ=JAPA;V8ZMX*5[)NX4+A2CY_.Q6N+,J#`[VQ\D-"B9#Z;C/H,2'%Y;,7 M1+JJ.#E&6Z9@DJI82AS6)C&9`G((`I15Z]ET`3,(6!P4[`BQM$%+`)A\GS0E MF)<=Y8VP-]:3A6M3+Y75OX8J*646-^.OC/GBC@7^!I`$,D[DO$^E"O"%WO2\ M'45'#G)^#7*B@P8=%<8K2WI!1=4R_Q&]+AM)T MF4I7(\NOEI'']#9E#6SK!TO?&&5OFD)C M""9G]^&2>NK8]+)B&P:79FS=8LO;*18PL;V^>KVYN6*6.0:7=&\"IX8L4C5/ MKN(3+`#A144>"E[+$0N>S&$T5A7'`\\-'C+.8NTAN,KUKC( M%G<&91VU#NLO0&0YE`S*6MC6;S@GOMF<+7V+GO^)0S;W5=(A,:'@7V).U9(I MWIR/.29>:@V9>OQ(3-[@97A4+,LD^Y88!+.C%.J.7F,US*%EJE"`L``00E#@``!#D!``#M?=USVSBR[_NMNO]#;LZS)LE\[$ZV=O:4+-NSKN/$ M+MN9.?NT19.0Q!V*T!*D8^U??P%2LF69`!HD"#05O$P\-@#VK_'57^C^ZW\_ MKK(W#Z1@*?OAN_=OWY`\IDF:+WYY^^5V,KV=75R\_>^__?7_32:_DIP4 M44F2-_>;-W?+*D](<4I7Y,W_GMQ[V9OOWW_X:?+A M_>2']Y/)W_Z:I?D??Q'_N8\8><,_F;/Z?W]YNRS+]5_>O?OZ]>MWC_=%]ATM M%N^^?__^AW>[UF^WS<5?D_*IPW[CG]XU?WQJ^FKHKS_4;3]\_/CQ7?W7IZ8L M;6O(!_WP[G\_7=[&2[**)FG.RBB/!2TL_0NK?WE)XZBLF::%\$;:0OS?9-=L M(GXU^?#]Y(?.F85U4Q`7-R`V9O]G^^.7FXC4OTKQ\EZ2K M=]LV[Z(LXR37(RP+,I>2NF.@H.`G\>W_VNM9;M;DE[3IR]VI%@QTH`\ M)O.HRLK^3'XYCI3@';6'I):T>"#Q=S%=O1-GV/N//[Q_5Y/*CX"2\*^4DYR6 M9$(F41P7%4GX_HWNTRPM4\)>4E_2AWBR&Z0FTV0,*>4<89JGXNRYY/^[;2U( MM(NA^3YY+`D_Y[>GT8Z$C,9M\U3/T3QB]_5$56RRB*)U3<([DI5L]YN:)Y/W M'[8'W7]M?_W/:1S3*B_9=;2)[C,R;6B[?"9MFB=7Y9(4>[\Z35F<45859%85 M!4=VQRD^X?3]L<.11?7T7]YRR;ZY-?\B M3@&2\/N)GWR[X;8718N# M^UCZ]ZYR`Y2H[6([YZLOROY!HN(L3TXYXUKHTS4=FM33[30V!%P3?B$DY_QW MA_(8J*U;8@6W8*2^:NF*T(9'\ME7MG-%Y!W_CH*V_3\/3=)9?8[,^%>+*+O@ M)\;C_Y!-"VW*=HZ(I*L5S6]+?I?<+J."L*NJ%$9G88B74PSHY(C\YMRY(6M: ME/SK0MAHW4F0YFY(/D\S4LSX!EG00KXH6ENY(?"&+%(AO^3EYVC5MJ54S=R0 M^!O-N`P5%0V;Y/,M:>>&R-])EOU/3K_FMR1B-"?)!6/5LQ3YBEA-^Q$;F(X` M0K"1!1M9L)$%&UFPD04;F6L;&4SF`H+Z'ATHI?X#1/4#(E0P6P@0V(^(@&DU M$R"FG]!A@NB%0'!_0@=.J00!4?T9'2J0M@1$]S,Z='`+"Q#B1T00Y28YZ,7L MSKL#1Z,P?D)A81(X0*9G*#!,0@?0_`^%ADGR4'B)G+@&Z^"^:%(NR80W6T?Y MIG:KW4?J?FIDSFC.: MI4G]/],\N=YC]-7\/,VC/$ZC[&FGL!9$$NQ#?6;$-L\C@!#,ML%L&\RVP6P; MS+;!;.M:(O_F0AN'%:'<:3#W$U:M5E&Q$;(\2Q[V\Q6_^.15>J=/T(157WZ<7Y\GV^[IF%HB8?;F9ZFF0MW(OJ4[Y7"1I5I7I M`[DE<574L=YGCW%6\0UUSD_B&5VMJ]V9>185.=^'[)H4M4GX9-,^@$)4=_!% M+&P4_E&ER@CM=C2`_*O"1V*0.A>7+KGD;$XNN$23+U+QCH,Q4K*3S:?H7[28 M91%3[<,.(Z""^4RB=E5V'.4;@>M_3S:Y53(NH4^3%2=>;"YQ@IP]KKDJ2UIO MTDY]W4.[R+G<2YYUM&WB%,6^!/1``T.Y#$%]C@"*__USS>GBVJMRG[2V<4_J M#=?`N1*]Y/OUE#R0C*X%0R$;W:#GB'T%1P#!_WZX;Z)_CPH1=JZDM[7-B)VJ6JLI&H>-U"!.X:L)E5]8Q7H*M;:[]1=: M].([L].B6<#&5ED*.G90K6F7LZM=3#H;E-O71$-$P.@E0G2KOUTQHD#?%BVVDP`RGM80)#N1LA$Z:?WU'M3>.9 M[N#5AN_H9]YBA,-.CW,Q=)@\V]W!7)9`QEE[\AD#I;R)0 MVE#YQPO$WJ3AQXA,J\7/,)NR&'ZT_?1`_/C<7L9V+ZKP`"0\`&G'9_@`I(N' MV=VSCGBR+B@7(,OFM3;Y=Y6N]U?) MV8ZS\'?D7888<<31$4!`$-83PD6.(5P$>3A#,'W@-WUXMA@$%2&H",.J"-W% M(W>*0C(I2,9_DTS6D9"Q1<)5QO'P+YF^]X8,Y4!A@),!4QHD;W!/:%0DC?]$ M_@17VLC"(^`+1N]H\>^*G*;S.1$I/=,HDY,":&Z!*+[D/Y/'BEU>SN2D2!M9 M(.!V=G%S-J/%FA:US5!.A;JECQ>C!8GYQY1AI^V-PO/6[CIP4L7E57%+BHZ@/&24 M4_-Z"J$:(!"KNZ(&@-VG,1BZ/5""'R[XX8;WPSG%V/NHP0_1ML@6G*LX9-+@ M7`5ICHA\J_/Z'S991YO]]05TITIZ._"@*K_L,M)R%JW3,LHN2<3(U7V6+FI- M2YU(!M3'@\.,W!L$5FI:!W]?1QB7-%^4I%@)_M[QKRO,A*JF_@E76I?5C4=) MO'^[^-5\SJ7`IQ`>Y1FD;(LHTOMDH]D$!CT1P=*N,8.>1P;+_SX*WK[@[0O> MOE$D;_R-+-,XTR1N;&]T!*Y)X[L/G49M[]`- M'C(%39Y MDS[3_(&*=#*S:E5E=4+.&?\5/V5%IJ1K/@`I"I+4N<3:E7,[@UEXCL>_+BZ& MJ[7<<:=M9^59XA9FS1/ETT1%0QO/$XDH23#[_IGO8CTI'BD"VML@2XS:,%], MPX>/'W]6T*1K;)\@WN`#F*#7C2T0M$V\SS[3\I0($8!?,]I6_Z-2H2C2^HM8U[4F?+E#S75&]L5>HWLX`>'F"(\^5J7B]=I?-` MWG!41/MW=6QIVF[&J^(F72Q+Q7K7MD<"`3(1JAXCAX%@8='5BN;RBUS;S@?) M+1(@``"H5XA.Z@CCK%8G1.I@FK]*!WL`0-EVA*3[W\:?N(ZXJE;*'=#:QD.( M")=R18)<5>1.2Q-_A*K#5EH;C8)8_ZOVI<(Z5==F5K7U3?J)`>DGODF_B?*% M:O>]^KLG$M65KE^W0$ZF_^T6HM=01:\UUC$#$1;0PP.,NBA$Q/CIQH4BDK.F M.(+0=1:U\9F=;)[;7$<;\;O:'/-LD\D3T/4UY*<"XPP_A6`#[=P;^P8;2#2E MK+U'"`=J!:B2NJI/",8-P;B(@G%O]QR/S;+]3$L"?U)FW-\]Q+NTS,C5_")/ MTH\?KIT6^;)V% MEED:E?IB-E^RF&"W0O`0E@.]"1O=5E/'+NW?$>J(.92;#38Q5,.-D6Q"@YDT M"!UT>]-;W)0`HS2ZS=C5YKP_N=``>Y0;5CUIJMGM8JX&LN!/Z-:V)*0)W7IN MBVK:@Z&(X$2Y.E^S_7!.5*%10$A_1K?:0E($KS=_2(I@QQ4T(H"]Q%7\.*'G M*'XD7@S+^-EBR_B('^E0`BM^Y&:&++OB0DC+$M*RM.,S3,O2,1#O&?;0B5J6 M$]YDE9;U53&)\F1"RR77,%9167*:=V0!4[8`1W.0O,6(DEYI7*9)4E,<97^G M5:%(>Z)L:"%KQ4D:+S5Z1K3:*-$TM$'-VGY9)=$+R>+F*"D7Z%V5#&VE6E$4,7^18`90[ M#!E+Y!E+SAY)7`G/+SACB;J'GS0'V\.3JP=\JPJ/-E^9*3$H2-UM$!\9!=H* MM;Y*(B"OYAK2'QC#..-W/]T0LN>Z5;)?V]X]!"'A7LUG!>'7^GD4IUFJ+$*O M:XX#P*40A`IUT19@MZ,!Y/_IWJ?H7[285:RD*RZ\*A:9O*%[HH5R?C5_09%R M&K3M1PS!_Q*2UWH\?(*O*0HY$J)Q<1Q6FU,!"EC<<[P)!HX`@O\E-_(W\H%Q MXT\N\,KN&YZS?_//V<-;[_#6^]MZZ_TM!X=";)DHX[E0!H?B>[3:52U!M^`5 MFBZ%&7Y1+N,.\R.9W:-\9XHOVA005:'5FBG\- M:4B(\)HG0-<7RFT]OL0([DX"M?@!#L1`APM^60$BHH#H\+W9O02Y>]$=:FUD MMSIWJ7%(%\H#2CM-FBG5^XF!L/$]<-7YDM&M7;T#^6G12H(A42Y1Q3Q0`'@4 MMV%X8V9G,O$##"^6G-H6\2.W>J MKK>T:.+4]1T\O(.(V%(L+[W$&5BR=?T;;3/'TSZ^GCBD3-.2U(+%D!$ M@"X>GA)$1[F'_DZ]Y! M7-"<_Q@W>IG)*NPZC'O`!X1H+BE-:P_D%RDM^"&6TN2&Q"+512T6U()D\J^* MU4+:*6%QD=:N(QFNCL/X`$S7A.M'P@)0\LTO[M:]K:];F*;=?;P;>"!YQ07? MF"X:.1&&#-QOQ"'V1P`!0:QVH^_?D#4MGL1MX+ENU!=+''_C-.>;G5^WG/CT M@8C=SY1R1H^10O1]B+Y'%'W_A9&K^1DKTQ6G1\;@]D9'$(F-+]SOFPJ(P^SX M"V9R3V9RD!*%SD2NHYJ:FS+180003KO8`]$M5#.@JML1",U=13PS:/T4?[>! MQO87L+F)WFU`X@#3W<7\X3:&S3KHCB9Q(&I+Z?NMHS:T!P'16DH?;QUM!\,$ M$/'/2!%W\(0`$7]$BKBW308JAF`5N&#N(BA*K-*6D6L6"A:K_-7/4>8DEJ9. MJ'L_8=5J%16;"9UKHT]*H:J:)@_N\04'"85[4]95=IG. M26TGD-GQ+8TV8O_+$4!`X$(*#H?@<)`FD5$=0.I&P>$0'`[!X1`<#I8=#JK# M!IT-7D(LM2R\N5,=XLEZ2W-=B(/L".ZF)@!'ND0Z!\<%!0`5 MA*``!`4@*`!!`0@*0%``@@+P[2@`7>4T=[(^$?9PSI=DDJ71O7C`W]D?`!G* M@90/)\.EB!^D8532<+PD227R=DR;M7+YO%1`PI#Y`$'D#R)_$/F#R!]$_B#R M!Y'_^$7^KA*".]%_7O_#)NMH(^CI)O2K!W$@[D,("()^$/1/R7UI*-K+NP1A M/@CS09@/PGP0YH,P'X3Y;TF8U\D$[L3WQ82)`B-+FG%VL3J:I=QT$^(A0SD0 MY>%D!($^"/22O.1QF3[P96,HZG<9#!_XO8I#S"HCX`/C8,I^%OI]VL6CXF9F M&:M6S>\Z,ZC_1X(:&=3(H$8&-3*HD4&-#&KDMZ1&VIPI<"R+*LR3N""/KQ+ M2"J(_%'\('CZX][EQG_US[.6VJC;:TWVYZZW[P`DV1+$H*1=DD64-02TR"Z* M%B:$25*:3S0]S*4Y78J=*!#ZK8X^.-2>;]@$4 M4KV#+V)AX^MBVR!>R&IT'P$@_UKSE#%27JS645J(6WK&U]1"6N%%W=@3\4IB M/1)W2M8%5R8B1<6\MB9^">4_9V2;"YF?Q469_@<*0-?5/;`S+LC2#>$[KWA( M8])NSKZ+'D](S@7<9\G1J;>.>U/:*+NK;`M0'&13E7!CT]`&K+JXD6_:'?QYQ<,`1 M0/!_XF\/;#7Y;6U&0"H"[NXN^I.*I3EA;'<_0@(R5'U"($P(A$'TH.*VNF=I MDG*N$;48(V_HGN@O>=%4(/P/29Y-:NRYE!E?!EGM]1`5W$I2$%9N4]Q(T%D8 MT3T;?H^*(LI+Y;2UMAEQO)76@8PFYEX:&T#AFPI5R)B*]10:>.`VE,AB@)\S MORR:!:Q&WF+ZI:!C!]6:=CF[VL6D,R^[?3PR1'"L7C!&M_K;52@*#.-!N=AA MT_&Z$#*><[WWO&E#P(!X+%6AM[C7P+X#=#L-YBR@/:QY*'3.$Y2;N8>'H4`9,Q/Z%9^>$/E M]=Q6OJ$R5/[Q`K$W:?@Q(M-J\3/,IBR&'VT_/1`_/K>7L=V+*KP-'?9M:,=P M9;PT*Q8)-I#$(TWZ&.'2NDWBRWE84KK//D5TYX9YY34R'=9##I!M)+G/K M;1-XLCLZC3EU!9$6>][1^.H-@^D`(P[M/@((B.*G7YU<(>AX1$''R*-!@^<( MO^?(L\,E6%@]2:5=909W(FHR*4C&?Y-,UI&0WKB>D[,HKI-Y]Q13NPSM0%3M M3A9,7)7E9H!KWLY"Y[81&1=*$FL@3MTD; M62#@E,Q)41RD5Q>!U(MZ#G]/R^5%GJ0/:5*SI;;QG9`\7JZBXK`8BKT!+0"[ M8/2.%O^NR&DZYQ3Q3Z=1)N37G MGR=?HZPI/M!&ID$WZT3>\$/F(H\+\?.TW'[SFO!;_?`%5K?.%@CFU]%G\EBQ MR\N9?"5*&UD@X*8YBJ^C8G/W?`[O;(G"$[/W:R;VZG./IC1_:=N/&()_"QXG;74O)Y"J.Z-[KT#8/=IG%5N#Y00[Q'B/8:/]W"*L?=1 M@Q^B;9'-[BX-03P#!_$HK;OH!%(UJ#ZN9G2WOS%40```$"2V)XV]O7-`W%@> M,'8-0@'"Q/*8L6,(&!`EEE>.@P1M`'F`[V&DY=`((!^PO)NT';,'%3JP/:RT MZ@&$,@&;Z*5[PSUT=/2\_H=-UM%&B+,]`Z*!HSF(@3:BI%?8\RQ:IV547U$M ML46J)A9"[YJ1LWKHK:RPO4'E=*A:NW=E[=-T=9^EB_HHE/GA-*W1D*^,G`/U M00/E,\WCJBCDST;!_?Q"2IK'X+\6E$%65UMS'P&J]^5%SO@=)7;I>12KZ[#K MFOL&L$NU(V39TZK@HGUKM'BWSIC`U9=_HBVG:SZ`;Y`-R].X_98QZN,;BB(2 M6-[00WPSS1=\7:P$37?\ZXHH%553_X0K@YO4C4=)O/^PK,]"!+YN)."9\@Y7 MM'1/]M5\GL;DZ>&H4I92MO423MW^^O5DH]F[!CT1P=)N#8.>1P;+__8/,;(A M1C;$R(ZB0.-O9)G&F:8X8WNC(PCH-;[[,$;=@:\Y:B2]H(QP,IDPR#SK;LW1 M!I#J-3)T2UFCB=%.=DR4JU@Y.8I)Q+-2ASN95'=-""@-`:4AH+1?0.E`UR=^ M[/T.7;N;-<25#ACAHG1ZCRRFU,Q!.,8H4FAHP$B#1[MX$D<6+VH4(C&R(-&. MH08C"Q(U\^*/-OI3[5H=63!G7T_^6(,W#3S\8PW-U/I$W45I+B:LI/$?2YIQ M5K&Z^$"YZ1FK:32F@XC-#O3TB]NLJP+RJ^.!BC<&LVI5974%E!G_%5>S1!W` MZV(;IEU7Q6JWSML9S$8L:-NG!$O_SEGZ)./!EEB M2=\?UAK<>]!PLJF;B!;;2Z)^U;&;+WYY"`/.12[/'CO0)VR`%RR]8*PBR;XV M<2I>;_#SZ5345DKO*UD&WP[=;1'=\$9LG`\?/_ZL6$6ZQO8)X@T^@`EZW=@" M07=%5)]S11J3JSE?="N:U]_]LJ;Y;URZXW]LH\VDGP4R?X_$%BBY$E2>$F$Q MXS)-JO;4625[5B#XJ+'80CF'7V`$Z<_IJHN]8V'MXI+%,R M/T_S*(_3*&NB`M39EP$]/,`0,L_5O#[LE&%:\H:C(MI_4-F6INU)27Y.BJNBL;P]EN45617UUH/0M?3 M*ZS&<#"MN#A1B,KF>CBR'CY@[*P#VR.T(6UK92#)!RD88#]?D%HL))H=`^J% M"$[#\49#%3J,U&YD823?C\+V2#\A.>%B%1>OGLD\)U%92<^1/D-Y`+XU,,!> M"&E:HR%_FB?:%\LF77T">[EWQ'^T@.1=W`,Y6ZTSNB%DFPRO74T4-G/"1&87 MH8JQ.UJ*3?+\]QEEY6=:_H.4-R2FBUQQ[PW^O2-B86-C/*?%]E>BG>P*]D.$ M!V;7+B=!-,WY":`4WI5M1TBZ?XWC4YJGJVJEE)U:VWAX-[@M>KJ52(4\$^4Q M$4M<^KP3T,4#D"S*/T`'-1=#8Z+(Y&76V3VX&Q']I2JV>/AW3R0JA=*6%LC)]*^OA.0V MJ)+;-&&F!FXP0`\/,%I-FZ]C3$\.@TSK_VQC^QJKILR8.L0G1L2HTY3%0E86 M]\FGJ/B#E-LX2;X*.+#3O23WMAAG\,D1,;*QXCY[&]E5N23%W?(I!OZ<%G.2 MEM*@:H\4'!.;Z[H$S!N/VS]_3`S^K?8J>6-P^^='Q.#/=`OE-=1G[>1SI;JJ M'7YZ3(RM";^:`ZT.@WUGO"Q[B-),Q%_PBZ(^QP;FG.QS(V+@]E#:>^LPS,[5 M?6>,+-N]OACLLM9_:7QLV\IPE;`L#LLVQ9?&Q[:78IFJYL2`7QH[VWXG(B*> M)-,'4D0+4O]1:&OG45JH?&Z>J!@?NP<7`'7?&1_+&G5`)%][7).8_WA'Q:]< M<=+T\R-B\'.&E*OY'I[&+A@]BK@OVTPU^"1"1C*EI;!^U)@GH%BD(3\5&&?X M*03&_%94A^IG7:+UX!T^>_%VO/877=*OI&A^2E>IF8IG]Y,C9^27]=HU(R6? M],1(0.Z/^U?FO2==3*^[V!Q_1"QJM7,^";=*-]:`GQLK`U^:G`9E7ONG/#!N ME\=K_X$\I$Z(K+U'"`=O(Q@$AJJ/1RB7HY+?D]0G%8TZ#X0&="U9=)S0]K[N MH=VE94:NYA=Y(@++JRA3G)#*M@A(%_FP;DC6N$B6Z?J.GN4EOT*5JG;'4;X1 MN/Z-!KMD9],\J1/9`&*E(5U40$92W0PH[Z(K!*5(TO6B*(GV+2#NFCK26:$J M5J`HJ#/,'+8^BD17L`.&#!QEC*YFAQH?--F[45XB[?-(AV5>KZL'7U$^8$I*=/L"DH62]LJSC'+)ZZ=+-[<65K&[ MFDN`^\I2[0>W$HC-ZLW2##'H]JSF%@*FN4>Y+UMGH6661J6^F,W7]Y(J`&Z% MX"$L!WH7$[JMIDZ0MG]'J#,(H]QLL(FA&FZ,9!,:S*1!9ENW-[W%30FPKJ/; MC%V-Y_N3"RTX@'+#JB=--;M=[.YNJVM:7-N2;!GHUG-;PHP]&(HTD2A7YVNV M'\Z)*NL&$)*E*J=#B#?R2`Z4T]6_1#V*FQ]4KKT_UA%A[.8*&A'`7N(J?IS0 M7RIJC^M"AI%9R2`0C*/FG3KV+(&U;!ND5OKOS64!KFHW5IA!T((2$Z- MSH75!:X"*2<.H33>K''?T.'"RR<_RY,C)]I M^0]2WI"8+O+.1I1D4/_Z[@`I_]0?S5_J/PA2;\C\C?CWR\W%$ZR2%@\D_BZFJSK-]ON/ M/[Q_5\-B.YHG.2W)9#GA3?BJJL7)"6?[A`J9S=YJ\Q] M_IH[]8J8)DF-(,K^3JOB(%W?-HNYOJ%)$G89(7G.D=UP!FQOL/H\NN*'322T MTDNAI;?29=#/&IFW9KJ/A# M3HJRH0U":FVD%OT6!6E>4Y/BL)`HI*D%8C[1O%QF&_/=;-31`J';[%[LA6"] M8\K-GC-SGTAP)PL$;KG`E<%I*8YYSH-/A`A6'-9$@3:W052M2%S-;XE0O/*8 M\,^V4J-H9X&,.O>#T'B*S1T?GD7QG@FF#@3:^S5[RA91]R@WLMFU-ZH%B+>S MBYNS&2W6M)'3Y.>+NJ4-4J),O!WF8@H3844R]BF:N2_5TII8%!67LU_I31AMS23E=J2M')/[FE:D)A_3,GH M]D8>B*W('=T[;$3M",7[B$,49KW=PWNRIS[;()33HFWO'L)%SO4X7V5MG];].]^>]=]$C8V6-91+3@USB_ MC6J57DP4'Y8KD9SXQ:XC^TQDTXZ!)"\34?MU3TGS[T4^C>NX-79#8I(^*"I8 MFG1U#ZP6@,6#=!&FF!VXFPZ0*-OZ()TQ0@11?)GLYV][*=US-N?D:Y2U:"\6 M1O(`F^O$5_-909*T/(_B-$O+C4(!26)P*95T_:+>C`>2_,N&GZ%^T MF%6LY(=UH:KH+&_HGFB1X>YJ_H(BY31HVX\8@O\E='""GE?B[<@VR_3N$1&7 M)&=*4;/;(&C!7N3GM"K^L?^&L1O@EH$0@[[C7R564+\>"3/LK]0.Z(-QW$/> MMTLISR-YPU$1[?_TW*>I@_$0@+3'J&C8P4XV^W]1R"GF`_@`^4!R>;7UPS^[ M)U";K_ZP/CPLO_TH(?@_(H9(.G:(?K"\9J-@E/XME2U^05]MH6);CW3YIGSK MG9D_,`[\*00GFS3^[!"^/%#-']%M55]D=,NK^'@A_4YAS5:EUG=)K++*PP'- M@+IS7DF'U9W0@3*I7G'T<$U.KR'K8H7JB5:J)T*B$AR#'W'U1$OO46Q63^RH MEZ-;\`K+UXMTAO(`$)3+N,/\2&;7PO*U]&#HJ,LQ`EYW:*TR%!YIC'+1'DFQ MR4%O67A4.S13#+K-J8C'Q+ZH=S67@H\CN0D4(L?X+AN=+C@ MEQ7@61DT/P"ZD^P2%,J%[E!K([LU<&LWA_!W7R@/*.TT::94'P,&?2N,;@7K MXL30K5U]<-C3HI6\F$2Y1!7S0`'@4=R&H0B[G.;W?OI/A3^'BZ_"NAEO5NSJ;4L0KT?W;BU2-F9T`[Y"-RJJW9@FB=1<:O2 M6%S$VB=Q0&38TGCV>7,!A(PM%V?/4'P@:FQ9.7N_N@#BQI9NL^\;&Z@\@25E M9I=4,U",6(2F72L\C]2A',0BG0'S[$!AH1*^%*G4H'A025G@Y$Q0=-BD*RSE M3]!5U_9?:1Z;[&;U31N4"5A$N4'RC$&9@$6N@V4+@QI+L$AM3R(M0<%B M$]_:WSA"T6`1I9XBF%7)R:"@L`A2>Q*V85:C9Z0#9GWF,GDBSKM$_,1HEB9B MPTSNHTR(L1.VY/+19+M7)NOZ`IQ4>50EJ6BVCL3OEUR$BJ/L";8^&_007QTV M2_1P%/?*'OU4(7J618S-OI>GIU2WM)&3].4'P)3X3AE74[$MRZQ\42-O."JB M_;]3W"M[Q6_FJZ(^0)NJWX?UVU^EK03W]`I+5N18#D==%MDKC)<5YW40VNK3 M>R6_I8"$#H.TYH3;S*@/*;]R$L;542$<3%="6M!L$%@G]V!>GOE395I195O? MI)\8D'Z"AO0N9ZU99]_@@"*<-T<`P;_0^*1E M[TNTD%P1LO8A/T?(SZ&)@!MU^@/@!G`<;J\WIRG4;`JW(#B&9?C`5CHEU%QS M1Q>F:3Z!K<8H=%&::EP&V@NZ.,PNR%J5&[=K\:@3$GQ33_;#TR0[-X3=%1M> M*@SK$NQB84%W*W:!JK:[H+L>@0$'!J97($0LP7.F1B<@/&S1+-9K6](L MN5AQRA^:%Y-*)QZ@AWM;YJ7*V8[H2!J"'#QB/XKF0AO"6-AY( M;5XVJ4EM:^.AM$[]2`FV+)1M??@,F]-$Y)(H]U?JR>8P@<4KOR&X)R)8@C2E M"\Z@YY'!\N]CE!+YI;[2+M.Y/%@"W-,]K!OQR$55Y.?P[YY(5)Y;+2V0D^E_ M/8<(!I01#*^4G^#^'Y'[?Z"B#^*IV9H69?TP$2;*@?H<022#L:2'+J;!1*BC M1K(Z2J^DR81!YEDG(X[6[2R1O-"MWS;ABX+48)3K\S7;#^=$)<&A\S;J9D=N M3T$'I>-!"3;9H7.?=@0,-NZA]2#PT63>9AR:1R#HT8<(#/J%-:J;)0Y15 M]>4WB1BK5MO?=O,SV_VH`[?S$`3W2KQP^T2..J'4_6%"J?,H+>IPF^DS?2+G M4%R2Y)P67CV#A M@XJ7@WXP^,^#_[R3_WPD3N?@F@NNN6_'-1>\&,&+$;P8P9*/WI+O2K!%%R@` MR>7NVCB,+KA@X&(0W11-()>P/?9V;N,`\@G;JW''!C9WGLE8]M2SF\\1.IP# M;Z(9*;W\A`5%=9]_'!^QB(66[)*A*2AFDO7L[Q32.JU55 M%_HX)>N"BZDU>?SGC-1;,4^F*TYT^I_Z]])8`(F%P_;P/E)BYXR?D74=FPM! MX()?5*QME@UZN(?1&N2I0J'O@.0=MPJ$O@.B=Y(J(+!.B,#LE2:$0GE5S7"4 MSM(C@(#`WQN\%<%;$8RNP>CJV^@:3)4^;'%&2MS(C(VFHNE(S810]6%D]CU# M37ZD5CFP!@O$ARV/HXDV!82(+87C,(87(#.PY7N$JYQ.#,224:_LN=2F'"C<>]/#&M(MD1>OT%*2 MD\T7#NXBO^*[*!+%W*?\:GA(15GHZ3V_*:)8:O\=\%,>;,'1.BVCK)9MKNZS M=%%/-+MHZF%+JSS">OF`PY9\08I_Q(GX$&5BGJ;EC*_0#6=][5^3@C+HBP7: M=5U:^+"8M!%"]1!>W!,/I!#J\Z[>09TYO?DU/WYD,<[@?KX@E2E799^2BC_E MA^='Q]7\+GI4P@+V=0\-(HI)D)ET=0_L5RZHBO/K^K5L"G(8ZYB)M,U)E$)ZW<0]H5RD:-->SM,\ MXIK.OO8B@6$^`&:0FGW7?2`TH"^X?,F,5.#N`V$&S05M_HN*_VY[='*-MC<# M5(.B84:+9<(,N&(`S""[+7.4=IQM(#&[H].8JQ<%,0UK-!_`2VA63$C"S@NZ M$O6-^!%;ZU;[9;HXI>T.*75?3FOLITB*"=;V\5#"ANR39[%KN:?::E3#W7-1QPA>`00 M0I!C"')4T>RYI,%MM5XW4651)N2J\XQ^OOT46?#\TB:P%]Z#@'.\V[ND;1G=$=@"C9H`M=0'?RVF:`N<<8W?EJ MFR7*B`AT!\``.P(2[(+NA<]0)P,\?@O=LZ!^+.GJYT2W,GJIM6"'/KJKL@>@ M?:&RHT\4W<5IB1U=_8?H;DT[_+`9!8+N_.QU<(##G\9R<$``279*U]B"L1PB MAJR!N9#'&;O1@\1F^[QP%]$D^'RQ'@>H3"'(4 MZ,GKE:/@5Y+S\3-A4DI6'))81_QJ)#/*2G;V&&?\B_FBW5VQ-=#NJ-E/6&!Q M6`N)=%]*^B>R#-^,_Q*:<)N:29-/-'>RL.S M]]V%]G*W2LC6M'9/_EE4Y'SW"5VK3D:O";[4-?6^]C1\1=L@V&_0)X1(] MV7-W?DIS6J3E9J>=\CEX.8HP2Y2;3Z1<"A.-,'37@J.$#1XH\,5F3OQV?382 MF^*AOJJUE^>2SPR>/D1I)LRQ=Y0+"RN:U_>42'K))<_ZM)3`ZCB*>[A/+MPM M_V5+5]K.(\G/'-81_;JE![)%$,UGFM.71*FO-%BG\"Q1\IJO3:97,QS4!QD4 MC?Q@U-<'M#JT2K:0#O\\X@>)1P`AO*D,;RI5-'M^4_D[21=+KKE.'_AUN2"? M*V'1OYK7RNU55;(RRH65#:8=]QL,%WBV1_"6T-.4":])532;0W.)V!T\/$<= MP#\;GJ.&YZ@F(0?']QRU75;$YT<'EFA0V/;Q.F*.A0H27H]GY7SO0) MB4"W_SLPH9,?%ITDTP.XQDF"3LBQ`57F6D%WMO`W@.W-W\UD(GN M2K+U9J+&PPT$[*[L6@_`/;,??<2,L4]$*E3.02T"[KJ"0OB@B%&+=E9".M#= M"C!-!Q;HB$ZUT9*M@*ATYZ"[EV#3.(3S!MVD6P8)9!_4$>CD24].2S(ADZA) M3C+)GK.33!)2\A/K:77HW^[`QQKVD8XI';#7.);*;+[*`C,3[_BD&>>U[3U4 M"FU($C(;84)TB;)S`L2AZ>0-S&V4105T,B2-/<4'FJXH6*<1!QP=`800,Q5B MIE0T@V.F0F1,B(P)D3$A,J9+"F^`L(/.!06#9B("H7,V&2-Y&YV0R@@B? MP*'5Z'G]#YNLFWQ<'15HS2@.5&<0!;U26$RKDJXHGS;RZ<4RV']T+VMC(1_` MC*XWGZ)XR5>7_/O21NZ%PTN:+TI2K$[)?7G'OZX0:U5-_1.NU(;4C4=)O'\] M#E"2+I2APP;!_[()ZG]0_]VI__I+"YWK2'-949@0@=*HH9P-Q:PA,FA8FS^U M$.H65;"W!7O;\/8VIQC['37!GHCC+`4FN@>D*A_:0K.8,!&!<1\U&3R?(^XG M3`1C36A3OVL2-;FF-QU-.'T_X\#&8X=$EY$304%$I2!N`]]>/ER9BJ)WBWJ9 MG6R>FVRKP$R_1D6R+9%W]LAEF92)PZ`)CI*Q8*COC)IE!^%EV[^0ZR*-I]"TPC#8=/61)O!P[,\8:7X,1&X( M(`?=)8)R?B>J3.5`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`\I@?U3(4^AY^ M8-"\YJQR^4N:>:@>]7PE2FAM:>&53#[9->.6-..Z$6L4"CWMRFY>`:GO*4PR MRVM:-#>6OH.?>FE"$P>4'%,U]5LC3;UF%"W=D_U2[YDJPW*4;7V3?F)`^@D: MTK5WD:*E%[+77,$Y>Q0V)<+/[*8&+D">-^CI`Q9=DZ+<7&<1/P+SV@JV%J++ M9R+'H^_B'LB->)*4V+1O+7=SBF:&OUT8,NTEIAM:)P M;P7N\%SIE%!S0QBZ,$?S"6QU?*$+2%3C,M`2T44(=D'6JD2&@/\0\!\"_FU@ M['9#V%VQ(=)_V#@E@,L4G72FIGE_<9H[4=%-(QBLL7T/G7`#AMH?E#NYQF#^ MH/9,=&\1#"<.^3*$'9Q0SQVZTQ-`N*3:=Y\-Y^[`-,,'"=Q#MT*-(4)B^]"= MG&8H+<%S=V@:PM-ZVM$]L.H\?YUPN7L(988+'(6%;O]!=2*8'1O=/0@@O,WP M)`L"0'V_D.)+G_P?<=^#U'G:Z@71757?/W';OS"S2=KG'V*JRX7)U[Z!P&,@2 M,Y,S2C%'#S_ZTQ\?4J8R4Y3($!_*V@-FNJILBO%C,!@,!H,1?_R/YW6*'G%> M$)K]Z:LWW[[^"N$LI@G)EG_ZZM/'L_G'B^OKK_[CSW_\7V=G/^,,YU&)$_3P M@NY759;@_)*N,?JO\[MWZ`R]>?W3FS_?[B_0=Z_?_/[LS>NS[U^?G?WY MCRG)_O$3_\]#5&#$2&:%^.>?OEJ5Y>:G5Z^>GIZ^?7[(TV]IOGSUW>O7W[]J M6G]5-^>_3M3UT_>B[9L??_SQE?CMMFE!NAJR3M^\^J_W M[S[&*[R.SDA6E%$6\FEZ%SW@E&$67:QR MO.C^+LWSO<\XCA\YCC=_X#C^I:NW\F6#__150=:;%'_U:C326YP3FKS-+$/N M[M8)]H]EE)JAP7M,ICN0$STMP@ MP-G9IX]?_;DAC`1E)$FCSY+X__WCJQW8XZ',\V9*HCP>@%:W>!53MOENROUA M+7*Z-N$Q-6:08Q5E5[`NEY584;5OUA/D^^EPNK3VOSDF)`8 MU!D_P26H#7N&M@-#&:U5E';9`F9?0JP"/0JN M-1E'@>XIVN)`6R"H1H)J*/YM!<-)H",X^X78#[Y-A:E:!2=O`$QJK_\RMO4O M:_OVNE-;W92+1A^?M?Y&&*$%B2/V]RB.:<5.>]GR;$-3$A-<;/_2M57;Z`^R M@8^AZUH_;1&U`.WP-"B:/_WO[%;FC%J?"`>2G3%CY.SAK*C6ZRA_.:.+06AE M])#J2_K8_FU)/A2'MY7``3[4\.BB=UU(9--8%:/GMV^5V)DTO[;SKU&>,W2] M#O_.-D`;=:\OU]):$POKRN_F'M5BB2L-&I]M?ER%F7)&?YG13;BMP!M MJ=F75X95Z5PC"_6;R-\HQIX^(6Y]*V?^GN8/Y,#E>$1XI`/>L0 MF>O5U::,=J319TX\C`[W,<\TP.2YVE\PMW;RBA]U2?1`4D$>LKGH=&1U9^DC MZ'5;P36.%HS);2I:LS.XH^BSW)6X+L0?[!@;O7"J$$'M[\*JB':3\BJ<"X&@ M!C`YL1R8BT&!U&'P2%&\SR,>DWR;DQC?+)@V7]-,A.]\VM#L%[;4V2^[Y,_D M.XC0Z?3O6M*T@9AX]1V.#N"=KX$@@031!9)8Z@"TBJ%!TQIC4H<.=41O]0SS M#F_8;[G?%)4KC.*4%GS493WZ33-Z*F+6"CGP1XGQ6_\*Q6AQ43"_7>UB2_8# M1G=%TX1)I#B9L4,:8"_3Z`2Q(53@':L'F[QIE.]&LABZC/&;U,X<"-?`1R="I,A!FGGZH M^(T+-T`+CFYKAGY-\_HG54;*XANT;EB4,%7%#5AFS&X$U`!6JBME0WU,IKN0 M`,6M!#?`U^+5657@1<6?I[(#QEDB@Q<-PP)&T;`<&@#"XC<\H.MB;(M/PA/H M:G`3LK''3K5&E("%^8-8Y@6.OUW2QU<))MPH_X'_A2^T'UJV./O1W^8,3<(1 M7:71H2=*^7M#$3_JQ[D9W1!#G)I7>5/SC`XRPGL4`$0[ZG;F)PX@A+[K#`28 MGF[3GBAX*,`H;67GKA$BPEH]>;AM#"&\'=>-TQ-=O0D"7CA:VV+ASJ\+'DPN M;[F(8/RQ\PF4+U=U?X.Z/X:[-^UJ.X`\-/:AK$`_B`=/G/@6SU*\<7F>Q.-]=8OGG=3:7"X;]@J[Q??2,BUMY.:J02$`/ M0-DTH.3K&9,!),C#)*XP(S6 M:IXEE_@1IU0876^?N:\&]P9R&WP)7(T:%%ROP@8"8C8I:H%`-8JPT>`F4T!' M\-57J!3$SA[HPVFP5`C;>B]::GI6]=!T&,=+3<"2EAI[^U:]R6[8>X>L]0W< M2E'W[5H8)?%6*H*&?-B;8SU^4Q`3`Y_;Q`5)87YN4WUGZ]QVV+\OBW@0",0. M=C`Z@/6[?S05.&;RUK5`6RC3.)Q;-MK2+ZOB-]$_)I1QBV= MU7>U9X]16LD$9E%15.OZIQ"KQ"Y)V_%Q%J!YCJ3;(JX!"[P";HUV"[:%=7K6 MD66QT`G,LS[7D["]>I[1:7QAU^[R\8RMQ^H*]Y!-A]/#%A?\(9D=";MEC!X, M">UN!)2C_QC:`RQ%A%? M%KD>&HA9[FJ<$,]T`T69_0II#=15Z+29V-%Q//9BJL(-OXD8W9+K-S&SP'(:^EKVL+\+O\"/.*OW+6,5W MUJY@#_H/=_%Z`,3.=>OHT0&VLH8FRG5&XNU^525(O;>JO?P+99'E&JY+]+../=L^>9.JMK9J'1@X:]VK9'M&D M[M<`:8%J,.T@3='F,)U##2,#-#%^5>![DI%UM>X-'.EL`U2">WVYELB:6-B8 MCV[N42V66$C97W1E;^_4;\.MH:GYNWOUD8Z_4.3C#Z!Z--A+#7GF655$S\.J MHJL-5%6T^W*N*B2QP*JBDWM4BR4C546=AK1@HG>)V0EE33*4P*+-*; M=,X[Z%N(&M&EX2FI;"%RXN^0S%"#I<[J$T2.8+-!1['8<_0K?X;<'7]DU4YK>@YHK3$)J&`$T MB@'GARV8;G9Z]OOD-,8X*7@NU>NBJ'@Y[)O%;?.P2+[(R1+Y`\Q^*7ZB\A"- MZ@SJ2P(1=2["N$2;&AGB`H2**&5"O?]JBR,)XX\:-U/4+OL])39Z.,S4<161 M_)G0M&-LZZI(NXH21H.P]*<\03ZD!H_QJDN[8K^.-\OQP MHQ3_J5,3RR1MJ@=*+D@`M9=-*+[B46QBAH2NA.69\ZR6#UUI+<4?3?9TK826 MCC8>)VN'^IA?E132>AYF*S7FE3^K2&Y MXY4KZA);'6[L2S:2E!95CN_QJOW#KL@`%9UM.*X%OHV7UR9O(18Y7MJ8 MN:.Y\_9DAQM]YLB1@!Y&U3J3!^IKDD/'O<]E+=TF&Q,;4YVIZ=TNH9]B,8[K MS&:2LD&B0?.5#:*SEKK,`1]@65)RWS?]0QSDVJSR+,/ MK'HH2$*BG$EH[Z6*NB'4'W74H6M1:5,,&Z78PTRJSZ%I1'R01R;"MVD4"]/' M,,*C^V/+$1W[1'P9!7IH($:`JW$"-OW;O5"5!@P_1-1PD.9(/<>K*.1.(SZE MC\F6`HA_)>6*5CPY)HPOUSNE/5[ MBX[D^J!OK>^4+1KA=\H6&+O;QZA1.MDIISE41SNE]F"][Y1=2TQKIU2RV:4O M[:+*\[VH);4[;:@IP*.FZM+]C;J@NQ==%LRQ-LA7:L*LD3O/11H5Q?P#S1XI M#_^XJ-95&O$RS'6"7\*D<_>(0:3^5;_Z'-T99&\"$W4N=!P8FB,&[4QB0SMP MJ(4.;>$U>:+UG'EAF0%3]/>L@2BPRU^_!"B6.UY$J5U6>S\6)55<%O,L^8CS M1Q+CHC]GZE![^$&INU_G69!JPN(VKR$=.*OJ((^I,>/&OB3#W$=_\=W^\S6U MXM=I#WJ[U=.O\]L501M=?-=6SYQ\P(?\6GRFQLP[D3!U69[]9B&5Z;QB-G5. M?L.)0G/4PMC'UQ6-F+9 M]69[[/;(%>F->%#*$Q:^^?''?^O9&X<:@S9&5:?.=T6Q`TK*2*24Y+1#;HF# M[*5F/+,K&ZS!&VW9.&YL039VG?J7#4X;?IBU.!#88?4Z6]!\+14V+VO.S&Q^ MBB\I*E=8#NYHS`'.M,-2I%@"*HX&.9/>Y/6!IB_U;D_3<2?1O2X#'4(#IN7M MX^OQZ;.'6:/S0`G!E"+:XVGL:P?+]7313@'`G) M"[*[AI%AJWWG1YO]CSDWVL#A];QH`S#XG!B&6V'.AZV;TM"/FZTNEL/3H/TY M]:NNNJX%+LDC27"6%!]P>;.XCYX5JLCH6Z":T:+A_,YLKWCJ+D-9QN@,.WUY5IX9,(1<=$=\$C7S3ZJ MQ1//^3YP*'MK;%IK0 MH:M/YUD9!-&I[)7];*5&O'(9C_DV*TGY4H?ZW6&^69-LR3,O=":NT6D.B,OL MZ]9Y5>;YX4I:")&J*!U&0W&ZDF;WSGXXY7),/YRSQ+]$QXC2_`&;J5/;L6GRUI M<4D]$:M>A],4P#X?V8NXJZ5#SW3]>D2N(MZ-MQ1%G%BPO$1[#*-#7)A8B'/1 MFXM7>.6RI"F&W/M"PR4I5X'.`$C.=TNF'MAN*7VW09^#.)U0DQ#;T;/D=\W] MC)FFCU*>JRY9DXSPFF+\.=9;F:2O=P M;"+H*.[ZOOXORIO%SY0FQ4>:JF*.%*W`5_I[O;F_O"]*?FTO"").$72H'@L: MQH-W[R7WT?,Z6YH*4//%8^S?URE0L M!+N=`]>/'1"^'%MVT$*6;"@^`59Z`[4)NT:J"+P98H!1C5BF`]P+T--BER,] M87EQ4+`#HYU!['W7NI?\5I^I\9?C7DP^;4S_[!R>/&OI(`@CDSQYB,S7FG6JOHPE4L;6Z\F4,M6E"3)IQF`&&B:SUOM%![$JG=LTXU6'))';XFPWF1_ZV MUC;;V7LZL+NC=Q#RMBRT$8$6CK3 M]3Q+;G@9HGE1X+*H@P\5Z\3@2_#[^4$*[I_3"PC;&NWX__+!+C7M$BLJ)*.-Z MR[FB^0*3LN(I++-6%A.G]K(/3+[5MPWLD]?K-@;I5>&'F170(RNF0E.FWFG. MO0N$IZ(Y)U/>,+EPM%C+@5Q+)!HW?>$;G0W M&BL\]S["-[;4T&=!+["\W*MB(?JX\[1([<[B?)R;=9,C4^3O209:KB+!ZG0#+@.R%-L6)' M/?X'=^D]1JDPL\J+*,]?&.Y?HK12;3Y&WX*3U6C0\!*'SX,:1#0;WN&`):UQ M,B*P@E4.#D4E>L!+DHFB&SP=,#@IN-,Q&ZO"WA%C'KNB-U9GN7Q,EA4=Q>43 MJ1A0Z]-?<,%4Z'X`69]A[(B4[SH"/9`F7U*@![O7Z@)6>1CF3K,>P@S)01Q7 MICNMP@,Z"\U�+MF?>K"^]P&I4<:5Z^B#SA/"1^^X*SX"\[6S\6%>S;GRC4 MGJ5>@1IN)'5?RFPD3(C>\LX9@(JJ"2)!$;7@S)K'UO4SU#92],2@HKU/@Z@A M6X)/'A"((I!V M-$1[*CK3<%@A-*ESS@<^XG$WJY-H"LS9SC](/J-F)%C1'&@1/T?K38IGK-6;O_[^_9OO+W_' M0&P89G'GQAC)_TES3G+!X'"'-LTP>L%1SGK@N7'7#.F*D>*7=N6*L*8X0TGT M4GSKOU;WA&2H;0I,#5M8WWK!9"?FEZ&7^!&G5!0>Z$]XJO4-V"_>T[<_KWZBT."N*C7]6PE\!C M(,E1;UN@*NCLTWG\4IV%11(/DU^HGYG4B$.G%;6BC@)4;9[?.0IJ&8$D4,P+ M`/&IA,0`AA8B8L;+#(R^SK%V:)QHE,R8E6LQB&:T,(ST%_=/@WQ&$[I`>#>J M8H-CLB`RV6F4M7\5-3`#>"R&E@(U8>J$3O(#YKO1MRY.]K[,^SO%`3B,H6_& M=MTSXV0.`B-NV5I^;C?YO(;H!(H3.,)S*I$`1\!#W/5;X![PG4S[7D8\`"S$ MNT#YUR"/*BWP(G!D0VL$IYEY;%#'6`Q+&)CN*;R4E!$3UUF<\WKJEUC^J5#L MD"ZLOIOL)N5+'9M@LO?*T-:8@040ODYJBM^P0X'\&S\=Q+`GI5Z?'`X(YN#+ M0QW.GY8KMZ60]D-?WSCRV`X3#.2850,[%?^K>@0AW*PV^3DR!"F+T3% M7O3]ZQGBB^DDO:8:J\>B$D;FEK7#>8Z3C[QNR%]HRAVS M4NO>\2V%_>:*YO*#HN7?:GO2+'0'\:6.(.O%WSH"G[$STRLO0-69M_C0%B`2 M"&>HQE@':J,&I8C\.A6>P)W`JWKT\H2-\O;HXQ;;-ENVB1(_J*3H`2.HBYU)!C(SU"V\+#[[A__8Z1:GSN\_(.9_@I2J7QT.7_,?X8XNW1)N+% MMZ.-QMAKX7"&."#4(.)^WAH3FMYPX2Z9:$VK3#PBS&5ZEWJX M)>4A>;L2Y*GX*5_LX@FB_."*,5^0=-QTG):;1;U3JT*0 M/=S-F2()?VFGB_A4_#:`H06^YG,W`^/N_[[\QQ1C%JZ;^T*8+%@U&]_A;%FN M;A;U1B$Q#AN,O9^--Q4[NP]@)';B&&DO61J;#<-00N$V4V,13FF$<%LPE>,B M&7I:D7C5RC7!!\^ZY)5AXZ@V]U"$XOJE[(&9&-P,[%]FW0:@!O?]FGX?<,DC MQ&YS^D@2G)R_?"JX8_M:9)9@J.=Q21Y)27#!]1[)*O:S>DA,72JL.#N=`@VR M<<1]V5;C4$+,)-]\`<9FBMC+KZM"W$U]@S8U7'ZM11JH*-IB#6+L6))OZF9R M3N3:Z9(4,?<*\)S-[Z/\'[@4[MR;Q8*=A[,E3VYG^Z[)@*3O"R8-:)._5=(8 M@]>K)"<\#7-MWPQ%)GN7@T%B-#/4C`<-,WAJETPF"]+&S9*Q1)R(+MTOH3%_ MC$C*C[!7-!>)0FWK44UROG7H`*S)Z\\!_%YUIW5>AM&;A^5XT'8D(KY3@Z]3 M4YFZ:\^&NC02@DF<6Z](%F7QGL%L=D;MZ<#N>;2#4."S9PJ;LD\?A\^,@TT_$OKG%;'*S,EHR4ZV5[TA$L+^/GLFZ.LPWY).D;SM' M`]KD;1V-,7BU=YSP-(S-LQL*MWO:.=G$:)`6>Z=F]I@L1QNFC[$\^-6D-=2" MV6801PAFKRYH88>YG&#!0X& M3YJT'6FFU]J^(JG+0B<7M<8-XP>_7R0O`I\9 M6B,XZ42K:HWKIJ1W^$2KPGO#$RLQ`9)UZ52;F;(A=#`' MEV%K$_\=TAF$JQ6G%@NJSRO//G9^FQB!]3^M@U/H'Z MV'NZ=E_,(*:/.'_AKNB'B-`@3-:/%7PIAFE_1DL+]'I,]#\4"]7X>^!"U:;C M>J'NDLBA%I09DC#0Y_I/C@<)0&&RQ9C/"QW-;,\6.UYR7'?-RTH3J37Z%FK7 MZ]!P+:TU"+1%,3E!-9L*.HJ_?@7TGH<2#TEB=R.@R.UWYLMDV:<*L4O&X@88 M'Q]HB0LD"(<)-%%,/-7CRHE<%&PWDGE15&OI]KDCQ3^N6=@W>0 MIG1]7R3HXG-^[F4TT8(1%6FK3LM5:3S'-ER7L(GS[=9IYS^73UMX7!I612P, M?P!VZ:@Z]A8TJ40`"IFT.!Y(P.1A&83ZR9?.@)SYJP9%AYKSS[.O*LIYVB-> M.4I`TCM":'X%]4OU]^YZ^33DN?]%2MGDS@VZ_*=`IH;7V?.J7-&<_&:DMX\_ MLJB[=YV'U-\[%+9T^)AQ6=3CN@/SJ,L[Q&E`GZMX><(G%EX-.BYQ\@M-63]P1*:C;')+;L:=;YRGD"XHD;=0FCCY+\@.&D^NQP#(5>BPP!)#'7DB)HR-*0Y>!OE-[G(YI^(5=S8KUIFX=#'5LQ# M%9$P9J(*S7AST=XX;9B-#`T/T)=XZCO)[8%M`B;DH.@I34D]/OM=DY M^RLI5]=90AY)4D6IJ$W-MUZ11P8G)H920SJO'.D`ZC'.D0FZN!.IQ`O]I'6=^T[47]M*&9 MLO"RA9Z`V@5`T9@)XB&&470>NBOF2+XWC=N' MN5P"X[4%"Y$VBTIL*,H2]%2C,W8M^V("S.LL\X-!F1'`"3U2BJG%6?%\4%T1 MO'C[C..J)(\\\3R)<=YYZ6/P!?3@J>[9]>H5I-&6-JJ):U[]N#H_:7":`M@7 M0,+JQ+]1JBUA_5^,D;#NGOU(V);VA"1L@-.'$J;#OBE$CQS&MWS*$IRW-/`M MFYYBKW+['3_D?-IL<"[^]HZLB5FI"KLDK<:+V($6-G..G3'82Y42BJ<6LZ9T M!+.AB@^C3O$J!X+$2'B.13D66>D'B3',D!B/_`?2X+#7(!_+*W(PNL>%2(P\ MZOV,,YQ'*;,WY\F:9*0H>4ZS1YGS]NUSG%;;1-)'P^$>G*PXC%RPW2WD$&B! MO&ME]O._1NO-O\_9`8A!FB'<@)(GGXZCHO$A,`@38"?"&JHXYT5[8"5_#MG3 M=7C$$G*`XZ%-8:>N)L^OT76''W%6*)"^%<9K:QE6O%WRJ\LOLMH]1[R848+AJV7&:-&9O%IAO;0/+[- MZ)*I@<<92G:>\/GZ'7WR?;Y6D)S"^?H`VDF>KP_&$/Q\/9JG$SM?B_%\6>=K MU8IT=;[N%0E'5ZD%9EVNF'E_R4RCE&[XFYO7IEUTIG!9ZO2:U,Z@ M[5Z.SMCH)2XQYF2';$(7HKU2.70-.LQUWU&ZZS73*2:G!9U/P'&WZJ[]!=BJ M,<`B:6V."10RRP%(G]*L29Q.6[G40]?)T!(H"N'HR'UM_T!RCC.\(/S:;Q=E M>X4C7BJC:U,S_ABRHVD3<;UZS-`8;V(NQOFC'&>&EWR_A9ZZ:U?M%A';SQI( M:#&AT8[:KXV&&V"K-E]K=!RK_6[2U]EM3F-<%-WV@\P*H]BMC;X%;MM:-)P_ M76=G2(D"W;6-R!:0R:4$,IL<.HKC(1W1=SC!,B)>'$B-GH,/?&O%*:V@$<8U MK0`SWD%M;90VW-0[,+6K9TKOP(=D3NFTUF*Q$V^+ZBY5W]\RU(,]CXN*DA+O1%#/+-A74WVQFXY$G^I#,B8C+=I<$WV^YOT6._[)5J.8Z9!>N.? MNQN!7YNU.W.M9!IJ8<.:%0RD>EP)FCNHWC-E!H/B9K']]?9IV#5_CLF?HVH9 MD)`.[>08,B`<*.^0`4(+N8B<\L-*?J+&!JW3B12\O-:NU18F?P^MQ18_68L@ M`J[.9`2>I=#U#WF%A$M2Q"GE)6`&*ZJ8?F^M6J*"CI<;QX/*@XAC03LPZ'-H MEXCYM/16*]3BM>"TS!IO?W-L>M4Q>J)\WV!%-,UOH^>]2I%##4'7Q-U=^O^9HC3 M18SP!"^`!CA-3=D7V):9/Q/5J;RWK2V[A/?I6IX$47XRW)%%GSGAB1@>>WSM M,R^.F>7;\4-CC)/BBHWG8\2QL9]L<%Z^\"#6*Y*)<-SBHY*] M_-`/+ZC=KAZ63!`]:QQ=K:$A,394LL'5KT^*&=J.C_MV=29@:H>?$:O;QC%H MK`!]*5K\`P\<+-@P/U0]]YO>Z4].@Q_@/'W]?3"@:6GOT=S>B"7[L8SRTDR# MWT`>&IPH>]YFAF'D(.:MIW>J?6[ZN_OW)=.[D_H\,+1V]CX!+I[]SUTNGD2[Y$*>4<9N40PHB:IJOHS\\SO`["YF_0K*"'!&4)PMRCN26-P@T` M%G)\O\(HJ7+IJF`C*;8CV40OB"S8?KG]_WQ3.M\.I;7D_:\RL%]L6Y7Q7+V MM]F*>OK??',RUM/9;7D];6<8@Q@P_><0BUUQO^HD1/5G5H;T4G;^\4*9&K),?@QF9PH+06.Q[RUI'KO4%(*D_$>M>Q\WU\1`\K[-%D.8DS=; M#,?CU6QQSNLP9LNA8<)5Z:YV+14_GK6S8<^0#O.G9KA`%[0-PV64Y/C5UTT] M08;RCBQ7I48Z2YU/@'JQKVM?NJP/`T3_V!T30&*) M%&X?/-O,E\M<)%J\SLJ<9`6)Q9NI;71&GP$4%)#OPN^C@7LUDH*,$&PVG\]>D@Q.D-1`PF1!A-ZY*#"V3QAU_"A%30!03B1<^S@J%L[UZ^8[V7, M1.07Q$M\A_DC=?;S"\H8$L5E%:7W.%^KW@=.$N/D'/F`L4S^V.QBT-.Z$O`R M:X!]HQV`?(:>:F@HDMA0WH#C:9X;=")6Y;1.STXUA)>[@=$"Y#G4.4E(*0)( M;R.27&<7T8:44:K0_`.MH<'-W;TZ#\W,9"B6E,-$`0_PEAHRS/,+ M<;E&BGLZC]D2R;'Q`W'C#J#OP[4)>4OUIXT(E-K/Q7A'E61@/U\QO'NRJI%FR2[.DK*CF-G"O.>?H`!0`:]EPZ6M.I`^VC_^T#FN MYP^%)I*8^8FYO+NINCGFN]YI&17&SJ`,0;G(1 M?M";:%KC"VBU5W7/KH5*D.:>@IHXHKF,)0F;0UJ'UQ3`P`G(6$]BT,'V-N7+ M1X+0'ND*ER9TF,M#DA4Z7>AQGH"!W7#X`Z!DJ3MV+EJ2'&HA"+,9:O"6FC/L M2XF*V`9]'%S6B0>9E^R4MLT:[CT8PAS:Y&(@](=P^J$/^F.=5L2#RSFRY.H[ M"G?`,HH.HXVH2,HSLB4T3:.\0(RDS,XVU`C.# MG\`KRBB[=BTWC(3-(#FK(P'<=$*'XZX2SK#04`C_7*I)N4;O\%*4B6?$H_6A MT3O4#*`PN[IS+?VUOMP119RJ=\79RTFJRQ[W(G&!^<."]#I+\/-_XL-,/X/M MP$)QT)\GJ:BI(D$6,;J!Y$+%3:K-(L^W,[@H,'Z'HX)DRY8Q6=PPW<8LS&S) M?X>+.YSA)_E$175M`^\)>I]C3M'7814`#;*%>^$`X!@H<:$:6#LO3,%SO]38 MD`0W0S4\-,P&5]=B(V276IP.][M"9]"(ZM?@/M3@:@':5U'FDRDZ5ZHW&D?H< M%AIJS#O/P4]TO2:E@,%.%:@?0^\BV]TQT[EA*.U#Z=B7M M\U#'F=3!&._USZIUE?*GO9=XD^.8B(L']O<4U_E?YVN:E^0W\7/3I]ZVNX?7 M5+,"PV/U-2MX@77:?/-JS!-S?BI#T0XS2EJ@0]5XLROSU/7D^+;&Q&5ES`%> MZS7C MYJ/TSO0)UO`'8.>EJF/WM\\U941:I`/YW0:Y2\U9YEE9R7P[`EPB'Q_V:JJ! MYE`UI>C6ESVBH@^Q+^R-!13!)(A+WW12O\/EY:X&!^-*\0X)##7EG(>[1W9$ MIIEX2REBDGH2>IM]!+^5[.G-ZHLR.,6X]\O>KO' MWI$$W4^/00S.G:$-VOTCRTXS5L44OY+[/HI7),/YBZYC>/@#H%RK.W9?XHMN M`D<=:G"5FK-J9/'UCU&*"Z%QBX(=X.^B\C"F<*@9I/1Z1W>N!4!%U[ANN17L MD%I,G"[:$4;AT,.*K@,&8'DE#HHRU>72R%5WLUB0F(G`WON.98Z%HT.U!K4_ M@JS(PT*,]R7)*\KD.',[P@I:3/\PSG]2&(L8'FK*6\$\IH=B80O30M MOT57K"TCM.9OU9A9R7LG65(59<[_R2%$&>'QB_A98.5'K!>4,,IQ*4];CSA? MX2B1M'A)7C:NHAF:*,<;,[B<`TM*DP(5-$V^]:_\]'4(A4F97\OV;93SS/K% M+,X:3E])IGB7B!WOK1+FZRSC,V%&KKA@@\=LPB&.>JOT:+:K@S5`-N M^TUE.0H!NOWC5B3O##5)[8*']#H2!NIGAD>:+!>?[N;#%HNZ%<1@.>[-^3T6 MHVC!7+$!W(6ULC>\`,9*CWA03=:%-55Z\M3V-;5DIGC)&=)II(1+3-O+UAX# M!9Y-1*$`SZN"9+@H>`0KCSJLTC+*2K4JU&D/48I]_;H6CH:VJ"6%=M0U-:4+ ME:+%9FK,NY'"\O:!E$ETCK-XM8[R?ZBEI+>71^?7\Y1UNJ\)W3 M$GS8YED/XVF%,T1*5.#\D3M;V?^X>[<>&LEXD#_-$YZ"##V1I-2D0@+ M18US,L#NVB]+5)_#8S7E_/JB1R\>_1:D!;>].-=YC%)(_7;,+CK`@['.R6VA MS[\PGA0][LF^AB`'95>'SL^INXJL@NH()Z4=^,!KL.P%K03^Z($^8F'N-W=B M=('>_"&$;[)70*@^V_P:_9<5OJ=W\L+N-LK;:>FSY`,;L_R'XAQ@^#7P:*!) MQ5?\GB8<2&R?LY$";M(9%GZ4KM&@&DZ0]M"4QYW]>D\2K"F%?*XW<],:L0ASR)3X_B4%1L_%TF![J.BH M^O4E/C/4(AWV?FF8Q]28<7ZEZE.6XY@N,_(;3NZCYW,9Y5-<9S%=8_:#6X8Y MK3WSUQG;4G!1UFY[A=Q9Z!$HF2,H^[(C1D"$V!9>.0*P-]KX$,.#&H0S)#&* M'VY1BLNT!B?2XHNCA6]#R*F#>?)\12U>1E[T'A9D.-M49(U/QI\*O"B2M^1!5MA#ZDR M*YFEWB#^(CA5UXNC0383-R4R2G>+#FWA(8D/<8#HLX"(M*,<`C,$YJ9B5*LT MRE&R2]5&%\)9A;=,J2134LX4]LO-EI>;+2^W;ZFX.YY_G?%;;QXLG255+"*= M'^J[G@!^+PNK@5J>40O1'_/DD10T?SFG49[TAX#T-(7&@71TZ248I*&+!.%Q M(2%6QN`L+F1_I(&B0_HDAYJP?!N`K.6UF3B*_5@RHX]6_P M+2]6U+6T)@,*].HR-'@_;SQ#C]+\369HQ%Y.TBTL7FI[GBIK@58=VT,:GIXU M/)6LC(K&P'N(4A$R4:PP+E'";!<4E>AI1>(56O+J)1@7*(YX>`4;?BZO,&6> M&L3^SX,Q$O&BCQ1%)7IB>QD6G&)6X)95];.[DC$+4,_V M@M+?YNQE.+"M8J*<'KG=:J<;.S&VP+?*;%M8@3\'ES66ZYVL?G>^D4-I[VO- M\V^^A\G]Z6NV%U89*;]I]KF9?/K]&*4D$7L;*:2[A+_*;>]T?9MRJ*W.KS*D M@07,)LJ-\8KF\[+$XIS]GMD3/(]&YVWA<'/0=:"Z6R]+L(>^^4V>S;$`EF=- M7TCT%@&:QG#@AG<<%2ON#%JD](EOF/'V#9C,%<56-V/@U$W')_%UG-$S#'ED3EMP\7&I--)<=L3)3/$*M^QZ\Q^ MO2Z*"B>75-HE)#4 MJ<)9(Z$@B05),#,DX,P0`X1TANHLZ-]$ZN@H)D]B+1X_3\H*4>*:Z(E6B-[PD>_GLV1F)'\J=W[1=X_S0KZ9L"'4]'G7H MS>-X1!GD:+2`'_+JD9%%.[HS-(S?E5]1+1%4GTU^Q5T9P3F4>T[_0^!R&"80 M-DS:-"#:D=`9S(-.H=U)5&P&7WO5MUL_\WB=XCJ3FTM?-0^'E*`6EWU$WLPS M^]!!MMP4.`@Q_%J9W?=SX>^@HX<7U&[7.$(%_AFZ:6[:Y1CX\X/&=`Q7NL_E M&J,>I_VT=.`5S1=8%AIHQN1(!_90"J0#.Q"=B@[L@!Y"!UKA8&`=V!K#3A&> MI`;L6V$6->#@I'M^GYS\O2IDK4.>$(;SF:3X`R[EPVI>W>&>7D3%BAFSCR3! MR?G+)S:PZ^R&F;81OUN:QR5YE)F)^^.)7)*"OI9V`,E]LK(M9GY_F3>H489+ ME/)J'.RG_._BIK,J9/$7V@!&T1;Q3V$>/+L4`^IS;OVN5`8[Y\66+['\LP6T MKL4\L/[,.P"N*GU"SI]OKKA6YCM3&%D'L)R.YZ/__-CXH%L"R9K_D:_VTO^.SHGD;_4_!5UC`)?Y=;PUA@UUTNQ@BZ`-L!F:$M%'%= MH3](9W=B!L)&QW`W6.0@0_6Q54-0/KT9CB/L_6Q\5&%G]P%B##MQC(PXM#0V M`&T9#A M,\G`H%N:DO@%'!ZD^-QVD-`!F:"A0NR'`@WZ7/\96O<:3XY.Y%`OQ_W*[AWF M&>1PTE3+9GM$M:Y$18%+O"`Q4;EK]#\$RNLP`>=W-#N*J"891`8-6$WA_)N( MSCQ_.2P.J*O'CK^TK2EW%`(K20XC9'$)DSG048@JQOJ5R>V]S#M^3U-<5?Q^ M_[TLO53'`!27%;[.KMBT_15'N4I$X1T!)=:ARH=LI5,7#W`' MB4_B8>X@2NL/=AWPQ=%#WAU2[JYO846Z[`GQQ%=?Z'6?_AK.V"2/4/T99&"= MN#TZ>G*^XK<4I[?FM]#&U6>O] M"5W]\N^*C9<=@=F:JMBRJM<7S8ISO*`Y;NH'OWWF#WRW_Y2?;RL.X^+M,QL2 MS1,VUOSEF@V]^,"8R[IEC&;@E\V'Q0?<\R@O."3X,[]@T'WMN"''"-FZ3VM. M`#9`7?/\:S[$;Q!76V@W2K0;)GH0X]R50J]'.MO]1';5+J/.38J]$2,QY!G: M'_2V"Y$D,$QDSR3T!IT&GLE>AHA?[A>#P".7%QZ=!*Q7K)]U5;I_#'0):2)N.E$P*@Y[7WX+4KY3)Z4\;@!?3'5'SO-.U`E^ M@`L"C!+PA)-#?11KK#0C4^@8H:KU].\\')8G+^P/4(A\V M+E"/WQ3$1+_2QO2^G62!\(Z`QP/6;*B M<3_=,:4O-'_"#J,QSV6T5!WKS#NP4N*BCU"8TA=]B,:7Q+`[7ANE,K8.9PYI M)NOR)DAWS%[*:&A)H[*\AC[+/6]&K>QV_7&C/2VAV\EQCY[3$AKE(W0X"'`U MZ]MF)%JQJJZVNA[)H`:<\NW]P`O,4,A,0Y>$;[!94DA7J=(AHO$-V$?2T[<_ M5V,/")A/Q>JH0.[%&H',CH6V&)K'#X'\+SJ21$&,]+N.?L5DN6+[V?R1V:1+ M_*'BYZN;A0!V4Y5%&8DJN^=10>)YEER2M"J5-WSC.@.N/!A1UTM2D!,^\9H@ M^IIDJ!#S_4T0F1TY.=0NQT,>;:ZB&,]%67NM@\QQ#EK=`B,\F2AXMPD7*C7F3"Q5>I>\RN[;M2F=_<)COY9D3I8 ME2YV-YNH7.6T6JY07'M:4PYP2D[5(_X/NU6[F>JY3HO,P/@Q2J/\N!+Z@7#T M-X;62NGLU)=V[J8.TIMN(J%1O M5Q-PD/.N*]>ROG44;ABQ0%&E'8RC.MSP;+$V1\3]DZ/*8.UO#;57NWMUGU6G M.?(7XLB?-##"F'8#K*6&_/*\J68E2?CYBSRVLB"\?8[3*L&)#&1>;ZI2*.J; M19,/\1;GXC37>TJRVC=TR[:!P=L.;P,LR"`(PR6(_=!"VLI=@AJLS7N(+5IN MFS=X^8V3]`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`0B_0-=NUX`DGQ+5O@-3%$C,%X%U@<#6PB] M@YH%6PZZ4D0AW!RY*.YP@=G'*WY#A1]Q2C)P,5SGGJQG:&Q M/@UU+1MKG4(6UFCBKI?>W;]&Z\V_7Z*8BI2ZN`$E(USK')?Z,?/38`%LP39` MQ4)-=E`E;]#7![Q!Q[QA[!.(OPFPKNV).74S<2-UPS9R^2*-BN*B,X?6<$/( M&N[LT%^HN:"*+C2S9+G##UM4NW'$8APQ6@OZ`59(OV!0?6Z%=$+((QB)Z[3# M6KX'Q3=67`X'?8?Q-!R`&.]@&#TJ&WZ%!@32&I879X)*DI0^A%Y&^EU'=VP/ MRRI\AV.ZS,3KV5N:DOCE'C^7YZGZ!9/V=\#U--B_$ZB:09^N'W3G2U\?TH6HZ/'8 M`5I9$I46_T_H?W_[^@W:1#EZY`!FZ(?7KV>OY?_K#"HHJLH5SL9XI(B@T]Q7/_TC?CI#S^A'WX_^S^__V'V M^H+=+`2J^3-1 MUT>[GEV<]WL)R2=<1R52: M7-D0JLN/.O0M-Y)JH+S-:G92?1X%V_-E?C59465XZ^]J/=X":/<:P!!HDQ]I M#XP;R4BS8':PSX=.IS8D-]V[LIJ%GC=GPFSU!8EY91,9_,V;(5=S\'LA1T$*S;#F!'![8:/ MTFZ0$)#ND'S9"QWRTVZ)E"M2GQY7 M-$W8/O([$2A6OB"R.,#!J+7^5;"AIB_<=URNV.\V3:8I_B]Q_LR[*)5XO:$Y M+ZJ]H\([7QO<3RS^NL M><=VAV/,=!*;2<569/(I_/78(`F/3\D&L0#?E3D8(\#@:X"@KQLHW_""T-MG MF),:YOY;NGM0DETYK%QS6.X>U.FO(CJ&G\$.A[=1?I/+BD_B0JU)\3)\2!SZ M"$+=LDI9=A0?W-PM%!WM[Z6EHH^9#U9&,N8U]\[\MS2S=H5W`+%.`U( M##5E7I.[L57PENHQS'?*LJ=6]$]. M,_;76(26US?%>G$#T&[`ZIO4[SBI MGV'.GZ)<6@TWX@*XX':",!WF15')2^'"<+.V263T]FX#C$^#0#JW94*)&C$2 MD&?U4XL:M315I0';`CX]6\*J-'1:'_:G./SR;.?0J#,AOH"7H7YG%I?;,-%0 MRZJ-;(8:;%->.083.+!"3&=E6BNAO::MK@K]CAVMD&$`TU@M!WO0J2T>@WDV M6$BFDQD0#1>XIH/. M3HR793Z,COJJ\339SPJ9Z8!C0;%,V(\BC>%[BP4S$M[>Z##SF?`=LY+R.;V- M&I3GD6UBF,2YS%?!S:T3[*)#6C#E2";I+A0*Y M&2@'USN2X6OVU\'D6T<-QV;=VG;HW,G24$2?.4TDB`;.MW7,S:Y$6PH63>,0 M<_[2_DU/_C;S#BP?88X)^3W!!$SP!N"]QA%EB*'A!+0W!9RZH06!\Y,"[D"P M0F:`Z^&F0H3"9X`;V)$'L@@9?NW&:O:57^AGI6$9I@">*?/U[;`II!WZ!:]( MG.*B,WE%?R.@F.UWYEJ:&FJ:>2H,Y-=+^8WQO M6Z!\=/;IZ\C>21QRH+4TBE&>+(&AF"&.(>@1ME],J!'7/._;O-;5;4[5E9X[ M6D#WWUU/WCQ4.Y(@K\T8Q`#/DZ"'WD?YD@S4HW)E"W1,-M7@A^]L$5E!T^91 MB%XF-(U/P/DAU%T[SWO6ICVYR&0MIE,()_U7*M*_61YH/:(Z48`;8_&B9TIW MPT/32[5+"EX27`<_8G^P$1!ZJ=NJV>F*AGT.RZ1F0<2U0 MIGB,T^XY'2O`7)4QAA+0?A'M&6I`H>F.&)9]\$,ERKS0Q4$*^42.GV??VPB0 M/&<8#SLL%M(#RC_9Y1I,&OXDK3$$2-@'6:9T[.SX?G).:"ZAW>&X3K08R\CJ MY.]547(AN,1%G)--AS8;VPWX";H9.?=>Y'T0DS/)P/-#;3'=L^E6+[,FC]!\ MS1^Y#>24T_L(:LCU=N[K8-R/`E1HTO*XQB<V!2ZE MSCY=KQU)%&VIAKVJ[V*5Y^AS_I"#R3%M;E.NLYBN!Z):]3Z"QJ7W=NY: MK@1U=AKE),-$1NOQEL(8YOE6B0GW.UH4-]G'B#\TO,TYQO+EEK&\Y$MATU/C MW>QCZ%V4%A%OUU1::$`W6+;'.?I1'4>$:,9=.AM:D,;ILR#/O)2P>%DV0QD. M4Q7>4/;H.$8'BDP^V(L*G0K!?=^,C5?NZMNW&5%,HEAP+Y>[XIB'63?R?F-> ME71-'TB*U=5_5&T@-Q6'?;F6@QV],`%4_0RD6ESQ78]L0WA@`X]DN7E(R5(X M_HK!L[WV=^`Z9`/]>RO2,`0$5*+!_N@@!1HD"AEXA5HX9DAW>*Y"#;2EBX*9 M.E*57M#-R_LH7I&L1YU2+)594N9"X>YRO MU?K[J`E<:6^[\JBIMS2!"FT$9K!.;E3R,&QW>NMXVJD.7T9*Y3F-\D1*N]J4 M5#:"2.919ZYE4Q!$DA:\!J\%V+!-M@9>5YIEGY/RY7<%>A"C8C]-2(YCQOXB M0#2;6C"H'MM\1_MOR^?U[K'*=N"X_H/^W)^>=N4/PVZX:E9VES4,+R3;T)]/ M&2F+5O%KE4$VU'YL39S#?GUYGY0`1E6]&3^:4>%<@OP,:8_&6?#DD-!T5;'I MY]U(2^`VIQ_PW>AM@24C2"6P%%GSH\@.46"(F(D`WJ5U%RD>JSQ?-V' M6JG8WFCOVM2V;L]0J1K_'4O;ACQL,T/B2'X`S`'&QE:-K+73S;9C1% M?#'MIS5^8FC17FZG&3H9)L%<#YP66M!\E[8\QS%=9N0WQ@+V796*Y!F"5V6; M5U_CYSBM$O%`K_WS>#KC5Z^=ATIU]GI1R$TWK\\\P/R6&B[*%L040NCW$)V*%$- MNUNBA(9"+VM9(`!JK72.6PR"! MBBH,R0@U9%=($_3\E5I@G8R:Z0)6@=V\0R)=7#7 MIRS!^3;KHXBHZ#(UC3Z$F)1:!+R8CEI(C&TA1^,#*-8F*%$D]FSJ!E<<##K( M_CF500*C1+K&^?^Q+'^RI]AK>EI"7S@?]^C+XNH@ M/:IVU9@1`!*CQS_*R3)QJ3/=(D^]`S_R0^H`,=X[W(P.-`277BTE".1-8T`X,DFC0`W^9 MS/#4#K>`Z3X@LT,ML'PR4KP#^2%:X]Z\=[$MS%[6P$CW;DV>.*FPN/.A4 MZ8GV,/]]WUJT\CO-LV2;XDF_4`2D"_`=ASXI#_'\`LL,"32B#MX6SZ1J38`F MB-K@NE]9?DPQ<(>:6Q0Y'Z9K+5%R#P]GF`YR=4"8ADW.]K!8 M#_]@/VQ^Q/[S$!68_>3_`5!+`P04````"`"&/61'YHZ[E,,\```9(P4`%0`< M`'1O=F,M,C`Q-3`Y,S!?<')E+GAM;%54"0`#F_TY5IO].59U>`L``00E#@`` M!#D!``#M?5MSXS:V[ONI.O^A3^]GIB])9M)3D]DERW;&M=TME^U.]CQ-T20D M,:$(#4&ZK?SZ`Y"ZT!(!+/`&$,++I,<"R+4^XK+NZ^___;**WSRCE$0X^?GM MA^_>OWV#D@"'4;+X^>W7!V_R,+VY>?O?__C[__.\7U""4C]#X9NGS9O'99Z$ M*+W$*_3F?R_N;]]X;SZ\_]N'O]Q]?O/U\?_P]CI(_ M_L;^Y\DGZ`U]94**__OSVV66K?_V[MVW;]^^>WE*X^]PNGCW\?W[[]_M1K_= M#F>_AME^0G7PC^_*'_=#3Q[][?MB[(=/GSZ]*W[=#R51W4#ZT`_O_O?S[4.P M1"O?BQ*2^4G`:"'1WTCQQUL<^%D!FI2%-]P1[/]YNV$>^Y/WX:/W_8?O7DCX M]A__]_^\>5-"E^(8W:/Y&_;?K_+N'L/?_E\HS MLLT:_?R61*MUC-Z^JU"^3A&ACRB@NJ5_V(YG1';+14D!>LD0799;\'9$Q#B0 M\,K^\N\O]"7D$5]'"?W8D1\_[%Y/)D\D2_T@V[TL]I]07#Y'859)8LP6#DZW M*/%(K"[SN4^>BC63$V_A^^L"I7I,DG&5+E%;^=!F1(,8D3]$T3U/*QR,%]8+2]\<1]_V^9'BP M#C3MB>%\=X49(V?#^ZB/D8<`)7X:X:\)6:,@FD-'R4<-J3C-;"P.POH MT8=NZ#\)CW;N0(U$[P"=O$12NNO&:B3]D9U$,II?#1(16[W$)FGP!J=4\OGY M+965Z"]S1`^P\+9\!_>F+^ZS@A#ZPD):^1O;W>B3(0[R MXA]^$GKTOU&VH?KQ'*>KXD5PI1+XH+XU2R4R8.IE598A]/4+_/PN1!$CX0?V M#X;(#Q7IA?[IWQ-*0\CHN([]Q9'@POV]J8`%)6J[X*[I"O3C?R$_O4K"2PI< M#7VRH7V3>KG]C"4!=XA>5>$U_=NQX`H:.RRQ#"T8J2/D?M*FA33AN("+Q:H63AXS>)P]+>M^1 M69XQ:R>S`/,I!DP:B/SRW+E':YQF].U,4JG=29#APY!\'<4HG=(-LL`I?U'4 MCAJ&P'NTB)@,DV1?_%7=EA(-&X;$7W%,Y2@_+6'B?V_.N&&(_`W%\?\D^%OR M@'R"$Q3>$)*CE$NL9+P*T1P+]^XLI&)F^&06<8=(;!,2BM M\"WM3(+.).A,@N,Q"6I"HM8:"!,0K5L5$BR$.AX8C(]C!P-F)@+C\?W8\9#J M>F`H?K`#"HB"#L;D1SLP$2JQ8##^8@<8("49#,I?[0`%;H\#(_/3V)'AVWW! M&'RR!0.!71XNB(U>*@4Y4^!XC%XR!?K!X(B,7CP5>%D'M M_613.*:??!(1#\^]ZEOAOO8F3QTDI+L132[(V\4M&QRW/$L7?A+]62S<*4X( MCJ.P/"J3\*ZRJ&?SFN54PQ.'^[Y>X_PYSI_C_#ECL,>Z0&_GU7%>'7N].B[0 MVYQUHACHW:]P-J0N^N21?+7RTPW3R4BT2.B1$/@L7KJ,98^2A;>F[`7J&<5- M'CV(5MJ5IDP5R]!'%. M-]8U/96G>+7.=^?GE9\F=#^2.Y06KH^+3?T#!+K-`&\T!486B"'4K:'31FX? MLH0-G68N>GA$&;JEZR2\H?=NLHA81ALA*",7F\_^[SB=QCX1[;L&3S"*S0.) MTFW5\"G#LUO6^(FIF#H)5Y1HML[867#ULD8)0;6W7*.YP[-VDU#!#QTTG&T! M'\$"!F]"0MHP0`5DUTW1@.I!U5RLM7,:>7-Z(C9_(E1%HJ@A\6R8U MY(T=`A&#&+Z?S\P[CP# MH2+U&%F7G,;=06#SERW[!\(P;F'9L65'*>+4P"YL7=HC=Y,U=H+8LNF:`(!! M]F'K\D0'"60T].R1*&GB&!A;]HJ+XC1"OU(+DK!%Y5*\]15\CK8@!-8T`'XI M6[9FR^N]5>`$&,.QU$9P0>HN2+V[(/4F'N4A0\\#;YWB-4JS,C,8_2>/"@U[ M1Q$PS%SVF$%"RF%$N,QF%_)I<,CGW78)W\5^64!RMXKA64O;Z5O>:"UY`J7^BE**9_"3T*`-656/5@ M0CFB;U+-+H8\:A#5#TY(*_7O`OMI6+K!^+FHW$$=I*+>$/R(T__DZ#*:TUU# M^:>7/Y\4P'#+\F,Y)-*=^06]Y.3V=LI'BSNH`P(>IC?W5U.*1 M.C3K%`7T9<*XYOI!(S<#6,*&9FM&F`?9+'U`Z7,4((&N*1JJC7#6+')+#Q%: M)Z3C=:33%3?B';L0A;3S!^HE^K%RB5]LJK\(EI'Z`\QA$F[B:_`$9^%S%CYG MX1N#]NDL?"V--TWO`%L0:L`_ALGRMA@`FR$$UL]L";9J`9-$F;9E( M8\NQ(^04JYJD;,D!:K&'))9$6TX9Y[)S+KO6AXNB(<:6Y*=VHI[,\F/+&>S\ MO<[?VX._M[$5;DAW[[SX#_'6_J:Z^($>7L[L09RZPG>[,-Y7AK.IOXXR/[Y% M/D&SISA:%%]`7#P)-$>#\PL]*02[2D:/W'=G"1LZ79"W.%G0.W;%%LHC?;O` M&"X:JI]PH>]$/%A#@Z[YG(K>^P`HX3DD'&M0!/[%1K)^%&8:Q)9T;2G,=$Y& MYV04T&VUD[$?8G]%RRB()64PZPN5AL MRVH1MIPWT*,88OAP;BSG MQG)N+*Z*!#*A#^FR6G@DHP0L<4S1)D4AEVRCZ+@2/F,0]Q6`@E9.K+*FUQ>< M/&-65&B:K_*XJ/DZI7^B=P:KXG6W6Z5%#;YZ(T(W#^LDCS!AU]QLS7==2<>= M2SKC]DL4GTV8TB@8V$5:(V*=&J8?#TN#+7E!6ZX.ME`^?/OTD MH$DVN'N"Z(`/8().!W=`T+9]`:'+]A(Q^8E>H>'5"TJ#B-"-'@7U#=<:S1W> M:#KYYJ>AQ%E3.T:#XWX9H4.#\M+N),ZU!PJF-=X)`(':C#V);2 M"7!0X%YKZXX9[GTD<)_:<@?5LXC!42C6G:WY6PI@E+5E*XE9K2X5:!PF&)G1M\CFA!C8LC1. MV:OP+HAH`O/_5[/Y=XFN)B2ZCN64@%AB9='@UIE0H'(((*33%AE->*IRX\%L MX9YK9!PN+LD6*$%F.>%@F]$!R[6M8A5L.;!Y%A=(J#48@Y_,QL"5&W#E!GHH M-]`P7NV`5O\%")8>';**LN)Z]?PD]'"V1*FW\C.V\':$`4L1`)\V2%$")5I: ME2>8A&'$*/;C?^(\%:3S"P=VD.I\,;D19,B?_MK%*W-"SPA"V"TQI9=F'F<^ MIP@N>'P'9$V_WD\FX7-$<+JI]):IHT@RM`-BKIZB+/0O4!(L5WXJJ!D@''@> M]1[&VSUZ;)GX5R\HR)GC&9R)+YZA)Y5Z>[Y3O8^>)LRA3C=/A!3ZRS9[B(YT M7]>YM.5>DW&+EP(GSR=62.19L620"/O?+@Q/<8YW4 M/G0.BN$7C'AI*'JQ;`%E3)D&AN\[PV+I#5]XD-N\F6/?EO74SCXE\VA;EUGH M\A%`'.&IZ= M:S]*?_7C''U&/KL@V'8OB8,QICQ_>!9ODKL4!XB0>WK$TYN.;9-+](QBO#Y0 MRV%/::X.UNAEA![]%]C'D@W7$+&+OE4.XA0G])]!J:2KK,*FC]'0F.DU(9)+ M2C)ZI.3K3):X2R.<%`+T)2)!&A5N/AYG#1^C M@V&\1E2C9O:LC)Y>3#BHG%VRG:4Z74?P^3-*R@:>YTEQ3HNC+J`"Z0^@E2XF/GA';,D0H7;1XDHN!=S'P!L7` M?R5H-K\B6;2B]/``KA]D61AX)^83%R#.0\%%;9ZK,]RY31JX38`:F"U[1Z8O M8W7[KRW0`/C%36ROMAPO:OB(1!E;O/EJB+2SB-@23J^XR]1]-K:$"JLNKB96 M*%MB9=6P:NB1L26Z1@TL12,@&"3#*^"K@=3`'@<&RO#:L6I`-?`6@H'Z9!-0 MK0V?<*G3*K$GDL- MJ!DS":G6,V[QAD%J'+>FKU58(5?DWFF](=6!YWE\&\U189'C>?4Z>EH'Y6?K M3/-MD99%3G;S)9WSV;DJG:NRHYI7HL-*/&@4Q,*BJ\9EQ.[O>'6>5AX*SM/J M/*W.TPKVM(H/85NV#.=>Q!V+^4,JFH&WWE)=])%!.Y*;*97`IPVB0"K1TGD. MF@H)("U*B1TC0JP;!U<;('DZ-="I@4X-=&J@25)(-_>#4_FO@A/2CU$'>#]+HX(PXS4>1 MA24*E/O0)>%T^V<;N=T.Z?;.=VN M(]VNJ2`XI(XW+_Y#O+6_810UT^[$#QE$KX.0T(]&)WXS2)>#$.^TN(9:W"5Z MRA3U-OX4IZDY3AID/>#M#4X(TYG:ZBS<=I0!5GT3+%6 MU.::/,P\YBOM4TFG0,`?;`8HU:9C5=I9W9;RRQ*2K\J_-0:H_4NK,4@,009R]P]@)G+W#V`FT+VP:,L&:X9B&YT$C)SA!:G:(Z>& M5O^6+-_+ELBCP]9^4N86/?DD(JS:1/6M7H@R/XJ)EU&2,T'88((8E_#6Y(1R>K'3BYU>[/3BUGHQ6)(84NA6 M*NK63O+NXE7F583M0`:O7O"$$KC`S^]"%#$B?V#_8*C^4+G2Z9_^?47)R#:U M0A_OYZ8R!Y2D6[3PX_+%-6*18$0'-6J4$\&P#HB8 M?KV?R&G@C^J`!'OUM@E=-F$4YZQ>_0,*\K3(C;AZ">*<;K!K>AXSVT9>G@"S M^7&5\LF*[5R.V-O)LW7J@RT9N-C4/T"@W0SP1E-@_.*OD%"[AD[3P!`A*+M9 MK?TH97MY2J%?YHVOUR]<+^R3.( M=/-PK?`4SO[/*%OB\"9Y1F6'N-FWA*I)RVA-#V36!,9?^@)SY@A7-TXBXD M3/@U%&;J8*MHGLE;^KN?G3^Z'0OE:2,B?2!1&%#4DODSY`XI>(?!)+FC;LLQ@+&-@_(-UYQD(%6ED"AB6 M[T<""W<'@0W#MNP?",.XA;'*EAVEB%,#CPD8J1_,1DJ^R1K[.VW9=$T`J#9C MX=OOP0C]:#9"PV8"&'KV2)0T<:RM+7O%I4$8H5^IQ1G:HG(IWOH*WGA;$`)K M&@`_EBU;L^7UWBI&"HSA7\S&T&5Y-K7J)K^SO6C06R0Q=A M?W8F8]'K)?VG/U."N3B"$DCZ4X^-!887HM6?H&`L%**$&#`(^X4W^`2SMP`?`N`'Y MH9>BF/XE]"C?K%E&ZB?$#XHRXRW%[R:/'D0$;TY8*S%\DB3T@?>4C.W2^$H? ME>[-&K?(/TE%!L]K)IUR"+W`?AJ6$5_\\F[<01T0<+D]`%Y5<6H[``IC`Z7Z`D6*[\]+@W3OL'=HKM#<&/./U/CBZC.:6)OIS*)'R4 M`<,[(.HS3K)EO%%?FJ")G>)GHB[+(?4U"KW4_[6X0[J@(#[ M\OZX\]/-X^'RV!FFF2>U\F?"CI?#C&S#8*JCN/U3.T7Y87IS?S7%Z1JGQ8') MAUH\4D<5.(7C?NJ39=&GYA>6U(5"807-#IZLM3P>%4,#^C)ALG+]H.&)O46$ M(,0.%GJ^5$`FKP\=LCUG'E&ZXG#4X$E:Z^JD.,R#;)9NXX4$5B?14&V$L^B; M+3U$:*>4CM?"PIRN%KJM_?@:<8O1'`_36P[H<`D(X>8/U$MT@\L.P&&#IYKR M%:LT7FRJOPB.`O4'N!)/SM?B?"W.U^)\+::8T9N>X;8@U(!_#%-<;''%-$,( MK*7;DBK6`B:)W&B:`SK+]]J#*<+U)1ERQGL(F^:1-Y(C+-GE('X#*L\PF;EC1_4YIC[+ MBTWT'ST_+_Y#O+6_8?I9RX!YX-,&B9%7HJ556/S47T>97]SN-2%<=4,ZC7(L MGQT7#]^*:5OQ@T])W6CKHYR[\957`9P]Q=&B6*T\1S]GM,[X$`Y)PHA*T!QC M6/F"DR!/T],=`)YGRO<)R]H/OZ280%98=;C>)M9/V4U"Z/7*=NZU'R!)3'+] M<'-8V)5B8_K'99Y29:XVHT!MLIGL%0=N*.TV#7^`.6R6L$=!_?4(FF,.,X)H M\=.!.LF^Q/#PQ#,QBMR5LN]4>!G6C-3: M2'@^CP*T3RT6BB7"L5I"[^OSHR\VDH6O,-,@MJ2;0F&FBY-V<=("NJV.D^Z' MV%_1,@IB24/6^D$NJ-L%=>,6MY,MT*@PCI7$$EMBP^2+1R[3V[):A)SB1L8T M6Y9)PXTDNIU<"*Z%6TA;"*[ABZ3A_E'6OVPY;Z!',<1JXR)QSS`2%^*U/:,H M7%5GT[G%W<*]ZF<8;MO,&W9&$;:*P0)G%%;;V&%_1F&UJE[TLXR7E3E$SRC\ MM;T'_PS#796"`LXQF!7@11XRKG7AD0P'?RQQ3($F19.2;-,RNE7IF8/$N#:@ MJ%VD:]&)E]ZZSY@EM$SS51X7W9JF]$\HS5COW;O=>BY:+M9[G[IY6!>QLW6O M8I#^DT*Z%TWO45'^/+S&:3F!<"K?MGA/=DE/FR??_CTZ2?!2I(-[IX@.N`#F*#3P1T0])CZQ<&<1@&:S>G"6^&D M>._7-4Y^I?(P_;&.-LB\3C_E;S[;"!E5>=DA2#48*HR%5R]41H\(*LC@`ZDZ MMT-R6=X7SEF+OJBLV75)3_+MJVMB:)3F]H)O[4MG>48EKR3D+`;H7)UAE9.X M>-M6DCKIW;[-VSOB3FVR5O;832`)LJP=HR&_8QFA^5ZT*6-%Q/7,`3,TL,'D MG]F\./2$<9/\@=J(WF[867H?+9:98,E(QQO"`N0#B&9H8.-P98K7/F^<5I+O M_'26EF:R7_TX1U2>*XY&.1.\F5HSS@[DE7KV)*<761K]B7@)3H(9>AG9J=/; M\Z8D;JN6H_`#EQW)//U,U1@5)/L&-,L@=DK,2RV)2=%<4TN+)YF3OE4A_@(E MB%[I]&H_$'J-_"SGGB=-'J6W:TNIZ,(2DCBC#61@DH327&/(5#-8>[V'V/]( M63J=HI.5J]4ZQAN$MM4GZY459G"F^CD*"W6`/.*,;9;#[U-,,JHH_PME]RC` MBT1P"_;V/BM!+&U>USC=_HF-XUW(PQ*A%>["9\/(Q@DS<(L$>>'8X4G_'"71 M*E\)Q9#:,1I2&+>M;+?B'1,-J#*-V`KAIF0*IFCMK17[R1=_)AA M'1;W4/D#HH<'B*7:F88S5I@RFG-73#>'147K#FRR0>QM*2K#`^D%M_]YOYMN MF-\5^2EL$ZH\T!P8[E&(5J5WD;G`E#XR9ZXYS`'M>.))IK%36G046"DGF,8& MWYL(G&4$0U^I\J3"RO%XO4S@`*&PJ%*Z$^S9J14]TV.;BJ0!$M2'@DW6R=X] MBY@1-=H\_ET3B4)1M6:$JQ'3A(4R0$S!=0"8H8&-6A/0:738Q7%X6/$_VXB< MTOK#,SIU^0J=V[\Q'Y<1"9@$QTZVSW[Z!\JV\4UT'5#66#1+U]`!7CE**$M3 MW<%'0V;9$J6/RWVP[35.YRC*N"&1&BBP$^BBZCW1AO+KU]L)\:^%%5X;Q*]? M/TJ(O^`M,Z?,'B3F+[GHTA[@U>.$MB!]-@=JQ)V_QP;0GOTH9KYK>F44YUG/ MV!V_;I00;@^G2KQR/_N7]YYQ@[:+H.[MXN:_:UEC0+ZST?,_C04EM#7CQ+B0YV(V;S"46DU]%]8^$_7L`)>:3241&A) M+%*4DA`4/]/GJTP![EBC*KIJ'B6'DE?IC(7OX!9_0VGYKV@5J>DLW;S2O#78 MD*^OZ_704!Z]4CN4@,3TIQ/+U5ZYD(OB73Q_E"#5&O'VDIK05]/#Z\8/X6M; M2J_PO7Z55NAV!4*JR::0OA*\\1I9.(KR)A`V1'-<6Q+7EH0[2`>QM;50JAF7 M92)F):WM`05T:!;QS[-6#]5[<@DH_X*^%3\U8GL_V5CV*E+@7@+D"DG*#S*0 M[4+&:/A17\_5R=QCE,54\3ZT1Q>K/E M#JIG$?\,+>QKW=G*70S`&FZV+`PYN[A56=#^NH^8>L)V5*C_M\)`N=&ML>+>;7UP:7^RGK%-6IO%"_9W MR!@+E')#D/Z.%F,Q4BK$VY_S8R3X@*KZ]F<&'PE*LN(I_1DUC06HV]#V_A1Y M8P%L6G^Z/\.8L5#I*H/6GU!J+M2M\QG`H'VR!S1]Q1#A0K`]ZH)*+@`[:'/8KMP/.W1-@:HYP6'U1[U M1*'1*1P>>Y23!HUMX3"-7P4YA,"=2GH[@\EE1(62Z"G/6ET,]N@@1ZUE.E]5 M]J@0BEU"X!#9HS"`NX_`[;?VB/=-.M/"<1J_F"_!J3DT]DCQ*IV`X?C8(Y5W MT*(<#IL]4O>1#-"BO1PCZE?1.:5`GXE=H5Y8+8A M9(/0`TJ?Z4%9CQ>KAEA>XVP]DD><,=/TX7?F_/B"LW^A[!X%>)&T,JK^8(_^ MU!NXVT96.-W^B8UK'AC]@U.M.FHM"X;\1Z=XJ39G@V-KN_+53[]*.+[C5[AZ MP5?2Q!*.KR4*V"ZAC!5MP7EV,`:R([2+Z-P?QZ^$R8&JV/OY0/W]W0E.]'5_ ME+\5/S%J[]'\#?OOU_N;/6L93I]1\%V`5^]86Z'WG[Y_7T)%=G1["][IY3]C=B7'J[QQ<]B[IY>@D#B:B8 MA79(U`*Q'?_JH_;,>4D;_1NBIT?X5MC_Z12?8EU,PK"0[/SXGSA/C\J,Q^5Z MEP]4:43%(R1)*&?W%(#M_5VMM)B3T(8OH67[< M6^YT0*>OOIC<3/E?Z/37+EZ9$WJF$,+NHRF5I/*8GJB9@`C`^`[(FGZ]GTS" MYXC@='.!J:#'IT@RM`-BKIZB+/0O4!(L5W[Z!Y\4X<`N""ETP4+X7:2H+&:% MTE4M*?5#.UVNGW&2+>.-^IX&3>R45+5^;55:%3N]M2=U6WJ9O-*$=M_PGKZ] MCDKII$[1W'ZT:YQ.,G8WT4_V&2'VY8Z[.LJ&=TM6H?W-Y@^(Z=I)@.B+:^FI M&=3(,KC`C9;Y]?8F^(/9ASAAY&.'YZ%FX0JHN@6D^*^H`(\O85S M>A%O12]Z;UR@.4[134+U4D2R[>VR^[_E]/)_'_T71*Y>LM3'*;W2Z:U46";8 MIZ*/I5HP)7ZQFTB^(-Z'UTF2SM5$22X",2Y1^=^;9!(4@<7D'@4H>JY6J3V% M3#K52S3R5@CPK`@4,Z#$VR_&8:9VK,X/IP#(5 M2C1J#]&Y\8&4WB37.$__Q;+FV[%<>=`HV'ZD;T6=\'UXTC@8_X:[87O[')U, M5XTAPO.(/U`OT0V,/@`.&SS5E*]8I?%B4_U%<%.J/T`'D\\HR1&?A?)GG=]! MV@;LB&9@V[!!6>BPH"B/ZQYKEHX"*GYN7->(P;/PC`*N1;LK5>1:=]8:%#AN MR,LQVY*F/5J(KFNBR*.;WUM2"^F/`KL3IX72X,0*FW\=T0SH]:N5=%@[,AE3 M*DW-ZMGMJI55/$AD7!/7?%VGKYJ%#`X=-!0:"8^N#;:\#3;$;PE&QO!&BH`V MV`TU)EO63@/^7Q4\Y7MGX;7=S$;(==)6Z:0-#16TY821GKWP,$YXI0^S(9%O M&$'@CRT;1=HK&A@_80*OIN;+E@Q$M#,6K% M%E"DPEK_[@=;]AW8%M7*RFO+PH/"E?!(1R_"@$M707'9/P:PCZXMEG1(+CQ MU1Y5@94N@`5*_%HZD"&K*K(F3_(CB. M0K;?O2<_9EJ71Y94I/9V6WU=-K#)$S\/(S:L1&A)I>[`C_>\RXM*]_'6OHM- M]T=SJR+4=[L],HU]0J8?^:4BQ2.[J!'Z^@5@2G07;BNHF,V+4&AA:B!_H(YZ MB_N&:?1VGJ7%4106K3FH>E'H(#PNY#-UIG57R#MN]"!G2-8Z7BLC-X3D<";* MT48Q4&D*`>5"T$=BV&*?SQ$]O4-"57)VW4Y6[/Z5;!3Q))WLO#Y`)\)*F<*Q MNDF_4"#]PAC2FYRZL,E&+"J5LU<\R31VA"58$0 M4H^$-][5@%$C>C;?5Z:XPZ1(1IL\D2SU`U[!2)6IKKB-_N(VX\Q\4EIEKF8* M#P7Q,6D=(%QV,=Q>8DM*2F-0:LU9MJ2A@%!14/CZ"_X>#2ZUVJ1UN\@5C=&8 MBSN6V@:0S2,S?5MWTKI4-KB#LYEMJ[_#=B1`R:QE_>TI8P%2,[GW)\88"Q#< M2-G?-34J<#II9&X-0@U\OV"4[`E*57`H@]$9?[RIHJ<:C,SXPTB;>+\'BN]* M<(:\)V^=XC5B\=*4&`_])X_6Q:\L''U5A#'E!,WSV(NC9T2\L"SRO"-8'L_5 MQ5OZCM_JCL96\5H'@KHEK1I?U=<[-#4[7.(XO%E1RI_+2A#"F`'`#!V]YNC9 MDJ!T,TG"JQWH0C8`,W2P\<*2:B6$UXS10&J9_RLFM6Z,AHYA138N;%D(Q^H( M3BA/$U9:+*NNU(O-<3VSDP`%\$R#V&*D"8,5%&8:Q-;7XLR_C>;\X"7I3*V- MRUCRG:@OV?'OFD@4;NV:$2XXY^PB6UP`2+\M@E@RY!JGI38!NW-!<^R)9>E7 M@W!!+R!K.ZAGPC6"=?LY09[[/E:0'`E7T M7DV0=BU9L>9*'T18]OI"%SK@0@?.H';$H'*_<[\[#ZKSH)Z/!]7Y<9P?1[/]_ZJ#Z(I/2_IT5_T3;MA)"[H\4#J%J["#$,2Z$5< MR"<8DCXO8D(^P:#L6Q$CL$D&,?,%\0X%T13O>^?Y=WXKY[<:D]6H(]G'>:2< M07YP@_Q83(;.)"TWGBHIL]:M$*'Q""H&GY< M3M#[`<3#+'Y2IF[269T+U'>DL6$WFG/418A(FFK-%CU_77$#CHF M`LZ>XFA1?&A">6&-V[F]F6&S=+!#EG1!LO^P<_'9C]EWFF13ND(W%/K"`*Q_A$Z#>Q4B'Y&*:$[9M=CJ&CJ M4?Z9GJ^\#!/P/%TL9=%3C/8])_:M2^C9.)L_^B]"MH!SAV<-(J]R.(-,U5DF M]A<_2MA]-4L>Z%Z9S5^)EC*?-FRRE_RDC[_C37^34#V$;9E]-QWZ+8*`BO/A M;>0_L?@J>BES^&WV,)V?ET\Q%5L0/1_YOAK(5/,^+<.^E,+HB8%VWT6%Q?HG MF/41+[=GY#UZ1@GWPI?.,XNIO7"\%2TE0KCZ`TQ@DEYO:S\*=Q^"11]2C9&> M&[-LB=()(>A$&VOW,,U;M`P(OJ-4UO_B"3F::R-_U#3O^V/3^I%M\:@+J'&KCP:^PQ M:JS7/&`<;#9;ZD;:K[81_N013P*JC9 MG-V4U\RC)[E4(5-B,W7Z[@@Q(]WG_\FF>-T508J2-:.VFQ[0JJ5 M-H\+G.:AX`*G7>"T"YR&!%>U57UM0:L%#EBNKUBWNX1KJO^`H?Y6G88^`+W" M5?DL39SS/2SP)94C*%@AAM;;$GGZ!O9S@)B;5G*L&NOJ8N^ MA\M,^QG;``LADH!@'!NOJJYA;!1"T=\NUB!L=8VH),:HORO'`NS`X6?]I1S: M@:)R4&9_R8H:LLC:`=H\U,$6<;*5H0@<#M2[E#/LHFL!1U5W:1Z+88M)J2,@ MFX8[]"C<#'\2=H-EMW%OYU4NH&VDJ.7F=`@.G%W=-&RK=[70B"VN""PXMN<< MCD=%[)K'OO>H#(X5S#89K/W=+.OB_?3$3S-[0)7D=?>G$I9H7B6C/"D;I9&? M5RV@1L%:M@@ZJLR_,N7PU:@*-4<,,:/U,+O-1*)5ACNVJ+F%(5A@-J M^JM+X8/&W5=U*=$KC*@N)2>P576I7U!"GQ\SBWJXBI*(K24J,Z`I)AFY>@EB M^L9D4>\HW[K6=M142TUU^-@.&F&\UJ8O*&WS*(CH;MH?*-?(9SVDZE@!3VZ8 M-,*A^9XN,;H7F6!VB9Y1C`O#7LO/TME#.V"P_CV\A5/'C=H3FI5&4"S*5@5H)'/48+3*-OL]&GZ%5X_ MA1ENLLUGE"V949%YL0H)D@/$@!3H!WIOX9&7'Q*-UD4^17^[Q4K94TS^R6BM MJV(.&,O(/HS42CB+Y_R"$_R:+/'U#)MD=)D(G9C7:RABR(5SC&5&4#J;%QKN M+,](YB?,V`93D=L]S"SF287@+:&7$6$^E#PM-X?DY.WVX?:5U9"I,:ZB!@\% M5U'#5=1P%34@X3#U\J-UJT&(@=#M855,*0P/@7'5FD@,X.905@UM.3W46,?] M>*5M.8::@=G-.0*-X4U7:A M/U:==`T@;!BK8%5N3PO8I.Z[_JZ%D0+%=QC:DD;2!B4%ER08+GB?Z5&N+(T! M+.!/`.].K3/9MO5'D$><@!'[R>Y%RW?A@Q'Z9.N::AEJ#Q>*[5,S=E-!`+RMYEB?\67VGLB:P5T6QU9.RX)K8O+T,56\E!PL94NMM*\ MV$H-'F]@>RF0C&3=$A%BHB)P]>CA-WS)`+4#JWSY2@#)%<$AK2#SXC_$6V^+ MTS:S?TB>,HCE`T1#*YO'),_P"M./ASXC9MRJLV;PQG10\V>*UYO//EV&B>#] MW$$=$,`53B70@ZP]H,\WI%)RBY,%/6Q7E^@I>Z1O%ZA3HJ'Z"1=JW^+!&BHV M5"IE=@63)QEM$GW*8'V,:3A9N$1%EGSY)?UNP]) M2%2@PL$?'B[[1GM^V8)CT]"RT_8U@YA^NB&RGWB8MK2!C"?=`."49S46MF&7 MKW,`)ZQ)^Z+X-A>;PY!M%\K)-S\-MRW=KUY0&D2$'21EL!R/]:[?<]Q*9Z2@ M'04<;G]!=VD4<%7K8=X^9H"O<3I'$4MR(*RCY\LZ2G=M8WFA)3`>K91[Q&P5=*NR4A$L@R[WXT>4K@;`%TK)F('G MGX4\=C_V!'P#2K0"[P)`7`"(60$@K6W9+D+$N;]=$LQX7+WK0K2F[T\S$QV^ MO1MB^EMCYX.LBHGA#'-S#)!J>TSX,1KU?MT'8%35*WV.%M7^3#K]U=X:+]I= MNW7[*U5UOACWLL;AY45?22-7R<#%('5)>3\VQ%6Y".FYX*KBY0"C#2]H:OLI M`O:VP_65AJJ@I4M9&H<'![:A)F@_L+V<$1^<(MBA7PD.NV6:X"#NTF%3$/#A MSO`HN85BM3/,-Z^FJ?S<@9(,&E'5*JN@\V:QZ6?`&// M!WY[,Q>H"+0FF^V8;"*@6R$6Q0RB1@+Q%UQTOD#'.BOO>JG-DS&(O$YA%_A, M%<\F8%91HQ-O2']Z^<'85\8)I5N80B0WPZ$@KS.27]$"X]J.TES#_3HFS\_/L[YM^PMY5WS_*:.W1@6QRQ'9[ M)LT[9N"D6;[^1_UIK-PUZH$7G>>"C(ST7K0!&RC$%[[`Q37UQ^U-GG1T$W#L"9 MY,J$NMPQ789YEU-FD)7X7!/.3+4V]I>*-H;-88B!RV6N#1FLX#+7#`E+Z"^] MSD^0,AMJD`/<>L^G.[0NTCGIW MJ78ZPSH&R@D+4W?&6,=$MDJ@>QNMY>FL4_(]"._<;!X9`?)*TK/Z4?TMY^4!9"NBDBUD[^SH_"FV3JKZ/, MCWD,B$=K()\0E/%"2,H?C_N_#T^>9%%4QQA#[.2)%#('A.CCL<.3/O7)S1]8=59A!AM_H`:B\6H5985X MQ:"E\BL%$B4!/?%XU,MGZ&$#)P6BPA5T-$QGX&_E;N%06QFA\[2ID$$_>`'> M$L=432&EA"ZGOG::(2R)C_S3@6:1+3G\Y1,T,(&3!5..JPU$>>0+A@Y/>)4* M\:H1C!R>[-=JQ$08:BH2U1@DEA7%HS(>8+XO,CGS(\(_Z&A!MT@ZJTCTD:X(WWF6JJ!$]FU]'B4_U$#^^ MPZ0P?DBD(Y6I+@7'UA0#2ZU&KMUN\CEWFG,O5..H#=X\\A\ M2-:=M`8FW6E"XI3/"AH`=Z\M@(A9K>X5=;^Q+1T+;<2@-\*.E)/L2V+10T6 M2/BH+1*N,C*0P-3^KB(-YZT:0O*0'5L41D5'5D$LCW;20454+:*+>JU M&C2J85M6:=IJ4,D#-*R2<-3`40W'AR3+;G]A_\.R=^E?_C]02P,$%`````@` MACUD1TXY;STD#@``T)<``!$`'`!T;W9C+3(P,34P.3,P+GAS9%54"0`#F_TY M5IO].59U>`L``00E#@``!#D!``#M75MSZK86?C\SYS_X\')V9^H-)-UMD]G9 M'4*2EIG<)B%MWSK"%J"IL:@DD_#OSY)\P3;R%2?`@:M+J?.RT#NQ:UB3NY:+T\F[WG_F#0^N7;U_^8YJ_8Q0P);!NC MI3&<>JZ-V16=8>//RZ=;PS2ZG?/NCX]WQLNP;YQTNE_,;L<\[9CFMZ]OW#[G MUA3/D`'SN?S9"3^*W::1QB/MW1/+Z M^OI9D5$V@;Z=T[9L'B&.P^XN(A;73Z&:Y`S=Y`PN=5UOII_#%JPMEG/&%D8=S+4TJD5/)-6@)U(M&B(IJ)T"26#M+VV_ M,=Z5Y&"#N%P@UXJP\;:&I==3U;M[=G;65JU15V[K.L*PW?:?=[?/:IFV#"0$ M(R-/X!O*9E=XC#P'6/?P[UUNJ86$\F1Q'6M!T,:.X-%8YFJLS\!%JUV1 MH76;.PXU@*34I`(B=15'5#D!C#U]QAYI\X64Q!UEM') MBLJ_K*,5?>A44YRBH[*I2-QU6%`A+B MDAV6:P?PF57)@VM3QU@5S;A+]$+$VY%ME, MS=(R)-W+TR`OO?"9*S]FQ%G(V\I6?A)5)FO_UNET#-.X"N:*7_9 MT@PT!:^39N%E?'I,\'G$6]K<40=NTK$I-ULU.7\?9U5BMJ:0=%H.25$7;M"Q M\1!Q9'PZ.JF29K00GYICA[Y^"&BTLS4%FA_J@*8/'!DWDJ,C:*09(1O%)C+! MZ8(=9W/D+E70"CHFRH+QJ6OAI-($34'CBXR&";< MB@\#^(#-"?B0P'B,\7'@I;.7?4 MIBS]L];25W#QY$]N/,K)C6%L\@.W-I8.EWE@%X>@$7&(V,BMZX=KRKYGR8J7 MLNXU7/3\.8W;U9P';M:Q^L-AL2W1R,'U#9H>J"%3=CO:I7H37'!8J&J^`S?C M!#(J:OT]I8Z-&5=[HUC6-Z9^N*9,VM6:]%>5IZUF_:_::,7RP"T[E?G0C`@_ M69:!#X4DB9DS)`1HJ;Z-BP9NRMHG6FO_IC+Q:'X56#W(^8T[?_[#-7M!DK-9 M3E5Z\*;,?YHV?T':9'P*KPZ]W%(E\S6%W`0_*,T.)VL*(C\TD&T;GX:*J4,' M35:2O#%`B@9N"@SZFEQV$GXT?$Y"M;'5,U M96-];6TMC3M:-R493/B M?<_UFW,) ME69I"A+Z^F7^VP1'UU"JTK2Q7\@?MBD$?-$YAAG[-&[PQ@S]DVYY9]OYT.VK+S,VMKS+#=^4[:N6,X]K/6VL*6)8 M:E/&9$O_>]=7Q&S?BB:=^\'9`CF>7W%$G'NS>2)DVP@L3V*/.ZPE.)C30B`L&*_NB)9B'6PI;\I"3OWJVK=A'SF_48_P.ST:8M=1) M0Q>MK$;B.#+="`?C'HQ.A">[_LJH-[]HJ6,;SPE`JF7XAYWX)W">VW2&B#N` M!BE1R_`[^@8)[ M0;3U(H^1#;X5=R>W6)U*$\A0KF\=H?P[,^K"`F++M%3!N0T@$AX1L:&LSX)` M!&`GA5K=?$?N+8;MZNQGH\T3=$9'Q,$IJ*W?W[VEC;X5,J6,3.$\F0W M[Z8H^IU#V[+]C:./YD0@Y?.'F,TB;M=NUW>H(1\-\>HHKNZH*Z;.,MC!DFQG M]-BU#2T;1`[BO'=/W065&W+?FZEP@"NQZ^Q*XUG2'V=RC:IH-L M8[W[9P2+2K8-O^SNN?:U.KYP$#^(,=!%?I_ZH@)/L!X:Q^LUZ,=&D362F,UJ MW#YNKV=SAZK]HC=A6#7&=\7LYAW8'?W?$7$`(3U[1EPB+>/[?"[X]9OE>-+S M*2]X*6NH\65U_28OHPRQF:'V9K\=<#JD[!\/7Y$QN!SH2Y"3A&Q^E^T#-PAV MRA4`RG;>&P-"I".3G>`!0-)R&6V[ESK(XN20WA`7-$1D*2.HH0;%R&%8A0W% M*ME[Y[8&]9*!CG4>ERVSQQ[)TPM(BN6*]=R6?)$\#^,QL7#TQB=L`L]T+%XA M28#Y>62DXFX[%G^E!&0\$5>&^_D3F"0I8G['YH6L+$[";=]B=R*F#V-P[O@5 M.;[;BP0JU74'8IDDHU+5`]=B\KHG`G;]%$XO63Y!+=R6:(G@8/T,VQN2(($@DD[YM!Y/MJ&2@ZBC] MDV1`D=FZ>R%%BM5<.;8OQCK;?H8!RQ?\,.R7JR+-#4;"8WA-E!($.[=X=S0RTJY&7T^88\2L*=CW M"G8"ARH+URA2-#'0WF2XS_W!TW6?LCGUB9,.(;-U^U[A&3F8J]=MN/3#<9CK MF[84G65K'@8`-D^2>TQ*__E]=L`*\AG/VCJ(%=,OEZLN0?"I7M?U7P,?P+IF MJOZL7I0:3J-ZRO4;J)UP*=Z]EU#)1\ZX@>]7#[\V3<&>HS=F\X5-RQH6I:BM M?MQUX":3FN:'?4]%E0=B"9%&1;#@.;CX`Y/)%+;#GDPT)CAHP8^,6+BJ;M^3 MD0U+MHV!;70?RT3/F('E*`T]8NC/Y2)JZRMUZR)%/4/C[FZ4.2SM0":FM MD!M$F/RV`L<^JY"!CR74`^\Q)C(A2NS''S+5MJLO^I`PZXE7I)NJ5+L661;( M'R000ZJ:@R4#%%2BHQ`#_!]HHB99B^OW11<%!406:**+>=SV4!$0!\?YH M(?,LH0(%9-/MK^PE;9])MC^25SB?H4`954;:)_W4/06E4%VU!]Y3[6UP9E$5 M76XRS5YI-N=G#8KUE4>\%UHH_]M>V M`Q0````(`(8]9$?GCV%KF+D``$@9"0`1`!@```````$```"D@0````!T;W9C M+3(P,34P.3,P+GAM;%54!0`#F_TY5G5X"P`!!"4.```$.0$``%!+`0(>`Q0` M```(`(8]9$?+='2,)`@``$UG```5`!@```````$```"D@>.Y``!T;W9C+3(P M,34P.3,P7V-A;"YX;6Q55`4``YO].59U>`L``00E#@``!#D!``!02P$"'@,4 M````"`"&/61'*)9/3TD\``#KW`0`%0`8```````!````I(%6P@``=&]V8RTR M,#$U,#DS,%]D968N>&UL550%``.;_3E6=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`ACUD1R[A9T(840``F)H$`!4`&````````0```*2![OX``'1O=F,M M,C`Q-3`Y,S!?;&%B+GAM;%54!0`#F_TY5G5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`(8]9$?FCKN4PSP``!DC!0`5`!@```````$```"D@550`0!T;W9C M+3(P,34P.3,P7W!R92YX;6Q55`4``YO].59U>`L``00E#@``!#D!``!02P$" M'@,4````"`"&/61'3CEO/20.``#0EP``$0`8```````!````I(%GC0$`=&]V M8RTR,#$U,#DS,"YX`L``00E#@``!#D!``!02P4&```` /``8`!@`:`@``UIL!```` ` end XML 21 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note C - Property and Equipment
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]
NOTE C – PROPERTY AND EQUIPMENT
 
At September 30, 2015 and December 31, 2014, property and equipment consist of the following:
 
   
September 30,
2015
   
December 31,
2014
 
Office equipment and software
  $ 518,000     $ 218,000  
Shop equipment
    226,000       213,000  
Leasehold improvements
    253,000       253,000  
Transportation equipment
    17,000       90,000  
Construction in progress
    -       6,000  
      1,014,000       780,000  
Less accumulated depreciation
    556,000       509,000  
Net property and equipment
  $ 458,000     $ 271,000  
 
The Company has invested $308,000 in property and equipment during the nine months ended September 30, 2015. During the three month period ended September 30, 2015, the Company acquired the Z-Coach fatigue management software tool. This educational software will be enhanced and expanded to target an array of industry applications and become a key component of the CURA system product offerings.
XML 22 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note G - Outstanding Warrants Activities (Details) - Warrant [Member] - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Outstanding (in shares) 3,356,750  
Outstanding - weighted average exercise price (in dollars per share) [1] $ 1.99  
Outstanding - weighted average remaining contractual term 5 years [2] 5 years 219 days
Outstanding - aggregate intrinsic value $ 77,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 37,500  
Canceled or expired - weighted average exercise price (in dollars per share) $ 0.01  
Outstanding (in shares) 3,319,250 3,356,750
Outstanding - weighted average exercise price (in dollars per share) [1] $ 2.04 $ 1.99
Outstanding - aggregate intrinsic value $ 9,300 $ 77,000
Exercisable (in shares) 2,694,250  
Exercisable - weighted average exercise price (in dollars per share) $ 2.99  
Exercisable - weighted average remaining contractual term [3] 5 years  
Exercisable - aggregate intrinsic value $ 9,300  
[1] The weighted average exercise price for warrants outstanding as of January 1, 2015 and September 30, 2015 excludes 1,750,000 warrants with no determined exercise price.
[2] The weighted average remaining contractual term for warrants outstanding as of September 30, 2015 excludes 743,500 warrants with no expiration date.
[3] The weighted average remaining contractual term for warrants exercisable as of September 30, 2015 excludes 118,500 warrants with no expiration date.
XML 23 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Balance Sheet (Current Period Unaudited) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Preferred Class C [Member]    
Stockholders' Equity:    
Preferred stock $ 162,000 $ 162,000
Preferred Class C-2 [Member]    
Stockholders' Equity:    
Preferred stock 250,000 250,000
Preferred Class A [Member]    
Stockholders' Equity:    
Preferred stock 6,000 6,000
Preferred Class B [Member]    
Stockholders' Equity:    
Preferred stock 1,000 1,000
Cash and cash equivalents 1,946,000 3,724,000
Prepaid expenses and other current assets 40,000 15,000
Total current assets 1,986,000 3,739,000
Net property and equipment 458,000 271,000
Total Assets 2,444,000 4,010,000
Notes payable, current portion 2,000 6,000
Accounts payable 126,000 67,000
Accrued liabilities 56,000 41,000
Total current liabilities 184,000 $ 114,000
Notes payable, net of current portion 7,000
Total Liabilities $ 191,000 $ 114,000
Commitments and other matters (Note H)
Preferred stock
Common stock: $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at September 30, 2015 and December 31, 2014: 45,754,041 and 45,716,298, respectively $ 457,000 $ 457,000
Additional paid-in capital 71,907,000 71,559,000
Accumulated Deficit (70,530,000) (68,539,000)
Total Stockholders' Equity 2,253,000 3,896,000
Total Liabilities and Stockholders' Equity $ 2,444,000 $ 4,010,000
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note A - The Company and Basis of Presentation
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE A — THE COMPANY AND BASIS OF PRESENTATION
 
Management announced a name change for the
C
ompany during the third quarter of 2015. The company will establish its business around two divisions. The CURA
d
ivision will oversee the Fatigue Management Consulting business, and the Aegis
d
ivision that will oversee the Power and Hydraulic business. The new name of the company will be
CurAegis Technologies, Inc.
This will be used as a DBA until the next shareholders meeting when we will officially change the name.
 
 
The interim information contained herein with respect to the three and nine month periods ended September 30, 2015 and 2014 have not been audited but has been prepared in conformity with generally accepted accounting principles for interim financial information and instructions for Form 10-Q. Accordingly, the condensed consolidated financial statements do not include all information and footnotes required by generally accepted accounting principles for financial statements. Included are ordinary adjustments which, in the opinion of management, are necessary for a fair presentation of the financial information for the three and nine month periods ended September 30, 2015 and 2014. The results are not necessarily indicative of results to be expected for the entire year.
 
The Company was incorporated as a New York business corporation on September 25, 1996. The Company develops and markets advanced technologies in the areas of power, safety and wellness.  Currently, the Company is focusing its commercialization strategies on the following technologies: (i) the CURA system which encompasses a wearable device, the MyCadian™ Watch which measures degradation of alertness and sleep attributes and the Z Coach education and training tool (ii) the Hydraulic Pump. The MyCadian™ Watch consists of hardware and software that measures multiple metrics in order to establish that a person's ability to perform a task or job appears to be degrading. The Hydraulic Pump is an innovative hydraulic design, whose goal is to deliver better efficiencies in a package that is smaller and lighter than existing technologies. 
The Company has not yet had any significant revenue-producing operations.
 
 
As used in this quarterly report, unless otherwise indicated, the terms “we”, “our”, “us”, “the Company” and “CurAegis” refer to Torvec, Inc.
XML 25 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note B - Property and Equipment, Estimated Useful Lives (Details)
9 Months Ended
Sep. 30, 2015
Office Equipment [Member] | Minimum [Member]  
Property and equipment, estimated useful lives 3 years
Office Equipment [Member] | Maximum [Member]  
Property and equipment, estimated useful lives 7 years
Leasehold Improvements [Member]  
Property and equipment, estimated useful lives
Machinery and Equipment [Member] | Minimum [Member]  
Property and equipment, estimated useful lives 3 years
Machinery and Equipment [Member] | Maximum [Member]  
Property and equipment, estimated useful lives 7 years
Transportation Equipment [Member]  
Property and equipment, estimated useful lives 5 years
XML 26 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note C - Property and Equipment (Details) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Office equipment and software $ 518,000 $ 218,000
Shop equipment 226,000 213,000
Leasehold improvements 253,000 253,000
Transportation equipment $ 17,000 90,000
Construction in progress 6,000
$ 1,014,000 780,000
Less accumulated depreciation (556,000) (509,000)
Net property and equipment $ 458,000 $ 271,000
XML 27 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 28 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note B - Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
NOTE B — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Consolidation
: The financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (56% owned at September 30, 2015 and December 31, 2014). As of September 30, 2015, each of the subsidiaries is non-operational. We are intending to let Ice Surface Development, Inc. dissolve by proclamation. All material intercompany transactions and account balances have been eliminated in consolidation.
 
Use of Estimates:
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates are used in valuing the useful lives of any intangible assets and the future realizable value of such assets. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates.
 
Reclassifications
: Certain reclassifications have been made to prior year balances to conform to the current year’s presentation.
 
Cash and Cash Equivalents
: Cash and cash equivalents may include time deposits, certificates of deposit, and highly liquid debt instruments with original maturities of six months or less. We maintain cash and cash equivalents at financial institutions which periodically may exceed federally insured amounts.
 
Property and Equipment:
Property and equipment are stated at cost. Estimated useful lives are as follows:
 
Office Equipment and Software (years)
  
3 – 7
Leasehold Improvements
  
Lesser of useful life or lease term
Shop Equipment (years)
  
3 – 7
Transportation Equipment (years)
  
5
  
Depreciation and amortization are computed using the straight-line method. Betterments, renewals and repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and amortization expense for the three month periods ended September 30, 2015 and 2014 amounted to $27,000 and $39,000, respectively.   Depreciation and amortization expense for the nine month periods ended September 30, 2015 and 2014 amounted to $85,000 and $125,000, respectively.      
 
Whenever events or circumstances indicate, our long-lived assets, including any intangible assets with finite useful lives, are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may be indicated. The carrying amount is then compared to the estimated discounted cash flows, and if there is an excess, such amount is recorded as impairment. During the three and nine month periods ended September 30, 2015 and 2014, we did not record any impairment charges.
 
Fair Value of Financial Instruments:
As defined by U.S. GAAP
,
fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. All assets and liabilities are required to be measured and reported on a fair value basis. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:
 
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.
 
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
 
The FASB’s (Financial Accounting Standards Board) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at September 30, 2015 and December 31, 2014. The carrying amount of cash, prepaids and other current assets, accounts payable and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.
 
Revenue Recognition:
Our terms provide that customers are obligated to pay for products sold to them within a specified number of days from the date that title to the products is transferred to the customers. Our standard terms are typically net 30 days. We recognize revenue when transfer of title occurs, risk of ownership passes to a customer at the time of shipment or delivery depending on the terms of the agreement with a particular customer and collection is reasonably assured. The sale price of our products is substantially fixed and determinable at the date of the sale based upon purchase orders generated by a customer and accepted by us.
 
We occasionally enter into prototype development contracts with customers. In such cases, revenue is recognized using either (a) the proportional effort method based on the relationship of costs incurred to date to the total estimated cost to complete a contract, or (b) where appropriate, the milestone method, if milestones are clearly identifiable and substantive.
 
Business Segments:
During the third quarter of 2015, the company announced the monitoring of its business operations will focus on two divisions in future periods. The CURA division will oversee the Fatigue Management Consulting business and the Aegis division will oversee the Power and Hydraulic business. No revenue has been recognized by either business segment during the nine months ended September 30, 2015.
 
The CURA division incurred $201,000 and $446,000 in expenses in the three and nine month periods ended September 30, 2015. The CURA division incurred $17,000 and $19,000 in expenses in the three and nine month periods ended September 30, 2014.
 
 
The Aegis division incurred $170,000 and $514,000 in expenses in the three and nine months periods ended September 30, 2015, respectively. The Aegis division incurred $251,000 and $876,000 in expenses in the three and nine months periods ended September 30, 2014, respectively.
 
Corporate general and administrative expenses will not be allocated to the business segments. Corporate general and administrative expenses were $532,000 and $1,063,000 in the three and nine months periods ended September 30, 2015, respectively. Corporate general and administrative expenses were $354,000 and $1,036,000 in the three and nine months periods ended September 30, 2014, respectively.
 
Assets attributed to the CURA division at September 30, 2015 were $300,000. Assets attributed to the Aegis division at September 30 2015 were $144,000. Assets considered as corporate assets as of September 30, 2015 were $2,000,000.
 
 
Research and Development and Patents:
Research and development costs and patent expenses are charged to operations as incurred. Research and development includes personnel-related costs, materials and supplies, depreciation, consulting services, and amortization of acquired technology. Depreciation expense that was charged to research and development for the three month periods ended September 30, 2015 and 2014 was $21,000 in each period. Depreciation expense that was charged to research and development for the nine month periods ended September 30, 2015 and 2014 was $59,000 and $69,000, respectively.
 
Patent costs for the three month periods ended September 30, 2015 and 2014 amounted to $22,000 and $44,000, respectively, and are included in general and administrative expenses. Patent costs for the nine month periods ended September 30, 2015 and 2014 amounted to $69,000 and $90,000, in each of the respective periods, and are included in general and administrative expenses.
 
Stock-based Compensation:
FASB Accounting Standards Codification (“ASC”) 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. Under the modified prospective method that we adopted, awards that were granted, modified, or settled on or after January 1, 2006 are measured and accounted for in accordance with ASC 718-10. Unvested equity-classified awards that were granted prior to January 1, 2006 will continue to be accounted for in accordance with ASC 718-10, except that the grant date fair value of all awards are recognized in the results of operations over the remaining vesting periods. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with ASC 718-10.   
  
No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets. We elected to adopt the alternative method of calculating the historical pool of windfall tax benefits as permitted by FASB ASC 718-10-65 (previously known as: FASB Staff Position (FSP No. SFAS 123(R)-c, “Transition Election Related to Accounting for the Tax Effects of Share-Based Payment Awards.”). This is a simplified method to determine the pool of windfall tax benefits that is used in determining the tax effects of stock compensation in the results of operations and cash flow reporting for awards that were outstanding as of the adoption of FASB ASC 718-10.
 
FASB ASC 505-50, “Equity-Based Payments to Non-Employees,” requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as compensation expense generally over the service period of the consulting arrangement or until performance conditions are expected to be met. Using a Black-Scholes valuation model, we periodically reassess the fair value of non-employee options until service conditions are met, which generally aligns with the vesting period of the options, and we adjust the expense recognized in the consolidated financial statements accordingly.
 
FASB ASC 718-20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award.  Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.
 
Income Taxes:
We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized.
 
We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of September 30, 2015, there was no accrued interest or penalties related to uncertain tax positions. The tax years 2011 through 2014 remain open to examination by the federal and state tax jurisdictions to which we are subject.
 
 
Loss per Common Share:
FASB’s ASC 260-10 (previously known as FASB Statement 128, “Earnings Per Share”) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At September 30, 2015 and 2014, we excluded 54,172,069 and 53,514,325 potential common shares, respectively, relating to convertible preferred stock, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. We have excluded 625,000 warrants from the diluted net loss per common share calculation at September 30, 2015 and 2014 as the conditions for their vesting are not time-based.
 
 
Recent Accounting pronouncements:
ASU 2015-05 Intangibles – Goodwill and Other-Internal-Use Software (subtopic 350-40) Customer’s Accounting for Fees Paid in a Cloud Computing Agreement. The Financial Accounting Standards Board (“FASB”) added guidance to Subtopic 350-40 to help entities evaluate the accounting for fees paid in a cloud computing arrangement. The amendments provide a basis for evaluating whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a license to internal-use software, then the software license should be accounted for in accordance with Subtopic 350-40. If a cloud computing arrangement does not include a software license, then the arrangement should be accounted for as a service contract. This Update will be effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. This guidance will not have an immediate effect on the Company operations but will be considered as our product development and offering expands in future years.
 
In June 2015 the FASB issued ASU 2015-14 Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date. The standard is now effective for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect recognized at the date of adoption (which includes additional footnote disclosures). In May 2014, the FASB issued ASU 2014-09,”Revenue from Contracts with Customers”, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. We are currently evaluating the impact of the adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard.
 
XML 29 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Balance Sheet (Current Period Unaudited) (Parentheticals) - $ / shares
Sep. 30, 2015
Dec. 31, 2014
Preferred Class C [Member]    
Preferred Stock, Shares Authorized 16,250,000 16,250,000
Preferred stock, cumulative dividend per share (in dollars per share) $ 0 $ 0
Preferred Stock, Shares Issued 16,250,000 16,250,000
Preferred Stock, Shares Outstanding 16,250,000 16,250,000
Preferred Class C-2 [Member]    
Preferred Stock, Shares Authorized 25,000,000 25,000,000
Preferred stock, cumulative dividend per share (in dollars per share) $ 0 $ 0
Preferred Stock, Shares Issued 25,000,000 25,000,000
Preferred Stock, Shares Outstanding 25,000,000 25,000,000
Preferred Class A [Member]    
Preferred Stock, Shares Authorized 3,300,000 3,300,000
Preferred stock, cumulative dividend per share (in dollars per share) $ 0.40 $ 0.40
Preferred Stock, Shares Issued 565,721 587,101
Preferred Stock, Shares Outstanding 565,721 587,101
Preferred Class B [Member]    
Preferred Stock, Shares Authorized 300,000 300,000
Preferred stock, cumulative dividend per share (in dollars per share) $ 0.50 $ 0.50
Preferred Stock, Shares Issued 67,500 67,500
Preferred Stock, Shares Outstanding 67,500 67,500
Preferred Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Preferred Stock, Shares Authorized 100,000,000 100,000,000
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Common Stock, Shares Authorized 400,000,000 400,000,000
Common stock, shares issued (in shares) 45,754,041 45,754,041
Common stock, shares outstanding (in shares) 45,716,298 45,716,298
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note E - Accrued Liabilities (Tables)
9 Months Ended
Sep. 30, 2015
Notes Tables  
Schedule of Accrued Liabilities [Table Text Block]
 
 
September
30,
 
 
December 31,
 
 
 
2015
 
 
2014
 
Accrued compensation
  $ 40,000     $ 29,000  
Accrued benefits and other
    13,000       2,000  
Accrued legal
    3,000       10,000  
    $ 56,000     $ 41,000  
XML 31 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2015
Nov. 03, 2015
Entity Registrant Name TORVEC INC  
Entity Central Index Key 0001063197  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Entity Common Stock, Shares Outstanding (in shares)   45,754,041
Document Type 10-Q  
Document Period End Date Sep. 30, 2015  
Document Fiscal Year Focus 2015  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note F - Notes Payable (Tables)
9 Months Ended
Sep. 30, 2015
Notes Tables  
Schedule of Debt [Table Text Block]
 
 
September
30,
 
 
December 31,
 
 
 
2015
 
 
2014
 
Copy machine
  $ 9,000     $ 2,000  
Automobile
    -       4,000  
    $ 9,000     $ 6,000  
XML 33 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenue $ 50,000
Cost of Goods Sold 92,000
Gross Margin (42,000)
Research and development:        
R&D costs, excluding stock-based compensation $ 369,000 $ 262,000 $ 953,000 922,000
Stock-based compensation related to options and warrants 2,000 5,000 7,000 (27,000)
Total research and development 371,000 267,000 960,000 895,000
General and administrative:        
G&A costs, excluding stock-based compensation 283,000 269,000 721,000 876,000
Stock-based compensation related to options and warrants 249,000 85,000 342,000 160,000
Total general and administrative 532,000 354,000 1,063,000 1,036,000
Total costs and expenses 903,000 621,000 2,023,000 1,931,000
Loss from operations (903,000) (621,000) (2,023,000) (1,973,000)
Other income 3,000 7,000 31,000 27,000
Loss before income tax benefits $ (900,000) $ (614,000) $ (1,992,000) $ (1,946,000)
Income tax benefits
Net Loss $ (900,000) $ (614,000) $ (1,992,000) $ (1,946,000)
Preferred stock beneficial conversion feature 4,250,000
Preferred stock dividends $ 64,000 $ 66,000 $ 192,000 198,000
Net Loss attributable to common stockholders $ (964,000) $ (680,000) $ (2,184,000) $ (6,394,000)
Net Loss per common share attributable to stockholders        
Basic and Diluted (in dollars per share) $ (0.02) $ (0.01) $ (0.05) $ (0.14)
Weighted average number of shares of common stock:        
Basic and Diluted (in shares) 45,754,000 45,716,000 45,754,000 45,716,000
XML 34 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note G - Stockholders' Equity
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
NOTE G — STOCKHOLDERS’ EQUITY
 
Common Stock
We have 400 million common shares authorized with a par value of $0.01 per share. During the nine months ended September 30, 2015 we issued 21,380 common shares upon the election of a Class A preferred shareholder conversion and 16,363 common shares issued in satisfaction of Class A preferred dividend distribution.
 
Preferred Stock
Our certificate of incorporation permits the Company to issue up to 100,000,000 shares of $0.01 par value preferred stock. Under the amendment, the board of directors has the authority to allocate these shares into as many separate classes of preferred as it deems appropriate and with respect to each class, designate the number of preferred shares issuable and the relative rights, preferences, seniority with respect to other classes and to our common stock and any limitations and/or restrictions that may be applicable without obtaining shareholder approval.
 
Class A Non-voting Cumulative Convertible Preferred Stock
 
 
At September 30, 2015, there were 565,721 outstanding shares of Class A Preferred stock, of which 8,709 shares resulted from the settlement of dividends due to conversion, and those shares no longer accrue dividends. Dividends payable upon the conversion of the remaining 557,012 outstanding shares of Class A Preferred stock amounted to approximately $2,351,000 at September 30, 2015, of which $167,000 was accumulated during nine month period ended September 30, 2015. During the nine month period ended September 30, 2015, holders of Class A preferred shares converted 21,380 shares into common stock and the Company settled $65,000 Class A Preferred dividends with the issuance of 16,363 shares of common stock.
 
No Class A Preferred shares were sold or converted during the nine month period ended September 30, 2014 and no Class A Preferred dividends were settled during the nine months ended September 30, 2014. Accrued dividends payable upon the conversion of the Class A Preferred stock amounted to approximately $2,249,000 at December 31, 2014. The Company accumulated $173,000, during the nine month period ended September 30, 2014.
 
 
The Company has authorized the issuance of up to 3,300,000 Class A Non-Voting Cumulative Convertible Preferred Shares. Each Class A Preferred Share is convertible after a one year holding period, at the holder’s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of our common stock as a dividend or distribution and in the case of the subdivision or combination of our common stock. The Class A Preferred has no voting rights except with respect to matters directly impacting the rights and privileges accorded to such Class.
 
The holders of the Class A Preferred are entitled to receive cumulative preferential dividends in the amount of $0.40 per share of Class A Preferred for each annual dividend period. Dividends payable on the Class A Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class A Preferred at a rate of one share of Class A Preferred for each $4.00 of dividends. If dividends are paid in shares of Class A Preferred, such dividends are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one-to-one basis. Holders of Class A Preferred are permitted to request that dividends payable in Class A Preferred be immediately converted into shares of our common stock. At times, our board may elect to settle dividends through the issuance of common stock in lieu of cash. Accumulated and unpaid dividends on the Class A Preferred will not bear interest. Class A Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity.
 
The Company may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class A Preferred at the redemption price of $4.00 per Class A Preferred plus all unpaid accumulated dividends payable with respect to each Class A Preferred Share.
 
In the event of the liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred, Class A Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred shareholders’ liquidation preference was approximately $2,351,000 and $2,249,000 at September 30, 2015 and December 31, 2014, respectively. In the event of liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class A Preferred are payable in Class A Preferred shares at a rate of 1 share of Class A Preferred for each $4.00 of dividends.
 
Class B Preferred Stock
 
No Class B Preferred shares were sold during the nine month period ended September 30, 2015 and no Class B Preferred shares were issued to Class B Preferred shareholders as a dividend during the nine month period ended September 30, 2015. Depending upon our cash position, from time to time we may request that a converting preferred shareholder entitled to receive dividends in cash consent to receive shares of restricted common stock in lieu thereof.   
  
At September 30, 2015, there were 67,500 outstanding shares of Class B Preferred stock. At September 30, 2015, dividends payable upon the conversion of these outstanding shares of Class B Preferred amounted to approximately $344,000, of which $25,000 was accumulated during the nine month period ended September 30, 2015. At December 31, 2014, accrued dividends payable on the Class B Preferred shares was approximately $319,000.
 
Subject to the dividend rights and privileges of our Class A Preferred, the holders of the Class B Preferred are entitled to receive cumulative preferential dividends in the amount of $0.50 per share of Class B Preferred for each annual dividend period. Dividends payable on the Class B Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class B Preferred at a rate of one share of Class B Preferred for each $5.00 of dividends. If dividends are paid in shares of Class B Preferred, such dividends are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one-to-one basis. Holders of Class B Preferred are permitted to request that dividends payable in Class B Preferred be immediately converted into shares of our common stock. At times, our board may elect to settle dividends through the issuance of common stock in lieu of cash. Accumulated and unpaid dividends on the Class B Preferred will not bear interest. Class B Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity.
 
The Company may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class B Preferred at the redemption price of $5.00 per Class B Preferred plus all unpaid accumulated dividends payable with respect to each Class B Preferred Share.
 
In the event of the liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred and Class A Preferred shareholders, the Class B Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred shareholders’ liquidation preference was $344,000 and $319,000 at September 30, 2015 and December 31, 2014, respectively. In the event of a liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class B Preferred are payable in Class B Preferred shares at a rate of 1 share of Class B Preferred for each $5.00 of dividends.
 
Series C Preferred Stock
 
The Company has authorized and issued 16,250,000 shares of Series C Voting Convertible Preferred Stock. No Series C Preferred stock was converted during the nine month period ended September 30, 2015 or during the year ended December 31, 2014. The value of the Series C Preferred shareholders’ liquidation preference was $6,500,000 at September 30, 2015 and at December 31, 2014.
 
Each Series C Preferred Share is convertible after a one year holding period, at the holder’s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of our common stock as a dividend or distribution and in the case of the subdivision or combination of our common stock. The Series C Preferred shares have no right to receive dividends and no redemption right. The Series C Preferred shares vote with the common stock on an as-converted basis.
 
The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 that is senior to our common stock, and the Company’s Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, weather voluntary or involuntary or upon a deemed liquidation of the Company.
 
Series C-2 Preferred Stock
 
In March 2014, the board of directors authorized and the Class A Preferred, the Class B Preferred and the Series C Preferred shareholders approved, a series of preferred stock, designated as Series C-2 Voting Convertible Preferred Stock. On March 28, 2014, we sold and issued a total of 25,000,000 shares of Series C-2 Voting Convertible Preferred Stock in a private placement transaction, generating gross proceeds of $5,000,000. Direct expenses of approximately $46,000 pertaining to the transaction, consisting of primarily external legal costs, were incurred, resulting in net proceeds of approximately $4,954,000.
 
As of September 30, 2015, Series C-2 Preferred shareholders have not converted any shares of Series C-2 Preferred into common stock. At September 30, 2015, there were 25,000,000 shares of Preferred C-2 stock outstanding. The value of the Series C-2 Preferred shareholders’ liquidation preference was $5,000,000 at September 30, 2015 and at December 31, 2014.
 
Each Series C-2 Preferred Share is convertible, at the holder’s election, into one share of our common stock, par value $0.01 per share. The conversion rate is subject to adjustment in the event of the issuance of common stock as a dividend or distribution, and the subdivision or combination of the outstanding common stock or a reorganization, recapitalization, reclassification, consolidation or merger of the Company.  
  
The Series C-2 Preferred Shares have a liquidation preference at their stated value per share of $0.20 that ranks pari passu to our existing Series C Voting Convertible Preferred Shares and is senior to our common stock, and our Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or upon a deemed liquidation of the Company. A deemed liquidation includes, unless decided by the holders of at least two-thirds of the Series C-2 Preferred Shares, any consolidation, merger, or reorganization of the Company in which the shareholders of the Company own less than fifty percent of the voting power of the resultant entity, or an acquisition to which the Company is a party in which at least fifty percent of the Company’s voting power is transferred, or the sale, lease, exclusive license or transfer of all or substantially all of the assets or intellectual property of the Company other than to a wholly owned subsidiary.
 
The Series C-2 Preferred Shares are not entitled to receive preferred dividends and have no redemption right, but are entitled to participate, on an as converted basis; with holders of outstanding shares of common stock in dividends and distributions on liquidation after all preferred shares have received payment in full of any preferred dividends or liquidation preferences. The Series C-2 Preferred Shares vote with the common stock on an as-converted basis. We may not, without approval of the holders of at least two-thirds of the Series C-2 Preferred Shares, (i) create any class or series of stock that is pari passu or senior to the Series C-2 Preferred Shares; (ii) create any class or series of stock that would share in the liquidation preference of the Series C-2 Preferred Shares or that is entitled to dividends payable other than in common stock or Series C-2 Preferred Shares of its own series, (iii) acquire any equity security or pay any dividend, except dividends on a class or series of stock that is junior to the Series C Preferred Shares, payable in such junior stock, (iv) reissue any Series C-2 Preferred Shares, (v) declare or pay any dividend that would impair the payment of the liquidation preference of the Series C-2 Preferred Shares, (vi) authorize or issue any additional Preferred Shares, (vii) change the Certificate of Incorporation to adversely affect the rights of the holders of the Series C-2 Preferred Shares, or (viii) authorize, commit to or consummate any liquidation, dissolution or winding up in which the liquidation preference of the Series C-2 Preferred Shares would not be paid in full.
 
In conjunction with the issuance of the 25,000,000 shares of Series C-2 Preferred stock, we computed the value of the non-cash beneficial conversion feature associated with the right to convert the shares into common stock on a one-for-one basis. We compared the fair value of our common stock on the date of issuance with the effective conversion price, and determined that the value of the non-cash beneficial conversion feature is approximately $4,250,000, which is reflected in our condensed consolidated statements of operations for the nine month period ended September 30, 2014 as an adjustment to arrive at the net loss attributable to common stockholders.
 
The Series C-2 Preferred Shares will not be and have not been registered under the Securities Act of 1933, as amended, or the Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
    
Stock Options
 
1998 Stock Option Plan
 
In December 1997, our board approved a Stock Option Plan (the “1998 Plan”) which provided for the granting of up to 2,000,000 shares of common stock, pursuant to which officers, directors, key employees and key consultants/advisors are eligible to receive incentive, nonqualified or reload stock options which plan was ratified by the shareholders on May 28, 1998. Options granted under the 1998 Plan are exercisable for a period of up to 10 years from date of grant at an exercise price which is not less than the fair value on date of grant, except that the exercise period of options granted to a stockholder owning more than 10% of the outstanding capital stock may not exceed five years and their exercise price may not be less than 110% of the fair value of the common stock at date of grant.
 
By its terms, our 1998 Plan terminated as to the grant of future options on May 27, 2008. Consequently, no additional stock options will be granted under the 1998 Plan, and no outstanding options remain available for exercise in accordance with their terms. There were no options exercised under the 1998 Plan during each of the nine month periods ended September 30, 2015 and 2014.
 
Through September 30, 2015, a total of 1,823,895 stock options had been granted under the 1998 Plan, no stock options had been exercised, and 1,823,895 stock options have expired. During the three months ended September 30, 2015, 100,000 options expired. As of September 30, 2015, there were no outstanding stock options under the 1998 Plan.
  
2011 Stock Option Plan
 
In 2011, shareholders approved the 2011 Stock Option Plan (the “2011 Plan”) which provides for the grant of up to 3,000,000 common stock options to provide equity incentives to directors, officers, employees and consultants. Two types of options may be granted under the 2011 Plan: non-qualified stock options and incentive stock options.
 
Non-qualified stock options may be granted to our officers, directors, employees and outside consultants. Incentive stock options may be granted only to our employees, including officers and directors who are also employees. In the case of non-qualified stock options, the exercise price may be less than the fair market value of our stock on the date of grant. In the case of incentive stock options, the exercise price may not be less than such fair market value and in the case of an employee who owns more than 10% of our common stock; the exercise price may not be less than 110% of such market price. Options generally are exercisable for ten years from the date of grant, except that the exercise period for an incentive stock option granted to an employee who owns more than 10% of our stock may not be greater than five years.
 
During the three month period ended September 30, 2015, we granted 675,000 stock options under the 2011 Plan, 406,375 options became vested, and no options expired or were exercised. During the three month period ended September 30, 2014, we granted 500 stock options under the 2011 Plan, 6,250 options became vested, and 125,000 options expired unexercised and no options exercised.
 
During the nine month period ended September 30, 2015, we granted 695,000 stock options under the 2011 Plan, 472,000 options became vested, and no options expired or were exercised. As of September 30, 2015, there were 1,973,000 stock options outstanding under the 2011 Plan, 1,247,000 of which were vested. At September 30, 2015, there were 1,277,000 options remaining available for future grant under the 2011 Plan. During the nine month period ended September 30, 2014, we granted 11,000 stock options under the 2011 Plan, 131,750 options became vested, and 250,000 options expired unexercised or were forfeited and no options exercised.
 
During the nine months ended September 30, 2015 we modified 50,000 options previously granted to the Company’s former CFO. On February 5, 2015, in consideration for the former CFO’s willingness to assist in the transition to a new accounting team, the Company has agreed to modify the option agreement so that the unvested portion remains intact for the full term of the original stock option agreement. We used the Black-Scholes option-pricing model to value the cost of this modification which was an immaterial amount for the nine months ended September 30, 2015. These options vest upon the first day the closing trading price of the common stock of the Company shall be $10.00 or greater. Since they are now held by a non-employee we will revalue the fair value of these options on a quarterly basis through the vesting period.
  
Non-Plan Options
 
As of September 30, 2015, there were a total of 6,965,000 non-plan options outstanding, of which 4,815,000 were fully vested. During the nine month period ended September 30, 2015, we granted no non-plan stock options, 337,500 options became vested, and no options were exercised or cancelled.     During the nine month period ended September 30, 2014, we granted no non-plan stock options, 337,500 options became vested, and no options were exercised or cancelled.     
 
Option Summary
 
For the nine month periods ended September 30, 2015 and 2014, compensation cost related to all stock options amounted to $349,000 and $133,000, respectively. For the three month periods ending September 30, 2015 and 2014, compensation cost related to all stock options amounted to $252,000 and $90,000, respectively. As of September 30, 2015, there was approximately $199,000 of total unrecognized compensation costs related to outstanding stock options, which are expected to be recognized over a weighted average 1.5 years.
 
During the nine month period ended September 30, 2015 and 2014, we granted 695,000 stock options with a weighted average grant-date fair value of $0.53 and 11,000 stock options with weighted average grant-date fair value of $0.36, respectively. The total grant date fair value of all stock options vested during the nine month periods ended September 30, 2015 and 2014 was approximately $861,000 and $690,000, respectively.
 
The fair value of options granted during the nine month periods ended September 30, 2015 was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
 
   
2015
   
2014
 
Expected term in years
  5.0 - 6.5       6.3      
Expected forfeiture rate
    0.0%         0.0%  
Risk free rate
  1.5 - 2.0%       2.1%  
Volatility
   130 - 135%       135%  
Dividend yield
    0.0%         0.0%  
 
 
The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected term was generally determined using the simplified method as we do not believe we have sufficient historical stock option exercise experience on which to base the expected term. 
  
The following summarizes the activity of all of our outstanding stock options for the nine month period ended September 30, 2015:
 
           
Weighted
Average
Exercise
   
Weighted
Average
Remaining
Contractual
Term
   
Aggregate
Intrinsic
 
   
Shares
   
Price
   
(in years)
   
Value
 
Outstanding at January 1, 2015
    8,343,000     $ 0.63       6.0       -  
Granted
    695,000       0.53                  
Exercised
    -       -                  
Canceled or expired
    100,000       5.00                  
                                 
Outstanding at September 30, 2015
    8,938,000     $ 0.57       5.7     $ 265,000  
                                 
Exercisable at September 30, 2015
    6,062,000     $ 0.66       5.5     $ 121,000  
 
As of September 30, 2015, the exercise prices of all outstanding stock options, as well as all vested stock options, ranged from $0.20 per share to $5.00 per share.
  
 
 
Warrants
 
The following summarizes the activity of our outstanding warrants for the nine month period ended September 30, 2015:
 
           
Weighted
Average
Exercise
     
Weighted
Average
Remaining
Contractual
Term
     
Aggregate
Intrinsic
 
   
Shares
   
Price
     
(in years)
     
Value
 
Outstanding at January 1, 2015
    3,356,750     $ 1.99   (A)     5.6       $ 77,000  
                                     
Granted
    -       -                      
Exercised
    -       -                      
Canceled or expired
    37,500       0.01                      
                                     
Outstanding at September 30, 2015
    3,319,250     $ 2.04   (A)     5.0  
(B)
  $ 9,300  
                                     
Exercisable at September 30, 2015
    2,694,250     $ 2.99         5.0  
(C)
  $ 9,300  
 
 
 
(A)
The weighted average exercise price for warrants outstanding as of January 1, 2015 and September 30, 2015 excludes 1,750,000 warrants with no determined exercise price.
 
 
 
 
(B)
The weighted average remaining contractual term for warrants outstanding as of September 30, 2015 excludes 743,500 warrants with no expiration date.
 
 
 
 
(C)
The weighted average remaining contractual term for warrants exercisable as of September 30, 2015 excludes 118,500 warrants with no expiration date.
XML 35 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note F - Notes Payable
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Debt Disclosure [Text Block]
NOTE F — NOTES PAYABLE
 
As of September 30, 2015 and December 31, 2014, notes payable consists of the following:
 
 
 
September
30,
 
 
December 31,
 
 
 
2015
 
 
2014
 
Copy machine
  $ 9,000     $ 2,000  
Automobile
    -       4,000  
    $ 9,000     $ 6,000  
 
In the nine months ended September 30, 2015, a capital lease for a copy machine was fully paid and we entered into a new capital lease agreement for a copy machine with a term of 5 years. The capitalized value of the lease was approximately $9,000, with a monthly payment of approximately $170 and an implicit interest rate of approximately 4.8%. At September 30, 2015, the outstanding balance on this note was approximately $9,000, of which $7,000 was classified as a non-current liability.
 
In 2012, we purchased an automobile for $16,600, a vehicle that we had previously been leasing. We financed this purchase with a 36 month promissory note. The interest rate on the note was approximately 10% and the payments were approximately $540 per month. At December 31, 2014, the outstanding balance on this note was approximately $4,000 which was classified as a current liability. During the second quarter of 2015 this note was fully paid. 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note C - Property and Equipment (Details Textual) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Payments to Acquire Property, Plant, and Equipment $ 308,000 $ 43,000
XML 37 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note G - Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2015
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
2015
   
2014
 
Expected term in years
  5.0 - 6.5       6.3      
Expected forfeiture rate
    0.0%         0.0%  
Risk free rate
  1.5 - 2.0%       2.1%  
Volatility
   130 - 135%       135%  
Dividend yield
    0.0%         0.0%  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
           
Weighted
Average
Exercise
   
Weighted
Average
Remaining
Contractual
Term
   
Aggregate
Intrinsic
 
   
Shares
   
Price
   
(in years)
   
Value
 
Outstanding at January 1, 2015
    8,343,000     $ 0.63       6.0       -  
Granted
    695,000       0.53                  
Exercised
    -       -                  
Canceled or expired
    100,000       5.00                  
                                 
Outstanding at September 30, 2015
    8,938,000     $ 0.57       5.7     $ 265,000  
                                 
Exercisable at September 30, 2015
    6,062,000     $ 0.66       5.5     $ 121,000  
Schedule of Share-based Compensation, Activity [Table Text Block]
           
Weighted
Average
Exercise
     
Weighted
Average
Remaining
Contractual
Term
     
Aggregate
Intrinsic
 
   
Shares
   
Price
     
(in years)
     
Value
 
Outstanding at January 1, 2015
    3,356,750     $ 1.99   (A)     5.6       $ 77,000  
                                     
Granted
    -       -                      
Exercised
    -       -                      
Canceled or expired
    37,500       0.01                      
                                     
Outstanding at September 30, 2015
    3,319,250     $ 2.04   (A)     5.0  
(B)
  $ 9,300  
                                     
Exercisable at September 30, 2015
    2,694,250     $ 2.99         5.0  
(C)
  $ 9,300  
XML 38 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note B - Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2015
Notes Tables  
Property, Plant and Equipment Estimated Useful Life [Table Text Block]
Office Equipment and Software (years)
  
3 – 7
Leasehold Improvements
  
Lesser of useful life or lease term
Shop Equipment (years)
  
3 – 7
Transportation Equipment (years)
  
5
XML 39 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note H - Commitments and Other Matters
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
NOTE H — COMMITMENTS AND OTHER MATTERS
 
Leases
 
We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership in which one of our directors is associated. (See Note D).  In October 2014, we extended the lease for a three-year renewal term through May 31, 2018. The current rental rate is $6,256 per month ($75,070 per annum) for the remainder of the lease term. In addition, we are required to pay a proportionate share of the yearly real estate taxes and yearly common area costs.  
  
Rent expense for the nine month periods ended September 30, 2015 and 2014 was approximately $53,000 and $51,000, respectively. Including consideration for the renewal options, rent payments required under the lease for the twelve month periods ending December 31, 2015 through 2019 will amount to approximately $72,000, $75,000, $75,000, and $31,000, respectively.
 
Employment Agreements
 
In the third quarter of 2015, the Company hired a Vice President of business development for the CURA division. The hiring agreement includes a severance agreement including six months salary if a termination by the Company is initiated other than for cause or executive good reason. Such severance will be based on the salary at the time of the action in return for a general release of the Company and its officers, directors and agents satisfactory to the Company.
 
In 2010, we appointed a new chief executive officer and executed a five year employment agreement pursuant to which we will pay base compensation of $50,000 per annum, which compensation increases to $200,000 per annum on the first day of the calendar year immediately following the calendar year in which we have adjusted EBITDA of at least $300,000 (earnings before interest, taxes, depreciation and amortization, but excluding all non-cash expenses associated with stock options). In September 2014, the CEO agreed to temporarily reduce his base compensation to $25,000 per annum. Under the agreement, the executive is entitled to a performance bonus based upon financial targets established each year in good faith by the Governance and Compensation Committee and the achievement of individual management objectives established annually by such committee. The executive is entitled to participate in all employee benefit plans as are provided from time to time for senior executives. If we terminate the executive, remove him as CEO, or a change in control of the Company occurs, the executive is entitled to six years’ severance pay, consisting of base pay and any incentive compensation.
 
Consulting Agreements
 
The Company established the CURA Advisory Board during the third quarter of 2015 to assist in the design, development and commercialization of the CURA fatigue management products. This group consists of some of the most respected consultants, researchers and clinicians in the fatigue management industry. Each CURA member will interact in an advisory capacity with management to critique and assess the effectiveness of CURA products prior to product introduction in order to maximize the effectiveness and user experience. The CURA advisors will each received an annual stipend of $5,000, will be paid $4,000 per year for attendance at four meetings and receive a grant of 50,000 common stock options, vesting over four years at an exercise price equal to the market price on the date of issuance.
 
Effective as of January 1, 2013, we entered into a consulting agreement with SCIRE Corporation, of which one of our directors is president, to provide us with expertise and advice on hydraulic pump technology and related markets. During the nine month periods ended September 30, 2015 and 2014, we recorded expense of approximately $14,000 and $22,000, respectively, for consulting services and travel costs related to this agreement. In November 2014, we extended this consulting agreement through December 31, 2015, providing for a guaranteed minimum of $1,200 per month, based on 8 hours of consulting, plus travel costs. Additional hours above this minimum incurred in 2015 will be billed at a rate of $150 per hour.
 
In 2010, we engaged the services of a consulting firm to provide expertise with business development initiatives, strategic planning and general funding opportunities. In 2011, the agreement was modified to pay the consultant a commission equal to 4% of the value received by us from third parties introduced to us by or through the auspices of the consultant through January 1, 2017. Cumulatively, through September 30, 2015, we have recorded approximately $3,000 of expense for services rendered in relation to this agreement.
 
Prototype Development Agreements
 
In January 2013, we entered into a development agreement with Chinese automotive manufacturer, BAIC Motor Co., Ltd. (“BAIC”). During the second quarter of 2014, we recorded approximately $39,000 in revenue associated with this agreement, along with related expenses of approximately $50,000. In December 2014, we recorded an uncollectible reserve against the outstanding receivable balance of approximately $20,000 due to the delinquency in receiving payment from this customer. During the second quarter of 2015, the Company recovered the full amount of this previously reserved receivable. This recovery was recorded in general and administrative expense on the Statement of Operations.
 
XML 40 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2015
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]
Consolidation
: The financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (56% owned at September 30, 2015 and December 31, 2014). As of September 30, 2015, each of the subsidiaries is non-operational. We are intending to let Ice Surface Development, Inc. dissolve by proclamation. All material intercompany transactions and account balances have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates:
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates are used in valuing the useful lives of any intangible assets and the future realizable value of such assets. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates.
Reclassification, Policy [Policy Text Block]
Reclassifications
: Certain reclassifications have been made to prior year balances to conform to the current year’s presentation.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
: Cash and cash equivalents may include time deposits, certificates of deposit, and highly liquid debt instruments with original maturities of six months or less. We maintain cash and cash equivalents at financial institutions which periodically may exceed federally insured amounts.
Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment:
Property and equipment are stated at cost. Estimated useful lives are as follows:
 
Office Equipment and Software (years)
  
3 – 7
Leasehold Improvements
  
Lesser of useful life or lease term
Shop Equipment (years)
  
3 – 7
Transportation Equipment (years)
  
5
  
Depreciation and amortization are computed using the straight-line method. Betterments, renewals and repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and amortization expense for the three month periods ended September 30, 2015 and 2014 amounted to $27,000 and $39,000, respectively.   Depreciation and amortization expense for the nine month periods ended September 30, 2015 and 2014 amounted to $85,000 and $125,000, respectively.      
 
Whenever events or circumstances indicate, our long-lived assets, including any intangible assets with finite useful lives, are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may be indicated. The carrying amount is then compared to the estimated discounted cash flows, and if there is an excess, such amount is recorded as impairment. During the three and nine month periods ended September 30, 2015 and 2014, we did not record any impairment charges.
Fair Value Measurement, Policy [Policy Text Block]
Fair Value of Financial Instruments:
As defined by U.S. GAAP
,
fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. All assets and liabilities are required to be measured and reported on a fair value basis. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:
 
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.
 
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
 
The FASB’s (Financial Accounting Standards Board) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at September 30, 2015 and December 31, 2014. The carrying amount of cash, prepaids and other current assets, accounts payable and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition:
Our terms provide that customers are obligated to pay for products sold to them within a specified number of days from the date that title to the products is transferred to the customers. Our standard terms are typically net 30 days. We recognize revenue when transfer of title occurs, risk of ownership passes to a customer at the time of shipment or delivery depending on the terms of the agreement with a particular customer and collection is reasonably assured. The sale price of our products is substantially fixed and determinable at the date of the sale based upon purchase orders generated by a customer and accepted by us.
 
We occasionally enter into prototype development contracts with customers. In such cases, revenue is recognized using either (a) the proportional effort method based on the relationship of costs incurred to date to the total estimated cost to complete a contract, or (b) where appropriate, the milestone method, if milestones are clearly identifiable and substantive.
Segment Reporting, Policy [Policy Text Block]
Business Segments:
During the third quarter of 2015, the company announced the monitoring of its business operations will focus on two divisions in future periods. The CURA division will oversee the Fatigue Management Consulting business and the Aegis division will oversee the Power and Hydraulic business. No revenue has been recognized by either business segment during the nine months ended September 30, 2015.
 
The CURA division incurred $201,000 and $446,000 in expenses in the three and nine month periods ended September 30, 2015. The CURA division incurred $17,000 and $19,000 in expenses in the three and nine month periods ended September 30, 2014.
 
 
The Aegis division incurred $170,000 and $514,000 in expenses in the three and nine months periods ended September 30, 2015, respectively. The Aegis division incurred $251,000 and $876,000 in expenses in the three and nine months periods ended September 30, 2014, respectively.
 
Corporate general and administrative expenses will not be allocated to the business segments. Corporate general and administrative expenses were $532,000 and $1,063,000 in the three and nine months periods ended September 30, 2015, respectively. Corporate general and administrative expenses were $354,000 and $1,036,000 in the three and nine months periods ended September 30, 2014, respectively.
 
Assets attributed to the CURA division at September 30, 2015 were $300,000. Assets attributed to the Aegis division at September 30 2015 were $144,000. Assets considered as corporate assets as of September 30, 2015 were $2,000,000.
In Process Research and Development, Policy [Policy Text Block]
Research and Development and Patents:
Research and development costs and patent expenses are charged to operations as incurred. Research and development includes personnel-related costs, materials and supplies, depreciation, consulting services, and amortization of acquired technology. Depreciation expense that was charged to research and development for the three month periods ended September 30, 2015 and 2014 was $21,000 in each period. Depreciation expense that was charged to research and development for the nine month periods ended September 30, 2015 and 2014 was $59,000 and $69,000, respectively.
 
Patent costs for the three month periods ended September 30, 2015 and 2014 amounted to $22,000 and $44,000, respectively, and are included in general and administrative expenses. Patent costs for the nine month periods ended September 30, 2015 and 2014 amounted to $69,000 and $90,000, in each of the respective periods, and are included in general and administrative expenses.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-based Compensation:
FASB Accounting Standards Codification (“ASC”) 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. Under the modified prospective method that we adopted, awards that were granted, modified, or settled on or after January 1, 2006 are measured and accounted for in accordance with ASC 718-10. Unvested equity-classified awards that were granted prior to January 1, 2006 will continue to be accounted for in accordance with ASC 718-10, except that the grant date fair value of all awards are recognized in the results of operations over the remaining vesting periods. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with ASC 718-10.   
  
No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets. We elected to adopt the alternative method of calculating the historical pool of windfall tax benefits as permitted by FASB ASC 718-10-65 (previously known as: FASB Staff Position (FSP No. SFAS 123(R)-c, “Transition Election Related to Accounting for the Tax Effects of Share-Based Payment Awards.”). This is a simplified method to determine the pool of windfall tax benefits that is used in determining the tax effects of stock compensation in the results of operations and cash flow reporting for awards that were outstanding as of the adoption of FASB ASC 718-10.
 
FASB ASC 505-50, “Equity-Based Payments to Non-Employees,” requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as compensation expense generally over the service period of the consulting arrangement or until performance conditions are expected to be met. Using a Black-Scholes valuation model, we periodically reassess the fair value of non-employee options until service conditions are met, which generally aligns with the vesting period of the options, and we adjust the expense recognized in the consolidated financial statements accordingly.
 
FASB ASC 718-20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award.  Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.
Income Tax, Policy [Policy Text Block]
Income Taxes:
We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized.
 
We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of September 30, 2015, there was no accrued interest or penalties related to uncertain tax positions. The tax years 2011 through 2014 remain open to examination by the federal and state tax jurisdictions to which we are subject.
 
Earnings Per Share, Policy [Policy Text Block]
Loss per Common Share:
FASB’s ASC 260-10 (previously known as FASB Statement 128, “Earnings Per Share”) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At September 30, 2015 and 2014, we excluded 54,172,069 and 53,514,325 potential common shares, respectively, relating to convertible preferred stock, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. We have excluded 625,000 warrants from the diluted net loss per common share calculation at September 30, 2015 and 2014 as the conditions for their vesting are not time-based.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting pronouncements:
ASU 2015-05 Intangibles – Goodwill and Other-Internal-Use Software (subtopic 350-40) Customer’s Accounting for Fees Paid in a Cloud Computing Agreement. The Financial Accounting Standards Board (“FASB”) added guidance to Subtopic 350-40 to help entities evaluate the accounting for fees paid in a cloud computing arrangement. The amendments provide a basis for evaluating whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a license to internal-use software, then the software license should be accounted for in accordance with Subtopic 350-40. If a cloud computing arrangement does not include a software license, then the arrangement should be accounted for as a service contract. This Update will be effective for public business entities for annual periods, including interim periods within those annual periods, beginning after December 15, 2015. This guidance will not have an immediate effect on the Company operations but will be considered as our product development and offering expands in future years.
 
In June 2015 the FASB issued ASU 2015-14 Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date. The standard is now effective for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect recognized at the date of adoption (which includes additional footnote disclosures). In May 2014, the FASB issued ASU 2014-09,”Revenue from Contracts with Customers”, which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. We are currently evaluating the impact of the adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard.
 
XML 41 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note C - Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2015
Notes Tables  
Property, Plant and Equipment [Table Text Block]
   
September 30,
2015
   
December 31,
2014
 
Office equipment and software
  $ 518,000     $ 218,000  
Shop equipment
    226,000       213,000  
Leasehold improvements
    253,000       253,000  
Transportation equipment
    17,000       90,000  
Construction in progress
    -       6,000  
      1,014,000       780,000  
Less accumulated depreciation
    556,000       509,000  
Net property and equipment
  $ 458,000     $ 271,000  
XML 42 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note B - Summary of Significant Accounting Policies (Details Textual)
3 Months Ended 9 Months Ended
Sep. 30, 2015
USD ($)
Sep. 30, 2014
USD ($)
Sep. 30, 2015
USD ($)
shares
Sep. 30, 2014
USD ($)
shares
Dec. 31, 2014
USD ($)
Subsidiaries [Member]          
Equity Method Investment, Ownership Percentage 56.00%   56.00%   56.00%
Warrant [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares     625,000 625,000  
CURA Division [Member]          
Revenues     $ 0    
Operating Expenses $ 201,000 $ 17,000 446,000 $ 19,000  
Assets 300,000   300,000    
Aegis Division [Member]          
Revenues     0    
Operating Expenses 170,000 251,000 514,000 876,000  
Assets 144,000   144,000    
Research and Development Expense [Member]          
Depreciation 21,000 21,000 59,000 69,000  
General and Administrative Expense [Member] | Patents [Member]          
Research and Development Expense 22,000 44,000 69,000 $ 90,000  
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense     0    
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued 0   $ 0    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares     54,172,069 53,514,325  
Asset Impairment Charges $ 0 $ 0 $ 0 $ 0  
Revenues 50,000  
Depreciation, Depletion and Amortization $ 27,000 $ 39,000 $ 85,000 125,000  
Number of Operating Segments 2        
Operating Expenses $ 903,000 621,000 2,023,000 1,931,000  
General and Administrative Expense 532,000 354,000 1,063,000 1,036,000  
Assets 2,444,000   2,444,000   $ 4,010,000
Research and Development Expense $ 371,000 $ 267,000 $ 960,000 $ 895,000  
XML 43 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note E - Accrued Liabilities (Details) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Accrued compensation $ 40,000 $ 29,000
Accrued benefits and other 13,000 2,000
Accrued legal 3,000 10,000
$ 56,000 $ 41,000
XML 44 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Net loss $ (1,992,000) $ (1,946,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, Depletion and Amortization 85,000 125,000
Gain on disposition of fixed assets, net (19,000) $ (12,000)
Recovery of bad debt (20,000)
Stock-based compensation related to stock options and warrants 348,000 $ 133,000
Changes in:    
Accounts receivable 20,000 (20,000)
Prepaid expenses and other current assets $ (25,000) (26,000)
Deferred revenue (20,000)
Accrued payroll taxes (5,000)
Accounts payable and other accrued expenses $ 75,000 19,000
Net cash used in operating activities (1,528,000) (1,752,000)
Cash flows from investing activities:    
Purchase of property and equipment (308,000) (43,000)
Proceeds from sale of fixed assets 62,000 70,000
Net cash (used in) provided by investing activities $ (246,000) 27,000
Cash flows from financing activities:    
Net proceeds from sales of preferred stock 4,954,000
Repayments of notes payable $ (4,000) (46,000)
Net cash (used in) provided by financing activities (4,000) 4,908,000
Net (decrease) increase in cash and cash equivalents (1,778,000) 3,183,000
Cash and cash equivalents at beginning of period 3,724,000 1,072,000
Cash and cash equivalents at end of period $ 1,946,000 4,255,000
Supplemental Disclosures:    
Interest paid $ 1,000
Acquisition of equipment through capital lease $ 9,000
Conversion of preferred shares to common 86,000
Conversion of preferred dividends to common $ 65,000
XML 45 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note E - Accrued Liabilities
9 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
NOTE E — ACCRUED LIABILITIES
 
At September 30, 2015 and December 31, 2014, accrued liabilities consist of the following:
 
 
 
September
30,
 
 
December 31,
 
 
 
2015
 
 
2014
 
Accrued compensation
  $ 40,000     $ 29,000  
Accrued benefits and other
    13,000       2,000  
Accrued legal
    3,000       10,000  
    $ 56,000     $ 41,000  
XML 46 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note F - Notes Payable (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Aug. 31, 2012
Sep. 30, 2015
Dec. 31, 2014
Office Equipment [Member] | Capital Lease Obligations [Member]      
Debt Instrument, Interest Rate During Period   4.80%  
Office Equipment [Member]      
Capita Lease, Term   5 years  
Capital Leased Assets, Gross   $ 9,000  
Capital Lease, Monthly Payment   170  
Capital Lease Obligations   9,000  
Capital Lease Obligations, Noncurrent   7,000  
Vehicles [Member]      
Debt Instrument, Face Amount $ 16,600    
Debt Instrument, Term 3 years    
Debt Instrument, Interest Rate, Stated Percentage 10.00%    
Debt Instrument, Periodic Payment $ 540    
Notes Payable, Current     $ 4,000
Notes Payable, Current   $ 2,000 $ 6,000
XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 130 233 1 true 44 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://torvec.com/20150930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheet (Current Period Unaudited) Sheet http://torvec.com/20150930/role/statement-condensed-consolidated-balance-sheet-current-period-unaudited Condensed Consolidated Balance Sheet (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheet (Current Period Unaudited) (Parentheticals) Sheet http://torvec.com/20150930/role/statement-condensed-consolidated-balance-sheet-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheet (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://torvec.com/20150930/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://torvec.com/20150930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - Note A - The Company and Basis of Presentation Sheet http://torvec.com/20150930/role/statement-note-a-the-company-and-basis-of-presentation Note A - The Company and Basis of Presentation Notes 6 false false R7.htm 006 - Disclosure - Note B - Summary of Significant Accounting Policies Sheet http://torvec.com/20150930/role/statement-note-b-summary-of-significant-accounting-policies Note B - Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Note C - Property and Equipment Sheet http://torvec.com/20150930/role/statement-note-c-property-and-equipment Note C - Property and Equipment Notes 8 false false R9.htm 008 - Disclosure - Note D - Related Party Transactions Sheet http://torvec.com/20150930/role/statement-note-d-related-party-transactions Note D - Related Party Transactions Notes 9 false false R10.htm 009 - Document - Note E - Accrued Liabilities Sheet http://torvec.com/20150930/role/statement-note-e-accrued-liabilities Note E - Accrued Liabilities Uncategorized 10 false false R11.htm 010 - Disclosure - Note F - Notes Payable Notes http://torvec.com/20150930/role/statement-note-f-notes-payable Note F - Notes Payable Uncategorized 11 false false R12.htm 011 - Disclosure - Note G - Stockholders' Equity Sheet http://torvec.com/20150930/role/statement-note-g-stockholders-equity Note G - Stockholders' Equity Uncategorized 12 false false R13.htm 012 - Disclosure - Note H - Commitments and Other Matters Sheet http://torvec.com/20150930/role/statement-note-h-commitments-and-other-matters Note H - Commitments and Other Matters Uncategorized 13 false false R14.htm 013 - Disclosure - Significant Accounting Policies (Policies) Sheet http://torvec.com/20150930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 14 false false R15.htm 014 - Disclosure - Note B - Summary of Significant Accounting Policies (Tables) Sheet http://torvec.com/20150930/role/statement-note-b-summary-of-significant-accounting-policies-tables Note B - Summary of Significant Accounting Policies (Tables) Uncategorized 15 false false R16.htm 015 - Disclosure - Note C - Property and Equipment (Tables) Sheet http://torvec.com/20150930/role/statement-note-c-property-and-equipment-tables Note C - Property and Equipment (Tables) Uncategorized 16 false false R17.htm 016 - Disclosure - Note E - Accrued Liabilities (Tables) Sheet http://torvec.com/20150930/role/statement-note-e-accrued-liabilities-tables Note E - Accrued Liabilities (Tables) Uncategorized 17 false false R18.htm 017 - Disclosure - Note F - Notes Payable (Tables) Notes http://torvec.com/20150930/role/statement-note-f-notes-payable-tables Note F - Notes Payable (Tables) Uncategorized 18 false false R19.htm 018 - Disclosure - Note G - Stockholders' Equity (Tables) Sheet http://torvec.com/20150930/role/statement-note-g-stockholders-equity-tables Note G - Stockholders' Equity (Tables) Uncategorized 19 false false R20.htm 019 - Disclosure - Note A - The Company and Basis of Presentation (Details Textual) Sheet http://torvec.com/20150930/role/statement-note-a-the-company-and-basis-of-presentation-details-textual Note A - The Company and Basis of Presentation (Details Textual) Uncategorized 20 false false R21.htm 020 - Disclosure - Note B - Summary of Significant Accounting Policies (Details Textual) Sheet http://torvec.com/20150930/role/statement-note-b-summary-of-significant-accounting-policies-details-textual Note B - Summary of Significant Accounting Policies (Details Textual) Uncategorized 21 false false R22.htm 021 - Statement - Note B - Property and Equipment, Estimated Useful Lives (Details) Sheet http://torvec.com/20150930/role/statement-note-b-property-and-equipment-estimated-useful-lives-details Note B - Property and Equipment, Estimated Useful Lives (Details) Uncategorized 22 false false R23.htm 022 - Disclosure - Note C - Property and Equipment (Details Textual) Sheet http://torvec.com/20150930/role/statement-note-c-property-and-equipment-details-textual Note C - Property and Equipment (Details Textual) Uncategorized 23 false false R24.htm 023 - Statement - Note C - Property and Equipment (Details) Sheet http://torvec.com/20150930/role/statement-note-c-property-and-equipment-details Note C - Property and Equipment (Details) Uncategorized 24 false false R25.htm 024 - Disclosure - Note D - Related Party Transactions (Details Textual) Sheet http://torvec.com/20150930/role/statement-note-d-related-party-transactions-details-textual Note D - Related Party Transactions (Details Textual) Uncategorized 25 false false R26.htm 025 - Statement - Note E - Accrued Liabilities (Details) Sheet http://torvec.com/20150930/role/statement-note-e-accrued-liabilities-details Note E - Accrued Liabilities (Details) Uncategorized 26 false false R27.htm 026 - Disclosure - Note F - Notes Payable (Details Textual) Notes http://torvec.com/20150930/role/statement-note-f-notes-payable-details-textual Note F - Notes Payable (Details Textual) Uncategorized 27 false false R28.htm 027 - Statement - Note F - Notes Payable (Details) Notes http://torvec.com/20150930/role/statement-note-f-notes-payable-details Note F - Notes Payable (Details) Uncategorized 28 false false R29.htm 028 - Disclosure - Note G - Stockholders' Equity (Details Textual) Sheet http://torvec.com/20150930/role/statement-note-g-stockholders-equity-details-textual Note G - Stockholders' Equity (Details Textual) Uncategorized 29 false false R30.htm 029 - Statement - Note G - Share-based Payment Award, Stock Options, Valuation Assumptions (Details) Sheet http://torvec.com/20150930/role/statement-note-g-sharebased-payment-award-stock-options-valuation-assumptions-details Note G - Share-based Payment Award, Stock Options, Valuation Assumptions (Details) Uncategorized 30 false false R31.htm 030 - Statement - Note G - Share-based Compensation, Stock Options, Activity (Details) Sheet http://torvec.com/20150930/role/statement-note-g-sharebased-compensation-stock-options-activity-details Note G - Share-based Compensation, Stock Options, Activity (Details) Uncategorized 31 false false R32.htm 031 - Statement - Note G - Outstanding Warrants Activities (Details) Sheet http://torvec.com/20150930/role/statement-note-g-outstanding-warrants-activities-details Note G - Outstanding Warrants Activities (Details) Uncategorized 32 false false R33.htm 032 - Disclosure - Note H - Commitments and Other Matters (Details Textual) Sheet http://torvec.com/20150930/role/statement-note-h-commitments-and-other-matters-details-textual Note H - Commitments and Other Matters (Details Textual) Uncategorized 33 false false All Reports Book All Reports In ''Condensed Consolidated Balance Sheet (Current Period Unaudited)'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Condensed Consolidated Statements of Cash Flows (Unaudited)'', column(s) 2, 3 are contained in other reports, so were removed by flow through suppression. tovc-20150930.xml tovc-20150930_cal.xml tovc-20150930_def.xml tovc-20150930_lab.xml tovc-20150930_pre.xml tovc-20150930.xsd true true XML 48 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note A - The Company and Basis of Presentation (Details Textual)
3 Months Ended
Sep. 30, 2015
Number of Operating Segments 2